Sentence,class,file
https://www.gov.uk/ government/publications/nhs-reference-costs-2012-to-2013 .,Non-OADS,/arxiv_data1/oa_pdf/2f/11/40258_2015_Article_221.PMC4871905.pdf
https://www.gov.uk/government/publications/ nhs-reference-costs-2012-to-2013 .,Non-OADS,/arxiv_data1/oa_pdf/2f/11/40258_2015_Article_221.PMC4871905.pdf
The PROTECT consortium (Pharma-coepidemiological Research on Outcomes of Therapeutics by a European ConsorTium; http://www.imi-protect.eu ) was a public–private partnership co-ordinated by theEuropean Medicines Agency (EMA) and received support from the Innovative Medicines Initiative Joint Undertaking (http://www.imi.europa.eu ) under Grant Agreement No.,Non-OADS,/arxiv_data1/oa_pdf/30/8c/40264_2016_Article_405.PMC4871909.pdf
"Full details of IMI PROTECT, including speciﬁc information about Work Package 3 and a detailed technical report supporting the recommendations can be found athttp://www.imi-protect.eu/about.shtml .",Non-OADS,/arxiv_data1/oa_pdf/30/8c/40264_2016_Article_405.PMC4871909.pdf
"For adescription of the database structure see: http://www.imi- protect.eu/documents/Databasestructure.pdf [26] To facilitate signal detection, exact MedDRA /C210terms should be used to identify ADRs inSPC section 4.8 where feasible.When an ADR involves very large numbers of terms and requires an ad hoc name,mapping from this name to therelevant MedDRA /C210terms should be maintainedThis is essential to facilitate the construction of machine- readable data sources that havea number of potential usesincluding the facilitation of signal detection.",OADS,/arxiv_data1/oa_pdf/30/8c/40264_2016_Article_405.PMC4871909.pdf
2: http://ec.europa.eu/ health/documents/eudralex/vol-2/index_en.htm [27]Recommendations for Signal Detection from IMI PROTECT 473,Non-OADS,/arxiv_data1/oa_pdf/30/8c/40264_2016_Article_405.PMC4871909.pdf
The electronic medical records are collected from general practices in primary care ( http://www.ncbi.nlm.nih.gov/ pubmed/22828580 ).,OADS,/arxiv_data1/oa_pdf/30/8c/40264_2016_Article_405.PMC4871909.pdf
"The Bayesian hierarchicalmodel that can make use of the hierarchy, thereby bor- rowing strength, performed best among the quantitative 5Common Terminology Criteria for Adverse Events, US National Cancer Institute ( http://ctep.cancer.gov/ ).484 A. F. Z. Wisniewski et al.",OADS,/arxiv_data1/oa_pdf/30/8c/40264_2016_Article_405.PMC4871909.pdf
"Antoni Wisniewski is an employee and shareholder of AstraZeneca; Andrew Bate is an employee and shareholder of Pﬁzer Inc.; Andreas Brueckner is anemployee of Novartis and formerly of Bayer Pharma AG; KatrinManlik is an employee of Bayer Pharma AG; Naashika Quarcoo and Lionel Van Holle are both employees and shareholders of GlaxoSimthKline; Bharat Thakrar is an employee and shareholder ofRoche; Michael Kayser is an employee, a shareholder and is listed asan inventor in patents of Bayer Pharma AG; Harry Southworth was an employee of AstraZeneca for some of the time working on PROTECT and has since worked as a consultant to the pharmaceutical sector.Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/30/8c/40264_2016_Article_405.PMC4871909.pdf
2009. http://ec.europa.eu/ health/ﬁles/eudralex/vol-2/c/smpc_guideline_rev2_en.pdf .A c c e s - sed 15 Aug 2015.,Non-OADS,/arxiv_data1/oa_pdf/30/8c/40264_2016_Article_405.PMC4871909.pdf
http://www.imi-protect.eu/ methodsRep.shtml .,Non-OADS,/arxiv_data1/oa_pdf/30/8c/40264_2016_Article_405.PMC4871909.pdf
2012. http://www.imi-protect.,Non-OADS,/arxiv_data1/oa_pdf/30/8c/40264_2016_Article_405.PMC4871909.pdf
http://ec.europa.eu/health/ documents/eudralex/vol-2/index_en.htm .,Non-OADS,/arxiv_data1/oa_pdf/30/8c/40264_2016_Article_405.PMC4871909.pdf
http://www.imi-protect.eu/ documents/PROTECTsymposium_signaldetectioninClinicaltrials_ talk.pdf .,OADS,/arxiv_data1/oa_pdf/30/8c/40264_2016_Article_405.PMC4871909.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/89/3a/40258_2016_Article_234.PMC4871910.pdf
"Table 3a: mean expenses per person with care for selected conditions by type of service: United States, 2010. http://meps.ahrq.gov/mepsweb/data_stats/quick_tables_results.jsp .",OADS,/arxiv_data1/oa_pdf/89/3a/40258_2016_Article_234.PMC4871910.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/da/b1/40258_2016_Article_224.PMC4871927.pdf
Available from: http://www.webcitation.org/6bFTZaZ5I .,Non-OADS,/arxiv_data1/oa_pdf/da/b1/40258_2016_Article_224.PMC4871927.pdf
Available from: http://www.webcitation.,Non-OADS,/arxiv_data1/oa_pdf/da/b1/40258_2016_Article_224.PMC4871927.pdf
Available from: http://www.nice.org.uk/article/pmg9/ resources/non-guidance-guide-to-the-methods-of-technology- appraisal-2013-pdf .,Non-OADS,/arxiv_data1/oa_pdf/da/b1/40258_2016_Article_224.PMC4871927.pdf
"The second aim was to examine the use of http://dx.doi.org/10.1016/j.radonc.2016.02.017 0167-8140/ /C2112016 Published by Elsevier Ireland Ltd.⇑Corresponding author at: Laboratory of Radiation Physics, Odense University Hospital, DK-5000 Odense, Denmark.Radiotherapy and Oncology 119 (2016) 71–76 Contents lists available at ScienceDirect Radiotherapy and Oncology journal homepage: www.th egreenjournal.com",Non-OADS,/arxiv_data1/oa_pdf/48/ec/main.PMC4871929.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.radonc.2016.02.",OADS,/arxiv_data1/oa_pdf/48/ec/main.PMC4871929.pdf
"HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/ m9.ﬁgshare.hgv.790, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/74/ea/hgv20168.PMC4871931.pdf
"ﬁgshare.hgv.793, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/74/ea/hgv20168.PMC4871931.pdf
"Original  Article Obstet Gynecol Sci 2016;59(3):169-177 http://dx.doi.org/10.5468/ogs.2016.59.3.169 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 169Introduction Obesity has become an important global health concern, and  the increasing rate of obesity among women of reproduc - tive age has a significant impact on the outcomes of their  pregnancies [1].",Non-OADS,/arxiv_data1/oa_pdf/a2/c0/ogs-59-169.PMC4871932.pdf
"Corresponding author: Y oung-Han Kim Division of Maternal-Fetal Medicine, Department of Obstetrics and  Gynecology, Severance Hospital, Y onsei University College of Medicine,  50-1 Y onsei-ro, Seodaemun-gu, Seoul 03722, Korea Tel: +82-2-2228-2230  Fax: +82-2-313-8357 E-mail: yhkim522@yuhs.ac http://orcid.org/ 0000-0003-0645-6028",Non-OADS,/arxiv_data1/oa_pdf/a2/c0/ogs-59-169.PMC4871932.pdf
Original  Article Obstet Gynecol Sci 2016;59(3):178-183 http://dx.doi.org/10.5468/ogs.2016.59.3.178 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 178Introduction Gestational diabetes mellitus (GDM) is one of the most com - mon medical disorders during pregnancy with an increasing  worldwide prevalence [1].,Non-OADS,/arxiv_data1/oa_pdf/4b/6d/ogs-59-178.PMC4871933.pdf
"Corresponding author: Soo-young Oh Department of Obstetrics and Gynecology, Samsung Medical Center,  Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam- gu, Seoul 06351, Korea Tel: +82-2-3410-3517  Fax: +82-2-3410-0630 E-mail: ohsymd@skku.edu  http://orcid.org/ 0000-0003-3002-0048",Non-OADS,/arxiv_data1/oa_pdf/4b/6d/ogs-59-178.PMC4871933.pdf
"Original  Article Obstet Gynecol Sci 2016;59(3):184-191 http://dx.doi.org/10.5468/ogs.2016.59.3.184 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 184Introduction Carcinoma of the uterine cervix is the fourth most common  cancer in women worldwide, and the seventh overall, with  an estimated 528,000 new cases in 2012, with most of these  occurring in the developing world [1].",Non-OADS,/arxiv_data1/oa_pdf/cb/0c/ogs-59-184.PMC4871934.pdf
"Corresponding author: Kwang Beom Lee Department of Obstetrics and Gynecology, Gachon University Gil  Medical Center, 21 Namdong-daero 774beon-gil, Namdong-gu, Incheon  21565, Korea Tel: +82-32-460-3254  Fax: +82-32-460-3290 E-mail:  leekwbm@gachon.ac.kr http://orcid.org/0000-0001- 8311-940X",Non-OADS,/arxiv_data1/oa_pdf/cb/0c/ogs-59-184.PMC4871934.pdf
"Original  Article Obstet Gynecol Sci 2016;59(3):192-200 http://dx.doi.org/10.5468/ogs.2016.59.3.192 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 192Introduction Up to 30% of premenopausal and perimenopausal women  experience abnormal uterine bleeding (AUB) during their re - productive years [1], which is often a concern for endometrial  hyperplasia or cancer (EH+).",Non-OADS,/arxiv_data1/oa_pdf/9c/76/ogs-59-192.PMC4871935.pdf
"Corresponding author: Sun Mie Kim Department of Obstetrics and Gynecology, Healthcare Research Institute,  Seoul National University Hospital Healthcare System Gangnam Center,  152 Teheran-ro, Gangnam-gu, Seoul 06236, Korea Tel: + 82-2-2112-5636  Fax: + 82-2-2112-5635 E-mail: smkimmd@snu.ac.kr http://orcid.org/ 0000-0001-5122-2218",Non-OADS,/arxiv_data1/oa_pdf/9c/76/ogs-59-192.PMC4871935.pdf
Available from: http://www.wpro.who.int/nutri - tion/documents/Redefining_obesity/en .,Non-OADS,/arxiv_data1/oa_pdf/9c/76/ogs-59-192.PMC4871935.pdf
"Original  Article Obstet Gynecol Sci 2016;59(3):201-207 http://dx.doi.org/10.5468/ogs.2016.59.3.201 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 201Introduction The success rates for in vitro  fertilization (IVF) and embryo  transfer (ET) in humans have increased because of improve - ments in ovulation induction medications, regimens, and  culture technology [1].",Non-OADS,/arxiv_data1/oa_pdf/b4/cf/ogs-59-201.PMC4871936.pdf
"Corresponding author: Yun Hee Koo Busan Maria Fertility Clinic, 125 World cup-daero, Y eonje-gu, Busan  47596, Korea Tel: +82-51-441-6555  Fax: +82-51-441-0638 E-mail: yunee9@hotmail.com http://orcid.org/ 0000-0002-3968-6439",Non-OADS,/arxiv_data1/oa_pdf/b4/cf/ogs-59-201.PMC4871936.pdf
Original  Article Obstet Gynecol Sci 2016;59(3):208-213 http://dx.doi.org/10.5468/ogs.2016.59.3.208 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 208Introduction The occurrence of pelvic organ prolapse (POP) in women sig - nificantly increases with age [1].,Non-OADS,/arxiv_data1/oa_pdf/fc/b3/ogs-59-208.PMC4871937.pdf
Avail - able from: http://www.fda.gov/MedicalDevices/Safety/ AlertsandNotices/ucm262435.htm .,Non-OADS,/arxiv_data1/oa_pdf/fc/b3/ogs-59-208.PMC4871937.pdf
Original  Article Obstet Gynecol Sci 2016;59(3):214-219 http://dx.doi.org/10.5468/ogs.2016.59.3.214 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 214Introduction Pelvic organ prolapse (POP) is defined as the downward descent  of the pelvic organs resulting in protrusion of the vagina and/or  uterine cervix.,Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ogs-59-214.PMC4871938.pdf
"Corresponding author: Hyeon Chul Kim  Department of Obstetrics and Gynecology, CHA Bundang Medical  Center, CHA University, 59 Y atap-ro, Bundang-gu, Seongnam 13496,  Korea Tel: +82-31-780-5297  Fax: +82-31-780-6194 E-mail: philia@cha.ac.kr http://orcid.org/ 0000-0002-4894-6140",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ogs-59-214.PMC4871938.pdf
Original  Article Obstet Gynecol Sci 2016;59(3):220-226 http://dx.doi.org/10.5468/ogs.2016.59.3.220 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 220Introduction Hysteroscopic surgery is a minimally invasive approach and  it is the most widely used method to treat intrauterine pa - thologies.,Non-OADS,/arxiv_data1/oa_pdf/fd/f6/ogs-59-220.PMC4871939.pdf
"Corresponding author: Luisa Casadei  Section of Gynecology and Obstetrics, Academic Department of  Biomedicine & Prevention and Clinical Department of Surgery, Tor  Vergata University Hospital, Viale Oxford 81, 00133 Rome, Italy  Tel: +39-06-20-903-343  Fax: +39-06-20-902-921 E-mail: casadei@med.uniroma2.it http://orcid.org/ 0000-0003-0962-5237",Non-OADS,/arxiv_data1/oa_pdf/fd/f6/ogs-59-220.PMC4871939.pdf
"Original  Article Obstet Gynecol Sci 2016;59(3):227-232 http://dx.doi.org/10.5468/ogs.2016.59.3.227 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 227Introduction Since the cervicography was developed by Stafle in 1981 [1],  cervicography has been considered to be a reliable adjunct to  the Pap smear.",Non-OADS,/arxiv_data1/oa_pdf/2f/a9/ogs-59-227.PMC4871940.pdf
"Corresponding author: Seung-Cheol Kim Department of Obstetrics and Gynecology, Ewha Womans University  School of Medicine, 1071 Anyangcheon-ro, Y angcheon-gu, Seoul 07985,  Korea Tel: +82-2-2650-5587  Fax: +82-2-2650-5963 E-mail: onco@ewha.ac.kr http://orcid.org/ 0000-0002-5000-9914  *These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/2f/a9/ogs-59-227.PMC4871940.pdf
Case Report Obstet Gynecol Sci 2016;59(3):233-237 http://dx.doi.org/10.5468/ogs.2016.59.3.233 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 233Introduction Placental chorioangioma is a rare and benign non-trophoblas - tic tumor of the placenta originating from primitive chorionic  mesenchyme [ 1].,Non-OADS,/arxiv_data1/oa_pdf/b7/44/ogs-59-233.PMC4871941.pdf
"Corresponding author: Y oung Nam Kim Department of Obstetrics and Gynecology, Busan Paik Hospital, Inje  University College of Medicine, 75 Bokji-ro, Busanjin-gu, Busan 47392,  Korea Tel: +82-51-890-6374  Fax: +82-51-897-6380 E-mail: ob.youngnam@gmail.com http://orcid.org/ 0000-0002-2363-3586",Non-OADS,/arxiv_data1/oa_pdf/b7/44/ogs-59-233.PMC4871941.pdf
Case Report Obstet Gynecol Sci 2016;59(3):238-240 http://dx.doi.org/10.5468/ogs.2016.59.3.238 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 238Introduction Adrenal hemorrhage is generally diagnosed by sonography  during the newborn period but is rarely detected in uterus.,Non-OADS,/arxiv_data1/oa_pdf/66/ac/ogs-59-238.PMC4871942.pdf
"Corresponding author: Ju Y oung Cheon Department of Obstetrics and Gynecology, Seoul St. Mary’s Hospital, 222  Banpo-daero, Seocho-gu, Seoul 06591, Korea Tel: +82-2-2258-3021  Fax: +82-2-2258-3021  E-mail: ch1000@catholic.ac.kr  http://orcid.org/0000-0001-7899-7611",Non-OADS,/arxiv_data1/oa_pdf/66/ac/ogs-59-238.PMC4871942.pdf
Case Report Obstet Gynecol Sci 2016;59(3):241-244 http://dx.doi.org/10.5468/ogs.2016.59.3.241 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 241Introduction Uterine prolapse is a common condition in elderly females.,Non-OADS,/arxiv_data1/oa_pdf/b7/96/ogs-59-241.PMC4871943.pdf
"Corresponding author: Ji Y eon Lee Department of Obstetrics and Gynecology, CHA Bundang Medical  Center, CHA University School of Medicine, Seongnam 13496, Korea Tel: +82-31-780-5290  Fax: +82-31-780-5069 E-mail: lenna@hanmail.net http://orcid.org/ 0000-0002-6610-0245",Non-OADS,/arxiv_data1/oa_pdf/b7/96/ogs-59-241.PMC4871943.pdf
Case Report Obstet Gynecol Sci 2016;59(3):245-248 http://dx.doi.org/10.5468/ogs.2016.59.3.245 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 245Introduction The first case of ectopic pregnancy of cesarean scar in the  medical literature was reported in 1978 [ 1].,Non-OADS,/arxiv_data1/oa_pdf/f8/33/ogs-59-245.PMC4871944.pdf
"Corresponding author: Tak Kim Department of Obstetrics and Gynecology, Korea University Anam  Hospital, 73 Inchon-ro, Seongbuk-gu, Seoul 02841, Korea Tel: +82-2-920-6842  Fax: +82-2-921-5357 E-mail: tkim@kumc.or.kr http://orcid.org/ 0000-0002-1752-237X",Non-OADS,/arxiv_data1/oa_pdf/f8/33/ogs-59-245.PMC4871944.pdf
"Case Report Obstet Gynecol Sci 2016;59(3):249-252 http://dx.doi.org/10.5468/ogs.2016.59.3.249 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 249Introduction Retropneumoperitoneum is mainly caused by gastrointestinal  perforation, usually accompanied by pneumomediastinum  or pneumoperitoneum, and requires surgical treatment [1- 3].",Non-OADS,/arxiv_data1/oa_pdf/73/8f/ogs-59-249.PMC4871945.pdf
"Corresponding author: Nak Woo Lee Division of Gynecologic Oncology, Department of Obstetrics and  Gynecology, Korea University Ansan Hospital, 123 Jeokgeum-ro,  Danwon-gu, Ansan 15355, Korea Tel: +82-31-412-4801  Fax: +82-31-412-4226 E-mail: nwlee@korea.ac.kr http://orcid.org/ 0000-0001-9405-7574",Non-OADS,/arxiv_data1/oa_pdf/73/8f/ogs-59-249.PMC4871945.pdf
"This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 3.0  Unported License .© 2016 The authors http://www.edmcasereports.com  Published by Bioscientifica Ltd Thymic NET and Cushing’s  syndromeM J Trott and others A thymic neuroendocrine tumour in a young  female: a rare cause of relapsing and remitting  Cushing’s syndrome M J Trott1, G Farah1, V J Stokes1, L M Wang2 and A B Grossman1 1Radcliffe Department of Medicine, Oxford Centre for Diabetes, Endocrinology and Metabolism,  University of Oxford, Oxford, UK and 2Department of Cellular Pathology, John Radcliffe Hospital,  Oxford University Hospitals NHS Trust, Oxford, UK  Summary We present a case of a young female patient with a rare cause of relapsing and remitting Cushing’s syndrome due to  ectopic ACTH secretion from a thymic neuroendocrine tumour.",Non-OADS,/arxiv_data1/oa_pdf/19/ff/edmcr-2016-160018.PMC4872000.pdf
"M J Trott and others Thymic NET and Cushing’s  syndromeID: 16-0018; May 2016 DOI: 10.1530/EDM-16-0018 http://www.edmcasereports.com  2Cushing’s syndrome is most often due to a cortico ­ trophin (ACTH) ­ producing pituitary tumour, or is sec ­ ondary to cortisol secretion by an adrenal adenoma or  carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/19/ff/edmcr-2016-160018.PMC4872000.pdf
"M J Trott and othersID: 16-0018; May 2016 DOI: 10.1530/EDM-16-0018 Thymic NET and Cushing’s  syndrome http://www.edmcasereports.com  3were suggestive of ACTH ­ dependent hypercortisolaemia,  and the results of the CRH stimulation test pointed  towards an ectopic source of ACTH.",Non-OADS,/arxiv_data1/oa_pdf/19/ff/edmcr-2016-160018.PMC4872000.pdf
M J Trott and others Thymic NET and Cushing’s  syndromeID: 16-0018; May 2016 DOI: 10.1530/EDM-16-0018 http://www.edmcasereports.com  4She received thromboembolic prophylaxis with low ­ molecular ­ weight heparin and subsequently proceeded  to thymectomy under the Cardiothoracic Surgery service.,Non-OADS,/arxiv_data1/oa_pdf/19/ff/edmcr-2016-160018.PMC4872000.pdf
"M J Trott and othersID: 16-0018; May 2016 DOI: 10.1530/EDM-16-0018 Thymic NET and Cushing’s  syndrome http://www.edmcasereports.com  5Cushing’s syndrome due to thymic NETs ( 2, 3, 5, 6).",Non-OADS,/arxiv_data1/oa_pdf/19/ff/edmcr-2016-160018.PMC4872000.pdf
"This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 3.0  Unported License .© 2016 The authors http://www.edmcasereports.com  Published by Bioscientifica Ltd Diabetic foot and vertebral  osteomyelitisA Mantovani and others Diabetic foot complicated by vertebral  osteomyelitis and epidural abscess Alessandro Mantovani1, Maddalena Trombetta1, Chiara Imbriaco1, Riccardo Rigolon1,  Lucia Mingolla1, Federica Zamboni1, Francesca Dal Molin1, Dario Cioccoloni1,  Viola Sanga1, Massimiliano Bruti2, Enrico Brocco3, Michela Conti4, Giorgio Ravenna5,  Fabrizia Perrone1, Vincenzo Stoico1 and Enzo Bonora1 1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, 2Division of Plastic  Surgery, Department of Surgery, University and Azienda Ospedaliera Universitaria Integrata of  Verona, Verona, Italy, 3Regional Referral Center for the Treatment of Diabetic Foot, Policlinico Abano  Terme, Padova, Italy, 4Division of Infectious Disease, Department of Medicine, and 5Division of  Neurosurgery, Department of Surgery, University and Azienda Ospedaliera Universitaria Integrataof  Verona, Verona, ItalyID: 15-0132; May 2016 DOI: 10.1530/EDM- 15-013210.1530/EDM-15-0132ID: 15-0132; March 2016 Correspondence   should be addressed   to A Mantovani   Email   alessandro.mantovani24@ gmail.com Summary Vertebral osteomyelitis (or spondylodiscitis) is steadily increasing in Western countries and often results from  hematogenous seeding, direct inoculation during spinal surgery, or contiguous spread from an infection in the adjacent  soft tissue.",Non-OADS,/arxiv_data1/oa_pdf/11/f3/edmcr-2016-150132.PMC4872002.pdf
"A Mantovani and others Diabetic foot and vertebral  osteomyelitisID: 15-0132; May 2016 DOI: 10.1530/EDM-15-0132 http://www.edmcasereports.com  2Background Vertebral osteomyelitis (or spinal osteomyelitis,  spondylodiscitis, septic diskitis, disk-space infection) is  an infection of the disk space and the adjacent vertebral  bodies clinically characterized by back pain, fever,  and, sometime neurological disorders ( 1).",Non-OADS,/arxiv_data1/oa_pdf/11/f3/edmcr-2016-150132.PMC4872002.pdf
"A Mantovani and othersID: 15-0132; May 2016 DOI: 10.1530/EDM-15-0132 Diabetic foot and vertebral  osteomyelitis http://www.edmcasereports.com  3culture, as well as chest X-ray, ultrasound abdomen, and  transthoracic echocardiogram (TTE) had been performed.",Non-OADS,/arxiv_data1/oa_pdf/11/f3/edmcr-2016-150132.PMC4872002.pdf
A Mantovani and others Diabetic foot and vertebral  osteomyelitisID: 15-0132; May 2016 DOI: 10.1530/EDM-15-0132 http://www.edmcasereports.com  4pain and fever had developed after worsening of diabetic  foot infection.,Non-OADS,/arxiv_data1/oa_pdf/11/f3/edmcr-2016-150132.PMC4872002.pdf
"www.nature.com/scientificreports/10 Scientific  RepoRts  | 6:26344 | DOI: 10.1038/srep26344Additional Information Supplementary information accompanies this paper at http://www.nature.com/srep Competing financial interests: The authors declare no competing financial interests.How to cite this article: Latour, G. et al.",Non-OADS,/arxiv_data1/oa_pdf/e4/26/srep26344.PMC4872060.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/",Non-OADS,/arxiv_data1/oa_pdf/e4/26/srep26344.PMC4872060.pdf
"The nuclear hormone is a highaffinityligandofvitaminDreceptor(VDR)( 4),which isatranscriptionfactorbeingexpressedinmosthumantis- sues (http://biogps.org/#goto=genereport&id=7421 ).",Non-OADS,/arxiv_data1/oa_pdf/6c/8f/gkv1519.PMC4872072.pdf
For FAIRE-seq data analysis statistically significant peakswereidentifiedusingtheZinbaprogrampackagever- sion 2.02 by setting the mean fragment length at 200 bp and using other settings as recommended for FAIRE-seqin the Zinba website ( http://code.google.com/p/zinba/wiki/ UsingZINBA ) including peak refinement ( 38).,OADS,/arxiv_data1/oa_pdf/6c/8f/gkv1519.PMC4872072.pdf
RNA-seq reads were mapped to the reference genome (hg19) using Bowtie ( http://bowtie-bio.sourceforge.net/ index.shtml ).,OADS,/arxiv_data1/oa_pdf/6c/8f/gkv1519.PMC4872072.pdf
"Then, raw counts and fragments per virtual kb million were obtained for profiling gene expression.Finally,differentialexpressionwascalculatedwithCuffdiff (http://cole-trapnell-lab.github.io/cufflinks/cuffdiff )b a s e d on at-test over the ratio of normalized counts for the treated and untreated conditions using a cutoff FDR of 0.5%.",OADS,/arxiv_data1/oa_pdf/6c/8f/gkv1519.PMC4872072.pdf
CRISPR /Cas9-mediated genome editing TheguideRNAs(gRNAs)flankingthetargetenhancerre- gions were designed using a website tool ( http://crispr.mit.,OADS,/arxiv_data1/oa_pdf/1d/96/gkv1530.PMC4872074.pdf
"ACKNOWLEDGEMENTS The H3K4me3 HCT116 ChIP-seq data (ENCODE accession number ENCSR000DTQ), the H3K4me3HEK293 ChIP-seq data (ENCODE accession number ENCSR000DTU), and the CTCF HCT116 ChIP-seq data (ENCODE accession number ENCSR000DTW)were produced by the Stamatoyannopoulos labora- tory; the H3K27Ac HCT116 ChIP-seq data (ENCODE accession number ENCSR000EUT), the H3K27AcHEK293 ChIP-seq data (ENCODE accession number ENCSR000FCH), the TCF7L2 HCT116 ChIP-seq data (ENCODE accession number ENCSR000EUV), andthe TCF7L2 HEK293 ChIP-seq data (ENCODE acces- sion number ENCSR000EUY) were produced by the Farnham laboratory; and the CTCF HEK293 ChIP-seq data (ENCODE accession number ENCSR000BSE) was produced by the Myers laboratory and is available athttps://www.encodeproject.org/ .WethanktheUSC /Norris Cancer Center Next Generation Sequencing Facility for services rendered for production of the RNA-seq and ChIP-seq data, the USC Flow Cytometry Facility forassistance with sorting GFP positive cells, Vicky Ya- mamoto at USC for advice about cell proliferation assays, Kim Siegmund at USC for discussions about RNA-seqanalysis, Meng Li and Yibu Chen from the USC Norris Medical Library Bioinformatics Service for assisting with sequencing data analysis (the bioinformatics software andcomputingresourcesusedintheanalysis arefundedbythe USC Office of Research and the Norris Medical Library) and members of the Segal and Farnham laboratory forhelpfuldiscussions.",Non-OADS,/arxiv_data1/oa_pdf/1d/96/gkv1530.PMC4872074.pdf
The sequences of the probes and the original datafrom the microarray experiments were deposited in GEO (http://www.ncbi.nlm.nih.gov/geo )underaccessionnumber GSE66821.,OADS,/arxiv_data1/oa_pdf/63/9e/gkw008.PMC4872076.pdf
Venn diagrams were produced in the R statistical environ- ment (http://www.R-project.org ) as previously described (42).,OADS,/arxiv_data1/oa_pdf/63/9e/gkw008.PMC4872076.pdf
"Sequence reads were processed using BWA ( 43), SAM- tools (44) and MACS ( 45), and further analyzed in the R statisticalenvironment( http://www.R-project.org )asprevi- ouslydescribed ( 42).",OADS,/arxiv_data1/oa_pdf/63/9e/gkw008.PMC4872076.pdf
"MATERIALS AND METHODS Bioinformatics Gene promoter sequences were searched and retrieved by using Ensembl Biomart tool ( http://www.ensembl.org/ biomart/martview )(16) and genome versions Zv9 ( Danio rerio); GRCh37.p10 ( Homo sapiens ), and GRCm38.p1 (Mus musculus ).",OADS,/arxiv_data1/oa_pdf/10/f6/gkw011.PMC4872077.pdf
Gene On- tology (GO) data and GO term enrichment was analyzedwith Biological Networks Gene Ontology (BiNGO) plugin usingCytoscapev2.8( http://www.cytoscape.org/ )(18).GO terms statistical significance was analyzed using a hyperge-ometric test and a Benjamini & Hochberg false discovery rate correction(FDR).,OADS,/arxiv_data1/oa_pdf/10/f6/gkw011.PMC4872077.pdf
Oligonucleotides used as primers for polymerase chain reactions (PCRs) were designed using Primer- BLAST ( http://www.ncbi.nlm.nih.gov/tools/primer-blast/ ) and their specificity checked using MFE primer 2.0 (http://biocompute.bmi.ac.cn/CZlab/MFEprimer-2.0/ ).,OADS,/arxiv_data1/oa_pdf/10/f6/gkw011.PMC4872077.pdf
"ZFINDirectDataSubmission , http://zfin.org .",Non-OADS,/arxiv_data1/oa_pdf/10/f6/gkw011.PMC4872077.pdf
"Each of these chromosome profiles has a schematic chromosome under its profile, which were taken from the HapMap project ( 51) (http://hapmap.ncbi.nlm.nih.gov/karyogram/gwas.html ).Theaxesin(AandB)arethesameasinFigure 1E.Linecolorscorrespondtodifferentpatients.",OADS,/arxiv_data1/oa_pdf/1e/af/gkw031.PMC4872078.pdf
Themethodisavailableandcanbedownloadedtogether with the complete runs of some examples of the mod- eled target sites at the URL: http://circe.med.uniroma1.it/ MiREN.,OADS,/arxiv_data1/oa_pdf/01/b1/gkw043.PMC4872079.pdf
Promega CellTiter-Glo protocol isavailable on the web: http://www.promega.com/resources/ protocols/technical-bulletins/0/celltiter-glo-luminescent- cell-viability-assay-protocol/ .,OADS,/arxiv_data1/oa_pdf/d7/cb/gkw087.PMC4872086.pdf
"Additionally, we downloaded genome assembly and gene annotation of Nicotiana benthamiana v0.4.4 (18) from ftp://ftp.solgenomics.net/genomes/ Nicotiana benthamiana/assemblies/ for map- pingRNA-seq dataand assessing GeMoMapredictions.",OADS,/arxiv_data1/oa_pdf/30/ee/gkw092.PMC4872089.pdf
"The LncDis- ease software is freely available on the Software Page: http://www.cuilab.cn/ .INTRODUCTION Recently, analyses of human transcriptome revealed that protein-codingtranscriptsonlyaccountforasmallportion of the whole-genome ( 1).",OADS,/arxiv_data1/oa_pdf/bd/dc/gkw093.PMC4872090.pdf
"We previously built the long non-coding RNA disease database (LncRNADisease, http://www.cuilab.cn/lncrnadisease )(7), which shows that more than 200 diseases are associated with lncRNAs andmore than 250 lncRNAs have roles in at least one disease.",OADS,/arxiv_data1/oa_pdf/bd/dc/gkw093.PMC4872090.pdf
MATERIALS AND METHODS The data used in this studyWedownloadedthesequencedataofhumanlncRNAsfrom the lncipedia database ( 28)(http://www.lncipedia.org/ )a n d the miRNA sequence data from the miRBase database.,OADS,/arxiv_data1/oa_pdf/bd/dc/gkw093.PMC4872090.pdf
"Gene ontology (GO) analysis of the mutants was per- formedwiththeGOSlimMapperusingthe Saccharomyces GenomeDatabase (SGD, http://www.yeastgenome.org/ ).",OADS,/arxiv_data1/oa_pdf/22/ee/gkw110.PMC4872092.pdf
XII of rDNA unsta- ble mutants (RiUMs) migrates aberrantly with respect to sizeorappearance[Figure 1;andtheYeastrDNAStability DataBase (YRSD at http://lafula-com.info/kobayashiken/ geldata/index.php )].,OADS,/arxiv_data1/oa_pdf/22/ee/gkw110.PMC4872092.pdf
"Bioinformatics TheSOLiDcolorspacereadsobtainedforHIV-1andHIV- rtTAsampleswereanalysedwithLifeScopeGenomicAnal- ysis Software version 2.5 (Applied biosystems) using the smallRNApipelineandthehighestqualityvalue,allowingnomismatches.First,thelibrariesweremappedagainstthe human genome filter-sequences (supplied with LifeScope) andmiRBase(version21; http://www.mirbase.org )toiden- tifyreadsgeneratedfromcellularorirrelevantsources.The remaining reads were mapped to the reference sequence of HIV-1 LAI or HIV-rtTA.",OADS,/arxiv_data1/oa_pdf/9c/c1/gkw167.PMC4872094.pdf
"For example, Alnylam Pharmaceuti- cals has several siRNA products that are selectively mod-ified with 2 /prime-O-methyl or 2/prime-fluoro substitutions at vulner- able sites ( 9,26)(http://www.alnylam.com/Programs-and- Pipeline/index.php ).",Non-OADS,/arxiv_data1/oa_pdf/99/fe/gkw169.PMC4872095.pdf
"The intensi- tiesofthebandswereanalyzedusingImageJ1.45software (Rasband,W.S.,ImageJ,U.S.NationalInstitutesofHealth, Bethesda, Maryland, USA, http://imagej.nih.gov/ij/ , 1997– 2011).",OADS,/arxiv_data1/oa_pdf/99/fe/gkw169.PMC4872095.pdf
"ThenewlyidentifiedroleforRbfoxfamilyproteinsinreg- ulationofmiRNAsmaturation,directly,throughtheRbfox binding sites, and indirectly, through Dicer, links their ab- normal expression, mutation and altered splicing forms tochangesinthelevelsofspecificmiRNAsincancerandbrain diseases.MATERIALS AND METHODS Computationally screening miRNA hairpin sequences Human miRNA hairpin sequences were downloaded from miRBase (release 21) ( http://www.mirbase.org/ftp.html ) (28,29).",OADS,/arxiv_data1/oa_pdf/df/0c/gkw177.PMC4872098.pdf
Sitedirectedmutagenesis of SAUGI The website primer X ( http://www.bioinformatics.org/ primerx/) was used to design the mutagenic PCR primers for SAUGI (Supplementary Table S1).,OADS,/arxiv_data1/oa_pdf/c2/97/gkw185.PMC4872100.pdf
The SAUGI mutants were de-signed using the BeAtMuSiC server ( http://babylone.ulb.,Non-OADS,/arxiv_data1/oa_pdf/c2/97/gkw185.PMC4872100.pdf
"A similar de- creasing pattern of 24-nt siRNAs was observed in ovule cultures described here (Supplementary Figure S1A) and inpreviousstudies( 45,46).Acomprehensivepubliclyavail- able web portal has been produced for data interrogation (http://cotton.cropdb.org/cgi-bin/gb2/gbrowse/Gbmethy/ ).",OADS,/arxiv_data1/oa_pdf/57/a0/gkw238.PMC4872108.pdf
"3.0.2 (http://www.r-project.org/ ) and the Partek Genomics Suitepackagever.6.6(Partek,St.Louis,MO,USA).Low-levelanalysisandnormalizationweredoneusingGCRMA (26) and Partek.",OADS,/arxiv_data1/oa_pdf/e2/e5/gkw245.PMC4872111.pdf
(i) The relationships be- tweenmiR-145anditsdirectandindirectpartnerswereas-certainedbyregressionanalysis.Time-to-eventanalysiswas performed by the Mantel-Haenszel test and the 50% per- centilesofmiRNAswereusedtodichotomizepatientsintolowandhighexpressiongroups.Kaplan–Meiercurveswere drawn for CRC patients taken from The Cancer Genome Atlas (TCGA) dataset ( https://tcga-data.nci.nih.gov/tcga/ tcgaHome2.jsp ).,OADS,/arxiv_data1/oa_pdf/e2/e5/gkw245.PMC4872111.pdf
"PARE is freely available athttp://servers.binf.ku.dk/pare .INTRODUCTION Enhancers and promoters are cis-regulatory elements (CREs)thatcontrolthespatiotemporalexpressionofgenesin response to various external signals and across different cell types ( 1,2).",OADS,/arxiv_data1/oa_pdf/cb/5a/gkw250.PMC4872112.pdf
Data corresponding to the three histone marks and control in replicates was down-loaded ( http://hgdownload.cse.ucsc.edu/goldenPath/hg19/ encodeDCC/ )f r o mE N C O D Ei nB A Mf o r m a t( 21).,OADS,/arxiv_data1/oa_pdf/cb/5a/gkw250.PMC4872112.pdf
"Specifically,these have been predicted using two machine learning- based methods, ChromHMM ( 11) and Segway ( 12), and we include only those predicted by both meth-ods ( http://hgdownload.cse.ucsc.edu/goldenPath/hg19/ encodeDCC/wgEncodeAwgSegmentation/ ).",Non-OADS,/arxiv_data1/oa_pdf/cb/5a/gkw250.PMC4872112.pdf
BAM files corresponding to both the replicates of experimental assays mentioned above were downloaded ( http://hgdownload.cse.ucsc.edu/goldenPath/,OADS,/arxiv_data1/oa_pdf/cb/5a/gkw250.PMC4872112.pdf
(http://hgdownload.cse.ucsc.edu/goldenPath/hg19/ encodeDCC/wgEncodeSydhTfbs/ )(21).,OADS,/arxiv_data1/oa_pdf/cb/5a/gkw250.PMC4872112.pdf
"AVAILABILITY An implementation of the PVP-based approach as a com- putational method, PARE (Predict Active Regulatory Ele- ments)is freelyavailable at http://servers.binf.ku.dk/pare .",OADS,/arxiv_data1/oa_pdf/cb/5a/gkw250.PMC4872112.pdf
"We now significantly expanded our database (‘BindDB’, http://bind-db.huji.ac.il ) and collected over 450 genome- wide datasets in mouse and human ESCs, providing one ofthemostcomprehensiveESCs-specificdatabasestodate (15).",OADS,/arxiv_data1/oa_pdf/67/44/gkw259.PMC4872113.pdf
MATERIALS AND METHODS Data acquisition Data has been downloaded from http://bind-db.huji.ac.il (15).,OADS,/arxiv_data1/oa_pdf/67/44/gkw259.PMC4872113.pdf
"RESULTS Data curation and validation Our analysis is mostly based on data we collected over the years and which has been assembled in to the ‘BindDB’database( http://bind-db.huji.ac.il )(15).Totesttheintegrity of the data, we focused on genomic maps of histone modi- fications and compared the patterns in human and mouse.Principalcomponentanalysis(PCA)demonstratedthatthe patterns in human and mouse are highly similar in both therelativeorientationofthehistonemodificationsandthevariance within each individual modification (Supplemen- tary Figure S1).",OADS,/arxiv_data1/oa_pdf/67/44/gkw259.PMC4872113.pdf
Transformation of H. hispanica cells was conducted according to the online Halohandbook ( http://www.haloarchaea.com/resources/ halohandbook/Halohandbook 2009v7.2mds.pdf ).,OADS,/arxiv_data1/oa_pdf/6a/98/gkw260.PMC4872114.pdf
"Using the WebLogo server(http://weblogo.berkeley.edu/logo.cgi ), a sequence logo was generated from this multi-alignment.",OADS,/arxiv_data1/oa_pdf/6a/98/gkw260.PMC4872114.pdf
"Analysis During production runs, data was typically collected every 1 ps, which allowed us to study infrequent, but fast move-ments.Allthetrajectorieswerepre-processedwiththeCPP- TRAJ(38)moduleoftheAMBERTOOLS15package( 37), the NAFlex server ( 39) and tools developed in the group (http://mmb.irbbarcelona.org/www/tools ).DNAhelicalpa- rameters and backbone torsion angles associated with the eachbasepair(bp)andbasepairstep(bps)weremeasured with the CURVES+ and CANAL programs ( 40).",OADS,/arxiv_data1/oa_pdf/f7/dc/gkw264.PMC4872116.pdf
Deformation modes were determined from a principal component analysis of the collected simu- lations using PCASUITE ( http://mmb.pcb.ub.es/software/ pcasuite/pcasuite.html ).,OADS,/arxiv_data1/oa_pdf/f7/dc/gkw264.PMC4872116.pdf
A list oftheresidual‘masked’non-functionalgenomicintervalscan be downloaded from http://compgenomics.weizmann.ac.il/ tanay/?page id=667.,Non-OADS,/arxiv_data1/oa_pdf/3c/c6/gkw268.PMC4872117.pdf
Human heterozygosity data ( 35) were downloaded from http://hapmap.ncbi.nlm.nih.gov/downloads/genotypes .,OADS,/arxiv_data1/oa_pdf/3c/c6/gkw268.PMC4872117.pdf
"Broadly, DBHS proteins are rapidly emerging as clinically relevant in the contextsofdevelopment,innateimmunityandcancer(Fig- ure4).Furthermore, SFPQ,NONOandPSPC1allbelong to a class of human genes with the lowest tolerance for missense and loss of function mutations, suggesting strong involvement in selectable phenotypes in humans (ExomeAggregation Consortium ExAC, Cambridge, MA, URL: http://exac.broadinstitute.org , accessed March 2016).",Non-OADS,/arxiv_data1/oa_pdf/19/76/gkw271.PMC4872119.pdf
The random sampling was performed using a Perl script (http://meme-suite.org/doc/fasta-subsample.html ).,OADS,/arxiv_data1/oa_pdf/0c/8a/gkw283.PMC4872120.pdf
"The peaks containing identified binding sites were consid-ered as significant enrichment regions (total of 355 882 peaks).Analysispipelinesagplus( 37),PositionWeightMa- trix model generation and evaluation-PWMScan ( http:// ccg.vital-it.ch/pwmscan )(38,39),ChIP-CorAnalysisMod- ule(http://ccg.vital-it.ch/chipseq/chip cor.php)andvarious platforms of the Signal Search Analysis Server ( http://ccg.",OADS,/arxiv_data1/oa_pdf/0c/8a/gkw283.PMC4872120.pdf
The sequence and gene synteny of the S.solfataricus P1 chromosome (ENA Accession Number: http://www.ebi.ac.,Non-OADS,/arxiv_data1/oa_pdf/b5/40/gkw286.PMC4872121.pdf
"The computer alone was the size of a small refrigerator!Freely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services1Keywords: Tremor, transducer, accelerometry, measurement, Fourier analysis Citation: Elble RJ, McNames J.",OADS,/arxiv_data1/oa_pdf/66/c7/tre-06-375-7522-1.PMC4872171.pdf
"Many modern motion sensors contain a triaxial accelerometer and gyroscope for capturing this motion.Elble RJ, McNames J Using Portable Transducers Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/66/c7/tre-06-375-7522-1.PMC4872171.pdf
"Thus, our largest anticipated tremor acceleration is 9,478 cm/second2or 9.67 g, so if we also account for the gravitational effect, the accelerometer should have aUsing Portable Transducers Elble RJ, McNames J Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/66/c7/tre-06-375-7522-1.PMC4872171.pdf
"There is very little movement otherTable 1.Examples of Motion Transducers and their Technical Specifications Sensor Axes Range Mass Resolution Accuracy Sampling Rate (samples/s)Recording Duration Kinesia One Accelerometer 3 ¡5 g 8.5 grams 12 bit ¡2% 64 8 hr Gyroscope 3 ¡2000 deg/s ¡4% 64 8 hr ADPM Opal Accelerometer 3 ¡6go r¡2 g 22 grams 14 bit 2% 20-128 12-24 hr** Gyroscope 3 ¡2000 deg/s* 2% ActiGraph GT9X Accelerometer 3 ¡16 g 14 grams 16 bit 3% 100 .24 hr Gyroscope 3 ¡2000 deg/s 4% 100 Wacom Intuos tablets2 >10 cm*** >700 grams***0.005 mm ¡0.25 mm>100 As long as the pen is on the tablet *¡2000 deg/s for axes X and Y, and ¡1500 deg/s for axis Z **Depends on sampling rate: 12 hr when data are sampled at 128/s ***Depends on the size of the tabletElble RJ, McNames J Using Portable Transducers Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/66/c7/tre-06-375-7522-1.PMC4872171.pdf
"The mean tremor amplitude in degrees is the peak amplitude divided by 2 pf, where f is the tremor frequency (3.8 Hz).Using Portable Transducers Elble RJ, McNames J Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services5",Non-OADS,/arxiv_data1/oa_pdf/66/c7/tre-06-375-7522-1.PMC4872171.pdf
The Psychophysics toolbox version 3 (Psychtoolbox-3) for MATLAB is a free set of MATLAB programs for neuroscience research and contains MATLAB functions for interfacing tablets with MATLAB (http://psychtoolbox.org/download/).,OADS,/arxiv_data1/oa_pdf/66/c7/tre-06-375-7522-1.PMC4872171.pdf
"VBTablet (http:// greenreaper.co.uk/#VBTablet) is a free Wintab 32-bit ActiveX component that has been used to record tablet data into 32-bit Microsoft Excel for analysis in MATLAB (see online appendix).11,12,34There is also free tablet software for Archimedes spiral acquisition and analysis, written by Camilo Toro (http://www.neuroglyphics.org/).9 Tremor analysis Tremor is an oscillatory movement, and all methods of analyzing recordings of tremor capitalize on this property.",OADS,/arxiv_data1/oa_pdf/66/c7/tre-06-375-7522-1.PMC4872171.pdf
"Note how differentiation accentuates the 4.3 Hz tremor relative to the lower-frequ ency voluntary movement.Elble RJ, McNames J Using Portable Transducers Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services6",Non-OADS,/arxiv_data1/oa_pdf/66/c7/tre-06-375-7522-1.PMC4872171.pdf
"Bartlett’s method of smoothing M sequential frequencies in a power spectrum producesUsing Portable Transducers Elble RJ, McNames J Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services7",Non-OADS,/arxiv_data1/oa_pdf/66/c7/tre-06-375-7522-1.PMC4872171.pdf
"The 5 Hz tremor nearly stops at 21 minutes, when there is an abrupt increase in normal voluntary movement.Elble RJ, McNames J Using Portable Transducers Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services8",Non-OADS,/arxiv_data1/oa_pdf/66/c7/tre-06-375-7522-1.PMC4872171.pdf
"A logarithmic relationship between transducer measure and tremor rating has been found for all transducers used in tremor studies.Using Portable Transducers Elble RJ, McNames J Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services9",OADS,/arxiv_data1/oa_pdf/66/c7/tre-06-375-7522-1.PMC4872171.pdf
"Example software, written in MATLAB, is included in the online appendix.Contents of the online appendix The online appendix for this article is available here: http://dx.doi.",OADS,/arxiv_data1/oa_pdf/66/c7/tre-06-375-7522-1.PMC4872171.pdf
"doi: 10.1002/mds.25264.Elble RJ, McNames J Using Portable Transducers Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services10",Non-OADS,/arxiv_data1/oa_pdf/66/c7/tre-06-375-7522-1.PMC4872171.pdf
http://plan.geomatics.ucalgary.ca/papers/upinlbs%202012_bancroft% 202020etal_oct202012.pdf.,Non-OADS,/arxiv_data1/oa_pdf/66/c7/tre-06-375-7522-1.PMC4872171.pdf
http://www.parkablogs.com/content/which-graphics-drawing-tablet- buy-2015-non-display-types2014.,Non-OADS,/arxiv_data1/oa_pdf/66/c7/tre-06-375-7522-1.PMC4872171.pdf
National Instruments; 2015. http://www.ni.com/white-paper/4844/en/.,Non-OADS,/arxiv_data1/oa_pdf/66/c7/tre-06-375-7522-1.PMC4872171.pdf
"Erratum in: Mov Disord 1995;10:411.Using Portable Transducers Elble RJ, McNames J Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services11",Non-OADS,/arxiv_data1/oa_pdf/66/c7/tre-06-375-7522-1.PMC4872171.pdf
"Environmental Protection Agency; 2011. http://www.bae.ncsu.edu/programs/extension/wqg/319monitoring/ tech_notes.htm: U.S. 55.Heldman DA, Espay AJ, LeWitt PA, Giuffrida JP.",Non-OADS,/arxiv_data1/oa_pdf/66/c7/tre-06-375-7522-1.PMC4872171.pdf
"1973;34:390–395.Elble RJ, McNames J Using Portable Transducers Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services12",Non-OADS,/arxiv_data1/oa_pdf/66/c7/tre-06-375-7522-1.PMC4872171.pdf
Reprints and permissions:   http://www.sagepub.co.uk/journalsPermissions.nav Therapeutic Advances in Hematology http://tah.sagepub.com 157 Entospletinib overview B-cell receptor (BCR) signaling regulates many cell-fate decisions in normal B cells [Casola et al.,Non-OADS,/arxiv_data1/oa_pdf/83/b4/10.1177_2040620716636542.PMC4872176.pdf
"Therapeutic Advances in Hematology 7(3) 158 http://tah.sagepub.com differentiation (CD)79, which in turn initiates the  signaling cascade [Ackermann et al.",Non-OADS,/arxiv_data1/oa_pdf/83/b4/10.1177_2040620716636542.PMC4872176.pdf
"J Sharman and J Di Paolo http://tah.sagepub.com 159 lymphocytic lymphoma (SLL), and FL [Gopal  et  al.",Non-OADS,/arxiv_data1/oa_pdf/83/b4/10.1177_2040620716636542.PMC4872176.pdf
"Therapeutic Advances in Hematology 7(3) 160 http://tah.sagepub.com components and pathway activation, including  phosphorylation of SYK, PLCγ2, signal trans-ducers and activators of transcription 3 (STAT3) and extracellular signal regulated kinases 1 and 2 (ERK 1/2) compared with healthy B cells [Buchner et al.",Non-OADS,/arxiv_data1/oa_pdf/83/b4/10.1177_2040620716636542.PMC4872176.pdf
"J Sharman and J Di Paolo http://tah.sagepub.com 161 CCR7, which are required for increased migra- tion and homing to the protective lymph node microenvironment [Calpe et al.",Non-OADS,/arxiv_data1/oa_pdf/83/b4/10.1177_2040620716636542.PMC4872176.pdf
Therapeutic Advances in Hematology 7(3) 162 http://tah.sagepub.com et al.,Non-OADS,/arxiv_data1/oa_pdf/83/b4/10.1177_2040620716636542.PMC4872176.pdf
"J Sharman and J Di Paolo http://tah.sagepub.com 163 PFS in the FL cohort was 52% (95% CI: 33– 67%), and the median PFS of 5.7 months was demonstrated with a median follow up of 3.6 months.",OADS,/arxiv_data1/oa_pdf/83/b4/10.1177_2040620716636542.PMC4872176.pdf
"Therapeutic Advances in Hematology 7(3) 164 http://tah.sagepub.com another and mediate crosstalk with other path- ways regulating cytokine signaling, microtubule dynamics, microenvironment signaling and cell-survival proteins.",Non-OADS,/arxiv_data1/oa_pdf/83/b4/10.1177_2040620716636542.PMC4872176.pdf
J Sharman and J Di Paolo http://tah.sagepub.com 165 Table 2.,Non-OADS,/arxiv_data1/oa_pdf/83/b4/10.1177_2040620716636542.PMC4872176.pdf
Therapeutic Advances in Hematology 7(3) 166 http://tah.sagepub.com trials focusing on the interaction of entospletinib  with microtubule agents could open several regu-latory strategies for the molecule in a variety of lymphoid malignancies.,Non-OADS,/arxiv_data1/oa_pdf/83/b4/10.1177_2040620716636542.PMC4872176.pdf
"J Sharman and J Di Paolo http://tah.sagepub.com 167 Acknowledgements Editorial assistance was provided by Impact Communication Partners, Inc. Funding This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.",Non-OADS,/arxiv_data1/oa_pdf/83/b4/10.1177_2040620716636542.PMC4872176.pdf
"Therapeutic Advances in Hematology 7(3) 168 http://tah.sagepub.com in previously treated chronic lymphocytic leukemia/ small lymphocytic lymphoma (CLL/SLL): first results from a randomized, double-blind, placebo-controlled,  phase III study.",Non-OADS,/arxiv_data1/oa_pdf/83/b4/10.1177_2040620716636542.PMC4872176.pdf
J Sharman and J Di Paolo http://tah.sagepub.com 169 combination with ofatumumab (OFA) for previously  treated chronic lymphocytic leukemia (CLL).,Non-OADS,/arxiv_data1/oa_pdf/83/b4/10.1177_2040620716636542.PMC4872176.pdf
"Therapeutic Advances in Hematology 7(3) 170 http://tah.sagepub.com specific targeting with a novel spleen tyrosine kinase  inhibitor, R406.",Non-OADS,/arxiv_data1/oa_pdf/83/b4/10.1177_2040620716636542.PMC4872176.pdf
Visit SAGE journals online  http://tah.sagepub.com SAGE journals,Non-OADS,/arxiv_data1/oa_pdf/83/b4/10.1177_2040620716636542.PMC4872176.pdf
The full terms of this license are available at https://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/75/7a/jaa-9-093.PMC4872272.pdf
"com/terms.ph p and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/75/7a/jaa-9-093.PMC4872272.pdf
"For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).United airway disease: current perspectives Pedro Giavina-Bianchi* Marcelo Vivolo Aun* Priscila Takejima Jorge Kalil Rosana Câmara Agondi Clinical Immunology and Allergy  Division, Faculty of Medicine,   University of São Paulo, São Paulo,   Brazil *These authors contributed equally to  this work.",Non-OADS,/arxiv_data1/oa_pdf/75/7a/jaa-9-093.PMC4872272.pdf
Available from: http://www.ginas - thma.org/documents/ 4.,OADS,/arxiv_data1/oa_pdf/75/7a/jaa-9-093.PMC4872272.pdf
"Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-asthma-and-allergy-journa lThe Journal of Asthma and Allergy is an international, peer-reviewed  open-access journal publishing original research, reports, editorials  and commentaries on the following topics: Asthma; Pulmonary physi - ology; Asthma related clinical health; Clinical immunology and the  immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/75/7a/jaa-9-093.PMC4872272.pdf
Visit http://www.dovepress.com/testimonials.php to read  real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/75/7a/jaa-9-093.PMC4872272.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d8/79/imcrj-9-113.PMC4872273.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/d8/79/imcrj-9-113.PMC4872273.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Persistent corneal epithelial defect responding to  rebamipide ophthalmic solution in a patient with  diabetes Yusuke Hayashi Hiroshi T oshida Yusuke Matsuzaki Asaki Matsui T oshihiko Ohta Department of Ophthalmology,   Juntendo University Shizuoka  Hospital, Izunokuni, Shizuoka, Japan Correspondence: Hiroshi T oshida   Department of Ophthalmology,  Juntendo University Shizuoka Hospital,  1129, Izunokuni City, Shizuoka 410-2295,  Japan   T el +81 55 948 3111   Fax +81 55 948 3351   Email toshida@juntendo.ac.j pObjective:  Rebamipide ophthalmic suspension was developed for the treatment of dry eyes and  for other corneal diseases, promoting the secretion of both mucin in tear fluid and membrane- associated mucin, increasing the number of goblet cells, and restoring the barrier function of  the corneal epithelium.",Non-OADS,/arxiv_data1/oa_pdf/d8/79/imcrj-9-113.PMC4872273.pdf
Available from: http://www.lifescience.,Non-OADS,/arxiv_data1/oa_pdf/d8/79/imcrj-9-113.PMC4872273.pdf
"mext.go.jp/files/pdf/n1500_01.pd f. Accessed April 21, 2016. International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/d8/79/imcrj-9-113.PMC4872273.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/79/imcrj-9-113.PMC4872273.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/14/8e/ijwh-8-137.PMC4872274.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2016:8 137–144International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  137OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S10590 6T emporal trend in the use of hysteroscopic vs  laparoscopic sterilization and the characteristics  of commercially insured and Medicaid-insured  females in the Us who have had the procedures Patricia I carney1 Jay lin2 Fang Xia3 amy law3 1Medical affairs, Bayer Healthcare  Pharmaceuticals, Inc, Whippany,   2novosys Health, green Brook,   3Health economics and Outcomes  research, Bayer Health care  Pharmaceuticals, Inc., Whippany,   nJ, UsaPurpose:  Limited research has examined the factors associated with female permanent  contraception procedures.",Non-OADS,/arxiv_data1/oa_pdf/14/8e/ijwh-8-137.PMC4872274.pdf
"LS involves one or two abdominal wall skin incisions  followed by the insertion of a laparoscope into the peritoneal cavity, insufflation of the  cavity with carbon dioxide, and ligation of the fallopian tubes.2 The procedure generally correspondence: amy law Bayer Healthcare Pharmaceuticals Inc.,  100 Bayer Boulevard, Whippany,  nJ 07981, Usa Tel +1 862 404 5855 email amy.law@bayer.co m Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2016 Volume: 8 Running head verso: Carney et al Running head recto: Temporal trend in use of HS vs LS in the US DOI: http://dx.doi.org/10.2147/IJWH.S105906",Non-OADS,/arxiv_data1/oa_pdf/14/8e/ijwh-8-137.PMC4872274.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/14/8e/ijwh-8-137.PMC4872274.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/14/8e/ijwh-8-137.PMC4872274.pdf
Available from: http://investors.hologic.com/index.php?s =  43&item =447.,Non-OADS,/arxiv_data1/oa_pdf/14/8e/ijwh-8-137.PMC4872274.pdf
Available from: http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/14/8e/ijwh-8-137.PMC4872274.pdf
"Although current clinical trials using neural stem cells Molecular Vision  2016; 22:472-490 <http://www.molvis.org/molvis/v 22/472> Received 25 January 2016 | Accepted 13 May 2016 | Published 16 May 2016© 2016 Molecular Vision 472Gene expression changes in the retina following subretinal  injection of human neural progenitor cells into a rodent model for  retinal degeneration Melissa K. Jones,1,2 Bin Lu,1,2 Mehrnoosh Saghizadeh,1,2,3 Shaomei Wang1,2,3 1Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA; 2Eye Program, Board of Governors  Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA; 3David Geffen School of Medicine, University of  California Los Angeles, Los Angeles, CA Purpose:  Retinal degenerative diseases (RDDs) affect millions of people and are the leading cause of vision loss.",Non-OADS,/arxiv_data1/oa_pdf/f4/23/mv-v22-472.PMC4872275.pdf
"Molecular Vision  2016; 22:472-490 <http://www.molvis.org/molvis/v 22/472> © 2016 Molecular Vision  473are being tested for safety [ 9], another clinically relevant  stem cell population under investigation is human neural  progenitor cells (hNPCs).",Non-OADS,/arxiv_data1/oa_pdf/f4/23/mv-v22-472.PMC4872275.pdf
"Molecular Vision  2016; 22:472-490 <http://www.molvis.org/molvis/v 22/472> © 2016 Molecular Vision  474rats have slow, progressive photoreceptor degeneration due  to a mutation in the Mertk  gene, which is expressed by RPE  cells and is important in the binding of shed photoreceptor  outer segments for proper phagocytosis [ 26,27].",Non-OADS,/arxiv_data1/oa_pdf/f4/23/mv-v22-472.PMC4872275.pdf
Molecular Vision  2016; 22:472-490 <http://www.molvis.org/molvis/v 22/472> © 2016 Molecular Vision  475 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/f4/23/mv-v22-472.PMC4872275.pdf
"Molecular Vision  2016; 22:472-490 <http://www.molvis.org/molvis/v 22/472> © 2016 Molecular Vision  476by increasing sucrose before embedding in optimum cutting  temperature (OCT) compound (Sakura Finetek, Torrance,  CA) and storage at −80 °C.",Non-OADS,/arxiv_data1/oa_pdf/f4/23/mv-v22-472.PMC4872275.pdf
"Molecular Vision  2016; 22:472-490 <http://www.molvis.org/molvis/v 22/472> © 2016 Molecular Vision  477removed from the eye cup and oriented so that only the  hemisphere containing the injected cells was isolated, flash  frozen with liquid nitrogen, and stored at −80 °C until RNA  extraction.",Non-OADS,/arxiv_data1/oa_pdf/f4/23/mv-v22-472.PMC4872275.pdf
"Molecular Vision  2016; 22:472-490 <http://www.molvis.org/molvis/v 22/472> © 2016 Molecular Vision  478The qRT-PCR analyses were performed using 50 ng cDNA  on 96-well plates (Applied Biosystems, Paisley, UK),  and run in technical duplicates on a 7500 Real-Time PCR  System (Applied Biosystems).",OADS,/arxiv_data1/oa_pdf/f4/23/mv-v22-472.PMC4872275.pdf
Molecular Vision  2016; 22:472-490 <http://www.molvis.org/molvis/v 22/472> © 2016 Molecular Vision  479Differential gene expression due to hNPC-induced retinal  preservation in RCS rats:  Computational analysis of the  differential gene expression between RCShNPCs and RCSsham  was performed.,Non-OADS,/arxiv_data1/oa_pdf/f4/23/mv-v22-472.PMC4872275.pdf
"Molecular Vision  2016; 22:472-490 <http://www.molvis.org/molvis/v 22/472> © 2016 Molecular Vision  480by DAVID, the RCSsham versus LEsham upregulated biologic  processes mainly included immune system regulation  (Figure 5A).",Non-OADS,/arxiv_data1/oa_pdf/f4/23/mv-v22-472.PMC4872275.pdf
"Molecular Vision  2016; 22:472-490 <http://www.molvis.org/molvis/v 22/472> © 2016 Molecular Vision  481Cdc42ep5  encodes an effector protein that binds to Cdc42  to negatively regulate its function [ 77,78].",Non-OADS,/arxiv_data1/oa_pdf/f4/23/mv-v22-472.PMC4872275.pdf
"Molecular Vision  2016; 22:472-490 <http://www.molvis.org/molvis/v 22/472> © 2016 Molecular Vision  482in the RCSsham versus LEsham and downregulated in the RCSh- NPCs versus RCSsham gene profiles were compared, and three  pathways were found to coincide (Table 3).",OADS,/arxiv_data1/oa_pdf/f4/23/mv-v22-472.PMC4872275.pdf
"Molecular Vision  2016; 22:472-490 <http://www.molvis.org/molvis/v 22/472> © 2016 Molecular Vision  483the degenerating retina to the hNPC-treated retina, greater  knowledge of the responses that occur due to hNPCs will  aid in understanding the molecular mechanisms of treatment.",Non-OADS,/arxiv_data1/oa_pdf/f4/23/mv-v22-472.PMC4872275.pdf
Molecular Vision  2016; 22:472-490 <http://www.molvis.org/molvis/v 22/472> © 2016 Molecular Vision  484the RNA-seq and qRT-PCR analyses of RCShNPCs could be  due to the sample area of the neural retina.,Non-OADS,/arxiv_data1/oa_pdf/f4/23/mv-v22-472.PMC4872275.pdf
Molecular Vision  2016; 22:472-490 <http://www.molvis.org/molvis/v 22/472> © 2016 Molecular Vision  485Pathway analysis was used to identify affected pathways  following the subretinal transplantation of hNPCs into RCS  rats.,Non-OADS,/arxiv_data1/oa_pdf/f4/23/mv-v22-472.PMC4872275.pdf
Molecular Vision  2016; 22:472-490 <http://www.molvis.org/molvis/v 22/472> © 2016 Molecular Vision  486APPENDIX 1.,Non-OADS,/arxiv_data1/oa_pdf/f4/23/mv-v22-472.PMC4872275.pdf
Molecular Vision  2016; 22:472-490 <http://www.molvis.org/molvis/v 22/472> © 2016 Molecular Vision  487Lund RD.,Non-OADS,/arxiv_data1/oa_pdf/f4/23/mv-v22-472.PMC4872275.pdf
Molecular Vision  2016; 22:472-490 <http://www.molvis.org/molvis/v 22/472> © 2016 Molecular Vision  48840.,Non-OADS,/arxiv_data1/oa_pdf/f4/23/mv-v22-472.PMC4872275.pdf
Molecular Vision  2016; 22:472-490 <http://www.molvis.org/molvis/v 22/472> © 2016 Molecular Vision  489crystalline proteins by retinal degeneration in the rd1 mouse.,Non-OADS,/arxiv_data1/oa_pdf/f4/23/mv-v22-472.PMC4872275.pdf
Molecular Vision  2016; 22:472-490 <http://www.molvis.org/molvis/v 22/472> © 2016 Molecular Vision  49089.,Non-OADS,/arxiv_data1/oa_pdf/f4/23/mv-v22-472.PMC4872275.pdf
"Highly efficient systemic mitochondrial function  was recently shown to be protective against glaucomatous  optic neuropathy in those with elevated intraocular pressure Molecular Vision  2016; 22:454-471 <http://www.molvis.org/molvis/v 22/454> Received 21 December 2015 | Accepted 13 May 2016 | Published 16 May 2016© 2016 Molecular Vision 454Association of primary open-angle glaucoma with mitochondrial  variants and haplogroups common in African Americans David W. Collins, Harini V .",Non-OADS,/arxiv_data1/oa_pdf/5d/29/mv-v22-454.PMC4872278.pdf
Molecular Vision  2016; 22:454-471 <http://www.molvis.org/molvis/v 22/454> © 2016 Molecular Vision  455(IOP) [ 7].,Non-OADS,/arxiv_data1/oa_pdf/5d/29/mv-v22-454.PMC4872278.pdf
"Molecular Vision  2016; 22:454-471 <http://www.molvis.org/molvis/v 22/454> © 2016 Molecular Vision  456plate kits (Cat # A10510–01, Life Technologies).",Non-OADS,/arxiv_data1/oa_pdf/5d/29/mv-v22-454.PMC4872278.pdf
"Molecular Vision  2016; 22:454-471 <http://www.molvis.org/molvis/v 22/454> © 2016 Molecular Vision  457DNAs, and these means were compared to the Pool-seq  estimates.",OADS,/arxiv_data1/oa_pdf/5d/29/mv-v22-454.PMC4872278.pdf
Molecular Vision  2016; 22:454-471 <http://www.molvis.org/molvis/v 22/454> © 2016 Molecular Vision  458the common L2a haplogroup due to a lack of variable posi - tions that met these criteria.,Non-OADS,/arxiv_data1/oa_pdf/5d/29/mv-v22-454.PMC4872278.pdf
Molecular Vision  2016; 22:454-471 <http://www.molvis.org/molvis/v 22/454> © 2016 Molecular Vision  459sites as “noisy” and excluded them from subsequent analysis  (Appendix 1).,Non-OADS,/arxiv_data1/oa_pdf/5d/29/mv-v22-454.PMC4872278.pdf
"Molecular Vision  2016; 22:454-471 <http://www.molvis.org/molvis/v 22/454> © 2016 Molecular Vision  460Association of mitochondrial haplogroups with POAG in  African Americans:  We compared the prevalence of the  most common haplogroups in the study’s controls relative to  reported frequencies in African Americans, as well as the  haplogroup distribution in POAG cases versus controls.",Non-OADS,/arxiv_data1/oa_pdf/5d/29/mv-v22-454.PMC4872278.pdf
Molecular Vision  2016; 22:454-471 <http://www.molvis.org/molvis/v 22/454> © 2016 Molecular Vision  461case pools appeared to be substantially enriched in L1c and  L2 haplogroups relative to the controls.,Non-OADS,/arxiv_data1/oa_pdf/5d/29/mv-v22-454.PMC4872278.pdf
Molecular Vision  2016; 22:454-471 <http://www.molvis.org/molvis/v 22/454> © 2016 Molecular Vision  462of L1c2.,Non-OADS,/arxiv_data1/oa_pdf/5d/29/mv-v22-454.PMC4872278.pdf
Molecular Vision  2016; 22:454-471 <http://www.molvis.org/molvis/v 22/454> © 2016 Molecular Vision  463were correct.,Non-OADS,/arxiv_data1/oa_pdf/5d/29/mv-v22-454.PMC4872278.pdf
"Molecular Vision  2016; 22:454-471 <http://www.molvis.org/molvis/v 22/454> © 2016 Molecular Vision  464was estimated here to be more common in controls (7.9%)  than in POAG cases (4.5%), consistent with L3b ancestry not  conferring elevated POAG risk among African Americans or  being mildly protective (Figure 4).",Non-OADS,/arxiv_data1/oa_pdf/5d/29/mv-v22-454.PMC4872278.pdf
"Molecular Vision  2016; 22:454-471 <http://www.molvis.org/molvis/v 22/454> © 2016 Molecular Vision  465rRNA genes (MT-RNR1, MT-RNR2, and humanin):  The  MT-RNR2  gene, which encodes the 16S subunit of the  mitochondrial ribosome, harbored seven variants that have  associations with POAG that were potentially significant  (Figure 5).",Non-OADS,/arxiv_data1/oa_pdf/5d/29/mv-v22-454.PMC4872278.pdf
"Molecular Vision  2016; 22:454-471 <http://www.molvis.org/molvis/v 22/454> © 2016 Molecular Vision  466peptide, proline (“P3”), to be replaced by threonine.",Non-OADS,/arxiv_data1/oa_pdf/5d/29/mv-v22-454.PMC4872278.pdf
"Molecular Vision  2016; 22:454-471 <http://www.molvis.org/molvis/v 22/454> © 2016 Molecular Vision  467these variants, m.1892A>G and m.2755A>G, were located in  the MT-RNR2  16s RNA gene, but they were not detected in  the African American POAAGG cohort.",Non-OADS,/arxiv_data1/oa_pdf/5d/29/mv-v22-454.PMC4872278.pdf
"Molecular Vision  2016; 22:454-471 <http://www.molvis.org/molvis/v 22/454> © 2016 Molecular Vision  468Conclusions:  Pool-seq of 1,999 individuals demonstrated that  the mitochondrial haplotype distribution of the POAAGG  study population is broadly similar to that of other African  American populations, with all major African macro - haplogroups represented and with L3, L2, L1, and L0 in  decreasing order of frequency, consistent with a preliminary  survey of this population [ 10].",Non-OADS,/arxiv_data1/oa_pdf/5d/29/mv-v22-454.PMC4872278.pdf
Molecular Vision  2016; 22:454-471 <http://www.molvis.org/molvis/v 22/454> © 2016 Molecular Vision  4695.,Non-OADS,/arxiv_data1/oa_pdf/5d/29/mv-v22-454.PMC4872278.pdf
Molecular Vision  2016; 22:454-471 <http://www.molvis.org/molvis/v 22/454> © 2016 Molecular Vision  47028.,Non-OADS,/arxiv_data1/oa_pdf/5d/29/mv-v22-454.PMC4872278.pdf
Molecular Vision  2016; 22:454-471 <http://www.molvis.org/molvis/v 22/454> © 2016 Molecular Vision  471susceptibility to diseases.,Non-OADS,/arxiv_data1/oa_pdf/5d/29/mv-v22-454.PMC4872278.pdf
"The  TSPAN12 protein enhances FZD4 oligomerization through  physical binding and thus, efficiently induces the signaling Molecular Vision  2016; 22:491-502 <http://www.molvis.org/molvis/v 22/491> Received 10 December 2013 | Accepted 13 May 2016 | Published 16 May 2016© 2016 Molecular Vision 491Mutation spectrum of the Norrie disease pseudoglioma ( NDP )  gene in Indian patients with FEVR Ganeswara Rao Musada,1 Subhadra Jalali,2 Anjli Hussain,2 Anupama Reddy Chururu,3 Pramod Reddy  Gaddam,3 Subhabrata Chakrabarti,1 Inderjeet Kaur1 1Kallam Anji Reddy Molecular Genetics Laboratory, Brien Holden Eye Research Centre, BHERC, L V Prasad Eye Institute,  Hyderabad, India; 2Smt.",Non-OADS,/arxiv_data1/oa_pdf/bd/6a/mv-v22-491.PMC4872281.pdf
"Molecular Vision  2016; 22:491-502 <http://www.molvis.org/molvis/v 22/491> © 2016 Molecular Vision  492pathway [ 32,36].",Non-OADS,/arxiv_data1/oa_pdf/bd/6a/mv-v22-491.PMC4872281.pdf
Molecular Vision  2016; 22:491-502 <http://www.molvis.org/molvis/v 22/491> © 2016 Molecular Vision  493Confirmation of the observed variants and bioinformatics  analysis:  The observed variants in the NDP  gene were further  validated with resequencing by another investigator who  was masked to the genotype of the subjects.,Non-OADS,/arxiv_data1/oa_pdf/bd/6a/mv-v22-491.PMC4872281.pdf
Molecular Vision  2016; 22:491-502 <http://www.molvis.org/molvis/v 22/491> © 2016 Molecular Vision  494deletions led to a frame shift and the formation of prema - ture termination codons.,Non-OADS,/arxiv_data1/oa_pdf/bd/6a/mv-v22-491.PMC4872281.pdf
Molecular Vision  2016; 22:491-502 <http://www.molvis.org/molvis/v 22/491> © 2016 Molecular Vision  495Almost all probands harboring NDP  mutations presented  with a bilaterally severe form of FEVR at <1 year of age.,Non-OADS,/arxiv_data1/oa_pdf/bd/6a/mv-v22-491.PMC4872281.pdf
Molecular Vision  2016; 22:491-502 <http://www.molvis.org/molvis/v 22/491> © 2016 Molecular Vision  496Table  2. m UTaTions observed  in NDP  gene  in fevr PaTienTs.,Non-OADS,/arxiv_data1/oa_pdf/bd/6a/mv-v22-491.PMC4872281.pdf
"Molecular Vision  2016; 22:491-502 <http://www.molvis.org/molvis/v 22/491> © 2016 Molecular Vision  497It was found that Norrin exists as a homodimer in the solu - tion and contains different binding surfaces for FZD4, LRP5,  and the extracellular matrix [ 62,63].",OADS,/arxiv_data1/oa_pdf/bd/6a/mv-v22-491.PMC4872281.pdf
Molecular Vision  2016; 22:491-502 <http://www.molvis.org/molvis/v 22/491> © 2016 Molecular Vision  498 Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/bd/6a/mv-v22-491.PMC4872281.pdf
"Molecular Vision  2016; 22:491-502 <http://www.molvis.org/molvis/v 22/491> © 2016 Molecular Vision  499In summary, to the best of our knowledge, this is perhaps  the first study providing a mutation spectrum of the NDP   gene in Indian patients with FEVR.",Non-OADS,/arxiv_data1/oa_pdf/bd/6a/mv-v22-491.PMC4872281.pdf
"Molecular Vision  2016; 22:491-502 <http://www.molvis.org/molvis/v 22/491> © 2016 Molecular Vision  500Overview of the mutation spectrum in familial exudative  vitreoretinopathy and Norrie disease with identification of  21 novel variants in FZD4, LRP5, and NDP.",Non-OADS,/arxiv_data1/oa_pdf/bd/6a/mv-v22-491.PMC4872281.pdf
Molecular Vision  2016; 22:491-502 <http://www.molvis.org/molvis/v 22/491> © 2016 Molecular Vision  501development of the retinal vasculature.,Non-OADS,/arxiv_data1/oa_pdf/bd/6a/mv-v22-491.PMC4872281.pdf
Available at: http://evs.gs.washington.,Non-OADS,/arxiv_data1/oa_pdf/bd/6a/mv-v22-491.PMC4872281.pdf
Available at: http://evs.gs.washington.edu/niehsExome .,Non-OADS,/arxiv_data1/oa_pdf/bd/6a/mv-v22-491.PMC4872281.pdf
Available at: http://exac.broadinstitute.org .,Non-OADS,/arxiv_data1/oa_pdf/bd/6a/mv-v22-491.PMC4872281.pdf
Molecular Vision  2016; 22:491-502 <http://www.molvis.org/molvis/v 22/491> © 2016 Molecular Vision  502thresholds for variant predictions.,Non-OADS,/arxiv_data1/oa_pdf/bd/6a/mv-v22-491.PMC4872281.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/29/96/ehv419.PMC4872283.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/b4/ehv647.PMC4872284.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/11/ehv728.PMC4872285.pdf
"This is an Open Access article distributed under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/66/59/ciw133.PMC4872289.pdf
Available at: http://www.accessdata.fda.gov/drugsatfda_docs/ label/2015/206494lbl.pdf .,Non-OADS,/arxiv_data1/oa_pdf/66/59/ciw133.PMC4872289.pdf
"This is an Open Access article distributed under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d4/4a/ciw158.PMC4872294.pdf
Available at:http://apps.who.int/ebola/current-situation/ebola-situation-report-2-march- 2016 .,Non-OADS,/arxiv_data1/oa_pdf/d4/4a/ciw158.PMC4872294.pdf
Available at: http://apps.who.int/iris/bitstream/10665/61113/1/WHO_MNH_ PSF_94.8.pdf .,OADS,/arxiv_data1/oa_pdf/d4/4a/ciw158.PMC4872294.pdf
Available at: http://www.theguardian.com/world/2015/oct/21/ebola-nurse- pauline-cafferkey-condition-serious-but-stable-royal-free-hospital .,Non-OADS,/arxiv_data1/oa_pdf/d4/4a/ciw158.PMC4872294.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/eb/38/main.PMC4872312.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.03.004 189,OADS,/arxiv_data1/oa_pdf/eb/38/main.PMC4872312.pdf
2015; http://www.floridacharts.com/charts/OtherIndicators/NonVital IndNoGrpCountsDataViewer.aspx?cid=0174 .,OADS,/arxiv_data1/oa_pdf/eb/38/main.PMC4872312.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.03.009,Non-OADS,/arxiv_data1/oa_pdf/24/89/main.PMC4872313.pdf
"isolates were determined and interpreted according to the recommendations of the French Society for Microbiology and the European Committee on Antimicrobial Susceptibility Testing (CA-SFM/EUCAST, available at http://www.sfm-microbiologie.",Non-OADS,/arxiv_data1/oa_pdf/24/89/main.PMC4872313.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,8–17 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/24/89/main.PMC4872313.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,8–17 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/24/89/main.PMC4872313.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,8–17 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/24/89/main.PMC4872313.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,8–17 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/24/89/main.PMC4872313.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,8–17 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/24/89/main.PMC4872313.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,8–17 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/24/89/main.PMC4872313.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,8–17 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/24/89/main.PMC4872313.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,8–17 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/24/89/main.PMC4872313.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,8–17 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/24/89/main.PMC4872313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Next generation sequencingMalariaPlasmodium falciparum Chloroquine resistance Transcriptomics Speci ﬁcations Organism/cell line/tissue Plasmodium falciparum 3D7 (chloroquine sensitive) and Dd2 (chloroquine resistant) strains Sex N/ASequencer or array type Illumina HiSeq 2500Data format Raw and analyzedExperimental factors Laboratory strains.,Non-OADS,/arxiv_data1/oa_pdf/37/a2/main.PMC4872366.pdf
Direct link to deposited data The raw data have been deposited in the BioProject database of NCBI with the accession no PRJNA308455 ( http://www.ncbi.nlm.nih.gov/ bioproject/308455 ).,OADS,/arxiv_data1/oa_pdf/37/a2/main.PMC4872366.pdf
The processed data have been submitted in NCBI under the Gene Expression Omnibus (GEO) with the accession noGSE77499 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?,OADS,/arxiv_data1/oa_pdf/37/a2/main.PMC4872366.pdf
http://dx.doi.org/10.1016/j.gdata.2016.04.004 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/37/a2/main.PMC4872366.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/a2/main.PMC4872366.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: RibosomesrRNA biosynthesis RNA Pol I Storage lipidsTriacylglycerol Speci ﬁcations Organism/cell line/tissueSaccharomyces cerevisiae Wild-type (BY4741) and rpa12 Δ strain Sequencer or array typeAffymetrix Yeast Genome 2.0 Array Data format Raw data (CEL ﬁle) Experimental factorsWild-type Vs rpa12 Δcells Experimental featuresIdenti ﬁcation of genes that are regulated through RPA12 Consent Publicly available from NCBI GEOSample source locationYeast deletion strains are maintained in CSIR-CFTRI,Mysore-570020, Karnataka 1.",Non-OADS,/arxiv_data1/oa_pdf/8d/67/main.PMC4872367.pdf
Direct link to deposited data The data are available at the GEO database under: http://www.ncbi.,OADS,/arxiv_data1/oa_pdf/8d/67/main.PMC4872367.pdf
http://dx.doi.org/10.1016/j.gdata.2016.04.011 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/67/main.PMC4872367.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8d/67/main.PMC4872367.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1d/ce/main.PMC4872368.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.04.005,Non-OADS,/arxiv_data1/oa_pdf/1d/ce/main.PMC4872368.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,4 3–44 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/1d/ce/main.PMC4872368.pdf
This is an open access article under the CC BY-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/1e/main.PMC4872369.pdf
"A striking rise in cases of melioidosis was observed after the December 2004 tsunami, and the disease was also more common after ﬂoods in Malaysia in 2015 ( http://www.promedmail.org/direct.php?id=3218685 ).",Non-OADS,/arxiv_data1/oa_pdf/af/1e/main.PMC4872369.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.04.004,Non-OADS,/arxiv_data1/oa_pdf/af/1e/main.PMC4872369.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,3 1–34 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/af/1e/main.PMC4872369.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,3 1–34 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/af/1e/main.PMC4872369.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,3 1–34 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/af/1e/main.PMC4872369.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d8/f1/main.PMC4872371.pdf
A  computer-based  patient-matched  titanium  mesh http://dx.doi.org/10.1016/j.ijscr.2016.04.039 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/d8/f1/main.PMC4872371.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the online  version,  at  http://dx.doi.org/10.1016/j.ijscr.2016.04.039 .",OADS,/arxiv_data1/oa_pdf/d8/f1/main.PMC4872371.pdf
"When we applied this strategy to a stool sample from a healthy 1-year-old boy from Senegal, bacterium strain SIT15 was isolated by matrix-assisted desorption ionization –time of ﬂight mass spectrometry but failed to provide systematic identi ﬁcation ( http://www.mediterranee-infection.com/article.",Non-OADS,/arxiv_data1/oa_pdf/39/f9/main.PMC4872372.pdf
A BLASTn analysis was performed against the online GenBank database ( http://blast.ncbi.nlm.nih.gov.gate1.inist.fr/Blast.cgi ).,OADS,/arxiv_data1/oa_pdf/39/f9/main.PMC4872372.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.04.002,Non-OADS,/arxiv_data1/oa_pdf/39/f9/main.PMC4872372.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,5 2 –53 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/39/f9/main.PMC4872372.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.04.003,Non-OADS,/arxiv_data1/oa_pdf/85/b5/main.PMC4872373.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,5 4 –55 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/85/b5/main.PMC4872373.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/78/6a/rjw097.PMC4872392.pdf
Caucasian subjects were identi ﬁed using the Enhancing Neuroimaging Genetics through Meta-Analysis(ENIGMA) multidimensional scaling protocol (http://enigma.ini.usc.edu/protocols/genetics-protocols/).,Non-OADS,/arxiv_data1/oa_pdf/09/15/tp2015211a.PMC4872419.pdf
48The risk allele and odds ratio used to create GRS were derived from the PGC recent 2014 GWAS6(http://www.med.unc.edu/pgc/ downloads).,OADS,/arxiv_data1/oa_pdf/09/15/tp2015211a.PMC4872419.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)MicroRNA-137-regulated genes in ﬂuence gray matter C Wright et al 8 Translational Psychiatry (2016), 1 –8",Non-OADS,/arxiv_data1/oa_pdf/09/15/tp2015211a.PMC4872419.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c0/a0/main.PMC4872469.pdf
A  CT  scan  performed  4  days  after  admission http://dx.doi.org/10.1016/j.ijscr.2016.04.051 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/c0/a0/main.PMC4872469.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c2/70/main.PMC4872470.pdf
Omental  adhesions  to  the  gall- http://dx.doi.org/10.1016/j.ijscr.2016.04.050 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/c2/70/main.PMC4872470.pdf
"(New  York,  N.Y.)  24  (2011)  757–762,  http://dx.doi.org/ 10.1002/ca.21146 .",Non-OADS,/arxiv_data1/oa_pdf/c2/70/main.PMC4872470.pdf
"2013  (2013),  http://dx.doi.org/10.1155/2013/269543 , 269543.",Non-OADS,/arxiv_data1/oa_pdf/c2/70/main.PMC4872470.pdf
"10  (2015) 2400–2402, http://dx.doi.org/10.3892/ol.2015.3622 .",Non-OADS,/arxiv_data1/oa_pdf/c2/70/main.PMC4872470.pdf
"194 (2007)  225–226,  http://dx.doi.org/10.1016/j.amjsurg.2006.11.023 .",OADS,/arxiv_data1/oa_pdf/c2/70/main.PMC4872470.pdf
"24  (2004)  216–217,  http://dx.doi.org/10.1111/j.1478-3231.2004.",Non-OADS,/arxiv_data1/oa_pdf/c2/70/main.PMC4872470.pdf
"28  (2005)  640,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c2/70/main.PMC4872470.pdf
"17  (2013) 1893–1896,  http://dx.doi.org/10.1007/s11605-013-2239-9 .",Non-OADS,/arxiv_data1/oa_pdf/c2/70/main.PMC4872470.pdf
"41  (2013)  466–469,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c2/70/main.PMC4872470.pdf
"Zhang,  H.M.  Jia,  Symptomatic  accessory  spleen,  Surgery  144  (2008) 476–477, http://dx.doi.org/10.1016/j.surg.2007.10.024 .",OADS,/arxiv_data1/oa_pdf/c2/70/main.PMC4872470.pdf
"183  (2004)  1653–1657,  http://dx.doi.org/10.2214/ajr.183.",Non-OADS,/arxiv_data1/oa_pdf/c2/70/main.PMC4872470.pdf
This  is  an  open access article under the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f5/db/main.PMC4872471.pdf
"2)  At  the  time  the  patient’s  symptoms  were  interpreted  as  a left-sided pneumonia,  and  the  patient  was  treated  with  antibiotics http://dx.doi.org/10.1016/j.ijscr.2016.05.005 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/f5/db/main.PMC4872471.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/2d/main.PMC4872472.pdf
During  removal  of  his  port  a  large  abscess  cavity  was http://dx.doi.org/10.1016/j.ijscr.2016.04.048 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/03/2d/main.PMC4872472.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/cf/dd/JPI-7-25.PMC4872474.pdf
"J Pathol Inform 2016, 1:25  http://www.jpathinformatics.org/content/7/1/25of the available platforms and can be viewed at any time  as if one is using a light microscope.",Non-OADS,/arxiv_data1/oa_pdf/cf/dd/JPI-7-25.PMC4872474.pdf
"J Pathol Inform 2016, 1:25  http://www.jpathinformatics.org/content/7/1/25slide- and WSI-based diagnoses as well as the original  report diagnoses to determine the concordance.",OADS,/arxiv_data1/oa_pdf/cf/dd/JPI-7-25.PMC4872474.pdf
"J Pathol Inform 2016, 1:25  http://www.jpathinformatics.org/content/7/1/2514 (14.4%) cases at the time of WSI review and on  17 (17.5%) cases at the time of slide review.",Non-OADS,/arxiv_data1/oa_pdf/cf/dd/JPI-7-25.PMC4872474.pdf
"J Pathol Inform 2016, 1:25  http://www.jpathinformatics.org/content/7/1/25example, additional data from medical records, review of  the imaging studies, or discussions with the neurosurgeon  or clinical team as well as special stains to further specify  the diagnosis would affect the final report and none  were available to the reviewers in our study.",Non-OADS,/arxiv_data1/oa_pdf/cf/dd/JPI-7-25.PMC4872474.pdf
"International Journal of Preventive Medicine 2016, 7:72 http://www.ijpvmjournal.net/content/7/1/72this type of diabetes in Africa is varying between   %1.7   (in Uganda) and %4.5 (in South Africa), in Europe and  North America is varied between %4.9 (in the UK) and  %14.4 (in Portugal).",Non-OADS,/arxiv_data1/oa_pdf/04/c7/IJPVM-7-72.PMC4872475.pdf
"International Journal of Preventive Medicine 2016, 7:72 http://www.ijpvmjournal.net/content/7/1/72represent more realistic cost of the services, we analyzed  our findings based on the private tariffs.",Non-OADS,/arxiv_data1/oa_pdf/04/c7/IJPVM-7-72.PMC4872475.pdf
"International Journal of Preventive Medicine 2016, 7:72 http://www.ijpvmjournal.net/content/7/1/72In addition to the age distribution, the noteworthy  finding to be considered in managing diabetes was the  transition interval of the patients between different  patient groups (groups I to IV).",Non-OADS,/arxiv_data1/oa_pdf/04/c7/IJPVM-7-72.PMC4872475.pdf
"International Journal of Preventive Medicine 2016, 7:72 http://www.ijpvmjournal.net/content/7/1/72Diabetes Res Clin Pract 2013;100:280‑1.",Non-OADS,/arxiv_data1/oa_pdf/04/c7/IJPVM-7-72.PMC4872475.pdf
Available from: http://www.cadth.ca/media/pdf/186_ EconomicGuidelines_e.pdf.,Non-OADS,/arxiv_data1/oa_pdf/04/c7/IJPVM-7-72.PMC4872475.pdf
Available from:  http://www.cbi.ir/ExRates/rates_en.aspx; [Last accessed on 2014 Mar 08].,OADS,/arxiv_data1/oa_pdf/04/c7/IJPVM-7-72.PMC4872475.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/73/2c/JPI-7-21.PMC4872476.pdf
"J Pathol Inform 2016, 1:21  http://www.jpathinformatics.org/content/7/1/21based on the DNA distribution of these nuclei  (DNA ploidy analysis).",OADS,/arxiv_data1/oa_pdf/73/2c/JPI-7-21.PMC4872476.pdf
"J Pathol Inform 2016, 1:21  http://www.jpathinformatics.org/content/7/1/21and test sets by automatically scanning areas of about  0.5 cm × 0.5 cm using the same microscope.",Non-OADS,/arxiv_data1/oa_pdf/73/2c/JPI-7-21.PMC4872476.pdf
"J Pathol Inform 2016, 1:21  http://www.jpathinformatics.org/content/7/1/21several images at increasing defocus levels are available.",Non-OADS,/arxiv_data1/oa_pdf/73/2c/JPI-7-21.PMC4872476.pdf
"J Pathol Inform 2016, 1:21  http://www.jpathinformatics.org/content/7/1/21cytometry coincide for 85 cases.",Non-OADS,/arxiv_data1/oa_pdf/73/2c/JPI-7-21.PMC4872476.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/23/a6/JPI-7-26.PMC4872477.pdf
"J Pathol Inform 2016, 1:26  http://www.jpathinformatics.org/content/7/1/26INTRODUCTION Telepathology was first described in 1986 as a tool to  deliver pathology services over a distance.",Non-OADS,/arxiv_data1/oa_pdf/23/a6/JPI-7-26.PMC4872477.pdf
"J Pathol Inform 2016, 1:26  http://www.jpathinformatics.org/content/7/1/26video file is saved in.",OADS,/arxiv_data1/oa_pdf/23/a6/JPI-7-26.PMC4872477.pdf
"Digital slides (.svs format) were  viewed  using ImageScope software (Aperio ePathology,  Leica Biosystems; http://www.leicabiosystems.com/digital- pathology/digital-pathology-management/imagescope/).",OADS,/arxiv_data1/oa_pdf/23/a6/JPI-7-26.PMC4872477.pdf
"J Pathol Inform 2016, 1:26  http://www.jpathinformatics.org/content/7/1/26superior to WSI.",Non-OADS,/arxiv_data1/oa_pdf/23/a6/JPI-7-26.PMC4872477.pdf
"J Pathol Inform 2016, 1:26  http://www.jpathinformatics.org/content/7/1/26In this study, we have shown that the Panoptiq imaging  system can be used for frozen section telepathology.",Non-OADS,/arxiv_data1/oa_pdf/23/a6/JPI-7-26.PMC4872477.pdf
"J Pathol Inform 2016, 1:26  http://www.jpathinformatics.org/content/7/1/26engage in a bi-directional dialog and could reselect areas of  interest for recording Z-stacks.",OADS,/arxiv_data1/oa_pdf/23/a6/JPI-7-26.PMC4872477.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/ff/3a/JPI-7-24.PMC4872478.pdf
"J Pathol Inform 2016, 1:24  http://www.jpathinformatics.org/content/7/1/24of patient cases to be diagnosed, as well as an increased  complexity of pathology processes in individual  laboratories.",Non-OADS,/arxiv_data1/oa_pdf/ff/3a/JPI-7-24.PMC4872478.pdf
"J Pathol Inform 2016, 1:24  http://www.jpathinformatics.org/content/7/1/24time for processing surgical specimens.",Non-OADS,/arxiv_data1/oa_pdf/ff/3a/JPI-7-24.PMC4872478.pdf
"J Pathol Inform 2016, 1:24  http://www.jpathinformatics.org/content/7/1/24component of the second dashboard prototype, especially  the latter indicates which cases contain specimens that  exceed, or are close to exceeding, their target processing  time.",Non-OADS,/arxiv_data1/oa_pdf/ff/3a/JPI-7-24.PMC4872478.pdf
"J Pathol Inform 2016, 1:24  http://www.jpathinformatics.org/content/7/1/24report, namely, grossing, slide preparation, and pathologist  assessments.",Non-OADS,/arxiv_data1/oa_pdf/ff/3a/JPI-7-24.PMC4872478.pdf
"J Pathol Inform 2016, 1:24  http://www.jpathinformatics.org/content/7/1/24uncover additional stakeholder requirements.",Non-OADS,/arxiv_data1/oa_pdf/ff/3a/JPI-7-24.PMC4872478.pdf
"J Pathol Inform 2016, 1:24  http://www.jpathinformatics.org/content/7/1/24functionalities of the IBM® Cognos® BI tool thus allowed  us to develop a pathology-specific dashboard that met  both initial requirements identified for the first prototype  and new requirements that were identified through using  PowerJ.",Non-OADS,/arxiv_data1/oa_pdf/ff/3a/JPI-7-24.PMC4872478.pdf
"J Pathol Inform 2016, 1:24  http://www.jpathinformatics.org/content/7/1/24The list can also be sorted by case processing stage (needs  embedding, needs microtomy, needs quality control and  distribution, needs diagnosis, and needs finalized) and case  date of creation.",OADS,/arxiv_data1/oa_pdf/ff/3a/JPI-7-24.PMC4872478.pdf
"J Pathol Inform 2016, 1:24  http://www.jpathinformatics.org/content/7/1/24bottleneck issues.",Non-OADS,/arxiv_data1/oa_pdf/ff/3a/JPI-7-24.PMC4872478.pdf
"J Pathol Inform 2016, 1:24  http://www.jpathinformatics.org/content/7/1/24experience improvement.",Non-OADS,/arxiv_data1/oa_pdf/ff/3a/JPI-7-24.PMC4872478.pdf
"J Pathol Inform 2016, 1:24  http://www.jpathinformatics.org/content/7/1/24Conflicts of Interest Wei Chen Li and Randy Giffen are employees of IBM  Canada.",Non-OADS,/arxiv_data1/oa_pdf/ff/3a/JPI-7-24.PMC4872478.pdf
Available from: http://www.demo.altosoft.,Non-OADS,/arxiv_data1/oa_pdf/ff/3a/JPI-7-24.PMC4872478.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/34/9a/JPI-7-23.PMC4872480.pdf
"J Pathol Inform 2016, 1:23  http://www.jpathinformatics.org/content/7/1/23INTRODUCTION Currently, there are two key information technology (IT)  building blocks available to anatomic pathology laboratories  that intend to implement a digital surgical pathology  solution.",Non-OADS,/arxiv_data1/oa_pdf/34/9a/JPI-7-23.PMC4872480.pdf
"J Pathol Inform 2016, 1:23  http://www.jpathinformatics.org/content/7/1/23when a case is accessioned into the APLIS, the APLIS  acting as a web client sends notifications containing  case and histology data (e.g., patient name/identifiers/ date of birth/gender, case accession number/date/ priority/ordering provider identifier/primary pathologist  identifier, part/block/slide data, slide status, etc.)",Non-OADS,/arxiv_data1/oa_pdf/34/9a/JPI-7-23.PMC4872480.pdf
"J Pathol Inform 2016, 1:23  http://www.jpathinformatics.org/content/7/1/23ready in the histology laboratory for distribution until  they are available for pathologists to be viewed.",Non-OADS,/arxiv_data1/oa_pdf/34/9a/JPI-7-23.PMC4872480.pdf
"J Pathol Inform 2016, 1:23  http://www.jpathinformatics.org/content/7/1/23integrate these two systems using web services.",OADS,/arxiv_data1/oa_pdf/34/9a/JPI-7-23.PMC4872480.pdf
"J Pathol Inform 2016, 1:23  http://www.jpathinformatics.org/content/7/1/23Conflicts of Interest UPMC is a part owner of Omnyx.",Non-OADS,/arxiv_data1/oa_pdf/34/9a/JPI-7-23.PMC4872480.pdf
"International Journal of Preventive Medicine 2016, 7:73 http://www.ijpvmjournal.net/content/7/1/73two risk factors increases the risk of cutaneous malignant  melanoma 2–4 times and the presence of three or more  risk factors increases the risk 20 times.",Non-OADS,/arxiv_data1/oa_pdf/81/d5/IJPVM-7-73.PMC4872481.pdf
"International Journal of Preventive Medicine 2016, 7:73 http://www.ijpvmjournal.net/content/7/1/73rates in Denmark (21.9 per 100,000), Switzerland  (20.5 per 100.000), and The Netherlands (39 per  100,000).",Non-OADS,/arxiv_data1/oa_pdf/81/d5/IJPVM-7-73.PMC4872481.pdf
"International Journal of Preventive Medicine 2016, 7:73 http://www.ijpvmjournal.net/content/7/1/73Lens and Newton-Bishop conducted a systematic  review about the association between cutaneous  malignant melanoma and other types of cancer.",Non-OADS,/arxiv_data1/oa_pdf/81/d5/IJPVM-7-73.PMC4872481.pdf
"International Journal of Preventive Medicine 2016, 7:73 http://www.ijpvmjournal.net/content/7/1/73history family of melanoma, history of burns, body mass  index, weight, and parity.",Non-OADS,/arxiv_data1/oa_pdf/81/d5/IJPVM-7-73.PMC4872481.pdf
Available from:  http://www.iarc.fr/.,Non-OADS,/arxiv_data1/oa_pdf/81/d5/IJPVM-7-73.PMC4872481.pdf
Available from: http://www.who.int/ whosis.,OADS,/arxiv_data1/oa_pdf/81/d5/IJPVM-7-73.PMC4872481.pdf
Available from: http://www.un.org/.,Non-OADS,/arxiv_data1/oa_pdf/81/d5/IJPVM-7-73.PMC4872481.pdf
This experiment  was captured in an abridged video available on Y ouT ube  (http://www.youtu.be/flzGjnJLyS0); experimental procedures   were approved by an institutional animal care and use  committee.,Non-OADS,/arxiv_data1/oa_pdf/cb/96/JPI-7-19.PMC4872482.pdf
"J Pathol Inform 2016, 1:19  http://www.jpathinformatics.org/content/7/1/19when the birds were shown monochrome (grayscale) but  hue‑normalized images, where color and luminance cues  were now eliminated.",Non-OADS,/arxiv_data1/oa_pdf/cb/96/JPI-7-19.PMC4872482.pdf
Available from: http://www.tissuepathology.,Non-OADS,/arxiv_data1/oa_pdf/cb/96/JPI-7-19.PMC4872482.pdf
"J Pathol Inform 2016, 1:19  http://www.jpathinformatics.org/content/7/1/19This is an open access article distributed under the terms of the Creative Commons  Attribution‑NonCommercial‑ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non‑commercially, as long as the author is credited  and the new creations are licensed under the identical terms.Access this article online Quick Response Code: Website:    www.jpathinformatics.org This article may be cited as:  Pantanowitz L, Glassy E. Commentary: Has pathology gone to the ""birds"" because we  have just been ""winging"" it?.",Non-OADS,/arxiv_data1/oa_pdf/cb/96/JPI-7-19.PMC4872482.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/cb/96/JPI-7-19.PMC4872482.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/37/07/JPI-7-20.PMC4872483.pdf
"J Pathol Inform 2016, 1:20  http://www.jpathinformatics.org/content/7/1/20chemotherapy and appear to have an association with the  IG‑MYC translocation.",Non-OADS,/arxiv_data1/oa_pdf/37/07/JPI-7-20.PMC4872483.pdf
"J Pathol Inform 2016, 1:20  http://www.jpathinformatics.org/content/7/1/20translocation is detected by the Vysis LSI IGH/MYC/VYSIS  chromosome enumeration probe (CEP) 8 tricolor dual  fusion probe kit (Abbott Laboratories).",OADS,/arxiv_data1/oa_pdf/37/07/JPI-7-20.PMC4872483.pdf
"J Pathol Inform 2016, 1:20  http://www.jpathinformatics.org/content/7/1/20the identification of nuclei, and identified nuclei  are circled by the software [ Figure  2].",OADS,/arxiv_data1/oa_pdf/37/07/JPI-7-20.PMC4872483.pdf
"J Pathol Inform 2016, 1:20  http://www.jpathinformatics.org/content/7/1/202F signals are defined as having, at least, 2F signals  and, at least, 1G and 1O signal.",OADS,/arxiv_data1/oa_pdf/37/07/JPI-7-20.PMC4872483.pdf
"J Pathol Inform 2016, 1:20  http://www.jpathinformatics.org/content/7/1/20cutoffs, 100% (53/53) positive samples, 85% (17/20)  negative samples, and 50% (2/4) borderline samples were  accurately classified for a 94% rate of correlation between  GenASIs and traditional FISH analysis methods.",OADS,/arxiv_data1/oa_pdf/37/07/JPI-7-20.PMC4872483.pdf
"J Pathol Inform 2016, 1:20  http://www.jpathinformatics.org/content/7/1/20negative for an MYC  (8q14) rearrangement.",Non-OADS,/arxiv_data1/oa_pdf/37/07/JPI-7-20.PMC4872483.pdf
"J Pathol Inform 2016, 1:20  http://www.jpathinformatics.org/content/7/1/20a Metafer 4 scanning system (MetaSystems, Altlussheim,  Germany).",OADS,/arxiv_data1/oa_pdf/37/07/JPI-7-20.PMC4872483.pdf
"J Pathol Inform 2016, 1:20  http://www.jpathinformatics.org/content/7/1/20becomes an issue, since files stay large but is important  to maintain image quality and accuracy.",Non-OADS,/arxiv_data1/oa_pdf/37/07/JPI-7-20.PMC4872483.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/92/3a/JPI-7-22.PMC4872484.pdf
"J Pathol Inform 2016, 1:22  http://www.jpathinformatics.org/content/7/1/22or completely replace the real world with computer- generated data to facilitate user interaction via one’s  natural senses.",Non-OADS,/arxiv_data1/oa_pdf/92/3a/JPI-7-22.PMC4872484.pdf
"Initially, we investigated the possibility of creating our  own VR software using the development kit provided  by Oculus (SDK 0.8.0.0) and a unity 3D plugin  (http://www.unity3d.com/unity), a popular cross-platform  game engine.",Non-OADS,/arxiv_data1/oa_pdf/92/3a/JPI-7-22.PMC4872484.pdf
"For ease of use, we  opted to instead use commercially available Virtual  Desktop software (v0.9.34) (http://www.vrdesktop.net/)  for navigation of digital slides.",Non-OADS,/arxiv_data1/oa_pdf/92/3a/JPI-7-22.PMC4872484.pdf
"Navigation of digital  whole slides with the Oculus Rift was tested using  keyboard controls, an optical mouse, and a Leap Motion  controller (https://www.leapmotion.com/product/vr).",Non-OADS,/arxiv_data1/oa_pdf/92/3a/JPI-7-22.PMC4872484.pdf
"J Pathol Inform 2016, 1:22  http://www.jpathinformatics.org/content/7/1/22nonparticipants in the viewing phase of the study.",Non-OADS,/arxiv_data1/oa_pdf/92/3a/JPI-7-22.PMC4872484.pdf
"J Pathol Inform 2016, 1:22  http://www.jpathinformatics.org/content/7/1/22environment.",Non-OADS,/arxiv_data1/oa_pdf/92/3a/JPI-7-22.PMC4872484.pdf
"J Pathol Inform 2016, 1:22  http://www.jpathinformatics.org/content/7/1/22great potential use in pathology teaching, especially if  combined with 3D images (e.g., 3D models of gross  pathology specimens).",Non-OADS,/arxiv_data1/oa_pdf/92/3a/JPI-7-22.PMC4872484.pdf
Available from: http://csdl.computer.org/comp/proceedings/ vr/2003/1882/00/18820302abs.htm.,Non-OADS,/arxiv_data1/oa_pdf/92/3a/JPI-7-22.PMC4872484.pdf
Available from:  http://www.forbes.com/sites/erikkain/2016/01/06/is‑599‑too‑much‑to‑pay‑ for‑the‑oculus‑rift/.,Non-OADS,/arxiv_data1/oa_pdf/92/3a/JPI-7-22.PMC4872484.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/82/rjw098.PMC4872500.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/77/ae/rjw090.PMC4872504.pdf
"International Journal of Preventive Medicine 2016, 7:70 http://www.ijpvmjournal.net/content/7/1/70Search strategy To find published electronic studies until February 20, 2015,  national (Scientific Information Database, Iranmedex,  Magiran, and Irandoc) and international (PubMed,  Google Scholar, Scopus, and ScienceDirect) databases  were reviewed.",Non-OADS,/arxiv_data1/oa_pdf/24/eb/IJPVM-7-70.PMC4872517.pdf
"International Journal of Preventive Medicine 2016, 7:70 http://www.ijpvmjournal.net/content/7/1/70scores were excluded from the systematic review and  meta‑analysis.",Non-OADS,/arxiv_data1/oa_pdf/24/eb/IJPVM-7-70.PMC4872517.pdf
"International Journal of Preventive Medicine 2016, 7:70 http://www.ijpvmjournal.net/content/7/1/702014.",Non-OADS,/arxiv_data1/oa_pdf/24/eb/IJPVM-7-70.PMC4872517.pdf
"International Journal of Preventive Medicine 2016, 7:70 http://www.ijpvmjournal.net/content/7/1/7035 different HPV genotypes were reported.",Non-OADS,/arxiv_data1/oa_pdf/24/eb/IJPVM-7-70.PMC4872517.pdf
"International Journal of Preventive Medicine 2016, 7:70 http://www.ijpvmjournal.net/content/7/1/70age of 43.4 years.",Non-OADS,/arxiv_data1/oa_pdf/24/eb/IJPVM-7-70.PMC4872517.pdf
"International Journal of Preventive Medicine 2016, 7:70 http://www.ijpvmjournal.net/content/7/1/70infection among African American, Asian, and Hispanic women.",Non-OADS,/arxiv_data1/oa_pdf/24/eb/IJPVM-7-70.PMC4872517.pdf
"International Journal of Preventive Medicine 2016, 7:71 http://www.ijpvmjournal.net/content/7/1/71people every year across the world and causing billions  of dollars in economic loss.",Non-OADS,/arxiv_data1/oa_pdf/6f/3a/IJPVM-7-71.PMC4872545.pdf
"International Journal of Preventive Medicine 2016, 7:71 http://www.ijpvmjournal.net/content/7/1/71freedom from job preoccupations, it was coordinated  with each relevant department’s authority to provide the  respondents with questionnaires during hours in which  administrative visitors were scarce.",Non-OADS,/arxiv_data1/oa_pdf/6f/3a/IJPVM-7-71.PMC4872545.pdf
"International Journal of Preventive Medicine 2016, 7:71 http://www.ijpvmjournal.net/content/7/1/71counterpart groups, but their relationships were not  significant [Table  3].",OADS,/arxiv_data1/oa_pdf/6f/3a/IJPVM-7-71.PMC4872545.pdf
"International Journal of Preventive Medicine 2016, 7:71 http://www.ijpvmjournal.net/content/7/1/71In this study, the rate of tobacco use was higher among  individuals over 40 compared to the younger individuals.",Non-OADS,/arxiv_data1/oa_pdf/6f/3a/IJPVM-7-71.PMC4872545.pdf
"International Journal of Preventive Medicine 2016, 7:71 http://www.ijpvmjournal.net/content/7/1/71the latest studies conducted on the risk factors of NCD  in a sample of employees in Kermanshah, tobacco use  and other risk factors of diabetes and heart diseases were  substandard, just as in other groups in the society, which  necessitates further attention, as quitting smoking can  prevent the development of cardiovascular diseases in the  employees,[9,7] The first strength of this study was its large sample  size, which can be said to have covered samples from  all the classes of employees in Kermanshah Province.",Non-OADS,/arxiv_data1/oa_pdf/6f/3a/IJPVM-7-71.PMC4872545.pdf
Available from: http://www.who.int/tobacco/ global_report/2011/en/.,Non-OADS,/arxiv_data1/oa_pdf/6f/3a/IJPVM-7-71.PMC4872545.pdf
Available from: http://www.who.int/tobacco/surveillance/ policy/country_profile/en/.,Non-OADS,/arxiv_data1/oa_pdf/6f/3a/IJPVM-7-71.PMC4872545.pdf
< http://www.theglobeandmail.com/report-on-business/economy/ economic-insight/saudi-arabias-oil-supply-strategy-could-turn-ugly-for-all-producers/article28756025/ >.,Non-OADS,/arxiv_data1/oa_pdf/8a/9c/policy-11-012.PMC4872548.pdf
< http://caho-hospitals.com/wp-content/uploads/2013/09/CAHO-ARTIC-Phase-1- Evaluation-Final-Report.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/d3/4b/policy-11-027.PMC4872550.pdf
< http://cihc.ca/files/members/pke/ SpeedingUpTheSpread_KT08.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/d3/4b/policy-11-027.PMC4872550.pdf
< http://src-online.ca/index.php/src/ article/view/175 >.,Non-OADS,/arxiv_data1/oa_pdf/ca/bf/policy-11-040.PMC4872551.pdf
< http://socialwelfare.bl.uk/subject-areas/ services-activity/social-work-care-services/spru/135160Reablement10.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/cc/e2/policy-11-049.PMC4872552.pdf
"§Examples of methodological choices and indicator selection may be consulted online, including the CHWB (“Document méthodologique de l’analyse globale et intégrée  de la performance,” 2014, < http://www.csbe.gouv.qc.ca/publications.html >) and the QAHO (“Performance en ligne.",Non-OADS,/arxiv_data1/oa_pdf/de/c8/policy-11-060.PMC4872553.pdf
Acknowledgements This research was supported by grant funding from Genome Canada as part of a larger research  project called “IGNITE.” Some support was also received through the Canada Research Chair  in Bioethics and Philosophy on “Impact Ethics: Making a Difference” ( http://bit.ly/ X6YKO2 )  awarded to Françoise Baylis.,Non-OADS,/arxiv_data1/oa_pdf/ba/3e/policy-11-070.PMC4872554.pdf
< http://www.hc-sc.gc.ca/dhp-mps/ prodpharma/sbd-smd/sbd_qa_smd_fq-eng.php >.,Non-OADS,/arxiv_data1/oa_pdf/ba/3e/policy-11-070.PMC4872554.pdf
< http://www.orpha.net/national/ data/CA-EN/www/uploads/Initial-Draft-Discussion-Document-for-A-Canadian-Orphan-Drug--Regulatory- Framework.doc >.,Non-OADS,/arxiv_data1/oa_pdf/ba/3e/policy-11-070.PMC4872554.pdf
< http://nparc.cisti-icist.nrc-cnrc.gc.ca/ npsi/ctrl?action=rtdoc&an=5764504&lang=en >.,OADS,/arxiv_data1/oa_pdf/47/1b/policy-11-082.PMC4872555.pdf
< http://www.aidslaw.ca/site/ privacy-protection-and-the-disclosure-of-health-information-legal-issues-for-people-living-with-hivaids-in-canada/ >.,Non-OADS,/arxiv_data1/oa_pdf/47/1b/policy-11-082.PMC4872555.pdf
< http://www.aidslaw.ca/site/know-your-rights-5-disclosure-as-a-patient/ >.,Non-OADS,/arxiv_data1/oa_pdf/47/1b/policy-11-082.PMC4872555.pdf
< http://www.ocswssw.org/wp-content/uploads/2015/02/ann-cavoukian.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/47/1b/policy-11-082.PMC4872555.pdf
< http://www.aidslaw.ca/ site/a-plan-of-action-for-canada-to-reduce-hivaids-related-stigma-and-discrimination/ >.,Non-OADS,/arxiv_data1/oa_pdf/47/1b/policy-11-082.PMC4872555.pdf
< http://www.cprn.org/documents/50036_EN.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/47/1b/policy-11-082.PMC4872555.pdf
<http://www.cfhi-fcass.ca/sf-docs/default-source/reports/Primary-Care-Strategy-EN.pdf?sfvrsn=0 >.,Non-OADS,/arxiv_data1/oa_pdf/40/c8/policy-11-095.PMC4872556.pdf
< http://laws-lois.justice.gc.ca/ eng/acts/C-6/ >.,Non-OADS,/arxiv_data1/oa_pdf/40/c8/policy-11-095.PMC4872556.pdf
< http://www.hscic.gov.uk/qof >.,Non-OADS,/arxiv_data1/oa_pdf/40/c8/policy-11-095.PMC4872556.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 101 © 2016 Journal of Craniovertebral Junction and Spine | Published by Wolters Kluwer - MedknowCase Report Syringomyelia secondary to “occult” dorsal arachnoid  webs: Report of two cases with review of literature Parag P Sayal, Arif Zafar1, Thomas A Carroll1 Department of Neurosurgery, The National Hospital for Neurology and Neurosurgery, London, 1Department of Neurosurgery, Royal Hallamshire  Hospital, Sheffield, UK Corresponding author: Mr. Parag P Sayal, Department of Neurosurgery, The National Hospital for Neurology and Neurosurgery, Quee n Square, London, WC1N 3BG, UK.",Non-OADS,/arxiv_data1/oa_pdf/af/a7/JCVJS-7-101.PMC4872557.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 105 © 2016 Journal of Craniovertebral Junction and Spine | Published by Wolters Kluwer - MedknowCase Report Primary intradural sacral epidermoid in a nondysraphic  spine: Case report and review of literature Laxminadh Sivaraju, Sumit Thakar, Nandita Ghosal1, Alangar S Hegde Departments of Neurosurgery and 1Pathology, Sri Sathya Sai Institute of Higher Medical Sciences, Bengaluru, Karnataka, India Corresponding author: Dr. Laxminadh Sivaraju, Department of Neurosurgery, Sri Sathya Sai Institute of Higher Medical Sciences, Whitefield, Bengaluru - 560 066,  Karnataka, India.",Non-OADS,/arxiv_data1/oa_pdf/5d/ae/JCVJS-7-105.PMC4872558.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 109 © 2016 Journal of Craniovertebral Junction and Spine | Published by Wolters Kluwer - MedknowCase Report Atlantoaxial dislocation adjacent to kyphotic  deformity in a case of adult Larsen syndrome Sushanta K Sahoo, Arsikere N Deepak, Pravin Salunke Department of Neurosurgery, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, Punjab and Haryana, India Corresponding author: Dr. Pravin Salunke, Department of Neurosurgery, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, Punjab and  Haryana, India.",Non-OADS,/arxiv_data1/oa_pdf/6e/ba/JCVJS-7-109.PMC4872559.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 115 © 2016 Journal of Craniovertebral Junction and Spine | Published by Wolters Kluwer - MedknowCase Report Congenital defects of C1 arches and odontoid process  in a child with Down’s syndrome: A case presentation Catherine Hatzantonis, Samiul Muquit, Luigi Aurelio Nasto, Hossein Mehdian Centre of Spinal Studies, Queen’s Medical Centre, Nottingham, United Kingdom Corresponding author: Ms. Catherine Hatzantonis, Centre for Spinal Studies and Surgery, Queen’s Medical Centre, D Floor West, B lock, Derby Road, Nottingham  NG72UH, United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/ba/84/JCVJS-7-115.PMC4872561.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 118 © 2016 Journal of Craniovertebral Junction and Spine | Published by Wolters Kluwer - MedknowCase Report Late onset leptomeningeal and whole spine metastasis  from supratentorial Glioblastoma multiforme: An uncommon manifestation of a common tumor Divyam Sharma, Anshul Gupta, Gurupal S Dhillon, Satnam Singh Chhabra Department of Neurosurgery, Sir Ganga Ram Hospital, New Delhi, India Corresponding author: Dr. Satnam Singh Chhabra, Department of Neurosurgery, Room No - 2324 SSRB III Floor, New Building, Sir Ga nga Ram Hospital, Rajinder  Nagar, New Delhi - 110 060, India.",Non-OADS,/arxiv_data1/oa_pdf/93/5f/JCVJS-7-118.PMC4872562.pdf
Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 121 © 2016 Journal of Craniovertebral Junction and Spine | Published by Wolters Kluwer - MedknowStudent’s Corner Stem cell therapy in spinal cord injury:  Hollow promise or promising science?,Non-OADS,/arxiv_data1/oa_pdf/2a/20/JCVJS-7-121.PMC4872563.pdf
Available from: http://www.who.int/disabilities/policies/spinal_cord_injury/ en/.,Non-OADS,/arxiv_data1/oa_pdf/2a/20/JCVJS-7-121.PMC4872563.pdf
Available from: http://www.medicinenet.com/ spinal_cord_injury_treatments_and_rehabilitation/article.htm.,Non-OADS,/arxiv_data1/oa_pdf/2a/20/JCVJS-7-121.PMC4872563.pdf
Available from:  http://onlinelibrary.wiley.com/.,Non-OADS,/arxiv_data1/oa_pdf/2a/20/JCVJS-7-121.PMC4872563.pdf
Available from: http://link.springer.com.libproxy.ucl.ac.uk/article/10.1007/s00586-014-3416-6/fulltext.html.,Non-OADS,/arxiv_data1/oa_pdf/2a/20/JCVJS-7-121.PMC4872563.pdf
Available from: http://www.eurostemcell.org/regulations/regulation-stem-cell-research-united-kingdom.,Non-OADS,/arxiv_data1/oa_pdf/2a/20/JCVJS-7-121.PMC4872563.pdf
Available from: http://onlinelibrary.wiley.com/doi/10.1002/9780470151808.sca01bs9/abstract.,Non-OADS,/arxiv_data1/oa_pdf/2a/20/JCVJS-7-121.PMC4872563.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 69 © 2016 Journal of Craniovertebral Junction and Spine | Published by Wolters Kluwer - MedknowEditorial Atlantoaxial instability: Analyzing and reflecting  on the Nature’s reparative games Atul Goel Department of Neurosurgery, Seth Gordhandas Sunderdas Medical College and King Edward Memorial Hospital, Mumbai, Maharashtra, I ndia Corresponding author: Prof. Atul Goel, Department of Neurosurgery, Seth Gordhandas Sunderdas Medical College and King Edward VI I Memorial Hospital,  Parel, Mumbai - 400 012, Maharashtra, India.",Non-OADS,/arxiv_data1/oa_pdf/25/91/JCVJS-7-69.PMC4872564.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 72 © 2016 Journal of Craniovertebral Junction and Spine | Published by Wolters Kluwer - MedknowEditorial Interfacetal intra-articular spacers: Emergence  of a concept Atul Goel Department of Neurosurgery, King Edward Memorial Hospital and Seth Gordhandas Sunderdas (GS) Medical College, Mumbai, Maharasht ra, India Corresponding author: Prof. Atul Goel, Department of Neurosurgery, King Edward VII Memorial Hospital and Seth Gordhandas Sunder das (GS) Medical College, Parel,  Mumbai - 400 012, Maharashtra, India.",Non-OADS,/arxiv_data1/oa_pdf/36/a0/JCVJS-7-72.PMC4872565.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 75 © 2016 Journal of Craniovertebral Junction and Spine | Published by Wolters Kluwer - MedknowOriginal Article “Two-step” technique with OsiriXTM to evaluate  feasibility of C2 pedicle for surgical fixation Luis Miguel Sousa Marques, Gonçalo Neto d’Almeida, José Cabral Department of Neurosurgery, Egas Moniz Hospital, Lisbon, Portugal Corresponding author: Dr. Luis Miguel Sousa Marques, Department of Neurosurgery, Egas Moniz Hospital, Rua da Junqueira, Nº126, Lisbon - 1349-019, Portugal.",Non-OADS,/arxiv_data1/oa_pdf/42/96/JCVJS-7-75.PMC4872566.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 82 © 2016 Journal of Craniovertebral Junction and Spine | Published by Wolters Kluwer - MedknowOriginal Article Prediction of surgical outcome in compressive cervical  myelopathy: A novel clinicoradiological prognostic score Rishi Anil Aggarwal, Sudhir Kumar Srivastava, Sunil Krishna Bhosale, Pradip Sharad Nemade Department of Orthopaedics, Seth GS Medical College and King Edward Memorial (KEM) Hospital, Mumbai, Maharashtra, India Corresponding author: Dr. Rishi Anil Aggarwal, Department of Orthopaedics, Seth GS Medical College and King Edward Memorial (KE M) Hospital, Parel,  Mumbai - 400 012, Maharashtra, India.",Non-OADS,/arxiv_data1/oa_pdf/42/b4/JCVJS-7-82.PMC4872567.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 87 © 2016 Journal of Craniovertebral Junction and Spine | Published by Wolters Kluwer - MedknowOriginal Article Inequality in leg length is important  for the understanding of the pathophysiology of lumbar disc herniation Mehmet Sabri Balik, Ayhan Kanat1, Adem Erkut, Bulent Ozdemir1, Osman Ersagun Batcik1 Departments of Orthopedic Surgery and 1Neurosurgery, Recep Tayyip Erdogan University, Rize, Turkey Corresponding author: Dr. Ayhan Kanat, Department of Neurosurgery, Medical Faculty, Recep Tayyip Erdogan University, Rize, Turk ey.",Non-OADS,/arxiv_data1/oa_pdf/5c/f4/JCVJS-7-87.PMC4872568.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 91 © 2016 Journal of Craniovertebral Junction and Spine | Published by Wolters Kluwer - MedknowOriginal Article Cervical disc hernia operations through posterior  laminoforaminotomy Coskun Yolas, Nuriye Guzin Ozdemir1, Hilmi Onder Okay, Ayhan Kanat2, Mehmet Senol,  Ibrahim Burak Atci1, Hakan Yilmaz3, Mustafa Kemal Coban, Mehmet Onur Yuksel,  Umit Kahraman Department of Neurosurgery, Erzurum Regional Training and Research Hospital, Erzurum, 1Department of Neurosurgery, Istanbul Training and  Research Hospital, Istanbul, 2Department of Neurosurgery, Recep Tayyip Erdogan University, Rize, 3Department of Neurosurgery, Duzce Ataturk  State Hospital, Duzce, Turkey Corresponding author: Dr. Hakan Yilmaz, Department of Neurosurgery, Duzce Ataturk State Hospital, Duzce, Turkey.",Non-OADS,/arxiv_data1/oa_pdf/3b/c1/JCVJS-7-91.PMC4872569.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 96 © 2016 Journal of Craniovertebral Junction and Spine | Published by Wolters Kluwer - MedknowHistorical Vignette Management of basilar invagination: A historical  perspective Abhidha Shah, Elena Serchi1 Department of Neurosurgery, King Edward Memorial Hospital and Seth Gordhandas Sunderdas (GS) Medical College, Mumbai, Maharasht ra, India,  1Department of Neurosurgery, IRCCS Institute of Neurological Sciences, Bellaria Hospital, Bologna, Italy Corresponding author: Dr. Abhidha Shah, Department of Neurosurgery, King Edward VII Memorial Hospital and Seth Gordhandas Sunde rdas Medical College, Parel,  Mumbai - 400 012, Maharashtra, India.",Non-OADS,/arxiv_data1/oa_pdf/6e/4a/JCVJS-7-96.PMC4872570.pdf
Free Ca2þwas calculated using WebmaxC Standard (http://www.stanford.edu/~cpatton/ webmaxcS.htm).,OADS,/arxiv_data1/oa_pdf/0e/37/JCP-230-2848.PMC4872598.pdf
"Key Words: defibrillators, implantable ◼ health services research ◼ heart failure ◼ patient outcome assessment  Circulation is available at http://circ.ahajournals.org DOI: 10.1161/CIRCULATIONAHA.115.020677Received December 1, 2015; accepted March 23, 2016.",Non-OADS,/arxiv_data1/oa_pdf/86/37/cir-133-2030.PMC4872640.pdf
"Waltham, MA: Health Economics Research, Inc.; 2000. https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Reports/downloads/pope_2000_2.pdf Accessed October 20, 2015.",Non-OADS,/arxiv_data1/oa_pdf/86/37/cir-133-2030.PMC4872640.pdf
http://www.qualitynet.org/dcs/ContentServer?cid=1182785083979&pagename =QnetPublic%2FPage%2FQnetTier3&c=Page.,Non-OADS,/arxiv_data1/oa_pdf/86/37/cir-133-2030.PMC4872640.pdf
http://www.nhpco.org/sites/default/files/public/Statistics_Research/2015_Facts_Figures.pdf.,OADS,/arxiv_data1/oa_pdf/86/37/cir-133-2030.PMC4872640.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: EpilepsyArterial spin labelingPositron emission tomography Simultaneous PET/MR GlucoseCerebral blood ﬂow 1.,Non-OADS,/arxiv_data1/oa_pdf/a4/fb/main.PMC4872676.pdf
http://dx.doi.org/10.1016/j.nicl.2016.04.005 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a4/fb/main.PMC4872676.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a4/fb/main.PMC4872676.pdf
"Copyright © 2015 The Korean Society of Environmental Health and Toxicology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 11 http://e-eht.org/ Introduction  Glioma, the most common primary brain tumor that compris - es morphologically distinct cancers such as astrocytoma, epen - dymoma, and oligodendro glioma [1], is a malignant tumor in  the central nervous system with a corresponding high fatality  rate.",Non-OADS,/arxiv_data1/oa_pdf/0c/2f/eht-30-e2015015.PMC4872697.pdf
"In particu - lar, exposure to radiofrequency-electromagnetic field (RF- EMF) has been receiving attention due to its negative effect on  health, amidst the rapid spread of the use of wireless informa - tion service systems.Mobile phone use and risk of glioma: a case- control study in Korea for 2002-2007  Songyi Y oon1, Jae-Wook Choi1, Eunil Lee1, Hyonggin An2, Hyong Do Choi3, Nam Kim4   1Department of Preventive Medicine, Korea University College of Medicine, Seoul; 2Department of Biostatistics, Korea  University College of Medicine, Seoul; 3Electronics and T elecommunications Research Institute, Daejeon; 4Department of  Information and Communication Engineering, Chungbuk National University, Cheongju, Korea • Original ArticleOpen Access Environmental Health and Toxicology Volume: 30, Article ID: e2015015, 11 pages http://dx.doi.org/10.5620/eht.e2015015 eISSN: 2233-6567  Objectives  There has been a growing concern about the possible carcinogenic effects of  the electromagnetic radiofrequency fields emitted from mobile phones.",Non-OADS,/arxiv_data1/oa_pdf/0c/2f/eht-30-e2015015.PMC4872697.pdf
"Keywords  Electromagnetic field, Glioma, Brain tumor, Mobile phoneCorrespondence:  Jae-Wook Choi 73 Inchon-ro, Seongbuk-gu, Seoul 02841,  Korea  Tel: +82-2-920-6343 Fax: +82-2-920-7220 E-mail: shine@korea.ac.kr Received:  August 3, 2015 Accepted:  December 11, 2015 Published online:  December 21, 2015 This article is available from: http://e-eht.org/",Non-OADS,/arxiv_data1/oa_pdf/0c/2f/eht-30-e2015015.PMC4872697.pdf
http://e-eht.org/ Page 2 of 11Environmental Health and Toxicology    2015;30:e2015015 Most epidemiologic research studies conducted so far on the use of  mobile phones and gliomas have failed to show any increase in dan - ger caused by the long-term use of mobile phones [8-13].,Non-OADS,/arxiv_data1/oa_pdf/0c/2f/eht-30-e2015015.PMC4872697.pdf
"http://e-eht.org/ Page 3 of 11Songyi Yoon, et al.",Non-OADS,/arxiv_data1/oa_pdf/0c/2f/eht-30-e2015015.PMC4872697.pdf
http://e-eht.org/ Page 4 of 11Environmental Health and Toxicology    2015;30:e2015015 Results The general characteristics of the subjects are as shown in T able 2.,Non-OADS,/arxiv_data1/oa_pdf/0c/2f/eht-30-e2015015.PMC4872697.pdf
"http://e-eht.org/ Page 5 of 11Songyi Yoon, et al.",Non-OADS,/arxiv_data1/oa_pdf/0c/2f/eht-30-e2015015.PMC4872697.pdf
"http://e-eht.org/ Page 6 of 11Environmental Health and Toxicology    2015;30:e2015015 mas and mobile phone use, i.e., hours since the initial use of a  mobile phone, the period of use, the average daily frequency of  receiving a call, the average daily frequency of sending a call, and the monthly average service fee.",OADS,/arxiv_data1/oa_pdf/0c/2f/eht-30-e2015015.PMC4872697.pdf
"http://e-eht.org/ Page 7 of 11Songyi Yoon, et al.",Non-OADS,/arxiv_data1/oa_pdf/0c/2f/eht-30-e2015015.PMC4872697.pdf
"http://e-eht.org/ Page 8 of 11Environmental Health and Toxicology    2015;30:e2015015 possible to exclude the possibility of recall bias that might be  caused by the patients’ untruthful response, avoidance, memory  loss, or exaggeration as to some exposure factors of the ques - tionnaire that included the situation in which the patients knew  already they belonged to the patent group.",Non-OADS,/arxiv_data1/oa_pdf/0c/2f/eht-30-e2015015.PMC4872697.pdf
ORCID  Songyi Y oon http://orcid.org/0000-0003-0463-9306  Jae-Wook Choi http://orcid.org/0000-0002-1996-7524 Eunil Lee http://orcid.org/0000-0003-1524-5046   Nam Kim http://orcid.org/0000-0001-8109-2055 References 1.,Non-OADS,/arxiv_data1/oa_pdf/0c/2f/eht-30-e2015015.PMC4872697.pdf
Available from: http://kosis.kr/statHt - ml/statHtml.do?orgId=117&tblId=DT_117N_A00023&vw_ cd=MT_OTITLE&list_id=117_11744&scrId=&seqNo=&lang_ mode=ko&obj_var_id=&itm_id=&conn_path=E1 (Korean).,OADS,/arxiv_data1/oa_pdf/0c/2f/eht-30-e2015015.PMC4872697.pdf
"http://e-eht.org/ Page 9 of 11Songyi Yoon, et al.",Non-OADS,/arxiv_data1/oa_pdf/0c/2f/eht-30-e2015015.PMC4872697.pdf
Available from: http://www.index.go.kr/potal/ stts/idxMain/selectPoSttsIdxSearch.do?idx_cd=2755&stts_ cd=275502&clas_div=&idx_sys_cd=654&idx_clas_cd=1  (Korean).,OADS,/arxiv_data1/oa_pdf/0c/2f/eht-30-e2015015.PMC4872697.pdf
http://e-eht.org/ Page 10 of 11Environmental Health and Toxicology    2015;30:e2015015 Table S1.,Non-OADS,/arxiv_data1/oa_pdf/0c/2f/eht-30-e2015015.PMC4872697.pdf
"http://e-eht.org/ Page 11 of 11Songyi Yoon, et al.",Non-OADS,/arxiv_data1/oa_pdf/0c/2f/eht-30-e2015015.PMC4872697.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Neurostimulation Epilepsy SoftwareCosmicNeutronSafety 1.,Non-OADS,/arxiv_data1/oa_pdf/6e/44/main.PMC4872716.pdf
http://dx.doi.org/10.1016/j.ebcr.2016.04.0022213-3232/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6e/44/main.PMC4872716.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6e/44/main.PMC4872716.pdf
Heart Rhythm 2008;5(8):1201 –3 [Available from: http://www.sciencedirect.com/science/article/pii/S1547527108004815 ].,Non-OADS,/arxiv_data1/oa_pdf/6e/44/main.PMC4872716.pdf
IEEE Trans Device Mater Reliab 2001;1(1):17 –22 [Available from: https://www.researchgate.net/publication/3429937_Soft_errors_in_advanced_ semiconductor_devices-Part_I_The_three_radiation_sources ].,OADS,/arxiv_data1/oa_pdf/6e/44/main.PMC4872716.pdf
IEEE Trans Nucl Sci 1998;45(6):2929 –40.http://dx.doi.org/10.1109/23.736549 [Available from: http://www.uow.edu.au/~pbradley/publications/SEUinICD.pdf ].,OADS,/arxiv_data1/oa_pdf/6e/44/main.PMC4872716.pdf
Nucl Instrum Methods Phys Res A 2007; 579(1):252 –5 [Available from: https://www.researchgate.net/publication/ 222171821_Neutron-induced_soft_error_rate_measurements_in_semiconductor_ memories ].Table 3 Mitigation of software errors among selected medical devices.,OADS,/arxiv_data1/oa_pdf/6e/44/main.PMC4872716.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/0a/aew116.PMC4872863.pdf
"Published by Grapho Publications, LLC This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/33/5e/tom67.PMC4872873.pdf
ISSN 2379-1381 http://dx.doi.org/10.18383/j.tom.2016.00115 TOMOGRAPHY.ORG | VOLUME 2 NUMBER 1 |MARCH 2016 67,Non-OADS,/arxiv_data1/oa_pdf/33/5e/tom67.PMC4872873.pdf
Supplemental Materials Video 1: http://dx.doi.org/10.18383/j.tom.2016.00115.vid.01 Video 2: http://dx.doi.org/10.18383/j.tom.2016.00115.vid.02Video 3: http://dx.doi.org/10.18383/j.tom.2016.00115.vid.03Video 4: http://dx.doi.org/10.18383/j.tom.2016.00115.vid.04 ACKNOWLEDGMENTS Gary D. Luker and Huong (Marie) Nguyen contributed equally to this work; and Brian D. Ross contributed equally as the corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/33/5e/tom67.PMC4872873.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Reﬂex epilepsy Reading epilepsy NeuroimagingClinical neurophysiology 1.,Non-OADS,/arxiv_data1/oa_pdf/0f/84/main.PMC4872876.pdf
http://dx.doi.org/10.1016/j.ebcr.2016.04.004 2213-3232/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/84/main.PMC4872876.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0f/84/main.PMC4872876.pdf
http://dx.doi.org/10.1136/jnnp.2009.175935 .77 H.K.,Non-OADS,/arxiv_data1/oa_pdf/0f/84/main.PMC4872876.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a7/c7/main.PMC4872931.pdf
The  most  common clinical  manifestation  is  a  painful  breast  mass;  other  presentations http://dx.doi.org/10.1016/j.ijscr.2016.04.040 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/a7/c7/main.PMC4872931.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Antarctic stalked jelly ﬁsh Mitogenome Mt genomeGenetics Organism Haliclystus antarcticus Pfeffer, 1889 Sequencer or array typeComplete mitochondrial genome Data format RawExperimental factorsN/A Experimental featuresWhole genome analysis of Antarctic stalked jelly ﬁsh Consent On requestSample source locationCatalog number NMMBCR84.",Non-OADS,/arxiv_data1/oa_pdf/a9/bf/main.PMC4872960.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/genome/?term=KU947038 .,OADS,/arxiv_data1/oa_pdf/a9/bf/main.PMC4872960.pdf
http://dx.doi.org/10.1016/j.gdata.2016.04.012 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/bf/main.PMC4872960.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a9/bf/main.PMC4872960.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/54/main.PMC4873027.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.04.055 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/b9/54/main.PMC4873027.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/de/01/main.PMC4873028.pdf
The  virtual  mediastinoscopic http://dx.doi.org/10.1016/j.ijscr.2016.05.002 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/de/01/main.PMC4873028.pdf
Website http://www2.unil.ch/popgen/ softwares/fstat.htm [accessed 14 April 2016].,Non-OADS,/arxiv_data1/oa_pdf/8a/91/apps.1500133.PMC4873269.pdf
Website http://www.env   .go.jp/press/files/jp/20557.pdf [accessed 27 October 2015] [in Japanese].,Non-OADS,/arxiv_data1/oa_pdf/8a/91/apps.1500133.PMC4873269.pdf
Website  http://pgrc.ipk-gatersleben.de/misa/misa.html  [accessed 19 April 2016].,Non-OADS,/arxiv_data1/oa_pdf/16/d0/apps.1500136.PMC4873271.pdf
The library was sequenced with 2 × 300 bp on the MiSeq instrument at  LabGenomics (http://www.labgenomics.co.kr/).,OADS,/arxiv_data1/oa_pdf/1a/13/apps.1600002.PMC4873274.pdf
"Applications in Plant Sciences 2016 4(5): 1600002 Shim et al.—Chloroplast genome of Capsicum frutescens doi:10.3732/apps.16000023 of 6 http://www.bioone.org/loi/appsIllumina paired-end (2 × 300 bp) sequencing produced a total of 8,272,114  paired-end reads, with an average fragment length of 256 bp, which were then  analyzed to generate 1,796,432,923 bp of sequence.",OADS,/arxiv_data1/oa_pdf/1a/13/apps.1600002.PMC4873274.pdf
"SUPPLEMENTARY MATERIAL Supplementary material is linked to the online version of the paper  at http://www.nature.com/gim ACKNOWLEDGMENTS The eMERGE Network was initiated and funded by National Human Genome Research Institute through the following grants:  U01HG006828 (Cincinnati Children’s Hospital Medical Center/ Boston Children’s Hospital), U01HG006830 (Children’s Hospital of  Philadelphia), U01HG006389 (Essentia Institute of Rural Health),  GenetiCS in MediCine  |   Volume 18  |  Number 7  |  July 2016",Non-OADS,/arxiv_data1/oa_pdf/0c/f4/gim2015138a.PMC4873460.pdf
26 July 2011. http://www.gpo.gov/fdsys/pkg/ FR-2011-07-26/html/2011–18792.htm.,Non-OADS,/arxiv_data1/oa_pdf/0c/f4/gim2015138a.PMC4873460.pdf
28 August 2014. https://www.federalregister.gov/articles/2014/08/28/2014–20385/final-nih-genomic-data-sharing-policy.,Non-OADS,/arxiv_data1/oa_pdf/0c/f4/gim2015138a.PMC4873460.pdf
http://oprs.usc.edu/files/2013/01/ modelconsenthandouts.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0c/f4/gim2015138a.PMC4873460.pdf
"Press release, 7 August 2013. http://www.nih.gov/news/health/aug2013/nih-07.htm.",Non-OADS,/arxiv_data1/oa_pdf/0c/f4/gim2015138a.PMC4873460.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ GenetiCS in MediCine  |   Volume 18  |  Number 7  |  July 2016",Non-OADS,/arxiv_data1/oa_pdf/0c/f4/gim2015138a.PMC4873460.pdf
Growth curve  images were created using origin 8.6 (http://www.origin- lab.com/) Statistical analysis Statistical analysis was performed using the Pearson  correlation test in iBM SPSS Statistics 19.0.,OADS,/arxiv_data1/oa_pdf/15/3a/expanim-65-125.PMC4873481.pdf
"it is proposed that there is an initial activation of the TNFα  (Received 11 August 2015 / Accepted 9 November 2015 / Published online in J-STAGE 3 December 2015) Address corresponding: N. Shiojiri, Department of Biology, Faculty of Science, Shizuoka University, Oya 836, Suruga-ku, Shizuoka city, Shizuoka 422-8529, Japan*These authors contributed equally to this work.Supplementary figures: refer to J-STAGE: https://www.jstage.jst.go.jp/browse/expanimExp.",OADS,/arxiv_data1/oa_pdf/c3/58/expanim-65-135.PMC4873482.pdf
https://www.clinicaltrials.gov/ct2/results?term=1-methyl-D-t ryptophan&search=search date  of access: 16.09.2015.,Non-OADS,/arxiv_data1/oa_pdf/33/ef/expanim-65-147.PMC4873483.pdf
https://www.clinicaltrials.gov/ct2/show/results/nct01042535?term=1-methyl-D- Tryptophan&rank=1&sect=Xb70156 date of access:  16.09.2015.,Non-OADS,/arxiv_data1/oa_pdf/33/ef/expanim-65-147.PMC4873483.pdf
"China 19) JEM Utilization Center, Human Spaceflight Technology Directorate, JAXA, Tsukuba, Ibaraki 305-8505, Japan 20) Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and  Psychiatry, Kodaira, Tokyo, 187-8502, Japan (Received 5 August 2015 / Accepted 1 January 2016 / Published online in J-STAGE 28 January 2016) Adress corresponding: T. Kudo, Department of Anatomy and Embryology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan / S. Takahashi, Department of Anatomy and Embryology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, JapanSupplementary tables: refer to J-STAGE: https://www.jstage.jst.go.jp/browse/expanimExp.",Non-OADS,/arxiv_data1/oa_pdf/6c/9b/expanim-65-175.PMC4873486.pdf
http://www.rtog.org/members/ protocols/0413/0413.pdf 9.,Non-OADS,/arxiv_data1/oa_pdf/83/af/JCB-8-27333.PMC4873549.pdf
http://www.apbi.uni-erlangen.de/index.html 10.,Non-OADS,/arxiv_data1/oa_pdf/83/af/JCB-8-27333.PMC4873549.pdf
"EMBRACE – http://www.embracestudy.dk [18]), it can be tested if a systematic offset in dose correlates better with clinical  outcome.",Non-OADS,/arxiv_data1/oa_pdf/9c/4b/JCB-8-27385.PMC4873554.pdf
http://www.elekta.com/healthcare-professionals/products/elekta-brachytherapy/applicators/gyn/Cervix-Rotterdam-applicator.html.,Non-OADS,/arxiv_data1/oa_pdf/26/ca/JCB-8-27483.PMC4873556.pdf
"In humans, ADAMTS10  mutations are linked to Molecular Vision  2016; 22:503-517 <http://www.molvis.org/molvis/v 22/503> Received 5 November 2015 | Accepted 15 May 2016 | Published 17 May 2016© 2016 Molecular Vision 503Changes in posterior scleral collagen microstructure in canine  eyes with an ADAMTS10  mutation Craig Boote,1 Joel R. Palko,2 Thomas Sorensen,3 Ashkan Mohammadvali,4 Ahmed Elsheikh,4,5 András M.  Komáromy,6,7 Xueliang Pan,8 Jun Liu2 1Structural Biophysics Group, School of Optometry and Vision Sciences, Cardiff University, Cardiff, UK; 2Department of  Biomedical Engineering, The Ohio State University, Columbus, OH; 3Diamond Light Source, Harwell Science and Innovation  Campus, Harwell, UK; 4School of Engineering, University of Liverpool, Liverpool, UK; 5NIHR Biomedical Research Centre for  Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, UK; 6Department of Small  Animal Clinical Sciences, Michigan State University, East Lansing, MI; 7Department of Clinical Studies, School of Veterinary  Medicine, University of Pennsylvania, Philadelphia, P A; 8Center for Biostatistics, Department of Biomedical Informatics, The  Ohio State University, Columbus, OH Purpose:  We aimed to characterize alterations in the posterior scleral collagen microstructure before detectable disease  onset in a canine model of open-angle glaucoma caused by an ADAMTS10  mutation.",Non-OADS,/arxiv_data1/oa_pdf/ca/f0/mv-v22-503.PMC4873561.pdf
"Molecular Vision  2016; 22:503-517 <http://www.molvis.org/molvis/v 22/503> © 2016 Molecular Vision  504Weill-Marchesani syndrome, a systemic connective tissue  disorder that presents with ocular problems, including  glaucoma [ 18].",Non-OADS,/arxiv_data1/oa_pdf/ca/f0/mv-v22-503.PMC4873561.pdf
"Molecular Vision  2016; 22:503-517 <http://www.molvis.org/molvis/v 22/503> © 2016 Molecular Vision  505macromolecular crystallography beamline I02 in a custom- modified fiber-diffraction setup [ 14,22].",Non-OADS,/arxiv_data1/oa_pdf/ca/f0/mv-v22-503.PMC4873561.pdf
"Molecular Vision  2016; 22:503-517 <http://www.molvis.org/molvis/v 22/503> © 2016 Molecular Vision  506the “collagen orientation distribution”), 2) the ratio of the  preferentially aligned collagen scatter to the total collagen  scatter (referred to as the “collagen anisotropy”), and 3) the  total collagen scatter divided by the tissue thickness (referred  to as the “collagen density”).",Non-OADS,/arxiv_data1/oa_pdf/ca/f0/mv-v22-503.PMC4873561.pdf
"Molecular Vision  2016; 22:503-517 <http://www.molvis.org/molvis/v 22/503> © 2016 Molecular Vision  5072C) and the latter converted to a polar coordinate system,  introducing a π/2 angular shift for equatorial scatter, using  Statistica 7 (StatSoft Ltd, Bedford, UK).",Non-OADS,/arxiv_data1/oa_pdf/ca/f0/mv-v22-503.PMC4873561.pdf
Molecular Vision  2016; 22:503-517 <http://www.molvis.org/molvis/v 22/503> © 2016 Molecular Vision  508 DensityII d tai =+∫() φπ 02  (2) where t is the average local scleral thickness within the  MPS or PPS tissue sector that contains the sampled point of  interest (see Figure 1).,Non-OADS,/arxiv_data1/oa_pdf/ca/f0/mv-v22-503.PMC4873561.pdf
Molecular Vision  2016; 22:503-517 <http://www.molvis.org/molvis/v 22/503> © 2016 Molecular Vision  509sclera could lead to mechanical changes at the macroscopic  (tissue) level.,Non-OADS,/arxiv_data1/oa_pdf/ca/f0/mv-v22-503.PMC4873561.pdf
"Molecular Vision  2016; 22:503-517 <http://www.molvis.org/molvis/v 22/503> © 2016 Molecular Vision  510scleral extracellular matrix, and specifically in the density  and organization of fibrillar collagen.",Non-OADS,/arxiv_data1/oa_pdf/ca/f0/mv-v22-503.PMC4873561.pdf
"Molecular Vision  2016; 22:503-517 <http://www.molvis.org/molvis/v 22/503> © 2016 Molecular Vision  511[16], rats [ 29], and humans [ 14,22,30].",Non-OADS,/arxiv_data1/oa_pdf/ca/f0/mv-v22-503.PMC4873561.pdf
Molecular Vision  2016; 22:503-517 <http://www.molvis.org/molvis/v 22/503> © 2016 Molecular Vision  512 Figure 7.,Non-OADS,/arxiv_data1/oa_pdf/ca/f0/mv-v22-503.PMC4873561.pdf
"Molecular Vision  2016; 22:503-517 <http://www.molvis.org/molvis/v 22/503> © 2016 Molecular Vision  513in collagen density is more likely to affect the mechanical  performance of the sclera and, by extension, the nerve head,  as they were larger and more widespread, affecting the mid- posterior and peripapillary tissue equally.",Non-OADS,/arxiv_data1/oa_pdf/ca/f0/mv-v22-503.PMC4873561.pdf
Molecular Vision  2016; 22:503-517 <http://www.molvis.org/molvis/v 22/503> © 2016 Molecular Vision  514 Figure 9.,Non-OADS,/arxiv_data1/oa_pdf/ca/f0/mv-v22-503.PMC4873561.pdf
"Molecular Vision  2016; 22:503-517 <http://www.molvis.org/molvis/v 22/503> © 2016 Molecular Vision  515However, we found that the scleral thickness was higher in  affected animals [ 20], a result confirmed by the present study.",Non-OADS,/arxiv_data1/oa_pdf/ca/f0/mv-v22-503.PMC4873561.pdf
Molecular Vision  2016; 22:503-517 <http://www.molvis.org/molvis/v 22/503> © 2016 Molecular Vision  5164.,Non-OADS,/arxiv_data1/oa_pdf/ca/f0/mv-v22-503.PMC4873561.pdf
Molecular Vision  2016; 22:503-517 <http://www.molvis.org/molvis/v 22/503> © 2016 Molecular Vision  517eyes.,Non-OADS,/arxiv_data1/oa_pdf/ca/f0/mv-v22-503.PMC4873561.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Infection Ecology and Epidemiology 2016, 6: 31055 - http://dx.doi.org/10.3402/iee.v6.31055 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/98/86/IEE-6-31055.PMC4873563.pdf
"2 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 31055 - http://dx.doi.org/10.3402/iee.v6.31055",Non-OADS,/arxiv_data1/oa_pdf/98/86/IEE-6-31055.PMC4873563.pdf
"In bovine and canines, anGenetic diversity and antibiogram profile Citation: Infection Ecology and Epidemiology 2016, 6: 31055 - http://dx.doi.org/10.3402/iee.v6.31055 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/98/86/IEE-6-31055.PMC4873563.pdf
"4 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 31055 - http://dx.doi.org/10.3402/iee.v6.31055",Non-OADS,/arxiv_data1/oa_pdf/98/86/IEE-6-31055.PMC4873563.pdf
"The clustering was performed by UPGMA and the dice correlationcoefﬁcient.Genetic diversity and antibiogram profile Citation: Infection Ecology and Epidemiology 2016, 6: 31055 - http://dx.doi.org/10.3402/iee.v6.31055 5 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/98/86/IEE-6-31055.PMC4873563.pdf
"6 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 31055 - http://dx.doi.org/10.3402/iee.v6.31055",Non-OADS,/arxiv_data1/oa_pdf/98/86/IEE-6-31055.PMC4873563.pdf
"Correlation of PFGE and antibiogram proﬁle of DEC pathotypes isolates Antibiogram of the DEC pathotypes in clusters PFGE clusters DEC pathotypes AMP CIP COT CTR IPM TE CTX Resistant % similarity A E065 S S R S S R S 100% (7/7) E066 S S R S S R S B A258 R S R R S R R 1 and 2: 71.4% (5/7) A265 R R R R S R S 1 and 3: 85.7% (6/7)A266 R R R R S R R 2 and 3: 85.7% (6/7) C H316 R R R R S R R 100% (7/7) H325 R R R R S R R D A219 R R R R S R R 100% (7/7) H121 R R R R S R R E E166 R R R S S R R 85.7% (6/7) A103 R R R R S R R F A206 R R R R S R R 100% (7/7) A207 R R R R S R R G A082 R R R S S R R 100% (7/7) A216 R R R S S R R H H322 R R R R S R R 85.7% (6/7) A185 R S R R S R R R, resistant; S, sensitive; AMP , ampicillin; CIP , ciprofloxacin; COT, co-trimoxazole; CTR, ceftriaxone; IPM, imipenem; TE, tetracycline; CTX, cefotaxim.Genetic diversity and antibiogram profile Citation: Infection Ecology and Epidemiology 2016, 6: 31055 - http://dx.doi.org/10.3402/iee.v6.31055 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/98/86/IEE-6-31055.PMC4873563.pdf
"8 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 31055 - http://dx.doi.org/10.3402/iee.v6.31055",Non-OADS,/arxiv_data1/oa_pdf/98/86/IEE-6-31055.PMC4873563.pdf
Available from: http://www.who.int/ topics/diarrhoea/en/ [cited 7 February 2014].10.,Non-OADS,/arxiv_data1/oa_pdf/98/86/IEE-6-31055.PMC4873563.pdf
"J Clin Microbiol 1995; 33: 2233/C19.Genetic diversity and antibiogram profile Citation: Infection Ecology and Epidemiology 2016, 6: 31055 - http://dx.doi.org/10.3402/iee.v6.31055 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/98/86/IEE-6-31055.PMC4873563.pdf
"10 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 31055 - http://dx.doi.org/10.3402/iee.v6.31055",Non-OADS,/arxiv_data1/oa_pdf/98/86/IEE-6-31055.PMC4873563.pdf
"Data analysis was performed with the nonlinear mixed effects modeling software NONMEM version 7.3 (Icon Devel-opment Solutions [http://www.iconplc.com/technology/products/nonmem], Ellicott City, MD) 18using the first-order conditional estimation with interaction.",OADS,/arxiv_data1/oa_pdf/14/15/PSP4-5-264.PMC4873565.pdf
"Data handling wasperformed in R version 3.1.1 (R Foundation for StatisticalComputing [http://www.R-project.org], Vienna, Austria).",Non-OADS,/arxiv_data1/oa_pdf/14/15/PSP4-5-264.PMC4873565.pdf
"Time from inoculum (i.e., infection) to stationaryphase for the in vitro MTP model 15was investigated through simulations in Berkeley Madonna version 8.3.18(Department of Molecular and Cellular Biology, University ofCalifornia [http://www.berkeleymadonna.com], Berkeley,CA).",OADS,/arxiv_data1/oa_pdf/14/15/PSP4-5-264.PMC4873565.pdf
"Model selection and evaluation Models were evaluated by comparing the difference in OFV together with parameter precision and diagnostic plots gen- erated with the R package Xpose version 4.5.2 (Depart- ment of Pharmaceutical Biosciences, Uppsala University[http://xpose.sourceforge.net], Uppsala, Sweden).",OADS,/arxiv_data1/oa_pdf/14/15/PSP4-5-264.PMC4873565.pdf
"22,23In addition, prediction-corrected visual predictive checks24 were generated using PsN version 4.3.2 (Department of Pharmaceutical Biosciences [http://psn.sourceforge.",OADS,/arxiv_data1/oa_pdf/14/15/PSP4-5-264.PMC4873565.pdf
<http://www.icaaconline.com/php/icaac2014ab- stracts/data/papers/2014/A-024.htm >.,Non-OADS,/arxiv_data1/oa_pdf/14/15/PSP4-5-264.PMC4873565.pdf
<http://xpose.sourceforge.net/ >.,Non-OADS,/arxiv_data1/oa_pdf/14/15/PSP4-5-264.PMC4873565.pdf
<http://psn.sourceforge.net/ >.,Non-OADS,/arxiv_data1/oa_pdf/14/15/PSP4-5-264.PMC4873565.pdf
Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website (http://www.wileyonlinelibrary.com/psp4)The Multistate Tuberculosis Pharmacometric Model Svensson and Simonsson 273 www.wileyonlinelibrary/psp4,Non-OADS,/arxiv_data1/oa_pdf/14/15/PSP4-5-264.PMC4873565.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: ThraustochytridAurantiochytriumWhole genome sequencingDocosahexaenoic acid Speciﬁcations Organism/cell line/tissueAurantiochytrium sp.,Non-OADS,/arxiv_data1/oa_pdf/a2/c0/main.PMC4873566.pdf
http://dx.doi.org/10.1016/j.gdata.2016.04.013 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/c0/main.PMC4873566.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a2/c0/main.PMC4873566.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/41/fb/main.PMC4873567.pdf
No  free  peritoneal  air http://dx.doi.org/10.1016/j.ijscr.2016.03.038 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/41/fb/main.PMC4873567.pdf
This  is  an  open access article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0a/ef/main.PMC4873568.pdf
"Space-occupying  lesions of  the lesser sac  include  pancreatic  pseudocysts  or  abscesses,  lym- phadenopathy  along  the  lesser  curvature  of  the  stomach,  and http://dx.doi.org/10.1016/j.ijscr.2016.04.045 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/0a/ef/main.PMC4873568.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fe/26/main.PMC4873600.pdf
"Postoperatively,  she  received  3  courses  of cyclophosphamide,  epirubicin  and  5-ﬂuorouracil,  with  subsequent http://dx.doi.org/10.1016/j.ijscr.2016.05.001 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/fe/26/main.PMC4873600.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Myocardial infarctionHeart failure Left ventricular dysfunction ConductionOptical mappingConnexins 1.,Non-OADS,/arxiv_data1/oa_pdf/cf/f9/main.PMC4873602.pdf
http://dx.doi.org/10.1016/j.yjmcc.2016.03.011 0022-2828/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/cf/f9/main.PMC4873602.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cf/f9/main.PMC4873602.pdf
"For connexin quanti ﬁcation, single optical slice images showing Cx40 or Cx43 immunolabelling, together with myocyte and non- myocyte immunolabelling, were quantitatively analyzed using ImageJ (http://rsb.info.nih.gov/ij/ ).",OADS,/arxiv_data1/oa_pdf/cf/f9/main.PMC4873602.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/37/38/main.PMC4873608.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.03.005 193,OADS,/arxiv_data1/oa_pdf/37/38/main.PMC4873608.pdf
http://dx.doi.org/10.3402/jchimp.,OADS,/arxiv_data1/oa_pdf/37/38/main.PMC4873608.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e6/01/main.PMC4873609.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.03.006,Non-OADS,/arxiv_data1/oa_pdf/e6/01/main.PMC4873609.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,3 5–42 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/e6/01/main.PMC4873609.pdf
Results Phenotypic properties C. indologenes MARS15 ( http://www.mediterranee-infection.com/ arkotheque/client/ihumed/_depot_arko/articles/658/catalogue- csur-27-10-2015_doc.pdf ) was isolated in March 2013 from the sputum sample of a 15-year-old girl with CF on Cepacia medium.,Non-OADS,/arxiv_data1/oa_pdf/e6/01/main.PMC4873609.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,3 5–42 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/e6/01/main.PMC4873609.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,3 5–42 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/e6/01/main.PMC4873609.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,3 5–42 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/e6/01/main.PMC4873609.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,3 5–42 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/e6/01/main.PMC4873609.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,3 5–42 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/e6/01/main.PMC4873609.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,3 5–42 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/e6/01/main.PMC4873609.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/cb/main.PMC4873610.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.05.008 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/0b/cb/main.PMC4873610.pdf
This  is  an  open access article under the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/36/31/main.PMC4873611.pdf
"Her  breast  cancer  had been  treated  with  neoadjuvant  chemotherapy,  left  modiﬁed  radical http://dx.doi.org/10.1016/j.ijscr.2016.05.007 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/36/31/main.PMC4873611.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/34/a2/main.PMC4873613.pdf
"On  MRI  performed  two  days  after  dislocation,  no http://dx.doi.org/10.1016/j.ijscr.2016.05.009 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/34/a2/main.PMC4873613.pdf
"De novo assembly .First, TruSeq adapters from mate-pair data were removed using Nesoni default parameters (v0.115) (https://github.com/Victorian- Bioinformatics-Consortium/nesoni).",OADS,/arxiv_data1/oa_pdf/77/70/ncomms11519.PMC4873664.pdf
http://www.giraffeconservation.org/ programmes/giraffe-conservation-status-2/ (2014).,Non-OADS,/arxiv_data1/oa_pdf/77/70/ncomms11519.PMC4873664.pdf
We thank Carly Driebelbis and Michael Potter for constructing Giraffe Genome website (https://giraffegenome.science.psu.edu).,Non-OADS,/arxiv_data1/oa_pdf/77/70/ncomms11519.PMC4873664.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/77/70/ncomms11519.PMC4873664.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Agaba, M. et al.",Non-OADS,/arxiv_data1/oa_pdf/77/70/ncomms11519.PMC4873664.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms11519 8 NATURE COMMUNICATIONS | 7:11519 | DOI: 10.1038/ncomms11519 | www.nature.com/naturecommunications",Non-OADS,/arxiv_data1/oa_pdf/77/70/ncomms11519.PMC4873664.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7d/64/main.PMC4873688.pdf
"However,  the  likelihood  of  a http://dx.doi.org/10.1016/j.ijscr.2016.05.010 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/7d/64/main.PMC4873688.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/51/main.PMC4873689.pdf
The  intraductal  epithelial  prolifer- ation  was  arranged  in  a  cribriform  and  solid  pattern  of  growth; http://dx.doi.org/10.1016/j.ijscr.2016.04.053 2210-2612/© 2016  The  Authors.,OADS,/arxiv_data1/oa_pdf/44/51/main.PMC4873689.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/72/21/main.PMC4873691.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.03.007,Non-OADS,/arxiv_data1/oa_pdf/72/21/main.PMC4873691.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,1 8–23 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/72/21/main.PMC4873691.pdf
The exhaustive search for bacteriocin was performed using the database available in our laboratories (Bacteriocins of the URMITE database BUR; http://drissifatima.wix.com/bacteriocins ).,OADS,/arxiv_data1/oa_pdf/72/21/main.PMC4873691.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,1 8–23 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/72/21/main.PMC4873691.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,1 8–23 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/72/21/main.PMC4873691.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,1 8–23 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/72/21/main.PMC4873691.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,1 8–23 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/72/21/main.PMC4873691.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Major depressive disorderVolumetric analysisShape analysisPutamen Thalamus 1.,Non-OADS,/arxiv_data1/oa_pdf/bc/96/main.PMC4873692.pdf
http://dx.doi.org/10.1016/j.nicl.2016.04.008 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/96/main.PMC4873692.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bc/96/main.PMC4873692.pdf
"Subcortical grey matter volumetric analysis We segmented the bilateral hippocampus, amygdala, accumbens nucleus, caudate nucleus, pallidum nucleus, putamen nucleus and thal- amus, respectively, from each subject's T1 3D TFE image using FMRIB's Integrated Registration and Segmentation Tool (FIRST), part of FMRIB's Software Library (FSL 5.0.8, http://www.fmrib.ox.ac.uk/fsl ).",Non-OADS,/arxiv_data1/oa_pdf/bc/96/main.PMC4873692.pdf
"[13] Medline search “metronomic chemotherapy India” yielded 31 references, 17 of which are involving the Department of Medical Oncology, Tata Memorial Hospital, Mumbai (http://www.nlm.nih.gov/).",OADS,/arxiv_data1/oa_pdf/62/1f/SAJC-5-37.PMC4873693.pdf
Available from: http://www.clinicaltrials.,Non-OADS,/arxiv_data1/oa_pdf/33/e4/SAJC-5-52.PMC4873695.pdf
Available from: http://www.ncrpindia.org/ALL_NCRP_REPORTSPBCR_ REPORT_2009_2011/ALL_CONTENT/ALL_PDF/Chapter 2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/17/80/SAJC-5-59.PMC4873697.pdf
Available from: http://www.nccn.org/professionals/physician_gls/ pdf/ovarian.pdf.,Non-OADS,/arxiv_data1/oa_pdf/17/80/SAJC-5-59.PMC4873697.pdf
Available from: http://www.hss.iitb.ac.in/ties07/paper/ts2/psE/2.,Non-OADS,/arxiv_data1/oa_pdf/17/80/SAJC-5-59.PMC4873697.pdf
Available from: http://www.hss.iitb.ac.in/ties07/paper/ts2/psE/2.,Non-OADS,/arxiv_data1/oa_pdf/cc/5d/SAJC-5-62.PMC4873698.pdf
Available from: https://www.nccn.org/professionals/physician_gls/pdf/breast.,Non-OADS,/arxiv_data1/oa_pdf/54/57/SAJC-5-66.PMC4873700.pdf
Available  from: https://www.nccn.org/professionals/physician_gls/pdf/breast.,Non-OADS,/arxiv_data1/oa_pdf/24/45/SAJC-5-67.PMC4873701.pdf
"1, 20 –24 http://dx.doi.org/10.1080/08897077.2015.1129388",Non-OADS,/arxiv_data1/oa_pdf/2e/4a/wsub-37-020.PMC4873719.pdf
"Palliative Care Outcome Scale   (POS), http://www.pos-pal.org (2015, accessed 6 March 2015).",Non-OADS,/arxiv_data1/oa_pdf/4b/d2/10.1177_0269216315608348.PMC4873725.pdf
"EORTC Quality  of Life Group: guidelines for developing questionnaire mod- ules, http://groups.eortc.be/qol/sites/default/files/archives/ guidelines_for_developing_questionnaire-_final.pdf (2011, accessed 6 March 2015).",Non-OADS,/arxiv_data1/oa_pdf/4b/d2/10.1177_0269216315608348.PMC4873725.pdf
"The  Palliative care Outcome Scale Manual for cross-cultural  adaptation and psychometric validation, 2012, http://pos-pal.org/Resources.php  14.",Non-OADS,/arxiv_data1/oa_pdf/4b/d2/10.1177_0269216315608348.PMC4873725.pdf
"Supplemental Material Additional supporting information can be found at http://pss.sagepub.com/content/by/supplemental-data References Amabile, T. (1983).",Non-OADS,/arxiv_data1/oa_pdf/ca/ee/10.1177_0956797616634665.PMC4873726.pdf
"74 http://tac.sagepub.com Ther Adv Cardiovasc Dis 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/80/05/10.1177_1753944715622145.PMC4873729.pdf
"Reprints and permissions:   http://www.sagepub.co.uk/ journalsPermissions.nav Therapeutic Advances in Cardiovascular Disease Introduction Patients with severely calcified lesions who undergo percutaneous coronary intervention (PCI) have been shown to have worse clinical outcomes compared with patients with no, mildly, or moderately calcified lesions [Bangalore et  al.",Non-OADS,/arxiv_data1/oa_pdf/80/05/10.1177_1753944715622145.PMC4873729.pdf
http://tac.sagepub.com 75 considerably greater healthcare utilization and  costs [Chambers et al.,Non-OADS,/arxiv_data1/oa_pdf/80/05/10.1177_1753944715622145.PMC4873729.pdf
Therapeutic Advances in Cardiovascular Disease 10(2)  76 http://tac.sagepub.com (c) reduced revascularization events between day  30 and 1 year.,Non-OADS,/arxiv_data1/oa_pdf/80/05/10.1177_1753944715622145.PMC4873729.pdf
http://tac.sagepub.com 77 patients were compared with a sample of elderly  Medicare coronary-stent patients with reported CAC.,Non-OADS,/arxiv_data1/oa_pdf/80/05/10.1177_1753944715622145.PMC4873729.pdf
Therapeutic Advances in Cardiovascular Disease 10(2)  78 http://tac.sagepub.com H-A/AP data.,Non-OADS,/arxiv_data1/oa_pdf/80/05/10.1177_1753944715622145.PMC4873729.pdf
"http://tac.sagepub.com 79 differences in age, gender, and comorbidities,  the ORBIT II mean costs were 17% lower (approximately US$2700; p  < 0.001).",Non-OADS,/arxiv_data1/oa_pdf/80/05/10.1177_1753944715622145.PMC4873729.pdf
Therapeutic Advances in Cardiovascular Disease 10(2)  80 http://tac.sagepub.com 30-day MACEs and costs It is important to note that some types of MACE episodes in these patients are much more likely to occur during the index procedure than afterwards.,Non-OADS,/arxiv_data1/oa_pdf/80/05/10.1177_1753944715622145.PMC4873729.pdf
http://tac.sagepub.com 81 amounts to 2.6 lives saved or 29.9 life-years  gained for a cohort of 100 patients.,Non-OADS,/arxiv_data1/oa_pdf/80/05/10.1177_1753944715622145.PMC4873729.pdf
Therapeutic Advances in Cardiovascular Disease 10(2)  82 http://tac.sagepub.com The major cost driver is the projected cost offset  due to reduced length of stay in hospital (by avoiding complications) and lower costs during the index procedure itself.,Non-OADS,/arxiv_data1/oa_pdf/80/05/10.1177_1753944715622145.PMC4873729.pdf
"http://tac.sagepub.com 83 The second major cost consideration was attrib- uted to differences in the postprocedure MACE rate, and particularly the need for revasculariza-tion in the remainder of the first year.",Non-OADS,/arxiv_data1/oa_pdf/80/05/10.1177_1753944715622145.PMC4873729.pdf
Therapeutic Advances in Cardiovascular Disease 10(2)  84 http://tac.sagepub.com and ACUITY [Stone et al.,Non-OADS,/arxiv_data1/oa_pdf/80/05/10.1177_1753944715622145.PMC4873729.pdf
http://tac.sagepub.com 85 Outcomes With Revascularization and Stents   in Acute Myocardial Infarction) and ACUITY   (Acute Catheterization and Urgent Intervention  Triage Strategy) Trials.,Non-OADS,/arxiv_data1/oa_pdf/80/05/10.1177_1753944715622145.PMC4873729.pdf
"2014] (n = 6855) Average age (years) 71 61 Male (%) 65 73 History of (%)   Diabetes 36 24 Hypertension 92 62 Myocardial infarction 22 23 Coronary artery bypass graft 15 13 Renal insufficiency Chronic kidney disease excluded, acute kidney injury N/A17 Stroke  9  6 Hyperlipidemia 92 62 HORIZONS-AMI/ACUITY, Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction/Acute  Catheterization and Urgent Intervention Triage Strategy trials; ORBIT II, Evaluate the Safety and Efficacy of OAS in Treat-ing Severely Calcified Coronary Lesions trial.Visit SAGE journals online  http://tac.sagepub.com SAGE journals",Non-OADS,/arxiv_data1/oa_pdf/80/05/10.1177_1753944715622145.PMC4873729.pdf
"http://rer.aera.net 360The Trans-Contextual Model of Autonomous  Motivation in Education: Conceptual and  Empirical Issues and Meta-Analysis Martin S. Hagger and Nikos L. D. Chatzisarantis Curtin University The trans-contextual model outlines the processes by which autonomous  motivation toward activities in a physical education context predicts autono-mous motivation toward physical activity outside of school, and beliefs about, intentions toward, and actual engagement in, out-of-school physical activity.",Non-OADS,/arxiv_data1/oa_pdf/e0/1a/10.3102_0034654315585005.PMC4873731.pdf
Retrieved from http://www-unix.oit.umass.edu/~aizen,OADS,/arxiv_data1/oa_pdf/e0/1a/10.3102_0034654315585005.PMC4873731.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits noncommercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/bf/gnu057.PMC4873760.pdf
"Mental control  was measured using the Cogstate  Identification Task ( http://www.cogstate.com ) and  three modified versions of the Flanker task: Flanker  Center Letter, Flanker Center Symbol, and Flanker  Center Arrow ( Eriksen & Eriksen, 1974 ).",OADS,/arxiv_data1/oa_pdf/4a/bf/gnu057.PMC4873760.pdf
Supplementary Material Please visit the article online at http://gerontologist.oxford- journals.org .,Non-OADS,/arxiv_data1/oa_pdf/4a/bf/gnu057.PMC4873760.pdf
Retrieved from  https://itunes.apple.com/us/app/scrappad-scrapbook-for-ipad/ id353143273?mt=8 Alzheimer’s Association.,Non-OADS,/arxiv_data1/oa_pdf/4a/bf/gnu057.PMC4873760.pdf
"Retrieved  from https://itunes.apple.com/us/app/words-with-friends-free/ id321916506?mt=8  The Gerontologist , 2016,  Vol.",Non-OADS,/arxiv_data1/oa_pdf/4a/bf/gnu057.PMC4873760.pdf
e-mail: shibata@cc.tuat.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/4c/e7/jvms-78-529.PMC4873840.pdf
e-mail: hori@vmas.kitasato-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/03/79/jvms-78-535.PMC4873841.pdf
e-mail: i.stefanska@gmail.com ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/ab/a7/jvms-78-543.PMC4873842.pdf
e-mail: osawa@cc.miyazaki-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/94/98/jvms-78-551.PMC4873843.pdf
Statistical analysis: Statistical analysis was performed  using the statistical software EZR version 1.27 (http://www.jichi.ac.jp/saitama-sct/SaitamaHP.files/statmedEN.html)  [12].,OADS,/arxiv_data1/oa_pdf/94/98/jvms-78-551.PMC4873843.pdf
©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/39/60/jvms-78-557.PMC4873844.pdf
e-mail: ewaRST@interia.pl ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/71/d6/jvms-78-563.PMC4873845.pdf
e-mail: une@azabu-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/92/27/jvms-78-573.PMC4873846.pdf
[cited 2015 October 10] Available from https://www.avma.org/ KB/Policies/Documents/euthanasia.pdf.,Non-OADS,/arxiv_data1/oa_pdf/92/27/jvms-78-573.PMC4873846.pdf
Available from http://www.env.go.jp/nature/intro/1outline/files/siteisyu_list_e.pdf.,Non-OADS,/arxiv_data1/oa_pdf/92/27/jvms-78-573.PMC4873846.pdf
Available from http://www.oie.int/animal-health-in- the-world/oie-listed-diseases-2015/.,Non-OADS,/arxiv_data1/oa_pdf/92/27/jvms-78-573.PMC4873846.pdf
e-mail:	terumasa@vet.osakafu-u.ac.jp ©2016	The	Japanese	Society	of	 Veterinary	Science This	is	an	open-access	 article	distributed 	under	the	terms	of	the	Creative	 Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/c1/1b/jvms-78-579.PMC4873847.pdf
e-mail: katamoto@cc.miyazaki-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/48/79/jvms-78-587.PMC4873848.pdf
http://www.maff.go.jp/e/tokei/kikaku/nenji_e/88nenji/ (accessed 30 January 2015).,OADS,/arxiv_data1/oa_pdf/48/79/jvms-78-587.PMC4873848.pdf
e-mail: auchidak@mail.ecc.u-tokyo.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/a8/de/jvms-78-593.PMC4873849.pdf
e-mail: fl@hvri.ac.cn ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/3d/4f/jvms-78-601.PMC4873850.pdf
e-mail: taniyama@rakuno.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/d0/7c/jvms-78-607.PMC4873851.pdf
e-mail: mmatsui@obihiro.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/62/a9/jvms-78-613.PMC4873852.pdf
e-mail: ohkweon@snu.ac.kr ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/5b/fc/jvms-78-619.PMC4873853.pdf
e-mail: a0d901u@cc.miyazaki-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/8c/fc/jvms-78-627.PMC4873854.pdf
e-mail: skobaya@z7.keio.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/c2/76/jvms-78-633.PMC4873855.pdf
Available at: http://www.maff.,Non-OADS,/arxiv_data1/oa_pdf/c2/76/jvms-78-633.PMC4873855.pdf
Available at: http://www.level.com.tw/html/ezcatfiles/ vipweb20/img/img/34963/3-2Single_cell_cloning_protocol.pdf  (Accessed 04 November 2015)  19.,Non-OADS,/arxiv_data1/oa_pdf/c2/76/jvms-78-633.PMC4873855.pdf
e-mail: ningyibao@163.com ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/ea/cf/jvms-78-641.PMC4873856.pdf
e-mail: staka@vetmed.hokudai.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/1d/da/jvms-78-649.PMC4873857.pdf
e-mail: tulbakir@istanbul.edu.tr ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/f5/cf/jvms-78-657.PMC4873858.pdf
e-mail: thahn@chonnam.ac.kr ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/80/30/jvms-78-669.PMC4873859.pdf
e-mail: ishizum@vetmed.hokudai.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/56/82/jvms-78-675.PMC4873860.pdf
©2016	The	Japanese	Society	of	 Veterinary	Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/2a/28/jvms-78-681.PMC4873861.pdf
e-mail: michishita@nvlu.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/ba/e0/jvms-78-685.PMC4873862.pdf
e-mail: tshimo@yamaguchi-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/cd/0e/jvms-78-691.PMC4873863.pdf
e-mail: lhc@gnu.ac.kr ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/30/da/jvms-78-697.PMC4873864.pdf
e-mail:	itohiroy@affrc.go.jp ©2016	The	Japanese	Society	of	 Veterinary	Science This	is	an	open-access	 article	distributed 	under	the	terms	of	the	Creative	 commons Attribution Non-commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/0f/a4/jvms-78-701.PMC4873865.pdf
e-mail: tmizutan@cc.tuat.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/93/30/jvms-78-705.PMC4873866.pdf
©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/ac/34/jvms-78-709.PMC4873867.pdf
e-mail: sazaly@um.edu.my ©2016	The	Japanese	Society	of	 Veterinary	Science This	is	an	open-access	 article	distributed 	under	the	terms	of	the	Creative	 Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/c9/80/jvms-78-715.PMC4873868.pdf
"1, and its nucleotide sequences can  be	accessed	 at	the	PubMLST 	website	(http://pubmlst.org/ bordetella)	 [8].",OADS,/arxiv_data1/oa_pdf/c9/80/jvms-78-715.PMC4873868.pdf
e-mail: matsumoto.jun82@nihon-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/58/3f/jvms-78-719.PMC4873869.pdf
e-mail: ayako_morioka370@maff.go.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/8e/1d/jvms-78-723.PMC4873870.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/40/ed/bmjgast-2016-000092.PMC4873945.pdf
http://www.medicines.org.uk/emc/medicine/ 24128#NUMBER (accessed 7 Mar 2016).,Non-OADS,/arxiv_data1/oa_pdf/40/ed/bmjgast-2016-000092.PMC4873945.pdf
http://www.medicines.org.uk/emc/medicine/25624(accessed 19 Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/40/ed/bmjgast-2016-000092.PMC4873945.pdf
http://www.medicines.org.uk/emc/medicine/172 (accessed 19 Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/40/ed/bmjgast-2016-000092.PMC4873945.pdf
http://www.medicines.org.uk/emc/medicine/30253(accessed 19 Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/40/ed/bmjgast-2016-000092.PMC4873945.pdf
”December 2009. http://www.fda.gov/downloads/Drugs/ Guidances/UCM193282.pdf (accessed 19 Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/40/ed/bmjgast-2016-000092.PMC4873945.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjdrc-2016- 000193).,Non-OADS,/arxiv_data1/oa_pdf/94/b3/bmjdrc-2016-000193.PMC4873947.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/94/b3/bmjdrc-2016-000193.PMC4873947.pdf
http://www.renewinghealth.eu/en/assessment-method 26.,Non-OADS,/arxiv_data1/oa_pdf/94/b3/bmjdrc-2016-000193.PMC4873947.pdf
http://www.ntnu.edu/hunt 29.,Non-OADS,/arxiv_data1/oa_pdf/94/b3/bmjdrc-2016-000193.PMC4873947.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjdrc-2016-000211).,Non-OADS,/arxiv_data1/oa_pdf/0e/44/bmjdrc-2016-000211.PMC4873949.pdf
A complete list of staff and investigators has been provided by Sorlie et al27and is also available on the study website http://www.cscc.unc.edu/hchs/.,Non-OADS,/arxiv_data1/oa_pdf/0e/44/bmjdrc-2016-000211.PMC4873949.pdf
"Data sharing statement Data from HCHS/SOL can be accessed by submitting proposals for manuscripts or by submitting an ancillary study proposalthrough the HCHS/SOL website, https://http://www2.cscc.unc.edu/hchs/.",Non-OADS,/arxiv_data1/oa_pdf/0e/44/bmjdrc-2016-000211.PMC4873949.pdf
2015. http://www.census.gov/newsroom/facts-for-features/2014/cb14-ff22.html4.,OADS,/arxiv_data1/oa_pdf/0e/44/bmjdrc-2016-000211.PMC4873949.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjdrc-2015- 000163).,Non-OADS,/arxiv_data1/oa_pdf/8e/e5/bmjdrc-2015-000163.PMC4873950.pdf
http://nortonsafe.search.ask.com/web?q=An+Application+of+Gamma+Generalized+Linear+Model+for+Estimation+of+Survival+Function+of+Diabetic+Nephropathy+Patients+Gurprit+Grover%2C+Alka+Sabharwal*+and+Juhi+Mittal&geo=GB&prt=NSBU&locale=en_GB&o=APN10505&chn=retail&ver=22&tpr=2&ts=1452592694785 23.,Non-OADS,/arxiv_data1/oa_pdf/8e/e5/bmjdrc-2015-000163.PMC4873950.pdf
52–54Using the INDIRECT macro developed by Preacher and Hayes (http://www.comm.ohio-state.,Non-OADS,/arxiv_data1/oa_pdf/77/12/bmjdrc-2015-000184.PMC4873951.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/77/12/bmjdrc-2015-000184.PMC4873951.pdf
"Korean J Hepatobiliary Pancreat Surg 2016;20:89-92 http://dx.doi.org/10.147 01/kjhbps.2016.20.2.89 Case Report Nasogastric tube placement into the hepaticojejunostomy  anastomosis in pancreaticoduodenectomy: a simple surgical  technique for prevention of bile leak Bulent Kaya, Yetkin Ozcabi, Iksan Tasdelen, Ender Onur, and Kemal Memisoglu Department of General Surgery, Fatih Sultan Mehmet Training and  Research Hospital, Atasehir- İstanbul, Turkey Hepaticojejunostomy is an important part of many surgical procedures including pancreaticoduodenectomy.",Non-OADS,/arxiv_data1/oa_pdf/7b/5d/kjhbps-20-89.PMC4874041.pdf
"Korean J Hepatobiliary Pancreat Surg 2016;20:85-88 http://dx.doi.org/10.147 01/kjhbps.2016.20.2.85 Case Report Ciliated foregut cyst of the gallbladder:  a case report and literature review Ilseon Hwang1, and Jihyoung Cho2 Departments of 1Pathology and 2Surgery, Keimyung University School of Medicine, Daegu, Korea Ciliated foregut cyst of gallbladder is a very rare benign cystic lesion.",Non-OADS,/arxiv_data1/oa_pdf/35/6b/kjhbps-20-85.PMC4874042.pdf
"Korean J Hepatobiliary Pancreat Surg 2016;20:53-60 http://dx.doi.org/10.147 01/kjhbps.2016.20.2.53 Original Article Safe laparoscopic clearance of the common bile duct in emergentl y admitted patients with choledocholithiasis and cholangitis Kristaps Atstupens, Haralds Plaudis, Vladimir s Fokins, Maksims Mukans, and Guntars Pupelis Department of General and Emergency Surgery,  Riga East University Hospital, Riga, Latvia Backgrounds/Aims:  Laparoscopic treatment of patients with choledocho lithiasis and cholangitis is challenging due to  mandatory recovery of the biliary drainage and clearance of  the common bile duct (CBD).",Non-OADS,/arxiv_data1/oa_pdf/ec/16/kjhbps-20-53.PMC4874043.pdf
"Korean J Hepatobiliary Pancreat Surg 2016;20:49-52 http://dx.doi.org/10.147 01/kjhbps.2016.20.2.49 Original Article Changes in the types of liver dis eases requiring hepatic resection:  a single-institution experience of  9016 cases over a 10-year period Hwui-Dong Cho, Shin Hwang, Young-Joo Lee, Kw ang-Min Park, Ki-Hun Kim, Jin Cheon Kim,  Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, and Sung-Gyu Lee Department of Surgery, Asan Medical Center, Univ ersity of Ulsan College of Medicine, Seoul, Korea Backgrounds/Aims:  To understand the changing demands for hepatic resection (HR), we collected data regarding HR  performed in a tertiary centre over a period of 10 years.",Non-OADS,/arxiv_data1/oa_pdf/72/99/kjhbps-20-49.PMC4874044.pdf
"Korean J Hepatobiliary Pancreat Surg 2016;20:81-84 http://dx.doi.org/10.147 01/kjhbps.2016.20.2.81 Case Report Management of portal hypertensi on derived from uncommon causes Sung Hyun Kim1, Hae Min Lee1, Seung Ho Lee1, Jong Yoon Won2, and Kyung Sik Kim1 Departments of 1Hepatobiliary and Pancreatic Surgery and 2Radiology, Severance Hospital,  Yonsei University College of Medicine, Seoul, Korea Portal hypertension can arise from any condition interfering with normal blood flow at any le vel within the portal system.",Non-OADS,/arxiv_data1/oa_pdf/10/3a/kjhbps-20-81.PMC4874045.pdf
"Korean J Hepatobiliary Pancreat Surg 2016;20:61-65 http://dx.doi.org/10.147 01/kjhbps.2016.20.2.61 How-I-Do-It Conjoined unification venoplasty for triple portal vein branches o f  right liver graft: a case report and technical refinement Jae Hyun Kwon, Shin Hwang, Gi-Won Song, Deok-Bog Moon,  Gil-Chun Park, Seok-Hwan Kim, and Sung-Gyu Lee Division of Hepatobiliary Surgery and Liver Transplant ation, Department of Surgery, Asan Medical Center,  University of Ulsan College of Medicine, Seoul, Korea Anomalous portal vein (PV) branching of the donor liver is unc ommon and usually makes two, or rarely, more separate  PV branches at the right liver graft.",Non-OADS,/arxiv_data1/oa_pdf/cd/0c/kjhbps-20-61.PMC4874046.pdf
"Korean J Hepatobiliary Pancreat Surg 2016;20:66-70 http://dx.doi.org/10.147 01/kjhbps.2016.20.2.66 How-I-Do-It Cluster hepati cojejunostomy with radial spreading anchoring traction technique for secure reco nstruction of widely op ened hilar bile ducts Shin Hwang, Tae-Yong Ha, Gi-Won Song, and Dong-Hwan Jung Department of Surgery, Asan Medical Center, Univ ersity of Ulsan College of Medicine, Seoul, Korea Secure reconstruction of multiple hepat ic ducts that are severely damaged by tumor invasion or iatrogenic injury is  a challenge.",Non-OADS,/arxiv_data1/oa_pdf/3a/e5/kjhbps-20-66.PMC4874047.pdf
"Korean J Hepatobiliary Pancreat Surg 2016;20:71-74 http://dx.doi.org/10.147 01/kjhbps.2016.20.2.71 Case Report Case report of solitary giant hepatic lymphangioma Hwan Hyo Lee1, and Seon Youl Lee2 Departments of 1Surgery and 2Radiology, Gimpo Woori Hospital, Gimpo, Korea A hepatic lymphangioma is a rare beni gn neoplasm that is usually associated with systemic lymphangiomatosis.",Non-OADS,/arxiv_data1/oa_pdf/95/a1/kjhbps-20-71.PMC4874048.pdf
"Korean J Hepatobiliary Pancreat Surg 2016;20:75-80 http://dx.doi.org/10.147 01/kjhbps.2016.20.2.75 Case Report Associating liver partition and portal vein ligation for staged  hepatectomy (ALPPS) procedure fo r hepatocellular carcinoma with chronic liver disease: a case report and review of literature Michail Papamichail, Michail Pi zanias, Vincent Yip, Evangellos Prassas, Andreas Prachalias,  Alberto Quaglia, Praveen Peddu, Ni gel Heaton, and Parthi Srinivasan Institute of Liver Studies, Kings Health  Partners of King’s College Hospital,  NHS Foundation Trust, London, United Kingdom The incidence of complications after liver resection is closely related to functional  future liver remnant (FLR).",Non-OADS,/arxiv_data1/oa_pdf/3a/3f/kjhbps-20-75.PMC4874049.pdf
"Korean J Hepatobiliary Pancreat Surg 2016;20:93-96 http://dx.doi.org/10.147 01/kjhbps.2016.20.2.93 Case Report Incidental detection of panc reatic hemangioma mimicking  a metastatic tumor of renal cell carcinoma Sung Hyun Kim1, Ji-Ye Kim2, Jin Young Choi3, Young Deuk Choi4, and Kyung Sik Kim1 Departments of 1Hepatobiliary and Pancreatic Surgery, 2Pathology, 3Radiology, and 4Urology,  Severance Hospital, Yonsei University College of Medicine, Seoul, Korea Adult pancreatic hemangioma is a rare disease.",Non-OADS,/arxiv_data1/oa_pdf/24/9c/kjhbps-20-93.PMC4874050.pdf
doi:10.1136/openhrt-2016- 000461 Accepted 22 April 2016 ▸http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7c/cc/openhrt-2016-000461.PMC4874053.pdf
To view please visit the journal (http://dx.doi.org/10.1136/rmdopen-2015- 000213).,Non-OADS,/arxiv_data1/oa_pdf/b1/94/rmdopen-2015-000213.PMC4874056.pdf
"Lyon, France: International Agency for Research on Cancer, 2013. http://globocan.iarc.fr (accessed 29 Feb 2016).",Non-OADS,/arxiv_data1/oa_pdf/b1/94/rmdopen-2015-000213.PMC4874056.pdf
Retrieved fromhttp://corpus.byu.edu/coca/.,Non-OADS,/arxiv_data1/oa_pdf/e8/82/10.1177_2331216516646556.PMC4874060.pdf
[Data file].Retrieved from http://www.iphod.com/.,OADS,/arxiv_data1/oa_pdf/e8/82/10.1177_2331216516646556.PMC4874060.pdf
Available from: https://www.india.gov.in/transplantation-human- organs-amendment-act-2011.,Non-OADS,/arxiv_data1/oa_pdf/82/74/JOACP-32-143.PMC4874063.pdf
Available from: http://www.tnos.org/pdf/report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/73/15/JOACP-32-146.PMC4874065.pdf
Available from:  https://www.anaesthesia.ie/archive/ICSI/ICSI%20Guidelines%20 MAY10.pdf.,Non-OADS,/arxiv_data1/oa_pdf/73/15/JOACP-32-146.PMC4874065.pdf
Available  from: http://www.aomrc.org.uk/reports-guidance.html.,Non-OADS,/arxiv_data1/oa_pdf/73/15/JOACP-32-146.PMC4874065.pdf
Available  from: https://www.health.ny.gov/professionals/.../brain death  guidelines.,Non-OADS,/arxiv_data1/oa_pdf/73/15/JOACP-32-146.PMC4874065.pdf
": +91-9443138800 Email: nelcon2016@gmail.com Website: http://www.isacontamilnadu2016.com/ 18th Annual Rajasthan State  Conference of Indian Society of  Anaesthesiologists 2016 ISACONRAJASTHAN2016September  3rd-4th, 2016Government Medical  College Auditorium,  Kota, IndiaDr.",Non-OADS,/arxiv_data1/oa_pdf/2e/3c/JOACP-32-160.PMC4874067.pdf
"The Netherlandshttp://www.esra2016.com/ CONGRESS VENUE   MECC Maastricht   Address: Forum 100, 6229 GV Maastricht   Telephone: +31 (0)43 38 38 383   Email: info@mecc.nl Annual East Zone Conference of ISA ISACON EAST – 2016September  9th-11th, 2016Puri, Odisha Dr. Debaprasad Mohanty Mobile No.",Non-OADS,/arxiv_data1/oa_pdf/65/fd/JOACP-32-172.PMC4874069.pdf
": +91-9826168747 Email: ashsethi64@yahoo.com Website: http://www.isampchapter.com Society For Airway Management  19th Annual Meeting 2016  (SAM 2016) September  15th-18th 2016Atlanta, Georgia, USA http://samhq.com/2014-sam-meeting-in-seattle-washington/ The Society for Airway Management is a 501(c)(3) organization   5753 Tanager Street | Schererville, IN 46375   PH: (773) 834-3171 | FAX: (773) 834-3166 Administrator: amprince@peds.bsd.uchicago.edu   Webmaster: webpagesam@gmail.com 7th National Airway Conference  NAC 2016 September  16th-19th 2016Vadodara Dr. Amit Shah  Organizing Chairman   Dr. Apeksh Patwa   Organizing Secretary   Contact: Dr. Dinesh Patel Telephone : 9879925025 Email Id: nac2016vadodara@gmail.com Website: http://www.nac2016.in ISACON AP – 2016 25th Annual State Conference  of ISA AP State ChapterSeptember  16th-18th 2016Tanish Function  Hall, Kurnool, APOrg Secretary: Dr. G. Shantiraju Mobile No.",Non-OADS,/arxiv_data1/oa_pdf/65/fd/JOACP-32-172.PMC4874069.pdf
: +91 7702228107 9494491910 Email: gunnasraj@gmail.com Website: http://www.isaapcon2016.in/Conference Calendar April 2016,Non-OADS,/arxiv_data1/oa_pdf/65/fd/JOACP-32-172.PMC4874069.pdf
Available from: http://ispub.com/ IJA/26/1/6383.,Non-OADS,/arxiv_data1/oa_pdf/2b/02/JOACP-32-187.PMC4874072.pdf
PS  version 3.0.34 available at http://biostat.mc.vanderbilt.edu/ wiki/Main/PowerSampleSize assessed on 20.10.2013.).,Non-OADS,/arxiv_data1/oa_pdf/1c/5c/JOACP-32-214.PMC4874077.pdf
": +91-9435031489 Email: dhruba_borgohain@yahoo.co.in American Society of  Anesthesiologists (ASA) Annual  Meeting ANESTHESIOLOGY® 2016October  22nd-26th, 2016McCormick Place  Convention Center Chicago, Illinois  60616, United StatesEmail: annmtg@asahq.org URL: https://www.asahq.org/Annual%20Meeting/?utm_ source=asahq& utm_medium=landing-page& utm_ campaign=Annual-Meeting Difficult Airway Society Annual  Meeting 2016 (DAS 2016)November 16-18th, 2016Riviera International  Centre, Torquayhttps://www.das.uk.com/meetings 64th Annual National  Conference of Indian Society of  Anaesthesiologists  ISACON 2016November,  25th-29th, 2016Punjab Agricultural  University Campus,  LudhianaDr.",Non-OADS,/arxiv_data1/oa_pdf/37/7e/JOACP-32-229.PMC4874080.pdf
"Sunil Katyal, Organizing Secretary 19-H, Ashok Vihar, Rishi Nagar, Ludhiana -141001, Punjab, India   Mobile: +91 9814030552, Email ID: katyalsunilmd@gmail.com   Web: www.isacon2016.com Anaesthesiology 69th  Postgraduate Assembly 2016  (NYSSA 2016)December 9th-13th, 2016Marriott Marquis,  New York, USAhttp://pganyc.weebly.com/ THE NEW YORK STATE SOCIETY OF ANESTHESIOLOGISTS,  INC.  110 East 40th Street, Suite 300, New York, NY 10016 USA   Telephone: 1-212-867-7140 Fax: 1-212-867-7153   International: +00 followed by number   HQ@nyssa-pga.orgConference Calendar April 2016",Non-OADS,/arxiv_data1/oa_pdf/37/7e/JOACP-32-229.PMC4874080.pdf
Those interested in attending the workshop(s) should fill the application form (which asks for a summary of experience and  expertise in clinical research; available at https://sites.google.com/site/sgpgi msnihcourses/ ) and send it as an email attachment to sgpgi.,Non-OADS,/arxiv_data1/oa_pdf/c7/cc/JOACP-32-240.PMC4874082.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010770).,Non-OADS,/arxiv_data1/oa_pdf/82/47/bmjopen-2015-010770.PMC4874099.pdf
"Intersurgical Userguide: i-gel single use supraglottic airway, Adult and paediatric sizes ”, 2013. http://www.igel.com 15.",Non-OADS,/arxiv_data1/oa_pdf/82/47/bmjopen-2015-010770.PMC4874099.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-010709).,Non-OADS,/arxiv_data1/oa_pdf/fd/9e/bmjopen-2015-010709.PMC4874100.pdf
Competing interests All authors have completed the Unified Competing Interests form at http://www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author).,Non-OADS,/arxiv_data1/oa_pdf/fd/9e/bmjopen-2015-010709.PMC4874100.pdf
Mays N. Reorienting the New Zealand health care system to meet the challenge of long-term conditions in a fiscally constrained environment.http://www.victoria.ac.nz/sacl/about/cpf/publications/pdfs/Nick-Mays-Revised-Conference-Paper-Jan-2013-website-version.pdf(accessed 7 Sep 2015).,Non-OADS,/arxiv_data1/oa_pdf/fd/9e/bmjopen-2015-010709.PMC4874100.pdf
http://www.beehive.govt.nz/speech/ minister-civil-defence-statement-parliament-state-national-emergency-declared (accessed 6 Jan 2015).,Non-OADS,/arxiv_data1/oa_pdf/fd/9e/bmjopen-2015-010709.PMC4874100.pdf
http://www.nzdoctor.co.nz/un-doctored/2011/february-2011/27/earthquake-update-thirteen-%E2%80%93-canterbury-dhb-26-february.aspx (accessed 6 Jan 2015).,Non-OADS,/arxiv_data1/oa_pdf/fd/9e/bmjopen-2015-010709.PMC4874100.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-010964).,Non-OADS,/arxiv_data1/oa_pdf/60/15/bmjopen-2015-010964.PMC4874101.pdf
http://www.smh.com.au/action/printArticle?id=1001576448 12.,Non-OADS,/arxiv_data1/oa_pdf/60/15/bmjopen-2015-010964.PMC4874101.pdf
http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/3101.0Jun%202014?OpenDocument 13.,Non-OADS,/arxiv_data1/oa_pdf/60/15/bmjopen-2015-010964.PMC4874101.pdf
SWS 990186. http://www.health.nsw.gov.au/Hospitals/Pages/role-delineation-levels.aspx Lastupdated 24 January 2014 (accessed 15 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/60/15/bmjopen-2015-010964.PMC4874101.pdf
http://www.homedoctor.com.au/ 27.,Non-OADS,/arxiv_data1/oa_pdf/60/15/bmjopen-2015-010964.PMC4874101.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011200).,Non-OADS,/arxiv_data1/oa_pdf/8c/6f/bmjopen-2016-011200.PMC4874104.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011291).,Non-OADS,/arxiv_data1/oa_pdf/6d/18/bmjopen-2016-011291.PMC4874105.pdf
https://www.npa.go.jp/archive/keibi/biki/higaijokyo_ e.pdf 2.,OADS,/arxiv_data1/oa_pdf/6d/18/bmjopen-2016-011291.PMC4874105.pdf
http://www.jst.go.jp/saigai.html 14.,Non-OADS,/arxiv_data1/oa_pdf/6d/18/bmjopen-2016-011291.PMC4874105.pdf
2006. http://www.mhlw.go.jp/bunya/kenkou/ undou02/pdf/data.pdf (accessed 3 Aug 2015).,OADS,/arxiv_data1/oa_pdf/6d/18/bmjopen-2016-011291.PMC4874105.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-011415).,Non-OADS,/arxiv_data1/oa_pdf/17/10/bmjopen-2016-011415.PMC4874106.pdf
"Auckland: ASH New Zealand, 2015. http://www.ash.org.nz/wp-content/uploads/2015/03/F1-General-Topline.pdf 7.",Non-OADS,/arxiv_data1/oa_pdf/17/10/bmjopen-2016-011415.PMC4874106.pdf
2010. http://www.parliament.nz/resource/en-nz/49SCMA_EVI_00DBSCH_INQ_9591_1_A31344/75f02240fc80e9529d2e821f96168a446bf46930 27.,Non-OADS,/arxiv_data1/oa_pdf/17/10/bmjopen-2016-011415.PMC4874106.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010314).,Non-OADS,/arxiv_data1/oa_pdf/44/57/bmjopen-2015-010314.PMC4874109.pdf
"Geneva: World Health Organization, 2009. http://www.who.int/tb/challenges/hiv/ factsheet_hivtb_2009.pdf 4.",Non-OADS,/arxiv_data1/oa_pdf/96/09/bmjopen-2015-010046.PMC4874111.pdf
"Geneva: World Health Organization, 2004; WHO/HTM/TB/ 2004.330. http://www.who.int/hiv/pub/tb/tbhiv/en/index.html 5.",Non-OADS,/arxiv_data1/oa_pdf/96/09/bmjopen-2015-010046.PMC4874111.pdf
"Geneva: World Health Organization, 2008. http://www.who.int/tb/publications/global_report/en/ 11.",Non-OADS,/arxiv_data1/oa_pdf/96/09/bmjopen-2015-010046.PMC4874111.pdf
http://www.cdc.gov/ nchs/nhanes/nhanes_questionnaires.htm.,OADS,/arxiv_data1/oa_pdf/98/28/bmjopen-2015-010708.PMC4874113.pdf
2014. http://hpmrg.org).,Non-OADS,/arxiv_data1/oa_pdf/60/09/bmjopen-2015-010420.PMC4874114.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/60/09/bmjopen-2015-010420.PMC4874114.pdf
10 February 2016. http://www.unaids.org/sites/default/files/en/dataanalysis/knowyourresponse/countryprogressreports/2012countries/ce_CN_Narrative_Report[1].pdf 17.,Non-OADS,/arxiv_data1/oa_pdf/60/09/bmjopen-2015-010420.PMC4874114.pdf
"Kaysville, UT: NCSS, 2014. http://www.ncss.com 21.",Non-OADS,/arxiv_data1/oa_pdf/60/09/bmjopen-2015-010420.PMC4874114.pdf
2014.http://hpmrg.org 27.,Non-OADS,/arxiv_data1/oa_pdf/60/09/bmjopen-2015-010420.PMC4874114.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010429).,Non-OADS,/arxiv_data1/oa_pdf/0d/6a/bmjopen-2015-010429.PMC4874115.pdf
2010;http://researchbriefings.files.parliament.uk/documents/SN05719/SN05719.pdf (accessed 1 July 2015).,Non-OADS,/arxiv_data1/oa_pdf/0d/6a/bmjopen-2015-010429.PMC4874115.pdf
2015. http://www.hscic.gov.uk/prescribing (accessed 1 July 2015).,Non-OADS,/arxiv_data1/oa_pdf/0d/6a/bmjopen-2015-010429.PMC4874115.pdf
2011. https://www.gov.uk/government/uploads/system/ uploads/attachment_data/file/6320/1870718.pdf (accessed 1 July 2015).,Non-OADS,/arxiv_data1/oa_pdf/0d/6a/bmjopen-2015-010429.PMC4874115.pdf
2012. https://www.nice.org.uk/guidance/cg147 4.,Non-OADS,/arxiv_data1/oa_pdf/be/ca/bmjopen-2016-011245.PMC4874117.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010880).,Non-OADS,/arxiv_data1/oa_pdf/ed/b2/bmjopen-2015-010880.PMC4874119.pdf
http://nbv.cardio.dk/ (accessed 1 Jun 2015).,Non-OADS,/arxiv_data1/oa_pdf/ed/b2/bmjopen-2015-010880.PMC4874119.pdf
http://www.whocc.no/ filearchive/publications/1_2013guidelines.pdf (accessed 1 Jun 2015).,Non-OADS,/arxiv_data1/oa_pdf/ed/b2/bmjopen-2015-010880.PMC4874119.pdf
http://www.ucr.,Non-OADS,/arxiv_data1/oa_pdf/ed/b2/bmjopen-2015-010880.PMC4874119.pdf
doi:10.1136/bmjopen-2016- 011068 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011068).,Non-OADS,/arxiv_data1/oa_pdf/55/e6/bmjopen-2016-011068.PMC4874120.pdf
An advertisement will be placed on the USAIS website (http://www.AIS.southampton.ac.uk) from the date of ethical approval to the end of recruit- ment.,Non-OADS,/arxiv_data1/oa_pdf/b8/a5/bmjopen-2016-011342.PMC4874122.pdf
This will be in accordance with the University ’sd a t a security policy (http://www.calendar.soton.ac.uk/sectionIV/dppolicy.pdf) and the requirements of the Data Protection Act (1998).,Non-OADS,/arxiv_data1/oa_pdf/b8/a5/bmjopen-2016-011342.PMC4874122.pdf
This will be in accordance with the University ’s data security policy (http://www.calendar.soton.ac.uk/sectionIV/dppolicy.pdf) and the requirements of the Data Protection Act (1998).,Non-OADS,/arxiv_data1/oa_pdf/b8/a5/bmjopen-2016-011342.PMC4874122.pdf
Annual update 2014 –2015 2015. http://www.bcig.org.uk/ wp-content/uploads/2015/12/CI-activity-2015.pdf 3.,Non-OADS,/arxiv_data1/oa_pdf/b8/a5/bmjopen-2016-011342.PMC4874122.pdf
"http://www.earfoundation.org.uk/ files/download/1221 In: Ear Foundation information sheet, ed., 2016.",Non-OADS,/arxiv_data1/oa_pdf/b8/a5/bmjopen-2016-011342.PMC4874122.pdf
http://webarchive.nationalarchives.gov.uk/20160105160709/http://ons.gov.uk/ons/rel/npp/national-population-projections/2010-based-projections/index.html 2011.,Non-OADS,/arxiv_data1/oa_pdf/b8/a5/bmjopen-2016-011342.PMC4874122.pdf
http://www.gov.uk/government/uploads/system/uploads/attachment_data/file/442834/Work_Stream_1_1.pdf 2015.,Non-OADS,/arxiv_data1/oa_pdf/b8/a5/bmjopen-2016-011342.PMC4874122.pdf
Nucleus 6 care and maintenance accessed 01/03/ 2016. http://www.cochlear.com/wps/wcm/connect/us/recipients/nucleus-6/nucleus-6-basics/care-and-maintenance 37.,Non-OADS,/arxiv_data1/oa_pdf/b8/a5/bmjopen-2016-011342.PMC4874122.pdf
http://www.insigniahealth.com/products/pam-survey48.,OADS,/arxiv_data1/oa_pdf/b8/a5/bmjopen-2016-011342.PMC4874122.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 009964).,Non-OADS,/arxiv_data1/oa_pdf/8c/fa/bmjopen-2015-009964.PMC4874124.pdf
2015. http://www.iss.it/binary/riap2/cont/1_Report_RIAP_2014_Volume_completo.pdf (accessed Jul 2015).,OADS,/arxiv_data1/oa_pdf/8c/fa/bmjopen-2015-009964.PMC4874124.pdf
2014. http://www.salute.gov.it/portale/documentazione/p6_2_8_3_1.jsp?lingua=italiano&id=16 (accessed Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/8c/fa/bmjopen-2015-009964.PMC4874124.pdf
2015. http://www.jobpricing.it/shop/ jp-salary-outlook-2015 (accessed Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/8c/fa/bmjopen-2015-009964.PMC4874124.pdf
http://www.salute.gov.it/portale/temi/p2_6.jsp?,Non-OADS,/arxiv_data1/oa_pdf/8c/fa/bmjopen-2015-009964.PMC4874124.pdf
http://apps.who.int/gho/data/node.imr.LIFE_0000000030?lang=en (accessed Jul 2015).,OADS,/arxiv_data1/oa_pdf/8c/fa/bmjopen-2015-009964.PMC4874124.pdf
http://www.njrcentre.,Non-OADS,/arxiv_data1/oa_pdf/8c/fa/bmjopen-2015-009964.PMC4874124.pdf
http://www.cri.it/flex/cm/ pages/ServeBLOB.php/L/IT/IDPagina/18 (accessed Jul 2015).,OADS,/arxiv_data1/oa_pdf/8c/fa/bmjopen-2015-009964.PMC4874124.pdf
https://www.tim.it/offerte/ mobile/internet-da-tablet-e-pc#section2 (accessed Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/8c/fa/bmjopen-2015-009964.PMC4874124.pdf
http://www.salute.gov.it/imgs/C_17_ pubblicazioni_2129_allegato.pdf (accessed Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/8c/fa/bmjopen-2015-009964.PMC4874124.pdf
http://www.nsis.salute.gov.it/portale/temi/p2_6.jsp?lingua=italiano&id=2515&area=eHealth&menu=vuoto (accessed Jul2015).,Non-OADS,/arxiv_data1/oa_pdf/8c/fa/bmjopen-2015-009964.PMC4874124.pdf
"Aarhus: Sun-Tryk Aarhus University, 2007. http://www.hope.be/03activities/docsactivities/SIMPATIE_Patient_safety_vocabulary_Professionals.pdf8.",Non-OADS,/arxiv_data1/oa_pdf/51/6b/bmjopen-2015-010180.PMC4874125.pdf
2015. https://med.uth.edu/chqs/files/2012/05/SAQ-Short-Form-Scale-Items_000.pdf [homepage on the Internet] (accessed 29 Sept 2015).,Non-OADS,/arxiv_data1/oa_pdf/51/6b/bmjopen-2015-010180.PMC4874125.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-011231).,Non-OADS,/arxiv_data1/oa_pdf/d1/0b/bmjopen-2016-011231.PMC4874126.pdf
http://www.fhi.no/artikler/?,Non-OADS,/arxiv_data1/oa_pdf/d1/0b/bmjopen-2016-011231.PMC4874126.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010667).,Non-OADS,/arxiv_data1/oa_pdf/bd/dd/bmjopen-2015-010667.PMC4874127.pdf
http://www.act.gov.au downloaded information 20 July 2015.,OADS,/arxiv_data1/oa_pdf/bd/dd/bmjopen-2015-010667.PMC4874127.pdf
http://apps.who.int/classifications/icd10/browse/2015/en 20.,Non-OADS,/arxiv_data1/oa_pdf/bd/dd/bmjopen-2015-010667.PMC4874127.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-011700).,Non-OADS,/arxiv_data1/oa_pdf/c5/5f/bmjopen-2016-011700.PMC4874128.pdf
2008;2011. http://ideas.repec.,Non-OADS,/arxiv_data1/oa_pdf/c5/5f/bmjopen-2016-011700.PMC4874128.pdf
2011. http://www.cdc.gov/injury/ overview/ 2.,OADS,/arxiv_data1/oa_pdf/c5/5f/bmjopen-2016-011700.PMC4874128.pdf
2011. http://www.ladhs.org/wps/portal/KingHomepage (accessed 9 Sep 2011).,Non-OADS,/arxiv_data1/oa_pdf/c5/5f/bmjopen-2016-011700.PMC4874128.pdf
2007. http://www.emsa.ca.gov/ systems/files/trauma/trma_ctr.pdf (accessed 9 Sep 2011).,OADS,/arxiv_data1/oa_pdf/c5/5f/bmjopen-2016-011700.PMC4874128.pdf
"Los Angeles: Los Angeles Healthcare Options Task Force, 2009.http://www.issuelab.org/resource/achieving_the_vision_healthcare_options_for_los_angeles_county 20.",Non-OADS,/arxiv_data1/oa_pdf/c5/5f/bmjopen-2016-011700.PMC4874128.pdf
"Los Angeles: Hospital Association of Southern California, 2008.http://www.hasc.org/ 21.",Non-OADS,/arxiv_data1/oa_pdf/c5/5f/bmjopen-2016-011700.PMC4874128.pdf
"Washington DC: Centers for Medicaire & Medicaid Services, 2008. https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/QualityInitiativesGenInfo/downloads/QualityMeasurementRoadmap_OEA1-16_508.pdf 29.",Non-OADS,/arxiv_data1/oa_pdf/c5/5f/bmjopen-2016-011700.PMC4874128.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-009775).,Non-OADS,/arxiv_data1/oa_pdf/37/17/bmjopen-2015-009775.PMC4874129.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/37/17/bmjopen-2015-009775.PMC4874129.pdf
Eur J Geriatr 2003. http://www.saltassociation.co.uk/wp/wp- content/uploads/IFusgen-Disordersofwaterandsodiummetabolism inolderpatients1.pdf 14.,Non-OADS,/arxiv_data1/oa_pdf/37/17/bmjopen-2015-009775.PMC4874129.pdf
2007. http://www.eusalt.com18.,Non-OADS,/arxiv_data1/oa_pdf/37/17/bmjopen-2015-009775.PMC4874129.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010510).,Non-OADS,/arxiv_data1/oa_pdf/51/3a/bmjopen-2015-010510.PMC4874131.pdf
All statistical analyses involved use of R V .2.13.1 (http://www.r-project.org).,Non-OADS,/arxiv_data1/oa_pdf/51/3a/bmjopen-2015-010510.PMC4874131.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-010868).,Non-OADS,/arxiv_data1/oa_pdf/64/dc/bmjopen-2015-010868.PMC4874133.pdf
http://statline.cbs.nl/statweb/ (accessed 18 Feb 2016).,OADS,/arxiv_data1/oa_pdf/64/dc/bmjopen-2015-010868.PMC4874133.pdf
"Geneva: World Health Organization, 2001. http://www.who.int/healthinfo/paper31.pdf (accessed 10 Jan2015).21.",Non-OADS,/arxiv_data1/oa_pdf/64/dc/bmjopen-2015-010868.PMC4874133.pdf
"Den Haag: ZONMW, 2015. http://www.zonmw.nl/uploads/tx_vipublicaties/ZonMw_Onderzoeksagenda_Suicidepreventie_juni2015.pdf(accessed 18 Feb 2016).",Non-OADS,/arxiv_data1/oa_pdf/64/dc/bmjopen-2015-010868.PMC4874133.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-010680).,Non-OADS,/arxiv_data1/oa_pdf/77/e1/bmjopen-2015-010680.PMC4874134.pdf
https://www.gov.uk/government/publications/nhs-choice-framework-2015-to-2016.,Non-OADS,/arxiv_data1/oa_pdf/77/e1/bmjopen-2015-010680.PMC4874134.pdf
https://www.england.nhs.uk/?s=prime +contractor 7.,Non-OADS,/arxiv_data1/oa_pdf/77/e1/bmjopen-2015-010680.PMC4874134.pdf
: HC 439 https://www.nao.org.uk/report/hours-gp-services-england-2/ 55.,Non-OADS,/arxiv_data1/oa_pdf/77/e1/bmjopen-2015-010680.PMC4874134.pdf
Pulse 2013. http://www.pulsetoday.co.uk/hot-topics/practice-news/public-turns-against-nhs-use-of-private-providers/20005345.fullarticle 57.,Non-OADS,/arxiv_data1/oa_pdf/77/e1/bmjopen-2015-010680.PMC4874134.pdf
The HUNT data access information (available here: http://www.ntnu.edu/hunt/data) describes in detail the policy regarding data availability.,OADS,/arxiv_data1/oa_pdf/53/89/bmjopen-2015-010783.PMC4874135.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010854).,Non-OADS,/arxiv_data1/oa_pdf/81/64/bmjopen-2015-010854.PMC4874136.pdf
"Cambodia: National Centre for HIV/AIDS, Dermatology and STDs, 2011. http://www.nchads.org/index.php?id=20&event=146 (accessed 8 Jul 2011).",Non-OADS,/arxiv_data1/oa_pdf/81/64/bmjopen-2015-010854.PMC4874136.pdf
doi:10.1136/bmjopen-2015- 009757 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-009757).,Non-OADS,/arxiv_data1/oa_pdf/e6/e5/bmjopen-2015-009757.PMC4874139.pdf
http://www.dopps.org/annualreport/ 5.,Non-OADS,/arxiv_data1/oa_pdf/e6/e5/bmjopen-2015-009757.PMC4874139.pdf
http://www.uptodate.com/contents/overview-of-central-catheters-for-acute-and-chronic-hemodialysis+access?source=search_result&search=Overview+of+central+catheters+for+acute+and+chronic+hemodialysis+access&selectedTitle=1~150 8.,Non-OADS,/arxiv_data1/oa_pdf/e6/e5/bmjopen-2015-009757.PMC4874139.pdf
"Croatian Registry of Renal Replacement Therapy, Report 2012. http://www.hdndt.org/registar/crt12.html 12.",Non-OADS,/arxiv_data1/oa_pdf/e6/e5/bmjopen-2015-009757.PMC4874139.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010639).,Non-OADS,/arxiv_data1/oa_pdf/5a/7a/bmjopen-2015-010639.PMC4874143.pdf
Data sharing statement Extra data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.c41b0.,OADS,/arxiv_data1/oa_pdf/5a/7a/bmjopen-2015-010639.PMC4874143.pdf
"Paris: HAS, 2005. http://www.has-sante.",Non-OADS,/arxiv_data1/oa_pdf/5a/7a/bmjopen-2015-010639.PMC4874143.pdf
"Paris: HAS, 2006. http://www.has-sante.fr/portail/jcms/c_ 459270/traitement-medicamenteux-du-diabete-de-type-2-recommandation-retiree-le-2-mai-2011 3.",Non-OADS,/arxiv_data1/oa_pdf/5a/7a/bmjopen-2015-010639.PMC4874143.pdf
"Forum: Qualitative Social Research, 2000. http://www.qualitative-research.net/index.php/fqs/article/view/1124 29.",Non-OADS,/arxiv_data1/oa_pdf/5a/7a/bmjopen-2015-010639.PMC4874143.pdf
"Rockville, MD: Agency for Healthcare Research and Quality (US),2014. http://www.ncbi.nlm.nih.gov/books/NBK241537/ 34.",Non-OADS,/arxiv_data1/oa_pdf/5a/7a/bmjopen-2015-010639.PMC4874143.pdf
2014. http://www.cosa.org.au/media/224898/cancer- survivorship-critical-components-model-for-wellness-draft-20150227.pdf 38.,Non-OADS,/arxiv_data1/oa_pdf/fe/7d/bmjopen-2015-010817.PMC4874152.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 011007).,Non-OADS,/arxiv_data1/oa_pdf/3e/95/bmjopen-2015-011007.PMC4874154.pdf
"Dropouts (as a measure of acceptability).Search methods for identification of studies Electronic searches We will search ALOIS (http://www.medicine.ox.ac.uk/alois), the Cochrane Dementia and Cognitive Improvement Group ’s Specialised Register.",Non-OADS,/arxiv_data1/oa_pdf/3e/95/bmjopen-2015-011007.PMC4874154.pdf
"To view a list of all sources searched for in ALOIS, see About ALOIS, on the ALOIS website (http://www.medicine.ox.ac.uk/alois).",Non-OADS,/arxiv_data1/oa_pdf/3e/95/bmjopen-2015-011007.PMC4874154.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/3e/95/bmjopen-2015-011007.PMC4874154.pdf
"GDP and PPP data will be taken from the World Economic Outlook database (http://www.imf.org/ external/data.htm) and Purchasing Power Parities data-base (http://www.oecd.org/std/prices-ppp/purchasing powerparitiespppsdata.htm), respectively.",OADS,/arxiv_data1/oa_pdf/3c/1e/bmjopen-2015-010556.PMC4874156.pdf
2012. http://www.ifompt.com/site/ifompt/files/pdf/IFOMT_Education_Standards_and_International_Monitoring_20080611.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3c/1e/bmjopen-2015-010556.PMC4874156.pdf
Healthline 2015. http://www.healthline.com/health/multiple-sclerosis/facts-statistics-infographic 2.,Non-OADS,/arxiv_data1/oa_pdf/fc/fc/bmjopen-2016-011210.PMC4874157.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-010733).,Non-OADS,/arxiv_data1/oa_pdf/5a/58/bmjopen-2015-010733.PMC4874159.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011585).,Non-OADS,/arxiv_data1/oa_pdf/b4/f4/bmjopen-2016-011585.PMC4874162.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b4/f4/bmjopen-2016-011585.PMC4874162.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011951).,Non-OADS,/arxiv_data1/oa_pdf/3a/80/bmjopen-2016-011951.PMC4874163.pdf
2010. http://jcqhc.or.jp/pdf/research/databook_h21.pdf 18.,OADS,/arxiv_data1/oa_pdf/88/8f/bmjopen-2015-010105.PMC4874164.pdf
http://shortellresearch.berkeley.edu/ICU%20Questionnaires.htm 19.,Non-OADS,/arxiv_data1/oa_pdf/88/8f/bmjopen-2015-010105.PMC4874164.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010719).,Non-OADS,/arxiv_data1/oa_pdf/96/98/bmjopen-2015-010719.PMC4874165.pdf
"The structure with lowest potential energy was extracted, veri ﬁed using Ramachandran plots that were generated by Procheck software (http://nihserver.mbi.",OADS,/arxiv_data1/oa_pdf/96/98/bmjopen-2015-010719.PMC4874165.pdf
"Web-based data-collection was gradually introduced following the launchof the B.OSS website (http://www.b-oss.be) in August 2013, facilitating monthly reporting and completion of data collection forms online.",OADS,/arxiv_data1/oa_pdf/47/0a/bmjopen-2015-010415.PMC4874166.pdf
2015.http://www.rcog.org.uk/globalassets/documents/guidelines/gtg_45.pdf (accessed 21 Oct 2015).,Non-OADS,/arxiv_data1/oa_pdf/47/0a/bmjopen-2015-010415.PMC4874166.pdf
Health and care of pregnant women and babies in Europe in 2010. http://www.europeristat.com/images/doc/EPHR2010_w_disclaimer.pdf(accessed 21 Oct 2015).,Non-OADS,/arxiv_data1/oa_pdf/47/0a/bmjopen-2015-010415.PMC4874166.pdf
"Centre d ’Épidémiologie Périnatale, 2015. http://www.cepip.be/pdf/rapport_CEPIP_Bxl2013_tma-FR.pdf(accessed 21 Oct 2015).",Non-OADS,/arxiv_data1/oa_pdf/47/0a/bmjopen-2015-010415.PMC4874166.pdf
"Centre d ’Épidémiologie Périnatale, 2015. http://www.cepip.be/pdf/rapport_CEPIP_wallonie2013_tmab.pdf(accessed 21 Oct 2015).",Non-OADS,/arxiv_data1/oa_pdf/47/0a/bmjopen-2015-010415.PMC4874166.pdf
Goedkeuring 2010-06-04. http://nvog-documenten.nl/index.php?,Non-OADS,/arxiv_data1/oa_pdf/47/0a/bmjopen-2015-010415.PMC4874166.pdf
https://www.idf.org/sites/default/files/ EN_6E_Atlas_Full_0.pdf 3.,Non-OADS,/arxiv_data1/oa_pdf/6e/20/bmjopen-2016-011144.PMC4874167.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011086).,Non-OADS,/arxiv_data1/oa_pdf/85/71/bmjopen-2016-011086.PMC4874168.pdf
d. https://www.admin.ch/opc/fr/official-compilation/2013/1925.pdf(accessed 9 May 2016).,Non-OADS,/arxiv_data1/oa_pdf/85/71/bmjopen-2016-011086.PMC4874168.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-009430).,Non-OADS,/arxiv_data1/oa_pdf/f2/77/bmjopen-2015-009430.PMC4874170.pdf
Data sharing statement Additional data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.gp545.,OADS,/arxiv_data1/oa_pdf/f2/77/bmjopen-2015-009430.PMC4874170.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f2/77/bmjopen-2015-009430.PMC4874170.pdf
http://www.gov.scot/Resource/0045/00453923.pdf(accessed 19 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/f2/77/bmjopen-2015-009430.PMC4874170.pdf
https://www.unodc.org/documents/wdr2014/World_ Drug_Report_2014_web.pdf (accessed 16 Mar 2015).,OADS,/arxiv_data1/oa_pdf/f2/77/bmjopen-2015-009430.PMC4874170.pdf
2012. http://www.emcdda.europa.eu/publications/ annual-report/2012 (accessed 16 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/f2/77/bmjopen-2015-009430.PMC4874170.pdf
https://www.gov.uk/ government/collections/psychoactive-substances-bill-2015 (accessed17 Jun 2015).,Non-OADS,/arxiv_data1/oa_pdf/f2/77/bmjopen-2015-009430.PMC4874170.pdf
https://volunteer.heart.org/apps/pico/Pages/PublicComment.aspx?q=773 (accessed Nov 2015).14.,Non-OADS,/arxiv_data1/oa_pdf/f9/31/bmjopen-2015-010609.PMC4874171.pdf
"The Cochrane Collaboration, 2011. http://www.cochrane-handbook.org 19.",Non-OADS,/arxiv_data1/oa_pdf/f9/31/bmjopen-2015-010609.PMC4874171.pdf
https://translate.google.ca (accessed Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/f9/31/bmjopen-2015-010609.PMC4874171.pdf
2015. http://www.iom.edu/Reports/2011/Finding-What-Works-in-Health-Care-Standards-for-Systematic-Reviews/Standards.aspx?page=2 (accessed Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/f9/31/bmjopen-2015-010609.PMC4874171.pdf
2011. http://www.google.com/sites/ overview.html (accessed Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/f9/31/bmjopen-2015-010609.PMC4874171.pdf
http://www.ephpp.ca/PDF/Quality20Assessment20Tool_2010_2.pdf (accessed Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/f9/31/bmjopen-2015-010609.PMC4874171.pdf
"Secondary Korea Pharmaceutical Information Center, 2000. http://www.health.kr 13.",Non-OADS,/arxiv_data1/oa_pdf/e2/97/bmjopen-2016-011212.PMC4874172.pdf
2001. http://ezdrug.mfds.go.kr (accessed 3 Jul 2015).,OADS,/arxiv_data1/oa_pdf/e2/97/bmjopen-2016-011212.PMC4874172.pdf
2010. http://www.facit.org (accessed 8 Jul 2015).19.,Non-OADS,/arxiv_data1/oa_pdf/e2/97/bmjopen-2016-011212.PMC4874172.pdf
"Secondary GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012, 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx 23.",Non-OADS,/arxiv_data1/oa_pdf/e2/97/bmjopen-2016-011212.PMC4874172.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-011633).,Non-OADS,/arxiv_data1/oa_pdf/61/b8/bmjopen-2016-011633.PMC4874176.pdf
"Geneva, Switzerland: WHO, 2015. http://apps.who.int/iris/bitstream/10665/175556/1/9789241564984_eng.pdf?ua=1 (accessed 9 Feb2016).",Non-OADS,/arxiv_data1/oa_pdf/61/b8/bmjopen-2016-011633.PMC4874176.pdf
"World Health Organization, 2005.http://www.euro.who.int/__data/assets/pdf_file/0005/124529/E87934.pdf (accessed 9 Feb 2016).",Non-OADS,/arxiv_data1/oa_pdf/61/b8/bmjopen-2016-011633.PMC4874176.pdf
"Discriminatory laws and practices and acts of violence againstindividuals based on their sexual orientation and gender identity.United Nations General Assembly, Human Rights Council 19thsession, 2011. http://www.ohchr.org/Documents/Issues/Discrimination/A.HRC.19.41_English.pdf (accessed 10 Feb 2016).",Non-OADS,/arxiv_data1/oa_pdf/61/b8/bmjopen-2016-011633.PMC4874176.pdf
"LSE Health and Social Care, London School of Economics and Political Science, 2011. http://www.lse.ac.uk/intranet/LSEServices/communications/pressAndInformationOffice/PDF/DP11_2003_Is_the_NHS_equitable.pdf (accessed 29 Jan2016).",Non-OADS,/arxiv_data1/oa_pdf/61/b8/bmjopen-2016-011633.PMC4874176.pdf
"Office for National Statistics, 2012. http://www.ons.gov.uk/peoplepopulationandcommunity/culturalidentity/ethnicity/articles/ethnicityandnationalidentityinenglandandwales/2012-12-11 (accessed 29 Jan 2016).",Non-OADS,/arxiv_data1/oa_pdf/61/b8/bmjopen-2016-011633.PMC4874176.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/23/68/bmjopen-2015-010050.PMC4874179.pdf
2010. http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf34.,OADS,/arxiv_data1/oa_pdf/23/68/bmjopen-2015-010050.PMC4874179.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010933).,Non-OADS,/arxiv_data1/oa_pdf/71/3b/bmjopen-2015-010933.PMC4874181.pdf
https://www.bhf.org.uk/~/media/files/publications/research/bhf_cvd-statistics-2014_web_2.pdf on the 7/10/2015.,Non-OADS,/arxiv_data1/oa_pdf/71/3b/bmjopen-2015-010933.PMC4874181.pdf
29 October 2013. http://www.hscic.gov.uk/catalogue/PUB12262/qual-outc-fram-12-13-rep.pdf on the7/10/2015.,Non-OADS,/arxiv_data1/oa_pdf/71/3b/bmjopen-2015-010933.PMC4874181.pdf
"London, UK: The Kings Fund, 2011. http://www.kingsfund.org.uk/publications/case_management.html on the7/10/15.",Non-OADS,/arxiv_data1/oa_pdf/71/3b/bmjopen-2015-010933.PMC4874181.pdf
"London, UK: Department of Health, 2005. http://www.dh.",Non-OADS,/arxiv_data1/oa_pdf/71/3b/bmjopen-2015-010933.PMC4874181.pdf
http://www.oecd.org/about/ membersandpartners/list-oecd-member-countries.htm on 07/10/ 2015.,Non-OADS,/arxiv_data1/oa_pdf/71/3b/bmjopen-2015-010933.PMC4874181.pdf
http://handbook.cochrane.org/ chapter_9/9_7_sensitivity_analyses.htmon07/10/2015.,OADS,/arxiv_data1/oa_pdf/71/3b/bmjopen-2015-010933.PMC4874181.pdf
http://handbook.cochrane.org/chapter_10/10_4_3_1_recommendations_on_testing_for_funnel_plot_asymmetry.htm on 07/10/2015.,Non-OADS,/arxiv_data1/oa_pdf/71/3b/bmjopen-2015-010933.PMC4874181.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-012277).,Non-OADS,/arxiv_data1/oa_pdf/ad/04/bmjopen-2016-012277.PMC4874201.pdf
"Intervention participants will also be assisted to ﬁnd suitable local exercise opportunities (eg, Tai Chi,balance and strength training) which will be identi- ﬁed using the NSW Ministry of Health ’sActive and Healthy online database (http://www.activeand healthy.nsw.gov.au/).",Non-OADS,/arxiv_data1/oa_pdf/ad/04/bmjopen-2016-012277.PMC4874201.pdf
http://www.abs.gov.au/ australianhealthsurvey (accessed 17 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/ad/04/bmjopen-2016-012277.PMC4874201.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010885).,Non-OADS,/arxiv_data1/oa_pdf/52/78/bmjopen-2015-010885.PMC4874203.pdf
(http://handbook.cochrane.org/ chapter_8/table_8_5_d_criteria_for_judging_risk_of_bias_in_the_risk_of.htm).,OADS,/arxiv_data1/oa_pdf/52/78/bmjopen-2015-010885.PMC4874203.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/52/78/bmjopen-2015-010885.PMC4874203.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011465).,Non-OADS,/arxiv_data1/oa_pdf/c9/42/bmjopen-2016-011465.PMC4874207.pdf
"34For example, of the nine trials in which develop- ment quotient (DQ) or IQ were assessed, six reported no effect of DHA supplementation on DQ or IQ at 10,22 12,3218 months,27 30 312.5,266.5,24720or 12 years of age,33although positive effects of DHA supplementation are reported by four trials on one subtest of a DQ assess-ment at 18 months, 312.526and 4 years of age,29as well as the DQ score at 4 years of age.19Most trials assessed too few children (15 –125 per group) and did not have the statistical power to detect the sort of differences that might realistically be expected between groups as a result of DHA supplementation.34 The DOMInO trialOur DHA to Optimise Mother Infant Outcome(DOMInO RCT; trial registration #12605000569606 at http://www.anzctr.org.au) was designed to evaluate the effects of a substantial dose of DHA during the secondhalf of pregnancy on symptoms of postnatal depression to 6 months postpartum and infant cognitive develop- ment at 18 months of age.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/bmjopen-2016-011465.PMC4874207.pdf
"36 Outcomes at 4 years : To further explore the differences found at 18 months, we assessed neurodevelopment again at 4 years with n=646 (92% of the 726 children in the neurodevelopment cohort) consenting to anassessment with a psychologist (trial registration #12611001125910 at http://www.anzctr.org.au).",Non-OADS,/arxiv_data1/oa_pdf/c9/42/bmjopen-2016-011465.PMC4874207.pdf
http://clinicaltrials.gov/ct2/show/NCT00266825?term=DHA+and +pregnancy&rank=5 29.,Non-OADS,/arxiv_data1/oa_pdf/c9/42/bmjopen-2016-011465.PMC4874207.pdf
"College Statement, 2011. http://www.ranzcog.edu.au/component/content/article/503-college-statements-and-guidelines/c-obs/279-vitamins-and-minerals-supplementation-c-obs-25.html(accessed Nov 2013).",Non-OADS,/arxiv_data1/oa_pdf/c9/42/bmjopen-2016-011465.PMC4874207.pdf
2014; http://www.unaids.org/sites/default/ files/media_asset/UNAIDS_Gap_report_en.pdf.,OADS,/arxiv_data1/oa_pdf/47/a2/olq-43-353.PMC4874231.pdf
2012; https://blogs.worldbank.org/ic4d/files/ic4d/mobile_phone_usage_kenyan_base_pyramid.pdf.,Non-OADS,/arxiv_data1/oa_pdf/47/a2/olq-43-353.PMC4874231.pdf
"Collectively, our results suggest that phagocytic signals  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/96/fa/nihms-782702.PMC4874242.pdf
Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.jconrel.2015.09.027 .,OADS,/arxiv_data1/oa_pdf/96/fa/nihms-782702.PMC4874242.pdf
"At the turn of the century, Ng et al.9 demon- strated that phenolic glycolipid-1 of M. leprae binds  specifically to laminin-2 (see Supplementary Digital Content 1, which displays structure of the C-terminal   laminin G-like domains 4 and 5 of the laminin   alpha-2 chain; http://links.lww.com/PRSGO/A179)  within the basal lamina of Schwann cell-axon units,  promoting bacterial invasion and, even after bacte-rial cell death, damage to Schwann cells and nerves.",Non-OADS,/arxiv_data1/oa_pdf/82/89/gox-4-e637.PMC4874281.pdf
"National Plastic Surgery Organization Websites Country Organization United States The American Board of Plastic Surgery https://www.abplsurg.org/ Norway Norsk Plastikkirurgisk Foreninghttp://legeforeningen.no/Fagmed/Norsk-plastikkirurgisk-forening/ Sweden Swensk Plastikkirurgisk Föreninghttp://www.spkf.se/ Germany Deutsche Gesellschaft der Plastischen, Rekonstruktiven und Ästhetischen Chirurgenhttp://www.dgpraec.de/ The Netherlands Nederlandse Vereniging voor Plastische Chirurgiehttp://www.nvpc.nl United Kingdom British Association of Plastic, Reconstructive and Aesthetic Surgeonshttp://www.baps.co.uk/ France Société Française de Chirurgie Plastique Reconstructrice et Esthétiquehttp://www.plasticiens.fr/ Spain Sociedad Española de Cirugia Plastica Reparadora y Estèticahttp://secpre.org/ Italy Società Italiana di Chirurgia Plastica Ricostruttiva ed Esteticahttp://www.sicpre.it/ Austria Österreichische Gesellschaft für Plastische, Ästhetische und Rekonstruktive Chirurgiehttp://www.plastischechirurgie.org/ Poland Polish Society of Plastic, Reconstructive and Aesthetic Surgeryhttp://www.ptchprie.pl/",Non-OADS,/arxiv_data1/oa_pdf/72/d5/gox-4-e641.PMC4874285.pdf
Available at: https://www.royalfree.nhs.uk/services/services-a-z/plas- tic-surgery/facial-reconstruction-and-face-transplants/history-of-plastic-surgery/.,Non-OADS,/arxiv_data1/oa_pdf/72/d5/gox-4-e641.PMC4874285.pdf
Available at:  https://www.acgme.org/acgmeweb/tabid/145/ProgramandInstitutionalAccreditation/SurgicalSpecialties/ PlasticSurgery.aspx.,Non-OADS,/arxiv_data1/oa_pdf/72/d5/gox-4-e641.PMC4874285.pdf
Available at: https://www.abplsurg.org/ModDefault.,Non-OADS,/arxiv_data1/oa_pdf/72/d5/gox-4-e641.PMC4874285.pdf
Available at: http://www.nrmp.org/.,Non-OADS,/arxiv_data1/oa_pdf/72/d5/gox-4-e641.PMC4874285.pdf
Available at: http://www.intercollegiatemrcs.org.uk/.,Non-OADS,/arxiv_data1/oa_pdf/72/d5/gox-4-e641.PMC4874285.pdf
Available at: http://specialtytraining.hee.nhs.uk/.,Non-OADS,/arxiv_data1/oa_pdf/72/d5/gox-4-e641.PMC4874285.pdf
Available at: http://www.jcie.org.uk/Content/content.aspx.,Non-OADS,/arxiv_data1/oa_pdf/72/d5/gox-4-e641.PMC4874285.pdf
Available at: http://www.bapras.org.uk/.,Non-OADS,/arxiv_data1/oa_pdf/72/d5/gox-4-e641.PMC4874285.pdf
Available at: http://www.nvpc.,Non-OADS,/arxiv_data1/oa_pdf/72/d5/gox-4-e641.PMC4874285.pdf
Available at:  https://www.acgme.org/acgmeweb/Portals/0/PDFs/jgme-monograph%5B1%5D.pdf.,Non-OADS,/arxiv_data1/oa_pdf/72/d5/gox-4-e641.PMC4874285.pdf
"1; see supplemental digital content 1, which  displays bottoming of the patient’s implants with a  ¾ view, http://links.lww.com/PRSGO/A180; see supple- mental digital content 2, which displays bottoming of  Disclosure: Dr. Ellsworth is a speaker and con- sultant for LifeCell and a consultant for Allergan.",Non-OADS,/arxiv_data1/oa_pdf/41/39/gox-4-e647.PMC4874291.pdf
"• Revision Breast Augmentation see supplemental digital content 3, which displays  the patient’s implants at 1 year follow up with a ¾ view, http://links.lww.com/PRSGO/A182; see sup- plemental digital content 4, which displays the pa-tient’s implants at 1 year follow up with a lateral view, http://links.lww.com/PRSGO/A183).",Non-OADS,/arxiv_data1/oa_pdf/41/39/gox-4-e647.PMC4874291.pdf
Available at: http://clinicaltrials.gov/show/NCT01389232.,Non-OADS,/arxiv_data1/oa_pdf/41/39/gox-4-e647.PMC4874291.pdf
This  video is available in the “Related Videos” section of  the Full-Text article on PRSGlobalOpen.com or avail- able at http://links.lww.com/PRSGO/A178.),Non-OADS,/arxiv_data1/oa_pdf/f0/63/gox-4-e661.PMC4874305.pdf
http://www.toyobo-global.,Non-OADS,/arxiv_data1/oa_pdf/0a/d1/gox-4-e665.PMC4874309.pdf
"Black arrows indicate the SIE vessels, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/0a/d1/gox-4-e665.PMC4874309.pdf
"The vascularized nerve conduit was anastomosed to both stumps of the sciatic nerve (see Supplemental Digital Content 1, part E, http://links.lww.com/PRSGO/A173), and the  surrounding fat tissue of the flap was sutured to the dorsal thigh muscle with 4-0 nylon (Fig.",Non-OADS,/arxiv_data1/oa_pdf/0a/d1/gox-4-e665.PMC4874309.pdf
"A, Representative fluorescent micrographs of the vascularized nerve conduit; B, the number of the  capillary vessels in the tube at 1, 2, and 4 weeks af- ter conduit implantation (n = 5 at each time point),   *P < 0.05, http://links.lww.com/PRSGO/A175.]",Non-OADS,/arxiv_data1/oa_pdf/0a/d1/gox-4-e665.PMC4874309.pdf
"B, Capillary vessels originating from the SIE vessels extended outside of the nerve conduit  (high magnification), http://links.lww.com/PRSGO/ A176].",Non-OADS,/arxiv_data1/oa_pdf/0a/d1/gox-4-e665.PMC4874309.pdf
"The SIE vessels extend-ed outside of the PGA tube and formed abundant  capillary vessels within the nerve conduit (Supple- mental Digital Content 3 and 4, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/0a/d1/gox-4-e665.PMC4874309.pdf
com/PRSGO/A175 and http://links.lww.com/PRSGO/ A176; Fig.,Non-OADS,/arxiv_data1/oa_pdf/0a/d1/gox-4-e665.PMC4874309.pdf
Available at: http://www.cancerresearchuk.org/health- professional/cancer-statistics/statistics-by-cancer-type/skin-cancer/incidence.,Non-OADS,/arxiv_data1/oa_pdf/8b/e6/gox-4-e666.PMC4874310.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1b/73/saw007.PMC4874362.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/66/main.PMC4874454.pdf
The http://dx.doi.org/10.1016/j.ijscr.2016.04.044 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/ac/66/main.PMC4874454.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/aa/89/hyw014.PMC4874470.pdf
Available at: https://nei.nih.gov/health/diabetic/retinopathy.,Non-OADS,/arxiv_data1/oa_pdf/2c/2c/i1552-5783-57-6-2706.PMC4874474.pdf
"Previous ﬁnite element (FE) modeling studies also predicted that a larger scleral stiffness would cause a decrease in LC tensile strain when all the other parameters were held constant (e.g., eye geometry, material properties of all other tissues).15 For instance, using the applet (http://www.ocularbiomechanics.com/Software.html) created by Sigal, 15 we can predict that a 40% increase in scleral modulus (from 3 to 4.2 MPa) would cause the median ﬁrst principal strain in the LC to decrease from 1.10% to 0.90% at 15 mm Hg (all otherparameters held at their default values), which corresponds toa relative LC strain reduction of 18%.",Non-OADS,/arxiv_data1/oa_pdf/8e/a0/i1552-5783-57-6-2666.PMC4874475.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/24/a0/ceor-8-197.PMC4874552.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/24/a0/ceor-8-197.PMC4874552.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Estimated hospital costs associated with  preventable health care-associated infections if  health care antiseptic products were unavailable Jordana K Schmier1 Carolyn K Hulme-Lowe1 Svetlana Semenova2 Juergen A Klenk3 Paul C DeLeo4 Richard Sedlak5 Pete A Carlson6 1Health Sciences, Exponent, Inc.,   Alexandria, VA, 2EcoSciences,   Exponent, Inc., Maynard, MA, 3Health  Sciences, Exponent, Inc., Alexandria,   VA, 4Environmental Safety, 5T echnical  and International Affairs, American  Cleaning Institute, Washington, DC,   6Regulatory Affairs, Ecolab, Saint Paul,   MN, USA Correspondence: Jordana K Schmier   Health Sciences, Exponent, Inc.,  1800 Diagonal Road, Suite 500,  Alexandria, VA 22314, USA   T el +1 571 227 7241   Fax +1 571 227 7299   Email jschmier@exponent.co mObjectives:  Health care-associated infections (HAIs) pose a significant health care and cost  burden.",Non-OADS,/arxiv_data1/oa_pdf/24/a0/ceor-8-197.PMC4874552.pdf
"Available from: http://www.medicare.gov/hospitalcompare/ about/rcd.htm l. Accessed June 5, 2015.",Non-OADS,/arxiv_data1/oa_pdf/24/a0/ceor-8-197.PMC4874552.pdf
"Available from http://www.fda.gov/downloads/AboutFDA/Reports - ManualsForms/Reports/UCM447035.pd f. Accessed February 15,  2016.",OADS,/arxiv_data1/oa_pdf/24/a0/ceor-8-197.PMC4874552.pdf
"Available  from http://www.cdc.gov/HAI/pdfs/hai/Scott_CostPaper.pd f. Accessed  February 15, 2016.",OADS,/arxiv_data1/oa_pdf/24/a0/ceor-8-197.PMC4874552.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/24/a0/ceor-8-197.PMC4874552.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/24/a0/ceor-8-197.PMC4874552.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/8a/06/ccid-9-115.PMC4874553.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/8a/06/ccid-9-115.PMC4874553.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical, Cosmetic and Investigational Dermatology 2016:9 115–125Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  115ClInIC al TrIal repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/CCID.S10069 7a randomized, placebo-controlled, single-blinded,  split-faced clinical trial evaluating the efficacy and  safety of Klo X-001 gel formulation with Klo X  light-emitting diode light on facial rejuvenation andreas nikolis1 Steven Bernstein2 Brian Kinney3 nicolo Scuderi4 Shipra rastogi5 John S Sampalis6 1Victoria park, plastic Surgery  Section, Westmount, QC, Canada;   2Dermatology Department, University  of Montreal Health Centre, Montreal,   QC, Canada; 3Department of plastic  Surgery, USC School of Medicine,   Beverley Hills, C a, USa; 4Department  of plastic and reconstructive Surgery,   la Sapienza, rome, Italy; 5KloX  T echnologies, laval, 6JSS Medical  research, Montreal, QC, Canada Correspondence: andreas nikolis   Victoria park, plastic Surgery Section,  376 Victoria, Suite 400, Westmount,  Quebec, H3Z1C3 Canada   T el +1 514 488 7722   Fax +1 514 488 3830   email anikolis@vicpark.co mPurpose:  Many treatment modalities exist to counteract the effects of cutaneous aging.",Non-OADS,/arxiv_data1/oa_pdf/8a/06/ccid-9-115.PMC4874553.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/8a/06/ccid-9-115.PMC4874553.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/06/ccid-9-115.PMC4874553.pdf
This  is an open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b6/92/main.PMC4874579.pdf
http://dx.doi.org/10.1016/j.bjm.2016.01.021 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.,Non-OADS,/arxiv_data1/oa_pdf/b6/92/main.PMC4874579.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b6/92/main.PMC4874579.pdf
Available  from: http://www.gbrcn.org/ﬁleadmin/gbrcn/media/downloads/GBRCN Final  Report/GBRCN-FinalReport2012.pdf .,Non-OADS,/arxiv_data1/oa_pdf/b6/92/main.PMC4874579.pdf
Available  from:  http://www.inmetro.gov.br/ sidoq/arquivos/Dicla/NIT/NIT-Dicla-61 02.pdf .,OADS,/arxiv_data1/oa_pdf/b6/92/main.PMC4874579.pdf
Available from: http://phl.incqs.ﬁocruz.br/controle/tc/Tatiana Forti.pdf .,Non-OADS,/arxiv_data1/oa_pdf/b6/92/main.PMC4874579.pdf
This  is an open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3b/33/main.PMC4874580.pdf
"In  the  second  phase, these  bubbles  grow  rapidly  and  implode  and  collapse  with  a new compression  phase,  releasing  a  shock  wave  that  prop- agates  through  the  liquid.1These  effects  disrupt  microbial structures  and  inactivate  and  decompose  toxic  chemicals.3 http://dx.doi.org/10.1016/j.bjm.2016.01.014 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/3b/33/main.PMC4874580.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3b/33/main.PMC4874580.pdf
This  is an open access article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/fb/main.PMC4874581.pdf
http://dx.doi.org/10.1016/j.bjm.2015.11.033 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.,Non-OADS,/arxiv_data1/oa_pdf/32/fb/main.PMC4874581.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/fb/main.PMC4874581.pdf
Available from:  http://www.pasteur.fr/ ip/resource/ﬁlecenter/document/01s-00004j-03q/ra-cnr344listeria-2011.pdf .,Non-OADS,/arxiv_data1/oa_pdf/32/fb/main.PMC4874581.pdf
Available  at:  http://www.sidra.ibge.gov.br/ bda/horti/default.asp?t=2&z=t&0=17&u1=1&u1=1&u3=1&u2=31 [accessed  16.07.13].,OADS,/arxiv_data1/oa_pdf/32/fb/main.PMC4874581.pdf
This  is an open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC4874584.pdf
http://dx.doi.org/10.1016/j.bjm.2016.01.001 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC4874584.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC4874584.pdf
This  is an open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/8b/main.PMC4874585.pdf
B.  braunii  cells  are  held  together  by  an  extracellu- lar  matrix  composed  of  a  cross-linked  aldehyde  polymer  core http://dx.doi.org/10.1016/j.bjm.2016.01.020 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.,Non-OADS,/arxiv_data1/oa_pdf/d6/8b/main.PMC4874585.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/8b/main.PMC4874585.pdf
This  is an open access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/76/main.PMC4874586.pdf
"They have  a  major  role  in  nutrient  cycling  and  in  debris  formation, being an  abundant  source  of  organic  matter.4,5Additionally, they  are  a  mixed  stands,  which  inﬂuences  the  physical  and chemical characteristics  of  water,  altering  the  turbulence, temperature,  sunlight  penetration,  concentration  and  distri- bution of  dissolved  oxygen  and  nutrients.6 http://dx.doi.org/10.1016/j.bjm.2015.08.001 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/b7/76/main.PMC4874586.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/76/main.PMC4874586.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c6/fa/main.PMC4874587.pdf
"E-mail: ayonroy.plantpathology@gmail.com  (A.  Roy).biocontrol ability  against  a  wide  range  of  plant  pathogenic fungi,1induction  of  localized  and  systemic  defense  responses in plants,2and  plant  growth  enhancement.3,4They  play  an important  role  in  ecology  by  taking  part  in  decomposition of  plant  residues,  as  well  as  in  biodegradation  of  man-made chemicals and  bioaccumulation  of  high  amounts  of  vari- ous  metals  from  wastewater  and  soil.5,6Metal-containing http://dx.doi.org/10.1016/j.bjm.2016.01.008 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/c6/fa/main.PMC4874587.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c6/fa/main.PMC4874587.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/76/main.PMC4874588.pdf
http://dx.doi.org/10.1016/j.bjm.2015.05.001 1517-8382/©  2016  Published  by  Elsevier  Editora  Ltda.,Non-OADS,/arxiv_data1/oa_pdf/d4/76/main.PMC4874588.pdf
This  is  an  open  access  article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/76/main.PMC4874588.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/22/02/main.PMC4874589.pdf
"anti-pseudomonal  penicillins, cephalosporins, carbapenems,  monobactams,  quinolones, aminoglycosides,  and  colistin,  while  it  is  a  PDR  if  it  showed resistance toward  all  7  anti-pseudomonal  antimicrobial http://dx.doi.org/10.1016/j.bjm.2016.01.007 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/22/02/main.PMC4874589.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/22/02/main.PMC4874589.pdf
This  is an open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/ad/main.PMC4874590.pdf
"Lignin peroxidase  (Lip),  manganese  peroxidase  (MnP)  and laccase  (Lac)  are  the  most  widely  distributed  ligninolytic http://dx.doi.org/10.1016/j.bjm.2016.01.002 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/dc/ad/main.PMC4874590.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/ad/main.PMC4874590.pdf
Blast and  Fungi  Barcode  (http://www.fungalbarcoding.org )  searches showed that  the  fungi  were  closely  related  to  the  genus Trametes  among  the  examined  basidiomycetes.,OADS,/arxiv_data1/oa_pdf/dc/ad/main.PMC4874590.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/75/01/main.PMC4874607.pdf
Integrons  are  natural  recombination  systems  that  are  able  to http://dx.doi.org/10.1016/j.bjm.2016.01.015 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.,OADS,/arxiv_data1/oa_pdf/75/01/main.PMC4874607.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/75/01/main.PMC4874607.pdf
The  integ- ron sequences  were  also  registered  within  the  INTEGRALL database  (http://integrall.bio.ua.pt/).24 The qac/SOHE1  gene  was  ampliﬁed  using  the  primers 3/primeCSF2  TCAGGTCAAGTCTGCTT)  and  qacR  (GGCACTGCATC- CATGACG).,OADS,/arxiv_data1/oa_pdf/75/01/main.PMC4874607.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/24/46/main.PMC4874608.pdf
"type  of  glycerol  (pure  or  crude),  various  agitation rates,  addition  of  NaCl  and  supplementation  with  minerals, however the  effect  of  surfactants  on  erythritol  production  has never  been  studied  so  far.14–18 Commonly used  surfactants  like  Triton  X-100,  Span  20  or T ween 80  were  successively  applied  in  culture  media  to  modify the  permeability  of  cell  membranes  of  ﬁlamentous  fungi,19–21 yeast22,23and  bacteria.24The  addition  of  these  compounds caused  a  signiﬁcant  increase  in  enzymatic  activity,  in  the quantity  of  biosynthesis  products,  in  the  rate  of  cell  biomass growth as  well  as  in  substrate  assimilation.25According  to http://dx.doi.org/10.1016/j.bjm.2016.01.011 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/24/46/main.PMC4874608.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/24/46/main.PMC4874608.pdf
This  is  an  open  access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/88/main.PMC4874609.pdf
http://dx.doi.org/10.1016/j.bjm.2016.01.005 1517-8382/©  2016  Published  by  Elsevier  Editora  Ltda.,Non-OADS,/arxiv_data1/oa_pdf/d4/88/main.PMC4874609.pdf
This  is  an  open  access  article under the  CC  BY -NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/88/main.PMC4874609.pdf
"Alignment  and  phylogenetic  construction The  obtained  sequences  were  edited  using  the  Staden  pro- gram  version  1.6,  and  were  compared  by  the  BLAST  program for detection of the similarities using  reference  sequences available  in  the  data  bank  (NCBI,  National  Center  for  Biotech- nology Information  –  http://www.ncbi.nlm.nih.gov/ ).21,22The Mafft  program  (http://mafft.cbrc.jp/alignment/server/ )  was used  for  the  alignment;  and  visual  inspection  was  done  by MEGA 5.1 version.23Forty  sequences  of  Candida  isolates  were submitted for  phylogenetic  analysis  using  Schizosaccharomyces pombe strain  U40085  as  outgroup.20The  Maximum  Likelihood phylogenetic tree  was  built  with  100  bootstraps,  based  on  the evolutionary  model  Tamura-3  parameters  with  using  5.1  ver- sion of the  MEGA  software  for  ﬁnal  editing.23 In  vitro  susceptibility  tests The in  vitro  susceptibility  tests  were  done  by  micro-dilution method  of  broth,  as  per  the  Norm  M27-A3  recommendations provided by  the  Clinical  and  Laboratory  Standards  Institute.24 The  antifungals  used  were  amphotericin  B  (Sigma–Aldrich 110 Química, Madrid, Spain),  ketoconazole  (Pharma  Nos- tra,  Brazil),  itraconazole  (Fragon),  ﬂuconazole  (Pﬁzer,  Madrid, Spain)  and  nystatin  (Pharma  Nostra,  Brazil).",OADS,/arxiv_data1/oa_pdf/d4/88/main.PMC4874609.pdf
This  is an open access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7a/1f/main.PMC4874610.pdf
http://dx.doi.org/10.1016/j.bjm.2016.01.012 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.,Non-OADS,/arxiv_data1/oa_pdf/7a/1f/main.PMC4874610.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7a/1f/main.PMC4874610.pdf
"Phylogenetics analysis The  NCBI  database  (http://www.ncbi.nlm.nih.gov )  was  BLAST searched for  the  16S  rRNA  gene  sequences,  which  were used  to  construct  a  phylogenetic  tree  by  the  character- based maximum-likelihood  method  based  on  the  Tamura–Nei model19with MEGA6  and  1000-iteration  bootstrapping.",OADS,/arxiv_data1/oa_pdf/7a/1f/main.PMC4874610.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ad/cf/main.PMC4874611.pdf
http://dx.doi.org/10.1016/j.bjm.2015.09.001 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.,Non-OADS,/arxiv_data1/oa_pdf/ad/cf/main.PMC4874611.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ad/cf/main.PMC4874611.pdf
"The  DEFB1  5/primeUTR  polymorphisms  −52G>A  (rs1799946), −44C>G (rs1800972)  and  −20G>A  (rs11362)  were  geno- typed  by  direct  sequencing,  according  to  Braida et  al.22Sequences  were  handled  using  the  4Peaks (http://nucleobytes.com/index.php/4peaks )  and  CodonCode Aligner  software  (http://www.codoncode.com/aligner/ ).",OADS,/arxiv_data1/oa_pdf/ad/cf/main.PMC4874611.pdf
All  the  sta- tistical analyses  were  carried  out  using  the  open-source  R package (http://www.r-project.org ).,OADS,/arxiv_data1/oa_pdf/ad/cf/main.PMC4874611.pdf
Global  T uberculosis  Report ;  2012. http://www.who.int/tb/publications/global report/en/ Accessed  30.07.13.,Non-OADS,/arxiv_data1/oa_pdf/ad/cf/main.PMC4874611.pdf
This  is an open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/b1/main.PMC4874612.pdf
"PTB  has  a  worldwide  distribution  and causes  economic  loss  in  dairy  cattle  due  to  reduced  milk production and premature  culling.1The  infected  animals start  to  excrete  Map  in  feces,  milk,  and  colostrums,  before  the appearance  of  clinical  symptoms2resulting  in  contamination http://dx.doi.org/10.1016/j.bjm.2016.01.013 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/f2/b1/main.PMC4874612.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/b1/main.PMC4874612.pdf
"Statistical  analysis Kappa  coefﬁcient  was  calculated  using  WinEpiscope  soft- ware version  2.0,  2000  (http://ww.clive.ed.ac.uk/winepiscope ) to  measure  the  agreement  between  different  pairs  of  tests (milk culture, fecal culture, and  ELISA  versus  IMS-IS1  PCR) performed  on  the  147  cows  that  belonged  to  infected  herds.",Non-OADS,/arxiv_data1/oa_pdf/f2/b1/main.PMC4874612.pdf
"2012;95:6946–6948, http://dx.doi.org/10.3168/jds.2012-5657 .",Non-OADS,/arxiv_data1/oa_pdf/f2/b1/main.PMC4874612.pdf
http://www.oie.int/ﬁleadmin/Home/eng/ Health standards/tahm/2.01.11  PARATB.pdf  (accessed  26 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/f2/b1/main.PMC4874612.pdf
This  is an open access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c7/2e/main.PMC4874613.pdf
"In particular,  the  consumption  of  foods  with  high-level concentration  of  histamine  can  have  vasodilation  effects1 in  humans  as  well  as  cause  headaches,  heart  palpitations, http://dx.doi.org/10.1016/j.bjm.2016.01.016 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/c7/2e/main.PMC4874613.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c7/2e/main.PMC4874613.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/e9/main.PMC4874614.pdf
"Their  applications  result  from  their  ability  to  catalyze  reac- tions, mainly  the  hydrolysis  and  inter-  and  transesteriﬁcation http://dx.doi.org/10.1016/j.bjm.2016.01.028 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",OADS,/arxiv_data1/oa_pdf/7c/e9/main.PMC4874614.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/e9/main.PMC4874614.pdf
Sequences  were  compared  to  18S  rRNA  data  obtained  from GenBank (http://www.ncbi.nlm.nih.gov ).,OADS,/arxiv_data1/oa_pdf/7c/e9/main.PMC4874614.pdf
This  is an open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0c/64/main.PMC4874615.pdf
http://dx.doi.org/10.1016/j.bjm.2016.01.022 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.,Non-OADS,/arxiv_data1/oa_pdf/0c/64/main.PMC4874615.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0c/64/main.PMC4874615.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/97/df/main.PMC4874616.pdf
http://dx.doi.org/10.1016/j.bjm.2015.10.001 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.,Non-OADS,/arxiv_data1/oa_pdf/97/df/main.PMC4874616.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/97/df/main.PMC4874616.pdf
430  b  r  a  z  i  l  i  a  n  j  o  u  r  n  a  l  o  f  m  i  c  r  o  b  i  o  l  o  g  y  4  7  (2  0  1  6)  424–430 de  Saúde  (SUS);  2013.  http://portal.saude.gov.br/portal/ saude/proﬁssional/visualizar texto.cfm?idtxt=31756 Accessed  05.03.13.,Non-OADS,/arxiv_data1/oa_pdf/97/df/main.PMC4874616.pdf
Geneva: WHO;  2013.  http://www.who.int/foodsafety/ foodborne disease/en/  Accessed  04.03.13.,Non-OADS,/arxiv_data1/oa_pdf/97/df/main.PMC4874616.pdf
Microbiology of Food  and  Animal  Feeding  Stuffs  –  Horizontal  Method  for  the Enumeration of  Clostridium  perfringens  –  Colony-count  Technique ; 2004. http://img.21food.cn/img/biaozhun/20100108/181/ 11285427.pdf Accessed  05.03.13.,Non-OADS,/arxiv_data1/oa_pdf/97/df/main.PMC4874616.pdf
Wayne:  CLSI;  2006. http://isoforlab.com/phocadownload/csli/M7-A7.pdf Accessed  05.03.13.,Non-OADS,/arxiv_data1/oa_pdf/97/df/main.PMC4874616.pdf
Brasília:  Diário  Oﬁcial  da  União;  2003. http://extranet.agricultura.gov.br/sislegis-consulta/ consultarLegislacao.do?operacao=visualizarandid=2851 Accessed  03.03.13.,Non-OADS,/arxiv_data1/oa_pdf/97/df/main.PMC4874616.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cb/41/main.PMC4874617.pdf
http://dx.doi.org/10.1016/j.bjm.2016.01.026 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.,Non-OADS,/arxiv_data1/oa_pdf/cb/41/main.PMC4874617.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cb/41/main.PMC4874617.pdf
This  is an open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/5d/main.PMC4874618.pdf
"ORF1 encodes  non-structural  proteins  (NS)  and  ORF2  encodes the two overlapping  capsid  proteins  (VP1/VP2)  and  a  small conserved  putative  protein.1Studies  demonstrated  high prevalence rates  of  UTV2  in  domestic  pigs  and  wild  boar populations  ranging  from  22.8%  to  50.5%.1,3,4UTV2  can  infect pigs of  different  ages  but  higher  prevalence  was  found  in http://dx.doi.org/10.1016/j.bjm.2016.01.025 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/f7/5d/main.PMC4874618.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/5d/main.PMC4874618.pdf
This  is an open access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c0/13/main.PMC4874619.pdf
"Showerhead  bioﬁlms  have,  for example,  been  shown  to  include  and  enrich  pathogenic (e.g., Legionella  pneumophilia,  Mycobacterium  avium )  and  oppor- tunistic  pathogens  such  as  non-tuberculous  mycobacteria.4 Microbes  which  dislodge  from  shower  bioﬁlms  come  into http://dx.doi.org/10.1016/j.bjm.2016.01.018 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/c0/13/main.PMC4874619.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c0/13/main.PMC4874619.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/77/e1/main.PMC4874620.pdf
"Yano).infection (UTI).4,5Adhesion  is  generally  mediated  by  ﬁmbriae, which are  ﬁlamentous  appendices  localized  on  the  bacterial surface, generally  of  protein  nature,  which  promote  speciﬁc binding  to  receptors  on  host  eukaryotic  cells  (uroepithelial cells, erythrocytes  and  urinary  glycocalyx),  being  also  capa- ble  of  bioﬁlm  formation  over  abiotic  surfaces  such  as  plastic catheters.4 Thirty-one E. coli  isolates  from  patients  with  recurrent cystitis, kindly supplied  by  Dr.  Ulysses  de  Oliveira  (FCM,  UNI- CAMP),  were  analyzed  for  a  number  of  genes  associated  with http://dx.doi.org/10.1016/j.bjm.2016.01.024 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/77/e1/main.PMC4874620.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/77/e1/main.PMC4874620.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/46/main.PMC4874621.pdf
"Hernández-Pérez).2014/2015, the  production  level  reached  634.8  millions  metric tons.2It  is  estimated  that  28%  (on  a  dry  weight  basis)  of  the harvested  sugarcane  corresponds  to  lignocellulosic  byprod- ucts, bagasse  and  straw  (tops,  dry  and  green  leaves),  which represent  two-thirds  of  the  energetic  potential  of  sugarcane.3 http://dx.doi.org/10.1016/j.bjm.2016.01.019 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/ce/46/main.PMC4874621.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/46/main.PMC4874621.pdf
http://www.fao.org/docrep/015/i2490e/i2490e00.htm Accessed  13.07.15.,Non-OADS,/arxiv_data1/oa_pdf/ce/46/main.PMC4874621.pdf
"Quarto  levantamento;  2015,  April,  29  p., http://www.conab.gov.br/  Accessed  13.07.15.",Non-OADS,/arxiv_data1/oa_pdf/ce/46/main.PMC4874621.pdf
http://www1.eere.energy.gov/bioenergy/  Accessed  16.06.14.,Non-OADS,/arxiv_data1/oa_pdf/ce/46/main.PMC4874621.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0f/67/main.PMC4874622.pdf
"Algae  have  developed several  mechanisms  to  alleviate  the  harmful  effects  of  ROS, including non-enzymatic antioxidants,  such  as  chlorophyll,1 http://dx.doi.org/10.1016/j.bjm.2016.01.003 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/0f/67/main.PMC4874622.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0f/67/main.PMC4874622.pdf
This  is  an  open  access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/6f/main.PMC4874623.pdf
"E-mail: rob.aitken@glasgow.ac.uk  (R.  Aitken).to  move  away  from  hybridoma  technologies,5,6libraries  of recombinant molecules  have  emerged  as  key  resources  for antibody  discovery.7–9 The bacterial  pathogen  Clostridium  difﬁcile  is  an  anaerobic, Gram-positive, spore-forming  organism,  ﬁrst  discovered  80 years  ago.10It  is  the  major  cause  of  antibiotic-associated  diar- rhoeal disease  and  pseudomembranous  colitis.11Although the  large  proteins,  toxins  A  and  B,  are  well-characterised  vir- ulence  factors;  other  molecules  are  likely  to  contribute  to  the http://dx.doi.org/10.1016/j.bjm.2016.01.017 1517-8382/©  2016  Published  by  Elsevier  Editora  Ltda.",Non-OADS,/arxiv_data1/oa_pdf/33/6f/main.PMC4874623.pdf
This  is  an  open  access  article under the  CC  BY -NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/6f/main.PMC4874623.pdf
This  is an open access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/14/97/main.PMC4874624.pdf
"It  combats  several plant  pathogenic  fungi  such  as  Fusarium  oxysporum  in  bean and  melon,1,2Botrytis  cinerea  in  tobacco,3Rhizoctonia  solani in  cucumber,4sheath  blight  in  rice,5creeping  bentgrass  and http://dx.doi.org/10.1016/j.bjm.2016.01.004 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/14/97/main.PMC4874624.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/14/97/main.PMC4874624.pdf
The  fragment sequences  were  assembled  by  Phrap  (http://www.phrap.org/ ),Non-OADS,/arxiv_data1/oa_pdf/14/97/main.PMC4874624.pdf
470  b  r  a  z  i  l  i  a  n  j  o  u  r  n  a  l  o  f  m  i  c  r  o  b  i  o  l  o  g  y  4  7  (2  0  1  6)  468–479 and  were  then  analysed  using  the  BLASTx  algorithm (http://www.ncbi.nlm.nih.gov/BLASTx/ )  and  ORF  ﬁnder (http://www.ncbi.nlm.nih.gov/gorf/gorf.html ).,OADS,/arxiv_data1/oa_pdf/14/97/main.PMC4874624.pdf
The  ampliﬁed  fragments  were  then  assembled  using  the program Phrap  (http://www.phrap.org/ ).,OADS,/arxiv_data1/oa_pdf/14/97/main.PMC4874624.pdf
The  conserved  PKS  domains  were  veriﬁed using CDD  Search/PRS-BLAST  (http://www.ncbi.nlm.nih.gov/ Structure/cdd/wrpsb.cgi ).,OADS,/arxiv_data1/oa_pdf/14/97/main.PMC4874624.pdf
"The  pksT  KS  domains  were  aligned with 55  fungal  PKS  protein  sequences  (reducing  and  non- reducing) retrieved  from  GenBank,  and  the  two  alignments analysed  using  CLUSTALW  were  embedded  in  the  MEGA  4.0 program (http://www.megasoftware.net/ ).",OADS,/arxiv_data1/oa_pdf/14/97/main.PMC4874624.pdf
"The  resultant  phylogenetic  tree  was  rooted  in animal fatty  acid  synthase  (Gallus  gallus  FAS),  as  previously described.21The  candidate  secondary  metabolite  product was  predicted  using  Natural  Product  Domain  Seeker  (NaPDoS) (http://npdomainseeker.sdsc.edu//run  analysis.html ).",OADS,/arxiv_data1/oa_pdf/14/97/main.PMC4874624.pdf
The  approximate  domain  boundaries  were  determined  using  the  iterative  PKS  domain  search  program (http://www.nii.ac.in/ ∼pksdb/sbsp  ks/master.html ).,OADS,/arxiv_data1/oa_pdf/14/97/main.PMC4874624.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9c/3d/copd-11-1015.PMC4874631.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1015–1022International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1015OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10283 1left ventricular structure and remodeling in  patients with COPD giovanna Pelà1 Mauro li Calzi1 silvana Pinelli1 roberta andreoli1 nicola sverzellati2 giuseppina Bertorelli1 Matteo goldoni1 alfredo Chetta1 1Department of Clinical and  experimental Medicine, 2Department  of surgery, University Medical school,   University hospital Parma, Parma,   ItalyBackground:  Data on cardiac alterations such as left ventricular (LV) hypertrophy, diastolic  dysfunction, and lower stroke volume in patients with COPD are discordant.",Non-OADS,/arxiv_data1/oa_pdf/9c/3d/copd-11-1015.PMC4874631.pdf
"In addition, coronary artery disease and heart failure may play important  roles in mortality and morbidity in patients with COPD.2 Cardiovascular complica - tions might not only be related to CODP itself but could also be due to a chronic sys - temic inflammatory condition, in which heart and lungs are differentially involved.3  Interestingly, changes in left ventricle function and structure such as left ventricular  hypertrophy (LVH), diastolic dysfunction, and reduction in cardiac chambers and  stroke volume have been described but might not be exclusively due to COPD.4–6 The  lower preload caused by hyperinflation may be responsible for reduced left ventricular Correspondence: giovanna Pelà Department of Clinical and experimental  Medicine, University Medical school  and University hospital Parma,  Via gramsci 14, 43100 Parma, Italy email giovanna.pela@unipr.i t Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Pelà et al Running head recto: Left ventricular geometry and COPD DOI: http://dx.doi.org/10.2147/COPD.S102831",Non-OADS,/arxiv_data1/oa_pdf/9c/3d/copd-11-1015.PMC4874631.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/9c/3d/copd-11-1015.PMC4874631.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9c/3d/copd-11-1015.PMC4874631.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2e/76/opth-10-879.PMC4874632.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 879–886Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  879Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10527 5T ear volume estimation using a modified Schirmer  test: a randomized, multicenter, double-blind trial  comparing 3% diquafosol ophthalmic solution and  artificial tears in dry eye patients hideki Miyake1 Yuri Kawano2 hiroshi Tanaka2 akihiro iwata3 Takahiro imanaka1 Masatsugu nakamura1 1Ophthalmic Disease area strategy  Department, 2Clinical Operations  Department, 3Data science  Department, r&D Division, santen  Pharmaceutical Co., ltd. Osaka, JapanPurpose:  We aimed to evaluate the feasibility of using a modified Schirmer test to determine  the increase in tear volume after administration of 3% diquafosol ophthalmic solution (diqua - fosol 3%) in dry eye patients.",Non-OADS,/arxiv_data1/oa_pdf/2e/76/opth-10-879.PMC4874632.pdf
"The Schirmer test is one of the most  important tests used to diagnose dry eye disease and clinical end points.4 A Schirmer  test score .10 mm in 5 minutes is widely accepted as the normal value, whereas a  score ,5 mm is indicative of tear deficiency.5,6Correspondence: hideki Miyake Ophthalmic Disease area strategy  Department, r&D Division, santen  Pharmaceutical Co., ltd., 4-20 Ofuka-cho,  Kita-ku, Osaka 530-8552, Japan Tel +81 6 4802 9384 Fax +81 6 6359 3846 email hideki.miyake@santen.co.j p Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Miyake et al Running head recto: Tear volume estimation using modified Schirmer test in dry eye patients DOI: http://dx.doi.org/10.2147/OPTH.S105275",Non-OADS,/arxiv_data1/oa_pdf/2e/76/opth-10-879.PMC4874632.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/2e/76/opth-10-879.PMC4874632.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2e/76/opth-10-879.PMC4874632.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8a/3d/ndt-12-1111.PMC4874633.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1111–1118Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1111OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8776 5spectrum of epilepsy – prevalence, impact, and  treatment gap: an epidemiological study from  al-Quseir, egypt hamdy N el-Tallawy1 Wafaa M Farghaly1 Tarek a rageh1 ghaydaa a shehata1 Nabil a Metwally2 reda Badry1 Mohammed a sayed3 ahmed M abdelwarith2 Mahmoud r Kandil1 Mohamed a hamed1 Khaled O Mohamed1 amal M T ohamy1 1Department of Neurology, assiut  University, assiut, 2Department of  Neurology, Faculty of Medicine,   al-azhar University – assiut Branch,   assiut, 3Department of Neurology,   sohag University, sohag, egyptBackground:  Epidemiology continues to be an important research tool in the study of epilepsy  and related disorders, providing a better understanding of the frequency, causes, and natural  history of the disorder.",Non-OADS,/arxiv_data1/oa_pdf/8a/3d/ndt-12-1111.PMC4874633.pdf
"The treatment gap  of epilepsy in New Valley was similar to that in developing countries (61.5%).4 So, in this research, we aimed to study the epidemiology of epilepsy, evaluate its  impact on the patient’s life, and estimate the magnitude of treatment gap of epilepsy  in Al-Quseir, Red Sea Governorate, Egypt.correspondence: ghaydaa a shehata Department of Neurology and Psychiatry,  assiut University hospital, assiut, egypt Tel +20 88 231 4031 Fax +20 88 233 3327 email ghaydaa83@yahoo.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: El-Tallawy et al Running head recto: Epilepsy in Al-Quseir, Egypt DOI: http://dx.doi.org/10.2147/NDT.S87765",Non-OADS,/arxiv_data1/oa_pdf/8a/3d/ndt-12-1111.PMC4874633.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/8a/3d/ndt-12-1111.PMC4874633.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/3d/ndt-12-1111.PMC4874633.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f4/88/ijn-11-2069.PMC4874634.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2069–2079International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2069OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10383 0Cellular uptake and fate of fibroin microspheres  loaded with randomly fragmented DNA in  3T3 cells Jin sil lee Won hur Department of Bioengineering and  T echnology, Kangwon National  University, Chuncheon, South KoreaAbstract:  Purified fibroin protein can be obtained in large quantities from silk fibers and  processed to form microscopic particles as delivery vehicles for therapeutic agents.",Non-OADS,/arxiv_data1/oa_pdf/f4/88/ijn-11-2069.PMC4874634.pdf
"In a previous report, fibroin microspheres were fabricated without any chemical  modification or cross-linking in order not to disturb the proteinous surface of the correspondence: Won hur Department of Bioengineering and  Technology, Kangwon National  University, Chuncheon 200-701,  South Korea Tel +82 33 250 6276 Fax +82 33 243 6350 email wonhur@kangwon.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Lee and Hur Running head recto: Cellular uptake and fate of fibroin microspheres in 3T3 cells DOI: http://dx.doi.org/10.2147/IJN.S103830",Non-OADS,/arxiv_data1/oa_pdf/f4/88/ijn-11-2069.PMC4874634.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/f4/88/ijn-11-2069.PMC4874634.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f4/88/ijn-11-2069.PMC4874634.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ea/0f/opth-10-887.PMC4874635.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 887–895Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  887CliniC al Trial repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10162 7The iMpa CT study: a prospective evaluation  of the effects of cyclosporine ophthalmic  emulsion 0.05% on ocular surface staining and  visual performance in patients with dry eye Karl G Stonecipher1,2 Gail l T orkildsen3 George W Ousler iii4 Scot Morris5 linda Villanueva6 David a Hollander6 1Department of Ophthalmology,   University of north Carolina,   Chapel Hill, 2TlC laser eye Centers,   Greensboro, nC, 3andover eye  associates, 4Ora, inc., andover,   Ma, 5eye Consultants of Colorado,   Conifer, CO, 6allergan plc,   irvine,  Ca, USaObjective:  The aim of this study was to evaluate the effects of cyclosporine ophthalmic emul - sion 0.05% on ocular surface staining and visual performance in patients with dry eye.",Non-OADS,/arxiv_data1/oa_pdf/ea/0f/opth-10-887.PMC4874635.pdf
"Patients with dry eye suffer from symptoms  of ocular discomfort, dryness, and visual disturbances, which may be episodic and  also vary during the day.5–7Correspondence: Karl G Stonecipher TlC laser eye Centers, 1002 north  Church Street, Suite 101, Greensboro,  nC 27410, USa Tel +1 336 288 8823 email stonenc@aol.co m Journal name: Clinical Ophthalmology Article Designation: Clinical Trial Report Y ear: 2016 Volume: 10 Running head verso: Stonecipher et al Running head recto: Cyclosporine effects on visual function in dry eye DOI: http://dx.doi.org/10.2147/OPTH.S101627",Non-OADS,/arxiv_data1/oa_pdf/ea/0f/opth-10-887.PMC4874635.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/ea/0f/opth-10-887.PMC4874635.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/0f/opth-10-887.PMC4874635.pdf
"Available from: http://www.eyeworld.org/supplements/oct-2013/ Allergan_supplement_ October2013.pd f. Accessed September 5, 2015.",Non-OADS,/arxiv_data1/oa_pdf/ea/0f/opth-10-887.PMC4874635.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1d/56/cia-11-641.PMC4874636.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 641–649Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  641OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S10582 1switching to low-dose oral prolonged-release  oxycodone/naloxone from WhO-step I drugs in  elderly patients with chronic pain at high risk of  early opioid discontinuation Marzia lazzari1 Claudio Marcassa2 silvia natoli1 roberta Carpenedo1 Clarissa Caldarulo1 Maria B silvi1 Mario Dauri1 1Department of emergency and  Critical Care Medicine, Pain Medicine  and Anaesthesiology, Tor Vergata  Polyclinic, University of rome, rome,   2Cardiology Division, Fondazione  Maugeri IrCCs Veruno, novara, ItalyPurpose:  Chronic pain has a high prevalence in the aging population.",Non-OADS,/arxiv_data1/oa_pdf/1d/56/cia-11-641.PMC4874636.pdf
"Keywords:  chronic pain, elderly, naloxone, opioid, oxycodone Introduction Chronic pain affects ~20% of the general population in Europe and its incidence  significantly increases after the age of 60.1 According to current estimates, the preva - lence of chronic pain in older people living in the community ranges from 25% to  76%, and reaches 83% to 93% among older people living in residential care.2 In older  adults, chronic pain is predominantly nociceptive and caused by musculoskeletal  disease; pain of neuropathic or mixed nature is also common.3 Persistent pain has a  negative impact on the quality of life, is a cause of depression and morbidity, and Correspondence: Marzia lazzari Pain Medicine, Tor Vergata Polyclinic,  University of rome, Viale Oxford 81,  00133 rome, Italy Tel +39 6 2090 0638 Fax +39 6 2090 4846 email marzialaz@hotmail.i t Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Lazzari et al Running head recto: Oxycodone/naloxone for chronic pain in opioid-naive elderly patients DOI: http://dx.doi.org/10.2147/CIA.S105821",Non-OADS,/arxiv_data1/oa_pdf/1d/56/cia-11-641.PMC4874636.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/1d/56/cia-11-641.PMC4874636.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/1d/56/cia-11-641.PMC4874636.pdf
"Available from: http://apps.who.int/iris/bi tstream/10665/37896/1/9241544821.pd f. Accessed January 11, 2016.",OADS,/arxiv_data1/oa_pdf/1d/56/cia-11-641.PMC4874636.pdf
Available from: http://www.medicines.ie/medicine/14383/SPC/ Targin+5+2.5mg%2c +10mg+5mg%2c+20mg+10mg+and+40+20mg+ prolonged+release+tablets /.,Non-OADS,/arxiv_data1/oa_pdf/1d/56/cia-11-641.PMC4874636.pdf
Available from: http://www.ema.europa.eu/ docs/en_GB/document_library/Press_release/2013/06/WC500144851.,Non-OADS,/arxiv_data1/oa_pdf/1d/56/cia-11-641.PMC4874636.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ab/b2/opth-10-871.PMC4874637.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 871–878Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  871Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S10196 3Ocular manifestations of Sturge–w eber syndrome:  pathogenesis, diagnosis, and management Flavio Mantelli1 Alice Bruscolini2 Maurizio La Cava2 Solmaz Abdolrahimzadeh2 Alessandro Lambiase2 1Department of Biology, College  of Science and T echnology, T emple  University, Philadelphia, PA, USA;   2Department of Sense Organs, Section  of Ophthalmology, University of Rome  “Sapienza”, Rome, italyAbstract:  Sturge–Weber syndrome has been included in the group of phakomatoses that is  characterized by hamartomas involving the brain, skin, and eyes.",Non-OADS,/arxiv_data1/oa_pdf/ab/b2/opth-10-871.PMC4874637.pdf
"Keywords:  Sturge–Weber syndrome, glaucoma, choroidal hemangiomas, port-wine stain,  congenital disease, glaucoma surgery Introduction Sturge–Weber syndrome (SWS) has been included in the group of phakomatoses that  includes neurofibromatosis, Klippel–Trenaunay syndrome, tuberous sclerosis, and von  Hippel–Lindau syndrome.1 SWS, also known as encephalotrigeminal angiomatosis, is  a condition that includes leptomemeningeal hemangioma, facial angiomatosis or nevus  flammeus (also called port-wine stain [PWS]), and ocular pathological changes.2–5 The  incidence of SWS is ~1:50,000 infants, with no significant difference between males  and females.6 No hereditary pattern or predisposition has been shown, and no malignant  transformation has been demonstrated.7,8 Several genes in the 17p1-p13 region, which  are known to be involved in SWS, are also known to be linked to rare abnormalities  and syndromes, such as retinitis pigmentosa, cerebral astrocytoma, subglottic stenosis,  Klippel–Trenaunay–Weber syndrome, and phakomatosis pigmentovascularis.9–13 The embryologic basis of SWS has been reported to be related to an impaired  development of the cell precursors in the neural crest during the first embryological  trimester, leading to the characteristic malformations observed in the central nervous  system, skin, and eyes.3 Happle suggested that somatic mosaic mutations involving  the skin cause sporadic or scattered birth defects, and the phase of embryonic devel - opment during which this occurs is fundamental.14 Shirley et al recently published a Correspondence: Alessandro Lambiase Department of Sense Organs, Section  of Ophthalmology, University of Rome  “Sapienza”, viale del Policlinico 155,  Rome 00161, italy Tel +39 06 4997 5837 email alessandro.lambiase@uniroma1.i t Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Mantelli et al Running head recto: Ocular manifestations of Sturge–Weber syndrome DOI: http://dx.doi.org/10.2147/OPTH.S101963",Non-OADS,/arxiv_data1/oa_pdf/ab/b2/opth-10-871.PMC4874637.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/ab/b2/opth-10-871.PMC4874637.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ab/b2/opth-10-871.PMC4874637.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/01/c4/cia-11-631.PMC4874638.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 631–639Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  631OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S10520 1The prevalence of risk factors for cardiovascular  diseases among Polish surgical patients over  65 years Aleksandra Kołtuniuk Joanna Rosińczuk Department of n ervous system  Diseases, Faculty of health science,   Wroclaw Medical University,   Wroclaw,  PolandBackground:  Cardiovascular diseases (CVDs) are the leading cause of mortality among  adults in Poland.",Non-OADS,/arxiv_data1/oa_pdf/01/c4/cia-11-631.PMC4874638.pdf
"Keywords:  cardiovascular diseases, risk factors, elderly Introduction Cardiovascular diseases (CVDs), due to their prevalence and significant contribution  to overall mortality, pose a significant health problem, particularly in developing  and developed countries.1,2 According to Eurostat data from 2010, a standardized  mortality rate due to CVDs for 28 countries of the European Union was 432.3 per  100,000 inhabitants and was 35% higher for men (507.7) than for women (372.2).3  Meanwhile, in the US, the mortality rate from CVD in 2010 amounted to 236.6 per  100,000 inhabitants and fell by 8.8% compared to 2007.4Correspondence: Aleksandra Kołtuniuk Department of nervous system Diseases,  Faculty of health science, Wroclaw  Medical University, 5 Bartla street,  51–618 Wroclaw, Poland Tel +48 71 603 357 879 email aleksandra.koltuniuk@umed.wroc.p lJournal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Kołtuniuk and Rosi ńczuk Running head recto: Risk factors for CVDs among Polish patients DOI: http://dx.doi.org/10.2147/CIA.S105201",Non-OADS,/arxiv_data1/oa_pdf/01/c4/cia-11-631.PMC4874638.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/01/c4/cia-11-631.PMC4874638.pdf
Available from: https://www.health.ny.gov/ diseases/cardiovascular/heart_disease/docs/burden_of_cvd_in_nys.,Non-OADS,/arxiv_data1/oa_pdf/01/c4/cia-11-631.PMC4874638.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/01/c4/cia-11-631.PMC4874638.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/01/c4/cia-11-631.PMC4874638.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/8b/b8/jpr-9-279.PMC4874639.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/8b/b8/jpr-9-279.PMC4874639.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Identifying the symptom and functional domains  in patients with fibromyalgia: results of a cross- sectional Internet-based survey in Italy Fausto Salaffi1 Flavio Mozzani2 Antonella Draghessi1 Fabiola Atzeni3 Rosita Catellani2 Alessandro Ciapetti4 Marco Di Carlo1 Piercarlo Sarzi-Puttini5 1Rheumatology Department,   Polytechnic University of Marche,   Jesi (Ancona), 2Department of  Internal Medicine and Rheumatology,   University Hospital of Parma,   Parma, 3IRCCS Galeazzi Orthopedic  Department, Milan, Italy;   4Rheumatology Department, Betsi  Cadwaladr University Health Board,   Glan Clwyd Hospital, Bodelwyddan,   Denbighshire, Wales; 5Rheumatology  Department, L. Sacco University  Hospital, Milan, Italy Correspondence: Fausto Salaffi   Rheumatology Dapartment, Polytechnic  University of Marche, Carlo Urbani  Hospital, Jesi (Ancona), Via Aldo Moro, 25,  60035, Italy   Email fausto.salaffi@gmail.co mObjective:  The aims of this cross-sectional study were to investigate the usefulness of using an  Internet survey of patients with fibromyalgia in order to obtain information concerning symptoms  and functionality and identify clusters of clinical features that can distinguish patient subsets.",Non-OADS,/arxiv_data1/oa_pdf/8b/b8/jpr-9-279.PMC4874639.pdf
Internet-based PROs The patients logged into the website ( http://www.fibromi - algiaitalia.i t) developed for the present study.,Non-OADS,/arxiv_data1/oa_pdf/8b/b8/jpr-9-279.PMC4874639.pdf
( http://www.appycom.it/sit e) for the creation  of the web-portal and the technical assistance provided  during  the study.,Non-OADS,/arxiv_data1/oa_pdf/8b/b8/jpr-9-279.PMC4874639.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/8b/b8/jpr-9-279.PMC4874639.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8b/b8/jpr-9-279.PMC4874639.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9e/4f/opth-10-851.PMC4874640.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 851–860Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  851Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S10283 0Neurofibromatosis: an update of ophthalmic  characteristics and applications of optical  coherence tomography Barmak Abdolrahimzadeh1 Domenica Carmen Piraino2 Giorgio Albanese2 Filippo Cruciani2 Siavash Rahimi3 1Polimed Beltramelli Medical  Center, Rome, italy; 2Section of  Ophthalmology, Department of  Sense Organs, University of Rome  “Sapienza”, Rome, Italy; 3Pathology  Centre, Queen Alexandra Hospital,   Portsmouth, UKAbstract:  Neurofibromatosis (NF) is a multisystem disorder and tumor predisposition syndrome  caused by genetic mutation on chromosome 17-17q11.2 in NF type 1 (NF1), and on chromo - some 22-22q12.2 in NF type 2.",Non-OADS,/arxiv_data1/oa_pdf/9e/4f/opth-10-851.PMC4874640.pdf
"Correspondence: Filippo Cruciani Section of Ophthalmology, Department  of Sense Organs, University of Rome  “Sapienza”, viale del Policlinico 155,  Rome 00161, italy Tel +39 06 4777 5348 Fax +39 06 4997 5304 email filippo.cruciani@uniroma1.i t Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Abdolrahimzadeh et al Running head recto: Neurofibromatosis ophthalmic update DOI: http://dx.doi.org/10.2147/OPTH.S102830",Non-OADS,/arxiv_data1/oa_pdf/9e/4f/opth-10-851.PMC4874640.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/9e/4f/opth-10-851.PMC4874640.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/4f/opth-10-851.PMC4874640.pdf
This  is an open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/7c/main.PMC4874675.pdf
http://dx.doi.org/10.1016/j.bjm.2015.11.034 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.,Non-OADS,/arxiv_data1/oa_pdf/d6/7c/main.PMC4874675.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/7c/main.PMC4874675.pdf
"2014;2014:782897, http://dx.doi.org/10.1155/2014/782897 .",Non-OADS,/arxiv_data1/oa_pdf/d6/7c/main.PMC4874675.pdf
"2014,  http://dx.doi.org/10.1016/j.jmii.2014.10.003 .",OADS,/arxiv_data1/oa_pdf/d6/7c/main.PMC4874675.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/12/21/main.PMC4874676.pdf
"are  fastidious  in nature,  and  their  isolation,  culture  and  identiﬁcation  in  a  rou- tine  diagnostic  microbiology  laboratory  are  complicated  and http://dx.doi.org/10.1016/j.bjm.2016.01.027 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/12/21/main.PMC4874676.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/12/21/main.PMC4874676.pdf
The  sequence  results  were analyzed  using  GenBank  (http://www.ncbi.nlm.nih.gov ).,OADS,/arxiv_data1/oa_pdf/12/21/main.PMC4874676.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/24/54/main.PMC4874677.pdf
"It  is  characterized  by  frequent  dry periods, and by  a  unique  biota,  with  thousands  of  endemic species  and  over  1000  species  of  vascular  plant.1,2However, http://dx.doi.org/10.1016/j.bjm.2016.01.023 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/24/54/main.PMC4874677.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/24/54/main.PMC4874677.pdf
"Then,  polyvinyl  alcohol  lacto- glycerol  (PVLG)  mixed  or  not  with  Melzer’s  reagent  was  used as permanent  mounting  medium.32Species  identiﬁcation was  based  on  the  descriptions  provided  by  Schenck  and Perez,33publications  with  descriptions  of  new  genera  and families,34and  by  consulting  the  international  culture  col- lection  of  arbuscular  mycorrhizal  fungi  database  –  INVAM (http://invam.caf.wvu.edu ).",OADS,/arxiv_data1/oa_pdf/24/54/main.PMC4874677.pdf
"2014;386:1–19, http://dx.doi.org/10.1007/s11104-014-2162-1 .",Non-OADS,/arxiv_data1/oa_pdf/24/54/main.PMC4874677.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/96/main.PMC4874678.pdf
One  bioactivity  of  a  metabolite http://dx.doi.org/10.1016/j.bjm.2016.01.006 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.,Non-OADS,/arxiv_data1/oa_pdf/4c/96/main.PMC4874678.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/96/main.PMC4874678.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/87/b9/main.PMC4874680.pdf
"Balieiro).the emission  of  particulate  matter  and  smoke,  resulting  in poor  air  quality  and  a  problem  for  public  health.3 The  government  and  other  organizations  proposed  the elimination  of  pre-harvest  burning,  which  resulted  in  the input of  10,000–30,000  kg  of  dry  mass  ha−1of  sugarcane  trash over the  soil.4–6This  biomass  can  be  used  for  energy generation,7,8for  cellulosic  ethanol  or  bio-oil  production,9,10 http://dx.doi.org/10.1016/j.bjm.2016.01.010 1517-8382/©  2016  Published  by  Elsevier  Editora  Ltda.",Non-OADS,/arxiv_data1/oa_pdf/87/b9/main.PMC4874680.pdf
This  is  an  open  access  article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/87/b9/main.PMC4874680.pdf
This  is an open access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/70/bc/main.PMC4874681.pdf
"How- ever, the  capacity  to  ﬁx  atmospheric  nitrogen  and  induce nodule  formation  in  leguminous  plants  is  restricted  to  mem- bers of  the  proteobacteria  phylum.1–4Legume  nodulating nitrogen-ﬁxing bacteria,  which  are  commonly  known  as  rhi- zobia,  are  abundant  in  the  soil  of  many  ecosystems5and have a  high  diversity  and  variability  regarding  symbiotic efﬁciency.6–8 http://dx.doi.org/10.1016/j.bjm.2016.01.009 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/70/bc/main.PMC4874681.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/70/bc/main.PMC4874681.pdf
Available  at: http://www.mrn.com.br/index  1024.htm  (accessed 10.11.2010).,Non-OADS,/arxiv_data1/oa_pdf/70/bc/main.PMC4874681.pdf
Available  at: http://viceroy.eeb.uconn.edu/estimates  (accessed 19.06.2010).,Non-OADS,/arxiv_data1/oa_pdf/70/bc/main.PMC4874681.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5f/70/ppa-10-825.PMC4874727.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 825–836Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  825Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S8394 6 Patient perspectives on fluticasone–vilanterol  versus other corticosteroid combination products  for the treatment of asthma Suzanne G Bollmeier Theresa R Prosser St Louis College of Pharmacy,   St Louis, MO, USAObjective:  Fluticasone furoate (FF), an inhaled corticosteroid (ICS), and vilanterol (VI),  a long-acting beta2 receptor agonist (LABA), is a new combination used in an Ellipta® device.",Non-OADS,/arxiv_data1/oa_pdf/5f/70/ppa-10-825.PMC4874727.pdf
"Keywords:  Breo, fluticasone–vilanterol, Ellipta®, patient preference, adherence, inhaled cor - ticosteroid, respiratory devices, long acting beta receptor agonist Introduction Asthma is common, affecting ~300 million people worldwide.1 The prevalence of  asthma is increasing in Africa, Latin America, Eastern Europe, Asia, and the US, and  especially among children.1 For example, the prevalence of asthma rose in the US  by 14.8% in ,10 years (2001–2010).2 Suboptimal control is common.1 Frequent day  and night time symptoms, missed work and school, exacerbations requiring urgent Correspondence: Suzanne G Bollmeier St Louis College of Pharmacy,  4588 Parkview Place, St Louis,  MO 63110, USA Tel +1 314 446 8525 Fax +1 314 446 8500 email sbollmeier@stlcop.ed u Journal name: Patient Preference and Adherence Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Bollmeier and Prosser Running head recto: Patient perspectives on the use of fluticasone–vilanterol for asthma DOI: http://dx.doi.org/10.2147/PPA.S8394 6",Non-OADS,/arxiv_data1/oa_pdf/5f/70/ppa-10-825.PMC4874727.pdf
"Available from: http://www.cdc.gov/ media/rel eases/2012/p0515_asthma_impact.htm l. Accessed April 25,  2016.",Non-OADS,/arxiv_data1/oa_pdf/5f/70/ppa-10-825.PMC4874727.pdf
Available from: http://www.medscape.org/viewarticle/512066_ 2.,Non-OADS,/arxiv_data1/oa_pdf/5f/70/ppa-10-825.PMC4874727.pdf
"Available from: http://www.nhlbi.nih.gov/guidelines/ asthma/asthgdln.pd f. Accessed January 28, 2016.",Non-OADS,/arxiv_data1/oa_pdf/5f/70/ppa-10-825.PMC4874727.pdf
Available from: http://www.mybreo.,Non-OADS,/arxiv_data1/oa_pdf/5f/70/ppa-10-825.PMC4874727.pdf
Available  from: http://www.medicines.org.uk/emc/medicine/2147 4.,Non-OADS,/arxiv_data1/oa_pdf/5f/70/ppa-10-825.PMC4874727.pdf
http://www.fda.gov/Drugs/Drug   Safety/ PostmarketDrugSafetyInformationforPatientsandProviders / ucm200776.ht ml.,Non-OADS,/arxiv_data1/oa_pdf/5f/70/ppa-10-825.PMC4874727.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/5f/70/ppa-10-825.PMC4874727.pdf
"Available from: http://www.prnewswire.com/news- releases/mylan-confirms-fda-submission-of-anda-for-generic-advair- diskus-300202571.htm l. Accessed January 28, 2016.",Non-OADS,/arxiv_data1/oa_pdf/5f/70/ppa-10-825.PMC4874727.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/56/13/tcrm-12-771.PMC4874728.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 771–775Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  771Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S8372 2 Clinical potential of eluxadoline in the treatment  of diarrhea-predominant irritable bowel  syndrome Aleksandra Sobolewska- Włodarczyk1 Marcin Włodarczyk1 Martin Storr2 Jakub Fichna1 1Department of Biochemistry, Faculty  of Medicine, Medical University  of Lodz, Lodz, Poland; 2Center of  endoscopy, Starnberg, GermanyAbstract:  Diarrhea-predominant irritable bowel syndrome (IBS-D) belongs to the group of  functional gastrointestinal disorders and is characterized by abdominal pain in conjunction  with diarrhea.",Non-OADS,/arxiv_data1/oa_pdf/56/13/tcrm-12-771.PMC4874728.pdf
"Ruling out parasitic infections, lactose intolerance, small-intestinal Correspondence: Jakub Fichna Department of Biochemistry, Faculty  of Medicine, Medical University of Lodz,  Mazowiecka 6/8, 92-215 Lodz, Poland Tel +48 42 272 5707 Fax +48 42 272 5694 email jakub.fichna@umed.lodz.p l Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Sobolewska-Włodarczyk et al Running head recto: Eluxadoline in IBS-D DOI: http://dx.doi.org/10.2147/TCRM.S83722",Non-OADS,/arxiv_data1/oa_pdf/56/13/tcrm-12-771.PMC4874728.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/56/13/tcrm-12-771.PMC4874728.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/56/13/tcrm-12-771.PMC4874728.pdf
"Available from: http://www.prnewswire.com/news-releases/ actavis- announces -fda-acceptance-for-filing-of-nda-for-eluxadoline- 273557591.htm l. Accessed June 1, 2015.",Non-OADS,/arxiv_data1/oa_pdf/56/13/tcrm-12-771.PMC4874728.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/af/ce/prbm-9-115.PMC4874729.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).The Healthy Weights Initiative: a community-based  obesity reduction program with positive impact  on depressed mood scores Mark Edgar Lemstra1 Marla Rochelle Rogers2 1Department of Psychiatry,   2Department of Physical Medicine  and Rehabilitation, College of  Medicine, University of Saskatchewan,   Saskatoon, SK, Canada Correspondence: Marla Rochelle Rogers   Department of Physical Medicine and  Rehabilitation, College of Medicine,  Saskatoon City Hospital, University  of Saskatchewan, 701 Queen Street,  Saskatoon S7K 0M7, SK, Canada   T el +1 306 655 8662   Fax +1 306 655 8813   Email marla.rogers@usask.c aObjectives:  The risk for many chronic diseases increases with obesity.",Non-OADS,/arxiv_data1/oa_pdf/af/ce/prbm-9-115.PMC4874729.pdf
"Available from: http://www5.statcan.gc.ca/olc-cel/ olc.action?ObjId=82-003-X19960043021&ObjType=47&lang=e n.  Accessed October 22, 2015.",OADS,/arxiv_data1/oa_pdf/af/ce/prbm-9-115.PMC4874729.pdf
"Available from: http://www.canada.com/business/Depression+   costs+Canada+billion+year/6002202/story.htm l. Accessed November  6, 2013.",Non-OADS,/arxiv_data1/oa_pdf/af/ce/prbm-9-115.PMC4874729.pdf
"Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/psychology-research-and-behavior-management-journa lPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and  its application in behavior management to develop improved outcomes  in the clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/af/ce/prbm-9-115.PMC4874729.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/af/ce/prbm-9-115.PMC4874729.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f5/a6/ppa-10-837.PMC4874730.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 837–850Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  837Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10305 7How payment scheme affects patients’ adherence  to medications?",Non-OADS,/arxiv_data1/oa_pdf/f5/a6/ppa-10-837.PMC4874730.pdf
"According to reports by the  World Health Organization, only 50% of patients with chronic disease adhere to their Correspondence: ernieda Hatah Faculty of Pharmacy, Universiti  Kebangsaan Malaysia, Jalan Raja Muda  Abdul Aziz, 50300 Kuala Lumpur,  Malaysia email ernieda@ukm.edu.m yJournal name: Patient Preference and Adherence Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Aziz et al Running head recto: How payment scheme affects adherence to medications DOI: http://dx.doi.org/10.2147/PPA.S103057",Non-OADS,/arxiv_data1/oa_pdf/f5/a6/ppa-10-837.PMC4874730.pdf
Available at: http://www.nehi.net/writable/publication_   files/file/pa_issue_brief_final.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f5/a6/ppa-10-837.PMC4874730.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/f5/a6/ppa-10-837.PMC4874730.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/18/29/ppa-10-807.PMC4874731.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 807–823Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  807OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S9954 4Association of psychological factors, patients’  knowledge, and management among patients  with erectile dysfunction hasniza Zaman huri1,2 nurul Diyana Mat sanusi1 Azad hassan Abdul razack3 raymond Mark1 1Department of Pharmacy, 2clinical  investigation center, University of  Malaya Medical centre, 3Department  of surgery, Faculty of Medicine,   University of Malaya, Kuala lumpur,   MalaysiaBackground:  Erectile dysfunction (ED) is one of the most common health problems in men.",Non-OADS,/arxiv_data1/oa_pdf/18/29/ppa-10-807.PMC4874731.pdf
"The psychological impact of ED can be seen in their current marital rela - tionship, the willingness to discuss ED, the feeling of guilt and denial, depression,  anger, decrease in self-confidence and self-esteem, as well as the feeling of failure  as a man.8,9 The socioeconomic state can also indirectly enhance ED progression correspondence: hasniza Zaman huri Department of Pharmacy, Faculty of  Medicine, University of Malaya, 50603  Kuala lumpur, Malaysia Tel +60 3 7967 6659 Fax +60 3 7967 4964 email hasnizazh@um.edu.m yJournal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Huri et al Running head recto: Psychological factors, patients’ knowledge, and management of ED patients DOI: http://dx.doi.org/10.2147/PPA.S99544",Non-OADS,/arxiv_data1/oa_pdf/18/29/ppa-10-807.PMC4874731.pdf
"Available from: http://uroweb.org/ wp-content/uploads/14-Male-Sexual-Dysfunction_LR.pd f. Accessed  November 18, 2013.",Non-OADS,/arxiv_data1/oa_pdf/18/29/ppa-10-807.PMC4874731.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/18/29/ppa-10-807.PMC4874731.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Infection Ecology and Epidemiology 2016, 6: 31234 - http://dx.doi.org/10.3402/iee.v6.31234 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/17/1e/IEE-6-31234.PMC4875039.pdf
"(20).Diana Tilevik 2 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 31234 - http://dx.doi.org/10.3402/iee.v6.31234",Non-OADS,/arxiv_data1/oa_pdf/17/1e/IEE-6-31234.PMC4875039.pdf
"The model allowed simultaneous carriage of the PNSP clone and the Long-term effects of penicillin resistance and fitness Citation: Infection Ecology and Epidemiology 2016, 6: 31234 - http://dx.doi.org/10.3402/iee.v6.31234 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/17/1e/IEE-6-31234.PMC4875039.pdf
"PSP/C30penicillin- susceptible pneumococci.Diana Tilevik 4 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 31234 - http://dx.doi.org/10.3402/iee.v6.31234",Non-OADS,/arxiv_data1/oa_pdf/17/1e/IEE-6-31234.PMC4875039.pdf
"Baselines values for the model parameters Model parameter Baseline value Transmission probability Households 0.07 contacts/C281week/C281(22) Day care centres 0.04 contacts/C281week/C281(18) School classes 0.03 contacts/C281week/C281(39) Other close contacts 0.04 contacts/C281week/C281(22) Age-related susceptibility Individuals B1 year 1.00 (22) Individuals 1 /C16 years 0.33 (22) Individuals 7 /C165 years 0.18 (22) Individuals /C2165 years 0.3 (52) Proportion of children attending day care centres 81% (38)Average number of children per group in the day care centres 16.9 (37)Average number of children per class in school 22.0 (32)Probability of other close contacts 0.75 (estimated)Between-clone competition factor 0.1 colonisation event /C281(51) Mean durations of carriage for different age groups Individuals B1 year 10.6 weeks (27) Individuals 1 /C12 years 6.7 weeks (27) Individuals 3 /C14 years 4.9 weeks (27) Individuals 5 /C16 years 3.7 weeks (27) Individuals 7 /C118 years 3.7 weeks (27) Individuals /C2118 years 3.6 weeks (27) Disease risk during first and second week of colonisation Individuals B1 year 0.031 colonisation event/C281week/C281(17, 42, 43) Individuals 1 /C12 years 0.0175 colonisation event/C281week/C281(17, 42, 43) Individuals 3 /C14 years 0.0095 colonisation event/C281week/C281(17, 42, 43) Individuals 5 /C16 years 0.007 colonisation event/C281week/C281(17, 42, 43) Individuals 7 /C118 years 0.0014 colonisation event/C281week/C281(17, 42, 43) Individuals 19 /C165 years 0.00051 colonisation event/C281week/C281(17, 42, 43) Individuals /C2165 years 0.002 colonisation event/C281week/C281(17, 42, 43)Long-term effects of penicillin resistance and fitness Citation: Infection Ecology and Epidemiology 2016, 6: 31234 - http://dx.doi.org/10.3402/iee.v6.31234 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/17/1e/IEE-6-31234.PMC4875039.pdf
"recipes 100 inhabitants/C281week/C281Individual probability week/C281 for receiving penicillin therapya 0/C14 301 0.58 0.0058 5/C114 163 0.31 0.0031 15/C144 101 0.19 0.0019 45/C164 93 0.18 0.0018 65/C174 99 0.19 0.0019 75/C184 81 0.16 0.0016 ]85 80 0.15 0.0015 aIn the model, the age groups 75 /C184 years and /C2184 years were pooled into one age group, ]75 years, and the individual probability per week for receiving penicillin therapy was averaged to 0.00155.Diana Tilevik 6 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 31234 - http://dx.doi.org/10.3402/iee.v6.31234",Non-OADS,/arxiv_data1/oa_pdf/17/1e/IEE-6-31234.PMC4875039.pdf
"PNSP , penicillin non-susceptible pneumococci.Long-term effects of penicillin resistance and fitness Citation: Infection Ecology and Epidemiology 2016, 6: 31234 - http://dx.doi.org/10.3402/iee.v6.31234 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/17/1e/IEE-6-31234.PMC4875039.pdf
"PNSP , penicillin non-susceptible pneumococci.Diana Tilevik 8 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 31234 - http://dx.doi.org/10.3402/iee.v6.31234",Non-OADS,/arxiv_data1/oa_pdf/17/1e/IEE-6-31234.PMC4875039.pdf
"PNSP , penicillin non-susceptible pneumococci.Long-term effects of penicillin resistance and fitness Citation: Infection Ecology and Epidemiology 2016, 6: 31234 - http://dx.doi.org/10.3402/iee.v6.31234 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/17/1e/IEE-6-31234.PMC4875039.pdf
Available from: http://www.scb.se/templates/tableOrChart_78315.asp [cited 15 March 2007].,OADS,/arxiv_data1/oa_pdf/17/1e/IEE-6-31234.PMC4875039.pdf
"PhD thesis,Lund, Sweden, 1990.Diana Tilevik 10 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 31234 - http://dx.doi.org/10.3402/iee.v6.31234",Non-OADS,/arxiv_data1/oa_pdf/17/1e/IEE-6-31234.PMC4875039.pdf
Available from: http://www.scb.se/statistik/UF/UF0526/ 2003M00/UF100%C3%96P0201_04.pdf [cited 18 June 2007] 33.,OADS,/arxiv_data1/oa_pdf/17/1e/IEE-6-31234.PMC4875039.pdf
Available from: http://www.scb.se/statistik/_publikationer/ BE0701_2005A01_BR_BE51ST0603.pdf [cited 18 June 2007].,OADS,/arxiv_data1/oa_pdf/17/1e/IEE-6-31234.PMC4875039.pdf
Available from: http://www.skolverket.se/sb/d/1667/a/9255 [cited 18 June2007].,OADS,/arxiv_data1/oa_pdf/17/1e/IEE-6-31234.PMC4875039.pdf
Available from: http://www.skolverket.se/content/1/c4/92/23/BO - Barn och grupper - Kommunniv%E5 - Tabell1 .xls [cited 18 June 2007].,Non-OADS,/arxiv_data1/oa_pdf/17/1e/IEE-6-31234.PMC4875039.pdf
Available from: http://www.skolverket.se/sb/d/1663/a/7697 [cited 18 June 2007] 37.,Non-OADS,/arxiv_data1/oa_pdf/17/1e/IEE-6-31234.PMC4875039.pdf
Available from: http://www.skolverket.se/sb/d/1664 [cited 9 March 2011] 38.,Non-OADS,/arxiv_data1/oa_pdf/17/1e/IEE-6-31234.PMC4875039.pdf
Available from: http://www.skolverket.se/sb/d/1664 [cited 9 March 2011] 39.,Non-OADS,/arxiv_data1/oa_pdf/17/1e/IEE-6-31234.PMC4875039.pdf
Available from: http://www.oron.mas.lu.se/utbildning/infektioner.html [ci- ted 9 March 2011] 43.,Non-OADS,/arxiv_data1/oa_pdf/17/1e/IEE-6-31234.PMC4875039.pdf
"Available from: http://www.strama.se/dyn/,227.html [cited 9 March 2011] 45.",Non-OADS,/arxiv_data1/oa_pdf/17/1e/IEE-6-31234.PMC4875039.pdf
"Infect Ecol Epidemiol2015; 5: 30048, doi: http://dx.doi.org/10.3402/iee.v5.30048 56.",Non-OADS,/arxiv_data1/oa_pdf/17/1e/IEE-6-31234.PMC4875039.pdf
"J Infect Dis 1993; 168: 158 /C163.Long-term effects of penicillin resistance and fitness Citation: Infection Ecology and Epidemiology 2016, 6: 31234 - http://dx.doi.org/10.3402/iee.v6.31234 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/17/1e/IEE-6-31234.PMC4875039.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s)and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/75/a6/10620_2015_Article_4011.PMC4875048.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/35/8f/10549_2016_Article_3808.PMC4875050.pdf
http://ganjoho.jp/en/professional/statistics/bro chure/2014_en.html .,Non-OADS,/arxiv_data1/oa_pdf/35/8f/10549_2016_Article_3808.PMC4875050.pdf
http://www.nccn.org/professionals/default.aspx .,Non-OADS,/arxiv_data1/oa_pdf/35/8f/10549_2016_Article_3808.PMC4875050.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/7a/4f/10620_2016_Article_4034.PMC4875057.pdf
"J. Santegoeds is a consultant for clinical psychiatric practice, human right activist and founder of the foundation Mindrights ;http://www.mindrights.nl .",Non-OADS,/arxiv_data1/oa_pdf/72/2d/10202_2008_Article_57.PMC4875058.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/f4/47/10549_2016_Article_3817.PMC4875067.pdf
doi: 10.1038/ modpathol.2015.38 12.http://www.nccn.org/ 13.,Non-OADS,/arxiv_data1/oa_pdf/f4/47/10549_2016_Article_3817.PMC4875067.pdf
doi: 10.1093/jnci/djr393 17.http://www.nordiqc.org/ 18.,OADS,/arxiv_data1/oa_pdf/f4/47/10549_2016_Article_3817.PMC4875067.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/44/4d/10549_2016_Article_3809.PMC4875068.pdf
"Funding This report was sponsored by Pﬁzer Inc. Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.Immunogenicity of Biopharmaceuticals 203",Non-OADS,/arxiv_data1/oa_pdf/27/d6/40259_2016_Article_174.PMC4875071.pdf
http://www.fda.gov/downloads /Drugs/GuidanceCompliance RegulatoryInformation/Guidances/UCM291128.pdf .,Non-OADS,/arxiv_data1/oa_pdf/27/d6/40259_2016_Article_174.PMC4875071.pdf
http://www.ema.europa.eu/docs/en_GB/ document_library/Scientiﬁc_guideline/2013/06/WC500144124.pdf .,Non-OADS,/arxiv_data1/oa_pdf/27/d6/40259_2016_Article_174.PMC4875071.pdf
http://www.who.int/ biologicals/areas/biological_therapeutics/BIOTHERAPEUTICS_FOR_WEB_22APRIL2010.pdf .,Non-OADS,/arxiv_data1/oa_pdf/27/d6/40259_2016_Article_174.PMC4875071.pdf
Atlanta: ACR;2015. http://www.rheumatology.org/Portals/0/Files/Biosimilars.,Non-OADS,/arxiv_data1/oa_pdf/27/d6/40259_2016_Article_174.PMC4875071.pdf
http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/27/d6/40259_2016_Article_174.PMC4875071.pdf
North Chicago: AbbVie Inc.; 2014. http://www.rxabbvie.com/ pdf/humira.pdf .,Non-OADS,/arxiv_data1/oa_pdf/27/d6/40259_2016_Article_174.PMC4875071.pdf
"Silver Spring: U.S. Department of Health and Human Services, Center for Drug Evaluation and Research (CDER), Center for BiologicsEvaluation and Research (CBER); 2014 (last update August 2014).http://www.fda.gov/downloads/drugs/guidancecomplianceregula toryinformation/guidances/ucm338856.pdf .",OADS,/arxiv_data1/oa_pdf/27/d6/40259_2016_Article_174.PMC4875071.pdf
Geneva: WHO; 2013. http://www.who.,OADS,/arxiv_data1/oa_pdf/27/d6/40259_2016_Article_174.PMC4875071.pdf
London:EMA; 2008. http://www.ema.europa.eu/docs/en_GB/document_ library/Scientiﬁc_guideline/2009/09/WC500003946.pdf .,Non-OADS,/arxiv_data1/oa_pdf/27/d6/40259_2016_Article_174.PMC4875071.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/06/45/hepatmon-16-03-30877.PMC4875503.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/3e/hepatmon-16-03-35106.PMC4875504.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/13/3a/ehw054.PMC4875560.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/a7/hepatmon-16-03-34266.PMC4875561.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bb/8d/hepatmon-16-03-35664.PMC4875562.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs279/en /.,Non-OADS,/arxiv_data1/oa_pdf/bb/8d/hepatmon-16-03-35664.PMC4875562.pdf
Available from: http://data.worldbank.org/about/country-and- lending-groups .,Non-OADS,/arxiv_data1/oa_pdf/bb/8d/hepatmon-16-03-35664.PMC4875562.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/00/5e/hepatmon-16-03-34356.PMC4875566.pdf
Available from: http://www.ipaq.ki.se .,Non-OADS,/arxiv_data1/oa_pdf/00/5e/hepatmon-16-03-34356.PMC4875566.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/16/00/hepatmon-16-03-37015.PMC4875567.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/69/4f/hepatmon-16-03-31951.PMC4875568.pdf
"Convergence was assessed by estimating the eﬀective sampling size (ESS) after a 10% burn-in, using Tracer soft- ware, version 1.5 (http://tree.bio.ed.ac.uk/software/tracer/), and accepting ESS values of 250 or more.",OADS,/arxiv_data1/oa_pdf/69/4f/hepatmon-16-03-31951.PMC4875568.pdf
Selective Pressure Analysis The CODEML program implemented in the PAML 3.14 software package (http://abacus.gene.ucl.ac.uk/software/ paml.html) was used to investigate the adaptive evolution of the HEV capsid gene.,OADS,/arxiv_data1/oa_pdf/69/4f/hepatmon-16-03-31951.PMC4875568.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/86/12/hepatmon-16-03-34763.PMC4875578.pdf
"This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 3.0  Unported License .© 2016 The authors http://www.edmcasereports.com  Published by Bioscientifica Ltd Metastatic malignant struma  ovariiM Russo, I Marturano   and others Metastatic malignant struma ovarii with  coexistence of Hashimoto’s thyroiditis Marco Russo1,*, Ilenia Marturano2,*, Romilda Masucci3, Melania Caruso4,  Maria Concetta Fornito5, Dario Tumino2, Martina Tavarelli2, Sebastiano Squatrito2  and Gabriella Pellegriti6 1Endocrinology, Department of Clinical and Experimental Medicine, University of Messina, Messina,  Italy, 2Endocrinology, Department of Clinical and Experimental Medicine, University of Catania,  Garibaldi-Nesima Hospital, Catania, Italy, 3Surgical Oncology, 4Gynecology and  Obstetrics,   5Nuclear Medicine and 6Endocrinology, Garibaldi-Nesima Hospital, Catania, Italy *(M Russo and I Marturano contributed equally to this work) Summary Struma ovarii is a rare ovarian teratoma characterized by the presence of thyroid tissue as the major component.",Non-OADS,/arxiv_data1/oa_pdf/11/23/edmcr-2016-160030.PMC4875765.pdf
"M Russo, I Marturano   and othersMetastatic malignant struma  ovariiID: 16-0030; May 2016 DOI: 10.1530/EDM-16-0030http://www.edmcasereports.com  2ranges from 4 to 23% of cases, depending on the series  reported in the literature, and adjacent pelvic structures  are typically involved ( 1) (2).",Non-OADS,/arxiv_data1/oa_pdf/11/23/edmcr-2016-160030.PMC4875765.pdf
"M Russo, I Marturano   and othersID: 16-0030; May 2016 DOI: 10.1530/EDM-16-0030Metastatic malignant struma  ovariihttp://www.edmcasereports.com  3progressive reduction in AAT antibodies levels (507 U/mL).",Non-OADS,/arxiv_data1/oa_pdf/11/23/edmcr-2016-160030.PMC4875765.pdf
"M Russo, I Marturano   and othersMetastatic malignant struma  ovariiID: 16-0030; May 2016 DOI: 10.1530/EDM-16-0030http://www.edmcasereports.com  4patient, 131I therapy effectively treated the metastatic  disease, and we believe that this therapeutic tool in  combination with thyroidectomy should be always  considered after proper risk stratification in accordance  with standard approaches in differentiated thyroid  cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/11/23/edmcr-2016-160030.PMC4875765.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original138 C. Scavone et al.",Non-OADS,/arxiv_data1/oa_pdf/72/77/40268_2016_Article_123.PMC4875918.pdf
Available at: http://www.fda.gov/ downloads/Drugs/ …/Guidances/ucm070246.pdf .,Non-OADS,/arxiv_data1/oa_pdf/72/77/40268_2016_Article_123.PMC4875918.pdf
Available at: http://www.agenziafarmaco.gov.it/sites/ default/ﬁles/Rapporto_OsMED_2013.pdf .,Non-OADS,/arxiv_data1/oa_pdf/72/77/40268_2016_Article_123.PMC4875918.pdf
Available at: http://www.ema.europa.eu/docs/en_GB/ document_library/Report/2012/11/WC500134717.pdf .,Non-OADS,/arxiv_data1/oa_pdf/72/77/40268_2016_Article_123.PMC4875918.pdf
Available at: https://farmaci.agenziafarmaco.gov.,Non-OADS,/arxiv_data1/oa_pdf/72/77/40268_2016_Article_123.PMC4875918.pdf
Available at: https://farmaci.agenziafa- rmaco.gov.it/aifa/servlet/Pdf DownloadServlet?pdfFileName= footer_000959_040389_RCP.pdf&retry=0&sys=m0b1l3 .,Non-OADS,/arxiv_data1/oa_pdf/72/77/40268_2016_Article_123.PMC4875918.pdf
Available at: https://farmaci.agenziafarmaco.,Non-OADS,/arxiv_data1/oa_pdf/72/77/40268_2016_Article_123.PMC4875918.pdf
"Berrino F, Campagnoli C, Veronesi U. Progesterone, progestinici e rischio di cancro mammario nella terapia ormonale sostitutiva.Available at: https://www.progettoasco.it/riviste/rivista_simg/ 2005/04_2005/8.pdf .",Non-OADS,/arxiv_data1/oa_pdf/72/77/40268_2016_Article_123.PMC4875918.pdf
Available at: http://www.ajog.,Non-OADS,/arxiv_data1/oa_pdf/72/77/40268_2016_Article_123.PMC4875918.pdf
Available at:http://www.mhra.gov.,Non-OADS,/arxiv_data1/oa_pdf/72/77/40268_2016_Article_123.PMC4875918.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/bc/04/40268_2016_Article_124.PMC4875919.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/56/f3/40268_2016_Article_125.PMC4875920.pdf
Available at: https://www.incb.org/ documents/Narcotic-Drugs/Technical-Publications/2014/ND_TR_2014_4_Tables_EFS.pdf .,Non-OADS,/arxiv_data1/oa_pdf/56/f3/40268_2016_Article_125.PMC4875920.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/e8/59/40268_2016_Article_126.PMC4875921.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/45/c8/40268_2016_Article_127.PMC4875922.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), whichTable 5 Minimum inhibitory concentrations of ampicillin, cloxacillin, and ampicillin–cloxacillin alone and in the presence of quinine using broth dilution Drug MIC ( lg/ml) Mean ±SD (lg/ml) % difference 95 % CI pvalue MIC increase (folds) 123 Amp 0.09 0.17 0.09 0.12 ±0.05 600.00 38.64, 120.1 0.0386 (S) Amp ?Qui 0.23 1.14 1.14 0.84 ±0.30 7 Clox 0.19 0.09 0.09 0.12 ±0.06 366.67 -29.87, 158.3 0.0112 (S) Clox ?Qui 0.24 0.96 0.48 0.56 ±0.21 5 Amp ?Clox 0.02 0.04 0.02 0.03 ±0.01 1166.67 53.51, 119.9 0.0424 (S) Amp ?Clox ?Qui 0.07 0.53 0.53 0.38 ±0.27 13 Amp ampicillin, CIconﬁdence interval, Clox cloxacillin, MIC minimum inhibitory concentration, Quiquinine, Ssigniﬁcant202 O.",Non-OADS,/arxiv_data1/oa_pdf/48/86/40268_2016_Article_128.PMC4875923.pdf
Available at http://www.prb.org/pdf12/2012-population-data- sheet_eng.pdf .,OADS,/arxiv_data1/oa_pdf/48/86/40268_2016_Article_128.PMC4875923.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/8b/39/40268_2016_Article_129.PMC4875924.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/4a/7a/40268_2016_Article_130.PMC4875925.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/54/4e/40268_2016_Article_131.PMC4875926.pdf
Available at https://www.gsksource.com/gskprm/htdocs/ documents/ANORO-ELLIPTA-PI-MG.PDF .,Non-OADS,/arxiv_data1/oa_pdf/54/4e/40268_2016_Article_131.PMC4875926.pdf
Available at http://www.medicines.org.uk/emc/medicine/ 28949#INDICATIONS .,Non-OADS,/arxiv_data1/oa_pdf/54/4e/40268_2016_Article_131.PMC4875926.pdf
Available at http://docs.boehringer-ingelheim.com/ Prescribing%20Information/PIs/Spiriva/Spiriva.pdf .,Non-OADS,/arxiv_data1/oa_pdf/54/4e/40268_2016_Article_131.PMC4875926.pdf
Available at https://www.medicines.,Non-OADS,/arxiv_data1/oa_pdf/54/4e/40268_2016_Article_131.PMC4875926.pdf
Available at https://www.pharma.us.novartis.com/product/pi/pdf/ arcapta.pdf .,Non-OADS,/arxiv_data1/oa_pdf/54/4e/40268_2016_Article_131.PMC4875926.pdf
Available at https://www.medicines.org.uk/EMC/ medicine/23260/SPC/Onbrez ?Breezhaler ?150?and?300?,Non-OADS,/arxiv_data1/oa_pdf/54/4e/40268_2016_Article_131.PMC4875926.pdf
Available at http://www.ich.,Non-OADS,/arxiv_data1/oa_pdf/54/4e/40268_2016_Article_131.PMC4875926.pdf
Available at http://www.wma.,Non-OADS,/arxiv_data1/oa_pdf/54/4e/40268_2016_Article_131.PMC4875926.pdf
Available at http://www.ich.org/ products/guidelines/efﬁcacy/efﬁcacy-single/article/statistical-principles-for-clinical-trials.html .,Non-OADS,/arxiv_data1/oa_pdf/54/4e/40268_2016_Article_131.PMC4875926.pdf
"Sophie Boudriau, Cecilia Hanzel, Julie Massicotte, Laura Sayegh, Jing Wang, and MarcLefebvre are full-time employees and/or stockholders of AlgorithmePharma Inc. Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/aa/77/40268_2016_Article_132.PMC4875927.pdf
Available from: http://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/aa/77/40268_2016_Article_132.PMC4875927.pdf
Available from: http://www.accessdata.fda.gov/scripts/cder/ob/ docs/queryai.cfm .,OADS,/arxiv_data1/oa_pdf/aa/77/40268_2016_Article_132.PMC4875927.pdf
Available from http://www.fda.gov/ucm/groups/fda gov-public/@fdagov-afda-gen/documents/document/ucm126833.pdf 12.,Non-OADS,/arxiv_data1/oa_pdf/aa/77/40268_2016_Article_132.PMC4875927.pdf
"Funding No sources of funding were used to conduct this study or prepare this manuscript.Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/26/a9/40268_2016_Article_133.PMC4875928.pdf
Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/2010 23lbl.pdf .,Non-OADS,/arxiv_data1/oa_pdf/26/a9/40268_2016_Article_133.PMC4875928.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/cd/65/40268_2016_Article_134.PMC4875929.pdf
Available from http://www.idf.org/diabetesatlas .,Non-OADS,/arxiv_data1/oa_pdf/cd/65/40268_2016_Article_134.PMC4875929.pdf
Available from http://www.fda.gov/ downloads/Drugs/Guidances/ucm071624.pdf .,Non-OADS,/arxiv_data1/oa_pdf/cd/65/40268_2016_Article_134.PMC4875929.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/fd/a7/40262_2015_Article_347.PMC4875935.pdf
http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/fd/a7/40262_2015_Article_347.PMC4875935.pdf
http://www.accessdata.fda.gov/ drugsatfda_docs/label/2014/021227s033lbl.pdf .,Non-OADS,/arxiv_data1/oa_pdf/fd/a7/40262_2015_Article_347.PMC4875935.pdf
Cancidas: EPAR scientiﬁc discussion 2004. http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Scientiﬁc_Discussion/human/000379/WC500057186.pdf .,Non-OADS,/arxiv_data1/oa_pdf/fd/a7/40262_2015_Article_347.PMC4875935.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/cc/2d/40262_2015_Article_345.PMC4875954.pdf
Version 2.0. http://www.pallialine.nl .,Non-OADS,/arxiv_data1/oa_pdf/cc/2d/40262_2015_Article_345.PMC4875954.pdf
Version 2.0. http://www.pallialine.nl .,Non-OADS,/arxiv_data1/oa_pdf/cc/2d/40262_2015_Article_345.PMC4875954.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/4b/3a/40262_2015_Article_343.PMC4875959.pdf
http://www.idf.org/diabetesatlas .,Non-OADS,/arxiv_data1/oa_pdf/4b/3a/40262_2015_Article_343.PMC4875959.pdf
2012. http://www.idf.org/ sites/default/ﬁles/IDF-Guideline-for-Type-2-Diabetes.pdf .,Non-OADS,/arxiv_data1/oa_pdf/4b/3a/40262_2015_Article_343.PMC4875959.pdf
https://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/4b/3a/40262_2015_Article_343.PMC4875959.pdf
http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/4b/3a/40262_2015_Article_343.PMC4875959.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/e6/2b/40262_2015_Article_351.PMC4875961.pdf
Avail- able at: http://www.pharmacytimes.com/publications/issue/2012/ July2012/Top-200-Drugs-of-2011 .,Non-OADS,/arxiv_data1/oa_pdf/e6/2b/40262_2015_Article_351.PMC4875961.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/ad/3b/40262_2015_Article_342.PMC4875962.pdf
Available at:http://www.fda.gov/AdvisoryCommittees/CommitteesMeeting Materials/Drugs/CardiovascularandRenalDrugsAdvisoryCommi ttee/ucm420703.htm .,Non-OADS,/arxiv_data1/oa_pdf/ad/3b/40262_2015_Article_342.PMC4875962.pdf
2012.Available at: http://www.fda.gov/downloads/Drugs/Guidances/ ucm292362.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ad/3b/40262_2015_Article_342.PMC4875962.pdf
2009.Available at: https://static.medicine.iupui.edu/divisions/clinpharm/ content/p450_Table_Oct_11_2009.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ad/3b/40262_2015_Article_342.PMC4875962.pdf
"Available at: http://www.ich.org/ﬁleadmin/Pu blic_Web_Site/ICH_Products/654 D. A. Parasrampuria, K. E. Truitt",Non-OADS,/arxiv_data1/oa_pdf/ad/3b/40262_2015_Article_342.PMC4875962.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3e/ef/tcrm-12-777.PMC4876073.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 777–786Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  777Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S8795 6 Pathophysiology of hypophosphatasia and the  potential role of asfotase alfa Hideo Orimo Division of Metabolism and Nutrition,   Department of Biochemistry and  Molecular Biology, Nippon Medical  School, T okyo, JapanAbstract:  Hypophosphatasia (HPP) is an inherited systemic bone disease that is characterized  by bone hypomineralization.",Non-OADS,/arxiv_data1/oa_pdf/3e/ef/tcrm-12-777.PMC4876073.pdf
"Their prognosis for Correspondence: Hideo Orimo Division of Metabolism and Nutrition,  Department of Biochemistry and  Molecular Biology, Nippon Medical  School, 1-1-5 Sendagi, Bunkyo-ku,  Tokyo 113-8602, Japan Tel +81 3 3822 2131 ext 5238 Fax +81 3 5685 3054 email orimohd@nms.ac.j p Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Orimo Running head recto: Hypophosphatasia and asfotase alfa DOI: http://dx.doi.org/10.2147/TCRM.S87956",OADS,/arxiv_data1/oa_pdf/3e/ef/tcrm-12-777.PMC4876073.pdf
Available from: http://www.hgvs.org/ mutnomen /.,Non-OADS,/arxiv_data1/oa_pdf/3e/ef/tcrm-12-777.PMC4876073.pdf
Available from: http://www.sesep.uvsq.fr/ 03_hypo_mutations .,OADS,/arxiv_data1/oa_pdf/3e/ef/tcrm-12-777.PMC4876073.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/3e/ef/tcrm-12-777.PMC4876073.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3e/ef/tcrm-12-777.PMC4876073.pdf
"Available from:  http://strensiq.com/images/pi.pd f. Accessed April 18, 2016.",Non-OADS,/arxiv_data1/oa_pdf/3e/ef/tcrm-12-777.PMC4876073.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/02/a2/vhrm-12-209.PMC4876074.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).The effects of timing of prophylaxis, type of  anesthesia, and use of mechanical methods on  outcome in major orthopedic surgery – subgroup  analyses from 17,701 patients in the XAMOS study Sylvia Haas1 Gerlind Holberg2 Reinhold Kreutz3 Michael Rud Lassen4 Lorenzo Mantovani5 Verena Haupt6 Kai Vogtländer7 Alexander GG T urpie8 1Formerly Technical University of  Munich, 2Bayer HealthCare AG,   3Institut für Klinische Pharmakologie  und T oxikologie, Charité- Universitätsmedizin, Berlin, Germany;   4Glostrup Hospital, University of  Copenhagen, Glostrup, Denmark;   5CESP-Center for Public Health  Research, University of Milan-Bicocca,   Monza, Italy; 6Bayer Vital GmbH,   Leverkusen, 7Bayer Pharma AG,   Wuppertal, Germany; 8Department of  Medicine, Hamilton Health Services,   Hamilton, ON, Canada Correspondence: Sylvia Haas   Formerly T echnical University of Munich,  Normannenstrasse 34a, 81925 Munich,  Germany   T el +49 89 917191   Fax +49 89 917177   Email sylvia.haas@thromboscientific.co mPurpose:  Real-world data on the use of rivaroxaban in the perioperative period in patients   undergoing major orthopedic surgery are limited.",Non-OADS,/arxiv_data1/oa_pdf/02/a2/vhrm-12-209.PMC4876074.pdf
Available from: http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/02/a2/vhrm-12-209.PMC4876074.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/02/a2/vhrm-12-209.PMC4876074.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/02/a2/vhrm-12-209.PMC4876074.pdf
"231© 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Rare Case of Anal Canal Signet Ring Cell Carcinoma Associated   with Perianal and Vulvar Pagetoid Spread Na Rae Kim · Hyun Yee Cho   Jeong-Heum Baek1 · Juhyeon Jeong   Seung Yeon Ha · Jae Yeon Seok   Sung Won Park1 · Sun Jin Sym2  Kyu Chan Lee3 · Dong Hae Chung Departments of Pathology and 1General Surgery,  2Division of Hematology and Oncology,   Department of Internal Medicine, 3Department  of Radiation Oncology, Gachon University Gil  Medical Center, Incheon, KoreaA 61-year-old woman was referred to surgery for incidentally found colonic polyps during a health  examination.",Non-OADS,/arxiv_data1/oa_pdf/60/ad/jptm-2015-08-08.PMC4876076.pdf
"Key Words:  Carcinoma, signet ring cell; Anal canal; Paget disease, extramammaryReceived:  June 19, 2015 Revised:  July 27, 2015 Accepted:  August 7, 2015 Corresponding Author Dong Hae Chung, MD Department of Pathology, Gachon University   Gil Medical Center, 21 Namdong-daero   774beon-gil, Namdong-gu, Incheon 21565, Korea  Tel: +82-32-460-3866 Fax: +82-32-460-2394 E-mail: dhchung@gilhospital.comJournal of Pathology and Translational Medicine 2016; 50: 231-237 http://dx.doi.org/10.4132/jptm.2015.08.08▒ CASE STUDY ▒ According to the recent World Health Organization classifi - cation of the digestive system, patients with mucinous adeno - carcinoma have a significantly high survival rate compared to  those with signet ring cell carcinoma (SRCC).1 By definition,  SRCC has more than 50% intracellular mucin and mucinous  carcinoma has more than 50% extracellular mucin.",Non-OADS,/arxiv_data1/oa_pdf/60/ad/jptm-2015-08-08.PMC4876076.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.08.08232     •  Kim NR, et al.",OADS,/arxiv_data1/oa_pdf/60/ad/jptm-2015-08-08.PMC4876076.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.08.08Anal Canal Signet Ring Cell Carcinoma   •     233 cells were positive for epidermal growth factor receptor and  weakly positive for CK5/6.,Non-OADS,/arxiv_data1/oa_pdf/60/ad/jptm-2015-08-08.PMC4876076.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.08.08234     •  Kim NR, et al.",OADS,/arxiv_data1/oa_pdf/60/ad/jptm-2015-08-08.PMC4876076.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.08.08Anal Canal Signet Ring Cell Carcinoma   •     235Table 2.,Non-OADS,/arxiv_data1/oa_pdf/60/ad/jptm-2015-08-08.PMC4876076.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.08.08236     •  Kim NR, et al.",OADS,/arxiv_data1/oa_pdf/60/ad/jptm-2015-08-08.PMC4876076.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.08.08Anal Canal Signet Ring Cell Carcinoma   •     237 Clin Dermatol 2004; 58: 674-7.,Non-OADS,/arxiv_data1/oa_pdf/60/ad/jptm-2015-08-08.PMC4876076.pdf
"246pISSN 2383-7837 eISSN 2383-7845 © 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Soft Tissue Roasi-Dorfman Disease with Features of IgG4-Related Disease  in a Patient with a History of Acute Myeloid Leukemia Cheol Keun Park · Eun Kyung Kim · Ji-Ye Kim · Hayoung Woo · Mi Jang · Hyang Sook Jeong · Woo Ick Yang · Sang Kyum Kim Department of Pathology, Yonsei University College of Medicine, Seoul, KoreaJournal of Pathology and Translational Medicine 2016; 50: 246-249 http://dx.doi.org/10.4132/jptm.2015.10.08▒ BRIEF CASE REPORT ▒ Rosai-Dorfman disease (RDD), also known as sinus histiocy - tosis with massive lymphadenopathy, was first described by Ro - sai and Dorfman in 1969.1 A subtype of this disease shows  overlapping features with IgG4-related disease.2 Soft tissue in - volvement of RDD is very rare, and there has been no report of  RDD associated with acute myeloid leukemia to date.",Non-OADS,/arxiv_data1/oa_pdf/31/2c/jptm-2015-10-08.PMC4876077.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.10.08Soft Tissue Rosai-Dorfman Disease   •     247 histologic features to IgG4-related disease.2 These results as - sumed that RDD with features of IgG4-related disease could  possibly be on the spectrum of IgG4-related disease or the cer - tain phase of RDD.2,8 However, a general consensus regarding  cut-off values for IgG4-positive plasma cells and the IgG4/IgG ratio has not been established for patients with RDD.2,9 The  patient described here had dense lymphoplasmacytic infiltra - tions in a sclerotic stroma with increased number of IgG4-posi - tive plasma cells.",Non-OADS,/arxiv_data1/oa_pdf/31/2c/jptm-2015-10-08.PMC4876077.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.10.08248     •  Park CK, et al.",OADS,/arxiv_data1/oa_pdf/31/2c/jptm-2015-10-08.PMC4876077.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.10.08Soft Tissue Rosai-Dorfman Disease   •     249 139: 622-32.,Non-OADS,/arxiv_data1/oa_pdf/31/2c/jptm-2015-10-08.PMC4876077.pdf
"243© 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 A Rare Case of Pulmonary Arteriovenous Hemangioma Presenting   as a Peribronchial Mass Soomin Ahn · Sejin Jung · Jong Ho Cho1 · Tae Sung Kim2 · Joungho Han Departments of Pathology and Translational Genomics, 1Thoracic Surgery, and 2Radiology, Samsung Medical Center,   Sungkyunkwan University School of Medicine, Seoul, KoreaJournal of Pathology and Translational Medicine 2016; 50: 243-245 http://dx.doi.org/10.4132/jptm.2015.10.15▒ BRIEF CASE REPORT ▒ Vascular tumors in the lung are unusual.",Non-OADS,/arxiv_data1/oa_pdf/0b/dd/jptm-2015-10-15.PMC4876078.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.10.15244     •  Ahn S, et al.",OADS,/arxiv_data1/oa_pdf/0b/dd/jptm-2015-10-15.PMC4876078.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.10.15Pulmonary Arteriovenous Hemangioma   •     245 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/0b/dd/jptm-2015-10-15.PMC4876078.pdf
"211© 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Aberrant Blood Vessel Formation Connecting the Glomerular Capillary  Tuft and the Interstitium Is a Characteristic Feature of Focal   Segmental Glomerulosclerosis-like IgA Nephropathy Beom Jin Lim1,2 · Min Ju Kim3  Soon Won Hong1 · Hyeon Joo Jeong1 1Department of Pathology, 2Severance Institute  for Vascular and Metabolic Research, Yonsei  University College of Medicine, Seoul;   3Department of Pathology, Gachon University Gil  Medical Center, Incheon, KoreaBackground:  Segmental glomerulosclerosis without significant mesangial or endocapillary prolif - eration is rarely seen in IgA nephropathy (IgAN), which simulates idiopathic focal segmental glo - merulosclerosis (FSGS).",Non-OADS,/arxiv_data1/oa_pdf/9a/a9/jptm-2016-02-01.PMC4876079.pdf
"Key Words:  Glomerulosclerosis, focal segmental; Glomerulonephritis, IgA; Kidney glomerulus; Neo - vascularizationReceived:  January 14, 2016 Revised:  January 28, 2016 Accepted:  February 1, 2016 Corresponding Author Hyeon Joo Jeong, MD Department of Pathology, Yonsei University College  of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul  03722, Korea Tel: +82-2-2228-1766 Fax: +82-2-362-0860 E-mail: jeong10@yuhs.acJournal of Pathology and Translational Medicine 2016; 50: 211-216 http://dx.doi.org/10.4132/jptm.2016.02.01▒ ORIGINAL ARTICLE ▒ IgA nephropathy (IgAN) is characterized by dominant or co- dominant IgA deposits in the mesangial matrix and is usually  accompanied by focal or diffuse mesangial proliferation.",Non-OADS,/arxiv_data1/oa_pdf/9a/a9/jptm-2016-02-01.PMC4876079.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.02.01212     •  Lim BJ, et al.",OADS,/arxiv_data1/oa_pdf/9a/a9/jptm-2016-02-01.PMC4876079.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.02.01Segmental Sclerosis in IgA Nephropathy   •     213 into the capillary networks of the interstitium.,Non-OADS,/arxiv_data1/oa_pdf/9a/a9/jptm-2016-02-01.PMC4876079.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.02.01214     •  Lim BJ, et al.",OADS,/arxiv_data1/oa_pdf/9a/a9/jptm-2016-02-01.PMC4876079.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.02.01Segmental Sclerosis in IgA Nephropathy   •     215 several to more than 10 per glomerulus.,Non-OADS,/arxiv_data1/oa_pdf/9a/a9/jptm-2016-02-01.PMC4876079.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.02.01216     •  Lim BJ, et al.",OADS,/arxiv_data1/oa_pdf/9a/a9/jptm-2016-02-01.PMC4876079.pdf
"173© 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Pathologic Evaluation of Breast Cancer after Neoadjuvant Therapy Cheol Keun Park · Woo-Hee Jung   Ja Seung Koo Department of Pathology, Yonsei University   College of Medicine, Seoul, KoreaBreast cancer, one of the most common cancers in women, has various treatment modalities.",Non-OADS,/arxiv_data1/oa_pdf/79/fc/jptm-2016-02-02.PMC4876080.pdf
"Key Words:  Breast neoplasms; Neoadjuvant therapy; Pathologic response evaluationReceived:  January 5, 2016 Revised:  February 1, 2016 Accepted:  February 2, 2016 Corresponding Author Ja Seung Koo, MD Department of Pathology, Severance Hospital,  Yonsei University College of Medicine,   50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722,  Korea  Tel: +82-2-2228-1772 Fax: +82-2-362-0860 E-mail: kjs1976@yuhs.acJournal of Pathology and Translational Medicine 2016; 50: 173-180 http://dx.doi.org/10.4132/jptm.2016.02.02▒ REVIEW ▒ Application of neoadjuvant therapy (NAT) has become a  more common breast cancer treatment due to the diversity and  rapid development of associated therapeutic agents.",Non-OADS,/arxiv_data1/oa_pdf/79/fc/jptm-2016-02-02.PMC4876080.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.02.02174     •  Park CK, et al.",OADS,/arxiv_data1/oa_pdf/79/fc/jptm-2016-02-02.PMC4876080.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.02.02Evaluation of Neoadjuvant Breast Cancer   •     175 residual heterogeneous tumors, except for the RCB system,  which recommends mentioning the average tumor cellularity.14 Lymphovascular invasion Lymphovascular invasion (LVI) is documented in most patho - logic reports because it is a significant prognostic factor in non- neoadjuvant breast cancer.27,28 Though there are insufficient data  on whether LVI is independently significant in neoadjuvant spec -imens, it should still be mentioned in pathologic reports.20 Duc- tal carcinoma in situ  (DCIS) and LVI are defined as resistant breast  cancer components after NAT.22 Therefore, in some situations,  the only residual after NAT is tumor emboli in lymphovascular  space, with no residual tumor in the breast parenchyma (Fig.",Non-OADS,/arxiv_data1/oa_pdf/79/fc/jptm-2016-02-02.PMC4876080.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.02.02176     •  Park CK, et al.",OADS,/arxiv_data1/oa_pdf/79/fc/jptm-2016-02-02.PMC4876080.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.02.02Evaluation of Neoadjuvant Breast Cancer   •     177 Pathologic complete response Though each system that evaluates treatment responses to  NAT has a unique definition of pCR, all systems record whether  the patient has invasive carcinoma and whether it is identified in  the breast parenchyma.9-14 Significant differences among these  evaluation systems are based on the inclusion or exclusion of  DCIS and axillary lymph node status.",Non-OADS,/arxiv_data1/oa_pdf/79/fc/jptm-2016-02-02.PMC4876080.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.02.02178     •  Park CK, et al.",OADS,/arxiv_data1/oa_pdf/79/fc/jptm-2016-02-02.PMC4876080.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.02.02Evaluation of Neoadjuvant Breast Cancer   •     179 and by the Ministry of Science, ICT, and Future Planning  (2015R1A1A1A05001209).",Non-OADS,/arxiv_data1/oa_pdf/79/fc/jptm-2016-02-02.PMC4876080.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.02.02180     •  Park CK, et al.",OADS,/arxiv_data1/oa_pdf/79/fc/jptm-2016-02-02.PMC4876080.pdf
"217© 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Core Needle Biopsy Is a More Conclusive Follow-up Method Than Repeat  Fine Needle Aspiration for Thyroid Nodules with Initially Inconclusive   Results: A Systematic Review and Meta-Analysis Jung-Soo Pyo · Jin Hee Sohn   Guhyun Kang1 Department of Pathology, Kangbuk Samsung  Hospital, Sungkyunkwan University School of  Medicine, Seoul; 1Department of Pathology,   Inje University Sanggye Paik Hospital, Seoul,  KoreaBackground:  This study investigated the appropriate management of thyroid nodules with prior  non-diagnostic or atypia of undetermined significance/follicular lesion of undetermined signifi - cance (AUS/FLUS) through a systematic review and meta-analysis.",Non-OADS,/arxiv_data1/oa_pdf/8d/0e/jptm-2016-02-15.PMC4876081.pdf
"Key Words:  Thyroid nodule; Non-diagnostic or atypia of undetermined significance/follicular lesion  of undetermined significance; Follow-up core needle biopsy; Repeat fine-needle aspiration; Meta- analysisReceived:  January 25, 2016 Revised:  February 12, 2016 Accepted:  February 15, 2016 Corresponding Author Jin Hee Sohn, MD Department of Pathology, Kangbuk Samsung  Hospital, Sungkyunkwan University School of  Medicine, 29 Saemunan-ro, Jongno-gu, Seoul  03181, Korea Tel: +82-2-2001-2391 Fax: +82-2-2001-2398 E-mail: jhpath.sohn@samsung.comJournal of Pathology and Translational Medicine 2016; 50: 217-224 http://dx.doi.org/10.4132/jptm.2016.02.15▒ ORIGINAL ARTICLE ▒ Papillary thyroid carcinoma, which has recently increased in  incidence, is the most common malignant tumor in endocrine  system.1 The cause for the increased incidence of papillary thyroid  carcinoma is not fully understood.1 One possible cause is the im - provement in ultrasonography and computed tomography.2,3 In  daily practice, the treatment and follow-up for thyroid nodules  are based on the results of initial fine needle aspiration (FNA).",Non-OADS,/arxiv_data1/oa_pdf/8d/0e/jptm-2016-02-15.PMC4876081.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.02.15218     •  Pyo J-S, et al.",OADS,/arxiv_data1/oa_pdf/8d/0e/jptm-2016-02-15.PMC4876081.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.02.15Core Needle Biopsy in Inconclusive Mass   •     219 Table 1.,Non-OADS,/arxiv_data1/oa_pdf/8d/0e/jptm-2016-02-15.PMC4876081.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.02.15220     •  Pyo J-S, et al.",OADS,/arxiv_data1/oa_pdf/8d/0e/jptm-2016-02-15.PMC4876081.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.02.15Core Needle Biopsy in Inconclusive Mass   •     221 1 0.9 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.1 0 0                 0.2               0.4                0.6               0.8                 1SROC curveSensitivity Fig.,Non-OADS,/arxiv_data1/oa_pdf/8d/0e/jptm-2016-02-15.PMC4876081.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.02.15222     •  Pyo J-S, et al.",OADS,/arxiv_data1/oa_pdf/8d/0e/jptm-2016-02-15.PMC4876081.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.02.15Core Needle Biopsy in Inconclusive Mass   •     223 management recommendations in subcategories of thyroid nodules  with atypia of undetermined significance or follicular lesion of un - determined significance: the role of ultrasound-guided core-needle  biopsy.,Non-OADS,/arxiv_data1/oa_pdf/8d/0e/jptm-2016-02-15.PMC4876081.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.02.15224     •  Pyo J-S, et al.",OADS,/arxiv_data1/oa_pdf/8d/0e/jptm-2016-02-15.PMC4876081.pdf
"238pISSN 2383-7837 eISSN 2383-7845 © 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Sclerosing Perivascular Epithelioid Cell Tumor of the Lung:   A Case Report with Cytologic Findings Ha Yeon Kim · Jin Hyuk Choi   Hye Seung Lee · Yoo Jin Choi   Aeree Kim · Han Kyeom Kim Department of Pathology, Korea University Guro  Hospital, Seoul, KoreaBenign perivascular epithelioid cell tumor (PEComa) of the lung is a rare benign neoplasm, a scle - rosing variant of which is even rarer.",Non-OADS,/arxiv_data1/oa_pdf/5d/28/jptm-2016-02-19.PMC4876082.pdf
"Key Words:  Lung neoplasms; Solitary pulmonary nodule; Perivascular epithelioid cell neoplasmsReceived:  January 21, 2016 Revised:  February 11, 2016 Accepted:  February 19, 2016 Corresponding Author Han Kyeom Kim, MD, PhD Department of Pathology, Korea University Guro  Hospital, 148 Gurodong-ro, Guro-gu, Seoul 08308,  Korea Tel: +82-2-2626-3251 Fax: +82-2-2626-1481 E-mail: sswords@naver.comJournal of Pathology and Translational Medicine 2016; 50: 238-242 http://dx.doi.org/10.4132/jptm.2016.02.19▒ CASE STUDY ▒ Benign perivascular epithelioid cell tumor (PEComa) of the  lung is a rare benign neoplasm.",Non-OADS,/arxiv_data1/oa_pdf/5d/28/jptm-2016-02-19.PMC4876082.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.02.19Sclerosing PEComa of the Lung   •     239 uoles (Fig.,Non-OADS,/arxiv_data1/oa_pdf/5d/28/jptm-2016-02-19.PMC4876082.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.02.19240     •  Kim HY, et al.",OADS,/arxiv_data1/oa_pdf/5d/28/jptm-2016-02-19.PMC4876082.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.02.19Sclerosing PEComa of the Lung   •     241 Patients with benign PEComas of the lung are generally as - ymptomatic.6 Our case was similar to most other cases in that the  patient had no symptoms and the tumor was detected inciden - tally.,Non-OADS,/arxiv_data1/oa_pdf/5d/28/jptm-2016-02-19.PMC4876082.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.02.19242     •  Kim HY, et al.",OADS,/arxiv_data1/oa_pdf/5d/28/jptm-2016-02-19.PMC4876082.pdf
"190pISSN 2383-7837 eISSN 2383-7845 © 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Interobserver Agreement on Pathologic Features of Liver Biopsy Tissue   in Patients with Nonalcoholic Fatty Liver Disease Eun Sun Jung1,2 · Kyoungbun Lee1,3  Eunsil Yu1,4 · Yun Kyung Kang1,5  Mee-Yon Cho1,6 · Joon Mee Kim1,7  Woo Sung Moon1,8 · Jin Sook Jeong1,9  Cheol Keun Park1,10 · Jae-Bok Park1,11  Dae Young Kang1,12 · Jin Hee Sohn1,13  So-Young Jin1,14 1Gastrointestinal Pathology Study Group of  Korean Society of Pathologist; 2Department of  Pathology, Seoul St. Mary’s Hospital, College  of Medicine, The Catholic University of Korea,  Seoul; 3Department of Pathology, Seoul National  University College of Medicine, Seoul;   4Department of Pathology, Asan Medical Center,  University of Ulsan College of Medicine, Seoul;  5Department of Pathology, Inje University Seoul  Paik Hospital, Seoul; 6Department of Pathology,  Yonsei University Wonju College of Medicine,  Wonju; 7Department of Pathology, Inha University  Hospital, Incheon; 8Department of Pathology,  Chonbuk National University Medical School,  Jeonju; 9Department of Pathology, Dong-A  University College of Medicine, Busan;   10Department of Pathology, Samsung Medical  Center, Sungkyunkwan University School of  Medicine, Seoul; 11Department of Pathology,  Daegu Catholic University College of Medicine,  Daegu; 12Department of Pathology,   Chungnam National University Hospital,   Chungnam National University School of  Medicine, Daejeon; 13Department of Pathology,  Kangbuk Samsung Hospital, Sungkyunkwan  University School of Medicine, Seoul;   14Department of Pathology, Soon Chun Hyang  University Seoul Hospital, Seoul, KoreaBackground:  The histomorphologic criteria for the pathological features of liver tissue from pa - tients with non-alcoholic fatty liver disease (NAFLD) remain subjective, causing confusion among  pathologists and clinicians.",Non-OADS,/arxiv_data1/oa_pdf/40/d1/jptm-2016-03-01.PMC4876083.pdf
"Key Words:  Non-alcoholic fatty liver disease; Pathologic features; Interobserver agreementReceived:  January 11, 2016 Revised:  February 25, 2016 Accepted:  March 1, 2016 Corresponding Author So-Young Jin, MD Department of Pathology, Soon Chun Hyang   University Seoul Hospital, 59 Daesagwan-ro,  Yongsan-gu, Seoul 04401, Korea  Tel: +82-2-709-9424 Fax: +82-2-709-9441 E-mail: jin0924@schmc.ac.krJournal of Pathology and Translational Medicine 2016; 50: 190-196 http://dx.doi.org/10.4132/jptm.2016.03.01▒ ORIGINAL ARTICLE ▒",Non-OADS,/arxiv_data1/oa_pdf/40/d1/jptm-2016-03-01.PMC4876083.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.01NAFLD: Interobserver Agreement   •     191 Nonalcoholic fatty liver disease (NAFLD) is a clinicopatho - logical spectrum characterized by hepatic steatosis without his - tory of significant alcohol use or other known liver disease.,Non-OADS,/arxiv_data1/oa_pdf/40/d1/jptm-2016-03-01.PMC4876083.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.01192     •  Jung ES, et al.",OADS,/arxiv_data1/oa_pdf/40/d1/jptm-2016-03-01.PMC4876083.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.01NAFLD: Interobserver Agreement   •     193 proposed NAS system is based on agreement data and a multi - ple regression analysis of the14 histological features of steatosis  grade, steatosis location, microvesicular steatosis, fibrosis, lobu - lar inflammation, microgranuloma, large lipogranuloma, portal  inflammation, ballooning degeneration, acidophilic bodies, pig - mented macrophages, megamitochondria, Mallory’s hyaline,  and glycogenated nuclei.",OADS,/arxiv_data1/oa_pdf/40/d1/jptm-2016-03-01.PMC4876083.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.01194     •  Jung ES, et al.",OADS,/arxiv_data1/oa_pdf/40/d1/jptm-2016-03-01.PMC4876083.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.01NAFLD: Interobserver Agreement   •     195 meeting and the determination of more detailed histomorpho - logic criteria.,OADS,/arxiv_data1/oa_pdf/40/d1/jptm-2016-03-01.PMC4876083.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.01196     •  Jung ES, et al.",OADS,/arxiv_data1/oa_pdf/40/d1/jptm-2016-03-01.PMC4876083.pdf
"204pISSN 2383-7837 eISSN 2383-7845 © 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Analysis of Surgical Pathology Data in the HIRA Database: Emphasis   on Current Status and Endoscopic Submucosal Dissection Specimens Sun-ju Byeon · Woo Ho Kim Department of Pathology, Seoul National   University Hospital, Seoul, KoreaBackground:  In Korea, medical institutions make claims for insurance reimbursement to the  Health Insurance Review and Assessment Service (HIRA).",Non-OADS,/arxiv_data1/oa_pdf/5a/2d/jptm-2016-03-04.PMC4876084.pdf
"Key Words:  Statistics; Sample size; Pathology; SurgeryReceived:  January 6, 2016 Revised:  February 15, 2016 Accepted:  March 4, 2016 Corresponding Author Woo Ho Kim, MD, PhD Department of Pathology, Seoul National University  Hospital, 103 Daehak-ro, Jongno-gu, Seoul 03080,  Korea  Tel: +82-2-740-8269 Fax: +82-2-765-5600 E-mail: woohokim@snu.ac.krJournal of Pathology and Translational Medicine 2016; 50: 204-210 http://dx.doi.org/10.4132/jptm.2016.03.04▒ ORIGINAL ARTICLE ▒ In Korea, all medical institutions claim insurance reimburse - ments for services to the Health Insurance Review and Assess - ment Service (HIRA).",Non-OADS,/arxiv_data1/oa_pdf/5a/2d/jptm-2016-03-04.PMC4876084.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.04Surgical Pathology Status in HIRA Data   •     205 This sample was composed of 26 text files, and the total file size  was 16.6 gigabytes (GB).",OADS,/arxiv_data1/oa_pdf/5a/2d/jptm-2016-03-04.PMC4876084.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.04206     •  Byeon S-j, et al.Table 3.",OADS,/arxiv_data1/oa_pdf/5a/2d/jptm-2016-03-04.PMC4876084.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.04Surgical Pathology Status in HIRA Data   •     207 RESULTS Pathologic examination statistics in Korea In the year 2013, 163,372 pathologic examinations were per - formed in 103,528 patients (45,897 men and 57,631 women).",OADS,/arxiv_data1/oa_pdf/5a/2d/jptm-2016-03-04.PMC4876084.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.04208     •  Byeon S-j, et al.",OADS,/arxiv_data1/oa_pdf/5a/2d/jptm-2016-03-04.PMC4876084.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.04Surgical Pathology Status in HIRA Data   •     209 (587/1,850) of cases changed diagnosis after endoscopic resec - tion in Asan Medical Center (Seoul, Korea) and Samsung Medi - cal Center (Seoul, Korea), respectively.5,6 Our HIRA-NPS data  revealed that only 10.9% of nation-wide cases experienced a  change of diagnosis after ESD.",OADS,/arxiv_data1/oa_pdf/5a/2d/jptm-2016-03-04.PMC4876084.pdf
http://dx.doi.org/10.1007/s00464-015-4710-z.,Non-OADS,/arxiv_data1/oa_pdf/5a/2d/jptm-2016-03-04.PMC4876084.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.04210     •  Byeon S-j, et al.",OADS,/arxiv_data1/oa_pdf/5a/2d/jptm-2016-03-04.PMC4876084.pdf
"225© 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Investigation of the Roles of Cyclooxygenase-2 and Galectin-3 Expression  in the Pathogenesis of Premenopausal Endometrial Polyps Esin Kasap · Serap Karaarslan1  Esra Bahar Gur · Mine Genc   Nur Sahin · Serkan Güclü Departments of Obstetrics and Gynecology and  1Pathology, Sifa University School of Medicine,  Izmir, TurkeyBackground:  The pathogenesis and etiology of endometrial polyps has not been elucidated.",Non-OADS,/arxiv_data1/oa_pdf/dd/36/jptm-2016-03-08.PMC4876085.pdf
"172/2, 35240,   Basmane/ I˙zmir, Türkiye  Tel: +90-232-4460880 Fax: +90-232-4460770 E-mail: dresincelik@windowslive.comJournal of Pathology and Translational Medicine 2016; 50: 225-230 http://dx.doi.org/10.4132/jptm.2016.03.08▒ ORIGINAL ARTICLE ▒ Focal endometrial projections containing endometrial glands  and stroma are termed endometrial polyps.1 The reported prev - alence of endometrial polyps in premenopausal women with ab - normal uterine bleeding is 33%, but only 10% in asymptom - atic women.2 While endometrial polyps can occur in women of  all ages, they are more common in women between the ages of  40 and 49.3 Because endometrial polyps have not been reported  to occur before the onset of menstruation, estrogenic stimulation  is thought to be associated with endometrial polyp growth.4  However, the pathogenesis and etiology of endometrial polyps  has not been clearly determined.",Non-OADS,/arxiv_data1/oa_pdf/dd/36/jptm-2016-03-08.PMC4876085.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.08226     •  Kasap E, et al.",OADS,/arxiv_data1/oa_pdf/dd/36/jptm-2016-03-08.PMC4876085.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.08Cox-2 and Galectin-3 in Endometrial Polyps   •     227 RESULTS Patient demographics  There was no statistically significant difference between the  ages of healthy control individuals and patients with endome - trial polyps.,OADS,/arxiv_data1/oa_pdf/dd/36/jptm-2016-03-08.PMC4876085.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.08228     •  Kasap E, et al.",OADS,/arxiv_data1/oa_pdf/dd/36/jptm-2016-03-08.PMC4876085.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.08Cox-2 and Galectin-3 in Endometrial Polyps   •     229 ia, the galectin-3 expression did not differ significantly among  these groups.",OADS,/arxiv_data1/oa_pdf/dd/36/jptm-2016-03-08.PMC4876085.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.08230     •  Kasap E, et al.",OADS,/arxiv_data1/oa_pdf/dd/36/jptm-2016-03-08.PMC4876085.pdf
"197© 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Non-small Cell Lung Cancer with Concomitant EGFR , KRAS , and   ALK Mutation: Clinicopathologic Features of 12 Cases Taebum Lee · Boram Lee   Yoon-La Choi · Joungho Han   Myung-Ju Ahn1 · Sang-Won Um2 Department of Pathology, 1Division of Hematology- Oncology, Department of Medicine, 2Division of  Pulmonary and Critical Care Medicine,   Department of Medicine, Samsung Medical  Center, Sungkyunkwan University School of  Medicine, Seoul, KoreaBackground:  Although epidermal growth factor receptor ( EGFR ), v-Ki-ras2 Kirsten rat sarcoma  viral oncogene ( KRAS ), and anaplastic lymphoma kinase ( ALK) mutations in non-small cell lung  cancer (NSCLC) were thought to be mutually exclusive, some tumors harbor concomitant muta - tions.",Non-OADS,/arxiv_data1/oa_pdf/88/c2/jptm-2016-03-09.PMC4876086.pdf
"Key Words:  Carcinoma, non-small-cell lung; Receptor, epidermal growth factor; KRAS; Anaplastic  lymphoma kinase; Targeted therapyReceived:  January 4, 2016 Revised:  March 7, 2016 Accepted:  March 9, 2016 Corresponding Author Joungho Han, MD Department of Pathology, Samsung Medical Center,  Sungkyunkwan University School of Medicine,   81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea  Tel: +82-2-3410-2800 Fax: +82-2-3410-0025 E-mail: hanjho@skku.eduJournal of Pathology and Translational Medicine 2016; 50: 197-203 http://dx.doi.org/10.4132/jptm.2016.03.09▒ ORIGINAL ARTICLE ▒ Genetic alterations in non-small cell lung cancer (NSCLC)  have been identified in recent years.1-4 Epidermal growth factor  receptor ( EGFR ), v-Ki-ras2 Kirsten rat sarcoma viral oncogene  (KRAS ), and anaplastic lymphoma kinase ( ALK) are the most  commonly mutated oncogenes that involve the pathogenesis of  lung cancer as “genetic drivers.” Advanced NSCLC has a dismal  prognosis with a short median overall survival,5 but several se - lective EGFR tyrosine kinase inhibitors (TKIs) and an ALK in - hibitor show effectiveness as personalized target therapy in pa - tients who harbor those specific genetic mutations.3,6 According  to guidelines from the College of American Pathologists, the  International Association for the Study of Lung Cancer (IASLC)  and the Association for Molecular Pathology, mutation analysis  is recommended and recent studies have demonstrated the cost- effectiveness of genetic screening, especially in Asians, who have  a higher prevalence of EGFR  mutations.7,8 Chromosomal alterations, closely related to unique histologic phenotypes through protein expression, determine differentia - tion, patterns, and cell types.",Non-OADS,/arxiv_data1/oa_pdf/88/c2/jptm-2016-03-09.PMC4876086.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.09198     •  Lee T, et al.",OADS,/arxiv_data1/oa_pdf/88/c2/jptm-2016-03-09.PMC4876086.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.09Lung Cancer with Concomitant Mutations   •     199Table 1.,Non-OADS,/arxiv_data1/oa_pdf/88/c2/jptm-2016-03-09.PMC4876086.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.09200     •  Lee T, et al.",OADS,/arxiv_data1/oa_pdf/88/c2/jptm-2016-03-09.PMC4876086.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.09Lung Cancer with Concomitant Mutations   •     201 cided not to receive targeted therapy due to old age and underly - ing diabetes mellitus died of disease after 53 months from sur - gery (patient No.,Non-OADS,/arxiv_data1/oa_pdf/88/c2/jptm-2016-03-09.PMC4876086.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.09202     •  Lee T, et al.",OADS,/arxiv_data1/oa_pdf/88/c2/jptm-2016-03-09.PMC4876086.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.09Lung Cancer with Concomitant Mutations   •     203 translocation.,Non-OADS,/arxiv_data1/oa_pdf/88/c2/jptm-2016-03-09.PMC4876086.pdf
"181© 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Nuclear Expression of Hepatitis B Virus X Protein Is Associated   with Recurrence of Early-Stage Hepatocellular Carcinomas:   Role of Viral Protein in Tumor Recurrence Jing Jin · Hae Yoen Jung · Kyu Ho Lee   Nam-Joon Yi1 · Kyung-Suk Suh1  Ja-June Jang · Kyoung-Bun Lee Departments of Pathology and 1Surgery,   Seoul National University College of Medicine,  Seoul, KoreaBackground:  Hepatitis B virus (HBV) plays well-known roles in tumorigenesis of hepatocellular  carcinoma (HCC) in infected patients.",Non-OADS,/arxiv_data1/oa_pdf/50/de/jptm-2016-03-18.PMC4876087.pdf
"Key Words:  Hepatitis B X protein; Hepatitis B surface antigens; Hepatitis B core antigens; Carcino - ma, hepatocellularReceived:  September 30, 2015 Revised:  March 12, 2016 Accepted:  March 18, 2016 Corresponding Author Kyoung-Bun Lee, MD, PhD Department of Pathology, Seoul National University  Hospital, 101 Daehak-ro, Jongno-gu, Seoul 03080,  Korea Tel: +82-2-2072-2968  Fax: +82-2-743-5530 E-mail: kblee@snuh.orgJournal of Pathology and Translational Medicine 2016; 50: 181-189 http://dx.doi.org/10.4132/jptm.2016.03.18▒ ORIGINAL ARTICLE ▒ Hepatocellular carcinoma (HCC) is the third most fatal can - cer worldwide and poses a major burden to the healthcare sys - tem.1 More than 50% of HCC cases overall and 70%–80% of  HCC cases in hepatitic B virus (HBV)–endemic regions are at - tributable to chronic HBV infection.2 The mechanism of viral  hepatitis-mediated induction of HCC involves the direct muta - genic effect of the virus on the host genome and the indirect ef - fect of the inflammation-necrosis regeneration cycle in the setting  of chronic hepatitis.3 HBV is a member of the Hepadnaviridae family and has four  important viral proteins: hepatitis B virus surface antigen (HB - sAg), hepatitis B virus core antigen (HBcAg), hepatitis B virus  X protein (HBx), and viral DNA polymerase.",Non-OADS,/arxiv_data1/oa_pdf/50/de/jptm-2016-03-18.PMC4876087.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.18182     •  Jin J, et al.",OADS,/arxiv_data1/oa_pdf/50/de/jptm-2016-03-18.PMC4876087.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.18Role of Viral Protein in Tumor Recurrence   •     183 Copenhagen, Denmark), HBsAg (1:200, HBsAg mouse mono - clonal antibody, clone number S1-210, Cell Marque, Rocklin,  CA, USA), and HBx (1:100, HBx mouse monoclonal antibody,  clone number 3F6-G10, Thermo, Rockford, IL, USA) after an - tigen retrieval using a microwave and pH 6.0 citrate buffer.",Non-OADS,/arxiv_data1/oa_pdf/50/de/jptm-2016-03-18.PMC4876087.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.18184     •  Jin J, et al.",OADS,/arxiv_data1/oa_pdf/50/de/jptm-2016-03-18.PMC4876087.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.18Role of Viral Protein in Tumor Recurrence   •     185 tumor invasion were statistically significant prognostic factors  for tumor recurrence in the entire sample of 328 patients (data  not shown).,OADS,/arxiv_data1/oa_pdf/50/de/jptm-2016-03-18.PMC4876087.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.18186     •  Jin J, et al.",OADS,/arxiv_data1/oa_pdf/50/de/jptm-2016-03-18.PMC4876087.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.18Role of Viral Protein in Tumor Recurrence   •     187 1.0 0.8 0.6 0.4 0.2 0.0 1.0 0.8 0.6 0.4 0.2 0.0 1.0 0.8 0.6 0.4 0.2 0.01.0 0.8 0.6 0.4 0.2 0.0 1.0 0.8 0.6 0.4 0.2 0.0 1.0 0.8 0.6 0.4 0.2 0.00                50             100            150             200 0                50             100            150             200 0                50             100            150             2000                50             100            150             200 0                50             100            150             200 0                50             100            150             200p = .095 p = .296 p = .870p = .379 p = .015* p = .541HBsAg (–) HBsAg (–) HBx nu (+)HBsAg (–) HBx nu (–) HBx cyto (–)HBsAg (+) HBsAg (+) HBx nu (–)HBsAg (+) HBx nu (+) HBx cyto (+)Negative Positive Negative-censor Positive-censor Negative Positive Negative-censor Positive-censor Negative Positive Negative-censor Positive-censorNegative Positive Negative-censor Positive-censor Negative Positive Negative-censor Positive-censor Negative Positive Negative-censor Positive-censorCumulative survival rate Cumulative survival rate Cumulative survival rate Cumulative survival rate Cumulative survival rate Cumulative survival rate Fig.,Non-OADS,/arxiv_data1/oa_pdf/50/de/jptm-2016-03-18.PMC4876087.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.18188     •  Jin J, et al.",OADS,/arxiv_data1/oa_pdf/50/de/jptm-2016-03-18.PMC4876087.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.18Role of Viral Protein in Tumor Recurrence   •     189 3.,Non-OADS,/arxiv_data1/oa_pdf/50/de/jptm-2016-03-18.PMC4876087.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/97/10/opth-10-903.PMC4876088.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 903–910Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  903Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S9514 5Segmentation and removal of fibrovascular  membranes with high-speed 23 G  transconjunctival sutureless vitrectomy, in  severe proliferative diabetic retinopathy erkan Celik1 Ozkan sever2 Fatih horozoglu2 Ates Yanyalı3 1sakarya University Medical education  and research hospital, sakarya,   2namik Kemal University, school  of Medicine, T ekirdag, 3haydarpasa  numune Medical education and  Research Hospital, Istanbul, T urkeyAim:  To evaluate the effectiveness and safety of high-speed (5,000 cuts per minute) 23 G  transconjunctival sutureless vitrectomy (TSV) in severe diabetic fibrovascular proliferation  (DFVP).",Non-OADS,/arxiv_data1/oa_pdf/97/10/opth-10-903.PMC4876088.pdf
"When  compared to the old 20 G vitrectomy systems, which use 0.89 mm sclerotomies, the  new techniques use smaller sclerotomies and are less complicated.2 Fujii et al first introduced 25 G transconjunctival sutureless vitrectomy (TSV) in  2002 following a self-sealing sclerotomy that was described by Chen.3,4 However,  usage of 25  G TSV presented some problems, including the significant flexibility of the  instruments, resulting in reduced manipulation, inadequate illumination, and reduced  lumen of the microcannula for fluid flow.5–7 In 2005, Eckardt8 presented a 23 G TSV Correspondence: erkan Celik sakarya University Medical education  and research hospital, sakarya 54000,  Turkey email drerkancelik@gma il.com Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Celik et al Running head recto: High-speed 23 G TSV in severe PDR DOI: http://dx.doi.org/10.2147/OPTH.S95145",Non-OADS,/arxiv_data1/oa_pdf/97/10/opth-10-903.PMC4876088.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/97/10/opth-10-903.PMC4876088.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/97/10/opth-10-903.PMC4876088.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0d/3d/ott-9-2919.PMC4876089.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2919–2925OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2919Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10339 2PIM1 polymorphism and PiM1 expression as  predisposing factors of esophageal squamous  cell carcinoma in the asian population Yuan-Bo Wu1 Di lu1 Zhi-Feng he1 chan-guan Jin2 1Department of cardiothoracic  surgery, The First affiliated hospital  of Wenzhou Medical University,   2Department of hepatobiliary surgery,   The second affiliated hospital  of Wenzhou Medical University,   Wenzhou, Zhejiang, People’s  republic of chinaAbstract:  Our study aimed to identify the association between a PIM1  polymorphism  and PIM1 expression levels with clinicopathological features of esophageal squamous cell  carcinoma (ESCC).",Non-OADS,/arxiv_data1/oa_pdf/0d/3d/ott-9-2919.PMC4876089.pdf
"Pim family kinases, including three closely related mammalian serine or threonine  kinases ( PIM1 , PIM2 , and PIM3 ), are small, constitutively active, and highly correspondence: chan-guan Jin Department of hepatobiliary surgery,  The Second Affiliated Hospital of  Wenzhou Medical University, no 109  Xueyuan West road, lucheng District,  Wenzhou 325000, Zhejiang, People’s  republic of china Tel +86 577 5557 9999 Fax +86 577 5557 9999 email jinchanguan1229@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Wu et al Running head recto: PIM1  polymorphism and PIM1 expression in ESCC DOI: http://dx.doi.org/10.2147/OTT.S103392",Non-OADS,/arxiv_data1/oa_pdf/0d/3d/ott-9-2919.PMC4876089.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/0d/3d/ott-9-2919.PMC4876089.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0d/3d/ott-9-2919.PMC4876089.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a7/b8/ndt-12-1221.PMC4876090.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1221–1227Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1221OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10418 8Treatment response in relation to subthreshold  bipolarity in patients with major depressive  disorder receiving antidepressant monotherapy:  a post hoc data analysis (KOMDD study) Y oung-Min Park1 Bun-hee lee2 1Department of Psychiatry, ilsan Paik  hospital, inje University college of  Medicine, goyang, 2Department of  Psychiatry, seoul eunpyeong hospital,   seoul, republic of KoreaBackground:  The aim of this observational study was to determine whether subthreshold  bipolarity affects treatment response and remission in patients with major depressive disorder  receiving antidepressant (AD) monotherapy over a 6-month follow-up period.",Non-OADS,/arxiv_data1/oa_pdf/a7/b8/ndt-12-1221.PMC4876090.pdf
"Eighty percent of patients with AD-resistant unipolar  depression were BD I, II, and not otherwise specified, and bipolar spectrum disorder  (BSD) at 1-year follow-up.3 In an analysis of treatment-resistant depression, AD was  associated with a poor outcome in both BD and BSD patients.4 Another study reported  that patients with subthreshold bipolarity exhibited a poor prognosis over a 5-year  follow-up period.5 Thus, the diagnosis of BD or BSD is underestimated, and the most correspondence: Young-Min Park Department of Psychiatry, ilsan Paik  hospital, inje University college  of Medicine, 2240, Daehwa-Dong,  ilsanseo-gu, goyang 411-706,   republic of Korea Tel +82 31 910 7260 Fax +82 31 910 7268 email medipark@hanmail.ne t Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Park and Lee Running head recto: Subthreshold bipolarity and treatment response DOI: http://dx.doi.org/10.2147/NDT.S104188",Non-OADS,/arxiv_data1/oa_pdf/a7/b8/ndt-12-1221.PMC4876090.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/a7/b8/ndt-12-1221.PMC4876090.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a7/b8/ndt-12-1221.PMC4876090.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/36/99/opth-10-897.PMC4876091.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 897–902Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  897Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10261 1Time of maximum cycloplegia after instillation of  cyclopentolate 1% in children with brown irises sittikorn laojaroenwanit Vimontip layanun Pokpong Praneeprachachon Parnchat Pukrushpan Department of Ophthalmology,   Faculty of Medicine, Chulalongkorn  University, Bangkok, ThailandPurpose:  We aimed to 1) determine the time of maximum cycloplegia after instillation of  cyclopentolate 1% in children with brown irises, 2) evaluate the correlation between the pupillary  reaction and time of maximum cycloplegia, and 3) identify any side effects of the medication.",Non-OADS,/arxiv_data1/oa_pdf/36/99/opth-10-897.PMC4876091.pdf
"This could result in  unnecessary long waiting time or measurement error if maximum cycloplegia occurs Correspondence: Parnchat Pukrushpan Pediatric Ophthalmology and strabismus  Division, Department of Ophthalmology,  Faculty of Medicine, Chulalongkorn  University, 1873 rama 4 road,  Pathumwan, Bangkok 10330, Thailand Tel +66 2 256 4142 Fax +66 2 252 8290 email parnchat@gmail.co mJournal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Laojaroenwanit et al Running head recto: Time of maximum cycloplegia in children with brown irises DOI: http://dx.doi.org/10.2147/OPTH.S102611",Non-OADS,/arxiv_data1/oa_pdf/36/99/opth-10-897.PMC4876091.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/36/99/opth-10-897.PMC4876091.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/36/99/opth-10-897.PMC4876091.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/2f/c3/prom-7-029.PMC4876092.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/2f/c3/prom-7-029.PMC4876092.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Related Outcome Measures Patient Related Outcome Measures 2016:7 29–35Dove press submit your manuscript | www.dovepress.co m Dove press  Reviewopen access to scientific and medical research Open Access Full T ext Article 29 http: //dx.doi.org/10.2147/PROM.S7485 7Understanding and optimizing health-related  quality of life and physical functional capacity in  idiopathic pulmonary fibrosis Amy L Olson Kevin K Brown Jeffrey J Swigris Department of Medicine Division of  Pulmonary Medicine, interstitial Lung  Disease Program and Autoimmune  Lung Center, National Jewish Health,   Denver, CO, USA Correspondence: Amy L Olson   National Jewish Health, 1400 Jackson  Street, F107, Denver, Colorado 80206,  USA  T el +1 303 398 1621   Fax +1 303 270 2440   email olsona@njhealth.or gAbstract:  Idiopathic pulmonary fibrosis (IPF) is a relentlessly progressive pulmonary disease  characterized by the insidious onset of shortness of breath due to parenchymal scarring.",Non-OADS,/arxiv_data1/oa_pdf/2f/c3/prom-7-029.PMC4876092.pdf
"Patient Related Outcome Measures Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-related-outcome-measures-journa lPatient Related Outcome Measures is an international, peer-reviewed,  open access journal focusing on treatment outcomes specifically  relevant to patients.",Non-OADS,/arxiv_data1/oa_pdf/2f/c3/prom-7-029.PMC4876092.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/2f/c3/prom-7-029.PMC4876092.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3f/6b/opth-10-913.PMC4876093.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 913–919Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  913Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S8913 2Clinical utility of the KAMRA corneal inlay Shehzad Anjam Naroo Paramdeep Singh Bilkhu Ophthalmic Research Group, School  of Life & Health Sciences, Aston  University, Birmingham, UKAbstract:  The treatment of presbyopia has been the focus of much scientific and clinical  research over recent years, not least due to an increasingly aging population but also the desire  for spectacle independence.",Non-OADS,/arxiv_data1/oa_pdf/3f/6b/opth-10-913.PMC4876093.pdf
"Typically affecting people from 40 years of age, the loss of near visual acuity  is often attributed to increased lens nucleus hardness and subsequent inability of the  lens capsule to compress the lens to a more convex state over time.1–3 However, as lens  thickness increases with age, the space between the lens and ciliary body reduces, and  the angle of zonule insertion may change and therefore render ciliary body contraction  ineffective.4–6 Presbyopia can significantly impact the quality of life and combined  with an increasingly aging global population it poses a greater demand for spectacle  independence.7 Approaches to treat presbyopia have included the use of intracorneal inlays to either  change the refractive power of the cornea based on corneal multifocality8 or increase  the refractive power of the central cornea by changing its curvature.9,10 Another inlay  method which has been studied in great detail is the use of small-aperture optics to  increase the depth of focus based on the pinhole effect.11,12 This commercially avail - able inlay is known as the KAMRA™ inlay (AcuFocus Inc., Irvine, CA, USA), and  this review aims to summarize the efficacy and safety of currently published clinical  studies of this procedure.Correspondence: Shehzad Anjam Naroo Ophthalmic Research Group, School of  Life & Health Sciences, Aston University,  Birmingham B4 7eT, UK Tel +44 121 204 4132 Fax +44 121 204 4048 email s.a.naroo@aston.ac.u k Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Naroo and Bilkhu Running head recto: KAMRA inlay utility DOI: http://dx.doi.org/10.2147/OPTH.S89132",Non-OADS,/arxiv_data1/oa_pdf/3f/6b/opth-10-913.PMC4876093.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/3f/6b/opth-10-913.PMC4876093.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/6b/opth-10-913.PMC4876093.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e8/dd/ott-9-2955.PMC4876094.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2955–2959OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2955Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10044 7Low-grade nasopharyngeal papillary  adenocarcinoma: a case report and review  of the literature Xiaoli Wang1,2 Hongjiang Yan1 Yijun Luo1,2 Tingyong Fan1 1Department of radiation Oncology,   shandong Cancer Hospital and  Institute, Jinan, 2school of Medicine  and Life sciences, shandong academy  of Medical sciences, University of  Jinan, Jinan, people’s republic of ChinaAbstract:  Low-grade nasopharyngeal papillary adenocarcinoma is an extremely rare tumor,  with only a limited number of cases reported in the literature.",Non-OADS,/arxiv_data1/oa_pdf/e8/dd/ott-9-2955.PMC4876094.pdf
"The cervical lymph nodes were not Correspondence: Tingyong Fan Department of radiation Oncology,  shandong Cancer Hospital and Institute,  Jiyan road 440, Jinan 250117, shandong  province, people’s republic of China Tel/fax +86 531 6762 6921 email fanty681105@163.co mJournal name: OncoTargets and Therapy Article Designation: Case report Y ear: 2016 Volume: 9 Running head verso: Wang et al Running head recto: Low-grade nasopharyngeal papillary adenocarcinoma DOI: http://dx.doi.org/10.2147/OTT.S100447",Non-OADS,/arxiv_data1/oa_pdf/e8/dd/ott-9-2955.PMC4876094.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e8/dd/ott-9-2955.PMC4876094.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/dd/ott-9-2955.PMC4876094.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e6/69/ott-9-2897.PMC4876095.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2897–2909OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2897Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S10198 3Comparative effects of different enteral feeding  methods in head and neck cancer patients receiving  radiotherapy or chemoradiotherapy: a network  meta-analysis Zhihong Zhang1,2 Yu Zhu1 Yun Ling3 Lijuan Zhang1 Hongwei wan1 1Department of Nursing, Shanghai  Proton and Heavy ion Center,   2Shanghai First Maternity and infant  Hospital, Tongji University School  of Medicine, 3Department of Human  Resource, Shanghai Proton and  Heavy ion Center, Shanghai, People’s  Republic of ChinaAbstract:  Nasogastric tube (NGT) and percutaneous endoscopic gastrostomy were frequently  used in the head and neck cancer patients when malnutrition was present.",Non-OADS,/arxiv_data1/oa_pdf/e6/69/ott-9-2897.PMC4876095.pdf
"In addition, mucositis,  anorexia, dysphagia, mouth sores, and other acute and late toxic effects of radiotherapy  (RT) and chemotherapy may worsen the nutritional status of patients.5–9 Poor nutritional status was associated with less resistance to chemotherapy or  RT-toxicity, leading to treatment interruption.9–11 Malnutrition was also associated  with higher risk of infection and hospital admission, worse survival outcomes, and  deterioration in the quality of life (QoL).4,12,13 Therefore, nutrition intervention is  essential to maintain nutritional status and improve outcomes in head and neck cancer  patients undergoing RT and chemotherapy.Correspondence: Hongwei wan Department of Nursing, Shanghai  Proton and Heavy ion Center,  4365 Kangxin Road, Shanghai 201321,  People’s Republic of China Tel +86 150 0054 3001 email hong_whw@aliyun.co m Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Zhang et al Running head recto: Malnutrition management in head and neck cancer patients DOI: http://dx.doi.org/10.2147/OTT.S101983",Non-OADS,/arxiv_data1/oa_pdf/e6/69/ott-9-2897.PMC4876095.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e6/69/ott-9-2897.PMC4876095.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e6/69/ott-9-2897.PMC4876095.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5f/c2/ott-9-2945.PMC4876096.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2945–2953OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2945Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S10257 3idelalisib for the treatment of indolent non-Hodgkin  lymphoma: a review of its clinical potential Jacqueline C Barrientos CLL Research and Treatment Program,   Division of Hematology/Oncology,   Department of Medicine, Hofstra  Northwell School of Medicine,   Hofstra University, Lake Success,   NY, USAAbstract:  Idelalisib is a first-in-class, oral, selective phosphatidylinositol 3-kinase δ inhibitor  that offers a chemotherapy-free option for patients with relapsed or refractory (R/R) indolent non- Hodgkin lymphoma (iNHL).",Non-OADS,/arxiv_data1/oa_pdf/5f/c2/ott-9-2945.PMC4876096.pdf
"Approximately 90% of NHLs arise from B lymphocytes.1 The  National Cancer Institute estimated that in 2012, 549,625 people in the USA were  living with NHL and that in 2015 there will be 71,850 new cases of NHL and 19,790  NHL-related deaths in the USA, which represents 4.3% of all new cases of cancer  and 3.4% of all cancer-related deaths.2 Based on 2010–2012 data, the National Cancer  Institute estimated that ~2.1% of men and women will be diagnosed with NHL during  their lifetime.2 Approximately one third of NHLs are indolent.3,4 Indolent NHLs (iNHLs) are slow- growing tumors with a prolonged natural history, and most patients present with advanced  disease.5 iNHLs are highly treatable but rarely cured.6 Subtypes of iNHL include the  most common form, follicular lymphoma (FL), marginal zone lymphoma (MZL),  and small lymphocytic lymphoma (SLL), and the least common form, Waldenström  macroglobulinemia (WM) or lymphoplasmacytic lymphoma.5,7Correspondence: Jacqueline C Barrientos CLL Research and Treatment  Program, Division of Hematology/ Oncology, Department of Medicine,  Hofstra Northwell School of Medicine,  Hofstra University, 410 Lakeville Road,  Lake Success, NY 11042, USA Tel +1 516 470 4050 Fax +1 516 470 4250 email jbarrientos@northwell.ed u Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Barrientos Running head recto: Idelalisib in indolent non-Hodgkin lymphoma DOI: http://dx.doi.org/10.2147/OTT.S102573",Non-OADS,/arxiv_data1/oa_pdf/5f/c2/ott-9-2945.PMC4876096.pdf
Available from:  http://seer.cancer.gov/csr/1975_2012 /.,Non-OADS,/arxiv_data1/oa_pdf/5f/c2/ott-9-2945.PMC4876096.pdf
"Available from: http://www.nccn.org/ professionals/physician_gls/f_guidelines.asp#sit e. Accessed October 6,  2015.",Non-OADS,/arxiv_data1/oa_pdf/5f/c2/ott-9-2945.PMC4876096.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/5f/c2/ott-9-2945.PMC4876096.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5f/c2/ott-9-2945.PMC4876096.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/55/03/ndt-12-1203.PMC4876097.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1203–1213Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1203Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S10084 3Clinical features, comorbidity, and cognitive  impairment in elderly bipolar patients ida vikan Rise1 Josep Maria Haro2–4 Bjørn Gjervan5,6 1Department of Psychiatry, Sorlandet  Hospital, Arendal, Norway; 2Research  Unit, Parc Sanitari Sant Joan de Déu,   Sant Boi de Llobregat, Spain; 3Faculty  of Medicine, Universitat de Barcelona,   Barcelona, Spain; 4CiBeRSAM  (Centro de  investigación Biomédica  en Red de Salud Mental), Madrid,   Spain; 5Department of Psychiatry,   North-Trondelag Hospital Trust,   Levanger, Norway; 6Department of  Medicine, institute of Neuromedicine,   Norwegian University of Science and  T echnology, Trondheim, NorwayIntroduction:  Data specific to late-life bipolar disorder (BD) are limited.",Non-OADS,/arxiv_data1/oa_pdf/55/03/ndt-12-1203.PMC4876097.pdf
"Due to no validated age-at-onset threshold,  this definition remains arbitrary.2 One out of four bipolar patients is reported to be  older than 60 years.3 A systematic review of the prevalence of BD in population-based  studies revealed heterogeneous findings concerning the prevalence of BD, ranging from Correspondence: ida vikan Rise Sørlandet Hospital, Psykiatrisk  Sykehusavdeling (Arendal), Postboks 416,  4604 Kristiansand, Norway Tel +47 37 01 44 00 email theida@gmail.co mJournal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Rise et al Running head recto: Impairment in elderly bipolar patients DOI: http://dx.doi.org/10.2147/NDT.S100843",Non-OADS,/arxiv_data1/oa_pdf/55/03/ndt-12-1203.PMC4876097.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/55/03/ndt-12-1203.PMC4876097.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/55/03/ndt-12-1203.PMC4876097.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f2/c8/ott-9-2927.PMC4876098.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2927–2934OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2927Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10626 4 The association of the CYP1A1  ile462Val  polymorphism with head and neck cancer risk:  evidence based on a cumulative meta-analysis Yadong Wang1,2,* haiyan Yang3,* guangcai Duan2 haiyu Wang1 1Department of Toxicology, henan  center for Disease control and  Prevention, Zhengzhou, 2henan  collaborative innovation center of  Molecular Diagnosis and laboratory  Medicine, Xinxiang Medical  University, Xinxiang, 3Department of  epidemiology, school of Public health,   Zhengzhou University, Zhengzhou,   People’s republic of china *These authors contributed equally  to this workObjective:  The aim of this study was to address the association between the Ile462Val  polymorphism in the gene encoding cytochrome P450 1A1 ( CYP1A1 ) and the risk of head and  neck cancer (HNC).",Non-OADS,/arxiv_data1/oa_pdf/f2/c8/ott-9-2927.PMC4876098.pdf
"Previous studies have demonstrated that an amino acid substitution from isoleucine  to valine in codon 462 (rs1048943, A4889G) in exon 7 of CYP1A1  enhances the correspondence: Yadong Wang Department of Toxicology, henan  center for Disease control and  Prevention, no 105 of south nongye  road, Zhengzhou 450016, People’s  republic of china Tel/fax +86 371 6808 9043 email wangyd76@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Wang et al Running head recto: CYP1A1  Ile462Val polymorphism and risk of head and neck cancer DOI: http://dx.doi.org/10.2147/OTT.S106264",Non-OADS,/arxiv_data1/oa_pdf/f2/c8/ott-9-2927.PMC4876098.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/f2/c8/ott-9-2927.PMC4876098.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/c8/ott-9-2927.PMC4876098.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1c/e9/oajsm-7-051.PMC4876099.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Open Access Journal of Sports Medicine 2016:7 51–54submit your manuscript | www.dovepress.co m Dove press  51 http: //dx.doi.org/10.2147/OAJSM.S10269 2Low recurrence rate after mini surgery outside  the tendon combined with short rehabilitation in  patients with midportion Achilles tendinopathy Håkan Alfredson1,2 1Department of Community Medicine  and Rehabilitation, Umeå University,   Umeå, Sweden; 2Institute of Sport,   Exercise and Health, University  College London Hospitals, London,   UK Correspondence: Håkan Alfredson   Department of Community Medicine and  Rehabilitation, Umeå University, S-901 87,  Umeå, Sweden   T el +46 7 0228 8441   Fax +46 90 13 5692   Email hakan.alfredson@umu.s eBackground:  There is a general opinion that a structured and specific rehabilitation is needed  after treatment of midportion Achilles tendinopathy to minimize recurrence of the condition.",Non-OADS,/arxiv_data1/oa_pdf/1c/e9/oajsm-7-051.PMC4876099.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/1c/e9/oajsm-7-051.PMC4876099.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1c/e9/oajsm-7-051.PMC4876099.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/06/2f/ott-9-2911.PMC4876100.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2911–2917OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2911Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10247 2Efficacy and safety of icotinib in patients with  brain metastases from lung adenocarcinoma Jianping Xu Xiaoyan liu sheng Yang Xiangru Zhang Yuankai shi Department of internal Medicine,   cancer hospital, chinese academy  of Medical sciences, Beijing, People’s  Republic of ChinaObjective:  The objective of this study was to evaluate the efficacy and safety of icotinib in  patients with brain metastases (BMs) from lung adenocarcinoma.",Non-OADS,/arxiv_data1/oa_pdf/06/2f/ott-9-2911.PMC4876100.pdf
"In clinical studies, the remission rate (RR) of  gefitinib for NSCLC patients with BMs was reported to be from 10% to 38% and the  median response time was 9–13.5 months.11–13 Erlotinib also showed effectiveness  for patients with BMs.14–16 Studies indicated that activating mutations of the EGFR  gene are strongly predictive of response to EGFR-TKIs in NSCLC.17,18 EGFR-TKIs  are recommended for all lines of treating advanced NSCLC with activating mutations correspondence: Yuankai shi Department of Medical Oncology, Beijing  Key Laboratory of Clinical Study on  anticancer Molecular Targeted Drugs,  national cancer center/cancer hospital,  chinese academy of Medical sciences  and Peking Union Medical college, no 17  Panjiayuannanli, chaoyang District, Beijing  100021, People’s Republic of China Tel +86 10 8778 8293 Fax +86 10 8777 8740 email syuankai@cicams.ac.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Xu et al Running head recto: Icotinib in patients with brain metastases DOI: http://dx.doi.org/10.2147/OTT.S102472",Non-OADS,/arxiv_data1/oa_pdf/06/2f/ott-9-2911.PMC4876100.pdf
"Available  from: http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_ QuickReference_5x7.pd f. Accessed June 14, 2015.",OADS,/arxiv_data1/oa_pdf/06/2f/ott-9-2911.PMC4876100.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/06/2f/ott-9-2911.PMC4876100.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/06/2f/ott-9-2911.PMC4876100.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8b/25/ndt-12-1215.PMC4876101.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1215–1220Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1215Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S8384 2Clinical efficacy of perampanel for partial-onset  and primary generalized tonic–clonic seizures Frank MC Besag1–3 Philip N Patsalos4,5 1east London Foundation NHS Trust,   2institute of Psychiatry, Psychology  and Neuroscience, 3UCL School of  Pharmacy, 4Department of Clinical and  experimental epilepsy, UCL institute  of Neurology, N iHR University  College London Hospitals Biomedical  Research Centre, London, 5epilepsy  Society, Chalfont Centre for epilepsy,   Chalfont St Peter, UKBackground and purpose:  Perampanel, a selective noncompetitive antagonist at the  α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor, is highly effective  in a wide range of experimental models.",Non-OADS,/arxiv_data1/oa_pdf/8b/25/ndt-12-1215.PMC4876101.pdf
"The AEDs that fulfill the criterion of treating tonic–clonic  seizures in juvenile myoclonic epilepsy include sodium valproate, lamotrigine, and Correspondence: Philip N Patsalos Department of Clinical and experimental  epilepsy, UCL institute of Neurology,  Queen Square, London wC1N 3BG, UK Tel +44 1494 60 1355 Fax +44 1494 87 5176 email p.patsalos@ucl.ac.u k Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Besag and Patsalos Running head recto: Perampanel in partial-onset and primary generalized seizures DOI: http://dx.doi.org/10.2147/NDT.S83842",Non-OADS,/arxiv_data1/oa_pdf/8b/25/ndt-12-1215.PMC4876101.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/8b/25/ndt-12-1215.PMC4876101.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8b/25/ndt-12-1215.PMC4876101.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/bf/77/ppa-10-795.PMC4876102.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 795–805Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  795OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10621 5 Attitudes toward anticoagulant treatment among  nonvalvular atrial fibrillation patients at high risk  of stroke and low risk of bleed concetta crivera1 Winnie W nelson1 Jeff r schein1 edward A Witt2 1Janssen scientific Affairs, llc, raritan,   2Kantar health, Princeton, nJ, UsABackground:  Atrial fibrillation (AF) is associated with an increased risk of stroke.",Non-OADS,/arxiv_data1/oa_pdf/bf/77/ppa-10-795.PMC4876102.pdf
"Keywords:  atrial fibrillation, anticoagulants, stroke risk, bleeding risk, treatment Introduction Atrial fibrillation (AF) is a supraventricular tachyarrhythmia with uncoordinated  atrial activation and consequently ineffective atrial contraction.1–3 AF is the most  common sustained cardiac arrhythmia and is associated with substantial morbidity  and mortality.4 AF is independently associated with an increased risk of stroke, throm - boembolism, dementia, and congestive heart failure.5–7 Nearly 500,000 hospitalizations  list AF as the primary diagnosis annually in the US, and AF is estimated to contribute  to nearly 100,000 deaths per year.8,9 According to recently updated clinical guidelines, AF patients should generally  receive an anticoagulant (AC) or antiplatelet (ie, aspirin [ASA]) regimen depending  on their degree of risk for stroke and serious bleeding.1,2,10,11 Risk scores (eg, CHADS2, correspondence: edward A Witt Kantar health, 1 independence Way,  suite #220, Princeton, nJ 08540, UsA Tel +1 609 720 5491 email edward.witt@kantarhealth.com  Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Crivera et al Running head recto: Attitudes toward anticoagulants DOI: http://dx.doi.org/10.2147/PPA.S106215",Non-OADS,/arxiv_data1/oa_pdf/bf/77/ppa-10-795.PMC4876102.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/bf/77/ppa-10-795.PMC4876102.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2d/cb/ppa-10-851.PMC4876103.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 851–861Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  851OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10062 6impact of telephonic interviews on persistence and  daily adherence to insulin treatment in insulin-naïve  type 2 diabetes patients: dropout study Dilek gogas Yavuz,1 habip Bilen,2  seda sancak,3 Tayfun garip,4  Zeliha hekimsoy,5 ibrahim sahin,6  Murat Yilmaz,7 hasan Aydin,8  Aysegul Atmaca,9 Murat sert,10  Pinar Karakaya,11 Dilek Arpaci,4  Aytekin Oguz,12 nilgun guvener13 On behalf of the Dropout study  group 1Department of endocrinology and Metabolism,  Marmara University Faculty of Medicine,  istanbul, 2Department of endocrinology and  Metabolism, Ataturk University Faculty of  Medicine, erzurum, 3clinic of endocrinology  and Metabolism, Fatih sultan Mehmet Training  and research hospital, istanbul, 4clinic of  endocrinology and Metabolism, sakarya  state hospital, sakarya, 5Department of  endocrinology and Metabolism, celal Bayar  University Faculty of Medicine, Manisa,  6Department of endocrinology and Metabolism,  inonu University Faculty of Medicine,  Malatya, 7Department of endocrinology  and Metabolism, Namık Kemal University  Faculty of Medicine, Tekirdag, 8Department  of endocrinology and Metabolism, Yeditepe  University Faculty of Medicine, istanbul,  9Department of endocrinology and Metabolism,  Ondokuzmayıs University Faculty of Medicine,  samsun, 10Department of endocrinology and  Metabolism, cukurova University Faculty of  Medicine, Adana, 11clinic of endocrinology  and Metabolism, Bakırkoy Training and  research hospital, istanbul, 12Department  of internal Medicine, Medeniyet University  Faculty of Medicine, istanbul, 13Department  of endocrinology and Metabolism, Baskent  University Faculty of Medicine, istanbul, TurkeyObjective:  The objective of this study is to evaluate the impact of sequential telephonic  interviews on treatment persistence and daily adherence to insulin injections among insulin-naïve  type 2 diabetes patients initiated on different insulin regimens in a 3-month period.",Non-OADS,/arxiv_data1/oa_pdf/2d/cb/ppa-10-851.PMC4876103.pdf
"Keywords:  type 2 diabetes, insulin analogs, HbA1c, self-monitoring of blood glucose Introduction Barriers toward insulin therapy have been associated with easily avoidable challenges  related to clinicians, patients, and health-care system in diabetes management.1,2  However, insulin omission/nonadherence and the consequent prolonged periods of  poor glycemic control have been closely linked to negative clinical outcomes, including  increased severity and progression of diabetic complications.3–6 Although data from the multinational The Global Attitudes of Patients and  Physicians in Insulin Therapy (GAPP) survey revealed that insulin omission/nonadher - ence was reported to be highest in Turkey, followed by the USA, the People’s Republic  of China, and Japan, and lowest in France, Germany, UK, and Spain,4,7 no country- specific data are available in Turkey considering the adherence to insulin therapy and  reasons for treatment withdrawal in insulin-naïve type 2 diabetes patients.correspondence: Dilek gogas Yavuz Department of endocrinology and Metabolism,  Faculty of Medicine, Marmara University, Fevzi  cakmak Mahallesi, Muhsin Yazicioglu caddesi,  no 10, Ust Kaynarca, Pendik, 34584 istanbul,  Turkey Tel/fax +90 216 625 4685 email dilekgogas@marmara.edu.t rJournal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Y avuz et al Running head recto: Telephonic interviews and insulin adherence DOI: http://dx.doi.org/10.2147/PPA.S100626",Non-OADS,/arxiv_data1/oa_pdf/2d/cb/ppa-10-851.PMC4876103.pdf
"Available from: http://www.pharmafile.com/news/161079/treatment- flexibi lity-wi ll-improve-adherence-diabetes-study-suggest s. Accessed  April 7, 2015.",Non-OADS,/arxiv_data1/oa_pdf/2d/cb/ppa-10-851.PMC4876103.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/2d/cb/ppa-10-851.PMC4876103.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4c/51/opth-10-911.PMC4876104.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 911–912Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  911Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/OPTH.S11147 3 Omega-3 fatty acid supplementation improves dry  eye symptoms in patients with glaucoma: results  of a prospective multicenter study Abdullah Kaya1 Yakup Aksoy2 1Department of Ophthalmology,   Anıttepe Military Dispensary,   Ankara, turkey; 2Department of  Ophthalmology, Girne Military  Hospital, Girne, CyprusDear editor We read the article entitled “Omega-3 fatty acid supplementation improves dry eye  symptoms in patients with glaucoma: results of a prospective multicenter study” by  Tellez-Vazquez, with great interest.1 The authors found omega-3 fatty acid supple - mentation to have very beneficial effects on symptoms and clinical findings of dry  eye.",Non-OADS,/arxiv_data1/oa_pdf/4c/51/opth-10-911.PMC4876104.pdf
"Correspondence: Abdullah Kaya Department of Ophthalmology,  Anıttepe Military Dispensary, Yucetepe  Mah Gençlik Cad 88 Sok Çankaya/Ankara  6400, turkey tel +90 312 456 2871 email abdullahkayamd@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Letter Y ear: 2016 Volume: 10 Running head verso: Kaya and Aksoy Running head recto: Omega-3 fatty acid supplementation improves dry eye symptoms in patients with glaucoma DOI: http://dx.doi.org/10.2147/OPTH.S111473",Non-OADS,/arxiv_data1/oa_pdf/4c/51/opth-10-911.PMC4876104.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/4c/51/opth-10-911.PMC4876104.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4c/51/opth-10-911.PMC4876104.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c7/88/opth-10-861.PMC4876105.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 861–869Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  861Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10609 2ranibizumab in monotherapy and combined with  photodynamic therapy for retinal angiomatous  proliferation luis arias1–3 Francisco gómez-Ulla2–4 José M ruiz-Moreno2,3,5 1Ophthalmology Department, Bellvitge  University hospital, C/Feixa llarga,   l’hospitalet de llobregat, Barcelona,   2spanish Vitreoretinal society (ser V),   C/Xosé Chao rego, santiago de  Compostela, 3reTiCs OFT areD,   institute of health Carlos iii, C/ sinesio Delgado, Madrid, 4gómez-Ulla  eye institute, santiago de Compostela,   5Department of Ophthalmology,   albacete University hospital, avenida  de almansa s/n, albacete, spainPurpose:  To compare the effects of intravitreal ranibizumab in monotherapy (group A) and  combined with photodynamic therapy (PDT) with verteporfin (group B) in retinal angiomatous  proliferation (RAP) treatment.",Non-OADS,/arxiv_data1/oa_pdf/c7/88/opth-10-861.PMC4876105.pdf
"Keywords:  age-related macular degeneration, intravitreal injection, photodynamic therapy,  ranibizumab, retinal angiomatous proliferation, verteporfin Introduction Retinal angiomatous proliferation (RAP) has recently been described as a variant  of exudative-type age-related macular degeneration (ARMD), characterized by the  initial presence of new intraretinal capillaries that grow toward the subretinal space  and choroid.1–3 Three stages of the disease are distinguished: stage I, characterized by the pres - ence of intraretinal neovascularization; stage II, in which new capillaries are formed  in the subretinal space (subretinal neovascularization); and stage III, characterized by  choroid neovascularization (CNV) with retinochoroidal anastomosis.1 Approximately 10%–15% of all eyes with exudative ARMD present RAP.1,4,5  The diagnosis of RAP is complex, since in most cases, fluorescein angiography  (FA) is used, revealing a blurred area of exudate within the intra- or subretinal space Correspondence: luis arias Ophthalmology Department, Bellvitge  University hospital, C/Feixa llarga  s/n 08907, l’hospitalet de llobregat,  Barcelona, spain Tel +34 93 6208 98469 email luisariasbarquet@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Arias et al Running head recto: Ranibizumab with or without PDT for RAP DOI: http://dx.doi.org/10.2147/OPTH.S106092",Non-OADS,/arxiv_data1/oa_pdf/c7/88/opth-10-861.PMC4876105.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/c7/88/opth-10-861.PMC4876105.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c7/88/opth-10-861.PMC4876105.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b1/47/ott-9-2835.PMC4876106.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2835–2844OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2835Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9597 3Transcatheter arterial embolization combined  with radiofrequency ablation activates cD8+  T -cell infiltration surrounding residual tumors  in the rabbit VX2 liver tumors Xu-hua Duan1,2 T eng-Fei li2 guo-Feng Zhou1,* Xin-Wei han2,* chuan-sheng Zheng1 Peng-fei chen2 gan-sheng Feng1 1Department of interventional  radiology, Union hospital, T ongji  Medical college, huazhong University  of science and T echnology, Wuhan,   2Department of interventional  radiology, The First affiliated  hospital, Zhengzhou University,   henan Province, Zhengzhou, People’s  republic of china *These authors contributed equally  to this workPurpose:  To evaluate the effect of transcatheter arterial embolization (TAE) combined with  radiofrequency ablation (RFA) treatment (TAE + RFA) on the expression of heat shock protein  70 (HSP70) in residual tumors and explore the relationship between the HSP70 and CD8+ T-cell  infiltrate surrounding residual tumors in the rabbit VX2 liver tumor model.",Non-OADS,/arxiv_data1/oa_pdf/b1/47/ott-9-2835.PMC4876106.pdf
"Keywords:  transcatheter arterial embolization, radiofrequency ablation, heat shock protein 70,  CD8+ T-cells, liver tumor Introduction Hyperthermic ablative therapies using radiofrequency, microwave, laser, or high- intensity focused ultrasonography have become common adjunctive treatments for the  local–regional control of unresectable focal malignancies.1 Radiofrequency ablation  (RFA) provides efficacious, cost-effective management of localized cancer sites with  survival time comparable to that of surgery in patients with hepatocellular carcinoma  nodules.2,3 Recently, a retrospective study demonstrated that single-session transcath - eter arterial embolization (TAE) combined with RFA treatment (TAE + RFA) was an  effective and safe treatment in patients with unresectable liver malignancies.4 In a previous study, we demonstrated that transcatheter arterial chemoemboliza - tion (TACE) combined with RFA (TACE + RFA) and TAE + RFA equally decreased correspondence: guo-Feng Zhou Department of interventional radiology,  Union hospital, Tongji Medical college,  huazhong University of science and  Technology, 1277, Jie-fang road, Wuhan  430022, People’s republic of china Tel +86 27 8572 6807 Fax +86 27 8572 6405 email zzudxh@yeah.ne t Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Duan et al Running head recto: Activation of CD8+ T-cells in the rabbit liver tumors DOI: http://dx.doi.org/10.2147/OTT.S95973",Non-OADS,/arxiv_data1/oa_pdf/b1/47/ott-9-2835.PMC4876106.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/b1/47/ott-9-2835.PMC4876106.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/47/ott-9-2835.PMC4876106.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ce/e1/ott-9-2873.PMC4876107.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2873–2884OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2873Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S10469 1Recent advancements in erythrocytes, platelets,  and albumin as delivery systems Peipei Xu1,* Ruju wang1,2,* Xiaohui wang1 Jian Ouyang1 1Department of Hematology, The  Affiliated Drum T ower Hospital of  Nanjing University Medical School,   2Medical School, Southeast University,   Nanjing, People’s Republic of China *These authors contributed equally  to this workAbstract:  In the past few years, nanomaterial-based drug delivery systems have been applied  to enhance the efficacy of therapeutics and to alleviate negative effects through the controlled  delivery of targeting and releasing agents.",Non-OADS,/arxiv_data1/oa_pdf/ce/e1/ott-9-2873.PMC4876107.pdf
"Although major advancements have  been observed in this field, neither passive targeting nor active targeting can achieve Correspondence: Peipei Xu; Jian Ouyang Department of Hematology, The  Affiliated Drum Tower Hospital of  Nanjing University Medical School,  321 Zhongshan Road, Nanjing 210008,  People’s Republic of China Tel +86 130 7259 0562;  +86 25 8310 5211 email xu_peipei0618@163.co m;  ouyangj211@163.co mJournal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Xu et al Running head recto: Recent advancements in erythrocytes, platelets, and albumin DOI: http://dx.doi.org/10.2147/OTT.S104691",Non-OADS,/arxiv_data1/oa_pdf/ce/e1/ott-9-2873.PMC4876107.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ce/e1/ott-9-2873.PMC4876107.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ce/e1/ott-9-2873.PMC4876107.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/30/95/ppa-10-781.PMC4876108.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 781–794Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  781OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10557 8Typology of end-of-life priorities in saudi females:  averaging analysis and Q-methodology Muhammad M hammami1,2 safa hammami1 hala A Amer1 nesrine A Khodr1 1clinical studies and empirical  ethics Department, King Faisal  specialist hospital and research  centre, 2college of Medicine, Alfaisal  University, riyadh, saudi ArabiaBackground:  Understanding culture-and sex-related end-of-life preferences is essential to  provide quality end-of-life care.",Non-OADS,/arxiv_data1/oa_pdf/30/95/ppa-10-781.PMC4876108.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/30/95/ppa-10-781.PMC4876108.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/87/73/ott-9-2935.PMC4876109.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2935–2943OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2935Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S10558 6 Advances of wogonin, an extract from Scutellaria  baicalensis , for the treatment of multiple tumors Xue wu1 Haijun Zhang2 Jumah Masoud Mohammad  Salmani1 Rong Fu3 Baoan Chen1 1Department of Hematology,   2Department of Oncology, The  Affiliated Zhongda Hospital, School  of Medicine, Southeast University,   3Department of Physiology, China  Pharmaceutical University, Nanjing,   People’s Republic of ChinaAbstract:  As the major bioactive compound of Scutellaria baicalensis  that has been approved  to be effective as an anti-inflammatory and antiviral inhibitor in cardiovascular diseases,  wogonin (WG) showed potent and promising antitumor effects both in vitro and in vivo.",Non-OADS,/arxiv_data1/oa_pdf/87/73/ott-9-2935.PMC4876109.pdf
"The key molecular pathways of  its antitumor effects include reactive oxygen species (ROS), Ca2+, NF-κB, tumor  necrosis factor-related apoptosis-inducing ligand (TRAIL), and tumor necrosis  factor-alpha,4–8 which participate in both intrinsic mitochondria-mediated and  extrinsic receptor-mediated pathways.9 In addition to its activation of Bax/Bak  protein and caspase-8/caspase-9/caspase-3, WG plays an important role to inhibit  lipopolysaccharide-induced or hydrogen peroxide (H2O2)-induced tumor angiogen - esis through PI3K/AKT/NF- κB pathway.10–12 In addition, the ability of WG to inhibit  tumor angiogenesis by decreasing the expression of hypoxia-inducible factor-1 α  protein was also observed.13 The current review is not only limited to the induction of apoptosis of tumor  cells by WG but also dedicated to its synergistic effects with other chemotherapeutic Correspondence: Baoan Chen Department of Hematology, The  Affiliated Zhongda Hospital, School  of Medicine, Southeast University,  Dingjiaqiao 87, Nanjing 210009, Jiangsu  Province, People’s Republic of China Tel +86 138 5166 5838 email cba8888@hotmail.co m Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Wu et al Running head recto: Wogonin for the treatment of tumors DOI: http://dx.doi.org/10.2147/OTT.S105586",Non-OADS,/arxiv_data1/oa_pdf/87/73/ott-9-2935.PMC4876109.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/87/73/ott-9-2935.PMC4876109.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/87/73/ott-9-2935.PMC4876109.pdf
Mouse model of diet-induced obesity and metabolic syndrome All mouse experiments were approved by the Animal Care and Use Subcommittee at Western University (pro- tocol number 2011 –044) in accordance with the require- ments of the Canadian Council on Animal Care (http://www.ccac.ca/en_).,Non-OADS,/arxiv_data1/oa_pdf/2c/55/PRP2-4-e00233.PMC4876143.pdf
Available at: http://www.bfs.admin.ch/bfs/portal/fr/index/news/ publikationen.html?publicationID.,Non-OADS,/arxiv_data1/oa_pdf/a0/5a/PRP2-4-e00234.PMC4876144.pdf
"Copyright © 2016  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/0e/aps-43-225.PMC4876149.pdf
"Branchial arch of human embryo at 13 weeks Each arch is composed of central mesen chymal unit (muscle and  cartilage), accompanied by an artery and a cranial nerve (Illustra - tion by Loki austanfell, https://commons.wikimedia.org/wiki/ File:PharyngealArchHuman.jpg).Fig.",Non-OADS,/arxiv_data1/oa_pdf/e7/0e/aps-43-225.PMC4876149.pdf
"Copyright © 2016  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/e1/aps-43-229.PMC4876150.pdf
"Copyright © 2016  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/37/10/aps-43-237.PMC4876151.pdf
"242Copyright © 2016  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/b8/aps-43-242.PMC4876152.pdf
"248Copyright © 2016  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/24/6c/aps-43-248.PMC4876153.pdf
Available from: http://www.ciru - estetic.com/resources/nasolabiaeval2013red.pdf.,Non-OADS,/arxiv_data1/oa_pdf/24/6c/aps-43-248.PMC4876153.pdf
"254Copyright © 2016  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/2b/aps-43-254.PMC4876154.pdf
"258Copyright © 2016  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/92/8e/aps-43-258.PMC4876155.pdf
"Copyright © 2016  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/74/b1/aps-43-265.PMC4876156.pdf
"272Copyright © 2016  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/fc/aps-43-272.PMC4876157.pdf
"278Copyright © 2016  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5c/be/aps-43-278.PMC4876158.pdf
Avail ­ able from: http://www.kita.net/newtri2/report/iitreport ­ er_view.jsp?pageNum=1&nGubun=3&s_con=&s_text=& sStartDt=&sEndDt=&sOrder=&sClassification=&actionN ame=&sNo=773.,Non-OADS,/arxiv_data1/oa_pdf/5c/be/aps-43-278.PMC4876158.pdf
"284Copyright © 2016  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/83/9a/aps-43-284.PMC4876159.pdf
"288Copyright © 2016  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0c/f0/aps-43-288.PMC4876160.pdf
"Received: 30 Jan 2016 • Revised: 16 Mar 2016 • Accepted: 16 Mar 2016   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/10.5999/aps.2016.43.3.291 • Arch Plast Surg 2016;43:291-292 Copyright  2016 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits   unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.broad nasal root and a bifid nasal tip (Fig.",Non-OADS,/arxiv_data1/oa_pdf/1c/e2/aps-43-291.PMC4876161.pdf
"Received: 9 May 2016 • Revised: 11 May 2016 • Accepted: 11 May 2016   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/10.5999/aps.2016.43.3.292 • Arch Plast Surg 2016;43:292 Copyright  2016 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits   unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/e2/aps-43-291.PMC4876161.pdf
"Received: 9 May 2016 • Revised: 11 May 2016 • Accepted: 11 May 2016   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/10.5999/aps.2016.43.3.292 • Arch Plast Surg 2016;43:292 Copyright  2016 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits   unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/55/b7/aps-43-292.PMC4876162.pdf
"Received: 10 Jun 2015 • Revised: 22 Jan 2016 • Accepted: 7 Feb 2016   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2016.43.3.293   Arch Plast Surg 2016;43:293-295 Copyright  2016 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d9/de/aps-43-293.PMC4876163.pdf
"Received: 13 Jul 2015 • Revised: 29 Dec 2015 • Accepted: 4 Jan 2016   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2016.43.3.295   Arch Plast Surg 2016;43:295-296 Copyright  2016 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d9/de/aps-43-293.PMC4876163.pdf
"Received: 13 Jul 2015 • Revised: 29 Dec 2015 • Accepted: 4 Jan 2016   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2016.43.3.295   Arch Plast Surg 2016;43:295-296 Copyright  2016 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/65/b0/aps-43-295.PMC4876164.pdf
"Received: 20 Oct 2015 • Revised: 29 Dec 2015 • Accepted: 18 Jan 2016   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2016.43.3.297   Arch Plast Surg 2016;43:297-299 Copyright  2016 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ba/2e/aps-43-297.PMC4876165.pdf
"Received: 1 Dec 2015 • Revised: 20 Jan 2016 • Accepted: 7 Feb 2016   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2016.43.3.299   Arch Plast Surg 2016;43:299-301 Copyright  2016 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ba/2e/aps-43-297.PMC4876165.pdf
"Received: 1 Dec 2015 • Revised: 20 Jan 2016 • Accepted: 7 Feb 2016   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2016.43.3.299   Arch Plast Surg 2016;43:299-301 Copyright  2016 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/45/b2/aps-43-299.PMC4876166.pdf
"Received: 9 Jun 2015 • Revised: 7 Jul 2015 • Accepted: 14 Jul 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2016.43.3.301   Arch Plast Surg 2016;43:301-303 Copyright  2016 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/45/b2/aps-43-299.PMC4876166.pdf
"Received: 9 Jun 2015 • Revised: 7 Jul 2015 • Accepted: 14 Jul 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2016.43.3.301   Arch Plast Surg 2016;43:301-303 Copyright  2016 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a6/98/aps-43-301.PMC4876167.pdf
"Received: 27 Aug 2015 • Revised: 25 Dec 2015 • Accepted: 4 Jan 2016   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2016.43.3.303   Arch Plast Surg 2016;43:303-305 Copyright  2016 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a6/98/aps-43-301.PMC4876167.pdf
"Received: 27 Aug 2015 • Revised: 25 Dec 2015 • Accepted: 4 Jan 2016   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2016.43.3.303   Arch Plast Surg 2016;43:303-305 Copyright  2016 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ad/93/aps-43-303.PMC4876168.pdf
"COMMUNICATIONS An Evolutionary Understanding of  Aging  Jeongho Choi Dr. Choi's Aesthetic Clinic, Seoul, Korea Correspondence: Jeongho Choi Dr. Choi's Aesthetic Clinic, 221 Gangnam-daero, Seocho-gu, Seoul 06749, Korea Tel: +82-2-571-2226, Fax: +82-2-571-2227, E-mail: dr.jurum@hanmail.net No potential conflict of interest relevant to this article was reported.CommunicationsReceived: 15 Apr 2016 • Revised: 9 May 2016 • Accepted: 9 May 2016   pISSN: 2234-6163 • eISSN: 2234-6171  http://dx.doi.org/ 10.5999/aps.2016.43.3.306 • Arch Plast Surg 2016;43:306-308 Copyright  2016 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cf/35/aps-43-306.PMC4876169.pdf
Supporting Information Additional Supporting Information may be found in the online version of this article at the publisher ’s web-site: http://onlinelibrary.wiley.com/doi/10.1111/bcp.,Non-OADS,/arxiv_data1/oa_pdf/c7/da/BCP-81-1078.PMC4876172.pdf
Available from:  http://www.bapen.org.uk/the-must.html.,Non-OADS,/arxiv_data1/oa_pdf/23/06/IJMS-41-171.PMC4876294.pdf
Available from: http://www.medindia.net/ doctors/drug_information/amikacin.htm 13.,Non-OADS,/arxiv_data1/oa_pdf/c9/3d/IJMS-41-191.PMC4876297.pdf
A	phylogenetic	 tree	 was constructed via Tamura 3-parameter option  of the neighbor-joining method using MEGA5  (http://www.megasoftware.net).,OADS,/arxiv_data1/oa_pdf/c3/1a/IJMS-41-209.PMC4876299.pdf
"This guide is provided in here under the  Creative Commons Attribution-Share Alike 3.0 United States License ( http://creativecommons.org/licenses/by-sa/3.0/us/ ):Erdemir A.  and Sibole S. Open Knee: A Three-Dimensional Finite Element Representation of the Knee Joint, User's Guide, Version 1.0.0,  December 17, 2010 – guide.pdf.This guide and its updated versions can also be accessed in the “Documents” section of the Open  Knee(s) project site – https://simtk.org/home/openknee.",Non-OADS,/arxiv_data1/oa_pdf/cc/fd/nihms778594.PMC4876308.pdf
FEBio is open source and freely  available for academic research ( http://febio.org/ ).,OADS,/arxiv_data1/oa_pdf/cc/fd/nihms778594.PMC4876308.pdf
Python programming language ( http://www.python.org ) was  used for this purpose.,OADS,/arxiv_data1/oa_pdf/cc/fd/nihms778594.PMC4876308.pdf
"Dissemination Open Knee (Open Knee(s) – Generation 1), including its intermediate components (data,  geometry, mesh, scripts, model), is freely available in the “Downloads” section of the project  site – https://simtk.org/home/openknee .",OADS,/arxiv_data1/oa_pdf/cc/fd/nihms778594.PMC4876308.pdf
"Those interested in the development of  next generation knee models are encouraged to browse the “Source Code Repository” and  particularly the “Wiki” at http://wiki.simtk.org/openknee , where roadmap, specifications and  work in progress can be accessed.",Non-OADS,/arxiv_data1/oa_pdf/cc/fd/nihms778594.PMC4876308.pdf
Project hosting has been provided by SimTK ( https://simtk.org ).,OADS,/arxiv_data1/oa_pdf/cc/fd/nihms778594.PMC4876308.pdf
Access to high performance  computing was provided by Ohio Supercomputer Center ( http://www.osc.edu ).,OADS,/arxiv_data1/oa_pdf/cc/fd/nihms778594.PMC4876308.pdf
at  http://www.nsf.gov/pubs/reports/sbes_final_report.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/cc/fd/nihms778594.PMC4876308.pdf
U.S.  Food and Drug Administration; 2011. at http://www.fda.gov/downloads/scienceresearch/ specialtopics/regulatoryscience/ucm268225.pdf 3.,Non-OADS,/arxiv_data1/oa_pdf/cc/fd/nihms778594.PMC4876308.pdf
California Polytechnic State University; 2013. at  http://digitalcommons.calpoly.edu/theses/1129 38.,Non-OADS,/arxiv_data1/oa_pdf/cc/fd/nihms778594.PMC4876308.pdf
University of Connecticut; 2011. at http://digitalcommons.uconn.edu/gs_theses/47 40.,Non-OADS,/arxiv_data1/oa_pdf/cc/fd/nihms778594.PMC4876308.pdf
"(Adapted from Open Knee(s) project site, https://simtk.org/home/ openknee , courtesy of Ahmet Erdemir.",Non-OADS,/arxiv_data1/oa_pdf/cc/fd/nihms778594.PMC4876308.pdf
"(Adapted from Open Knee(s) project site, https://simtk.org/home/openknee , courtesy  of Ahmet Erdemir.",Non-OADS,/arxiv_data1/oa_pdf/cc/fd/nihms778594.PMC4876308.pdf
"(Adapted from Open  Knee(s) project site, https://simtk.org/home/openknee , courtesy of Ahmet Erdemir.",Non-OADS,/arxiv_data1/oa_pdf/cc/fd/nihms778594.PMC4876308.pdf
"(Adapted from Open Knee(s) project site, https://simtk.org/home/openknee , courtesy  of Ahmet Erdemir.",Non-OADS,/arxiv_data1/oa_pdf/cc/fd/nihms778594.PMC4876308.pdf
"National Academy Press, http://www.nap.edu/ catalog/10078.htm (2001, accessed 29 October 2014).",Non-OADS,/arxiv_data1/oa_pdf/4e/58/10.1177_0962280215588245.PMC4876428.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/71/10/10.1177_2325967116648441.PMC4876440.pdf
http://www.ucdenver.edu/ academics/colleges/PublicHeal th/research/ResearchProjects/ piper/projects/RIO/Documents/C onvenience%20Report_2014_15.,Non-OADS,/arxiv_data1/oa_pdf/71/10/10.1177_2325967116648441.PMC4876440.pdf
http://www.iom.edu/ */media/ Files/Report%20File s/2013/Concussions/concussions-RB.pdf.,Non-OADS,/arxiv_data1/oa_pdf/71/10/10.1177_2325967116648441.PMC4876440.pdf
Indiana Football SEA 222. https://nfhslearn.co m/courses/35/indian a-football-sea-222.,Non-OADS,/arxiv_data1/oa_pdf/71/10/10.1177_2325967116648441.PMC4876440.pdf
http://usafootball.com/headsup.,Non-OADS,/arxiv_data1/oa_pdf/71/10/10.1177_2325967116648441.PMC4876440.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.TISSUE ENGINEERING: Part A Volume 22, Numbers 9 and 10, 2016 Mary Ann Liebert, Inc.DOI: 10.1089/ten.tea.2015.0427 742",Non-OADS,/arxiv_data1/oa_pdf/f2/2a/ten.tea.2015.0427.PMC4876526.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.ANTIOXIDANTS & REDOX SIGNALING Volume 24, Number 15, 2016 Mary Ann Liebert, Inc.DOI: 10.1089/ars.2014.6128 839",Non-OADS,/arxiv_data1/oa_pdf/07/ea/ars.2014.6128.PMC4876530.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF GYNECOLOGIC SURGERY Volume 32, Number 3, 2016DOI: 10.1089/gyn.2015.0115 182",Non-OADS,/arxiv_data1/oa_pdf/de/77/gyn.2015.0115.PMC4876544.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercialuse, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF ENDOUROLOGY Volume 30, Number 5, May 2016Mary Ann Liebert, Inc.Pp.",Non-OADS,/arxiv_data1/oa_pdf/f0/0d/end.2015.0760.PMC4876551.pdf
"The main characteristics and differences of the LatAm and Luanda children who had or not CRP measured are summarized in Table, Supplemental Digital Content 1, http://links.lww.com/INF/C421.",Non-OADS,/arxiv_data1/oa_pdf/91/d1/inf-35-617.PMC4876570.pdf
"Finally, we explored the power of raised (above median)  CRP levels on day 3 or 4 to predict adverse outcomes (see Table, Supplemental Digital Content 2, http://links.lww.com/INF/C422).",Non-OADS,/arxiv_data1/oa_pdf/91/d1/inf-35-617.PMC4876570.pdf
"PMID: 15907740. http://dx.doi.org/   10.1016/S0140 -6736(04)16305 -8  [2] Fahn, S. Description of Parkinson’s disease as a clinical syn drome.",OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
"PMID: 18668629.  http://dx.doi.org/10.1002/mds.21927   [4] Schaafsma, J.D.",OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
"PMID: 12823491.   http://dx.doi.org/10.1046/j.1468 -1331.2003.00611.x   [5] Moore, S.T.",OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
PMID: 17928063. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
", 2001 , 16(6), 1066 -1075.PMID: 11748737.   http://dx.doi.org/10.1002/mds.1206   [7] Nutt, J.G.",Non-OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
"PMID:  21777828.http://dx.doi.org/10.1016/S1474 -4422(11)70143 -0  [8] Panisset, M. Freezing of gait in Parkinson’s.",Non-OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
"PMID: 1550136.http://dx.doi.org/ 10.1016/   j.ncl.2004.05.004   [9] Giladi, N. Medical treatment of freezing of gait.",OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
"PMID: 18668620.http://dx.doi.org/   10.1002/mds.21914   [10] Moreau, C.; Delval, A.; Defebvre, L.; Dujardin, K.; Duhamel, A.;  Petyt, G.; Vui llaume, I.; Corvol, J.C.; Brefel -Courbon, C.; Ory - Magne, F.; Guehl, D.; Eusebio, A.; Fraix, V.; Saulnier, P.J.",OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
PMID: 22658702.   http://dx.doi.org/10.1016/S1474 -4422(12)70106 -0 Table 1.,OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
"PMID: 21464430.http://dx.doi.org/10.1212/   WNL.0b013e3182143537   [12] Kim, Y.E.",OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
"PMID: 21463965.  http://dx.doi.org/10.1016/j.parkreldis.2011.03.010   [13] Fietezk, U.M.",OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
PMID: 16222436.http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
PMID: 12823491.http://dx.doi.,OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
"PMID: 24691217.http://dx.doi.org/10.1177/0269215514527299   [17] Chang, F.C.",OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
PMID: 25578290.http://dx.doi.,OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
"PMID: 18067186.http://dx.doi.org/10.1002/   mds.21868   [19] Zúñiga, C.; Lester, J.; Cersósimo, M.G.",OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
"PMID:  16518130.http://dx.doi.org/10.1097/00002826 -200601000 -00007   [20] Shoulson, I.; Oakes, D.; Fahn, S.; Lang, A.; Langston, J.W.",OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
"Neurol ., 2002 , 51,  604-612.PMID: 12112107.http://dx.doi.org/10.1002/ana.10191   [21] Levin, O.S.",Non-OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
PMID: 5818715. http://dx.doi.org/10.1001/jama.,OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
"PMID: 24057149.http://dx.doi.org/10.1007/   s00415 -013-7108 -7  [24] Chan, H.F.; Kukkle, P.L.",OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
"PMID: 23218842.http://dx.doi.org/10.1016/j.parkreldis.2012.11.005   [25] Malkani, R.; Zadikoff, C.; Melen, O.; Videnovic, A.; Borushko, E.;  Simuni, T. Amantadine for freezing of gait in patients with  Parkinson diseas e. Clin.",OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
"PMID: 23123688.http://dx.doi.org/10.1097/WNF.0b013e31826e3406   [26] Kim, Y.E.",OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
PMID: 23185280.http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
PMID: 6287350.http://dx.doi.,OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
"Neurol ., 2004 , 55(6), 766 - 773.PMID: 15174010.  http://dx.doi.org/10.1002/ana.20089   [34] Volkow, N.D.; Wang, G.J.",OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
", 1998 , 155(10), 1325 - 1331.PMID: 9766762. http://dx.doi.org/10.1176/ajp.155.10.1325   [35] Camicioli, R.; Lea, E.; Nutt, J.G.",Non-OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
"PMID: 11479391. http://dx.doi.org/10.1097/   00002826 -200107000 -00003   [36] Auriel, E.; Hausdorff, J. M.; Herman, T.; Simon, E.S.",OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
",  2006 , 29(1), 15 -17.PMID: 16518128. http://dx.doi.org/10.1097/   00002826 -200601000 -00005  [37] Pollak, L.; Dobronevsky, Y.; Prohorov, T.; Bahunker, S.; Rabey,  J.M.",Non-OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
",  2007 , 72, 145 -148.PMID: 17982887. http://dx.doi.org/10.1007/ 978- 3-211-73574 -9_17   [38] Devos, D.1; Krystkowiak, P.; Clement, F.; Dujardin, K.; Cottencin,  O.; Waucquier, N.; Ajebbar, K.; Thielemans, B.; Kroumova, M.;  Duhamel, A.; Destée, A.; Bordet, R.; Defebvre, L. Improvement of  gait by chronic, high doses of methy lphenidate in patients with  advanced Parkinson’s disease.",Non-OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
"PMID: 17353373. http://dx.doi.org/   10.1001/archneur.64.3.319   [40] Devos, D.; Moreau, C.; Delval, A.; Dujardin, K.; Defebvre, L.;  Bordet, R. Methylphenidate: a treatment for Parkinson's disease?",Non-OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
"PMID: 23160937. http://dx.doi.org/   10.1007/s40263 -012-0017 -y  [41] Delval, A.; Moreau, C.; Bleuse, S.; Guehl , D.; Bestaven, E.;  Guillaud, E.; Dujardin, K.; Defebvre, L.; Devos, D. Gait and",OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
"Neurother ., 2007 , 7(6), 637 - 647.PMID: 17563247.http://dx.doi.org/10.1586/14737175.7.6.637   [43] Giladi, N.; Honigman, S. Botulinum toxin injections to one leg  alleviate freezing of gait in a patient with Parkinson’s disease.",Non-OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
"PMID: 9399243.http://dx.doi.org/   10.1002/mds.870120641   [44] Giladi, N.; Gurevich, T.; Shabtai, H.; Paleacu, D.; Simon, E.S.",OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
"PMID: 11517998.http://dx.doi.org/10.1007/   s004150170134   [45] Gurevich, T.; Peretz, C.; Moore, O.; Weizmann, N.; Giladi, N.  T he   effect of  injecting  botulinum  toxin  type  a into  the c alf muscles  on   freezing of gait in Pa rkinson's disease: a double blind placebo - controlled pilot study.",Non-OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
"PMID:  17290455.http://dx.doi.org/10.1002/mds.21396   [46] Wieler, M.; Camicioli, R.; Jones, C.A.",OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
"PMID: 16116132.  http://dx.doi.org/10.1212/01.wnl.0000172930.63669.c8   [47] Xie, T.; Vigil, J.; MacCracken, E.; Gasparaitis, A.; Young, J.;  Kang, W.; Bernard, J.; Warnke, P.; Kang, U.J.",OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
"PMID:  25540305.http://dx.doi.org/10.1212/WNL.0000000000001184   [48] Ricchi, V.;  Zibetti, M.;  Angrisano, S.;  Merola, A.;  Arduino, N.;  Artusi, C.A.",OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
"PMID: 21824834.http://dx.doi.org/10.1016/j.brs.2011.07.001   [49] Lee, S.Y.",OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
"Disord ., 2014 , 29(8), 1064 - 1069.PMID: 24789677.http://dx.doi.org/10.1002/mds.25897   [51] Fietzek, U.M.",OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
", 2014 , 28(9), 902 - 911.PMID: 24691217. http://dx.doi.org/10.1177/0269215514527299   [52] Delval, A.; Moreau, C.; Bleuse, S.; Tar d, C.; Ryckewaert, G.;  Devos, D. Defebvre L.Auditory cueing of gait initiation in  Parkinson’s disease patients with freezing of gait.",Non-OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
PMID: 24508190. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
"PMID: 22157432.http://dx.doi.org/10.1097/PHM.0b013e31823c7507   [54] Raffo -De-Ferrari, A.; Lagravinese, G.; Pelosin, E.; Pardini, M.;  Serrati, C.; Abbruzzese, G.; Avanzino, L. Freezing of gait and  affective theory of mind in Parkinson disease.",Non-OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
", 2015 , 30(8), 1090 -7. doi: 10.1002/   mds.26133.P MID: 25641204. http://dx.doi.org/10.1002/mds.26133   [56] Factor, S.A.; Scullin, M.K.",Non-OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
PMID: 25446341. http://dx.doi.org/10.1016/j.parkreldis.,OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
"PMID:  25603767.http://dx.doi.org/10.1016/j.parkreldis.2014.12.020   [58] Teramoto, H.; Morita, A.; Ninomiya, S.; Shiota, H.; Kamei, S.  Relation between freezing of gait and frontal funct ion in  Parkinson's disease.",OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
PMID: 25042341.http://dx.doi.org/10.1016/j.parkreldis.,OADS,/arxiv_data1/oa_pdf/93/00/CN-14-302.PMC4876585.pdf
"Gerontologist, 2015, 55(2), 237-244. http://dx.doi.org/10.1093/ geront/gnu122 [2] Alzheimer, A. Uber eine eigenartige Erkrankung der Hirnrinde.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Alzheimers Dement., 2011, 7(5), 532-539.http://dx.doi.org/10.1016/j.jalz.2011.",OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Psychogeriatrics, 2014, 14(4), 229-234.http://dx.doi.org/10.1111/psyg.12063 [5] Cipriani, G.; Lucetti, C.; Danti, S.; Nuti, A. Apathy and dementia.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Dis., 2014, 202(10), 718-724.http://dx.doi.org/10.1097/NMD.0000000000000190 [6] Fujii, M.; Butler, J.P.; Sasaki, H. Emotional function in dementia patients.",OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Psychogeriatrics, 2014, 14(3), 202-209.http://dx.doi.org/ 10.1111/psyg.12059 [7] Bidzan, M.; Bidzan, L. Neurobehavioral manifestation in early period of Alzheimer disease and vascular dementia.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Age Ageing, 2014, 43(4), 562-567.http://dx.doi.org/10.1093/ageing/afu062",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"P s y c h ., 2014, 29(6), 562-568.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"/ IPA, 2013, 25(12), 1963-1984.http://dx.doi.org/10.1017/s104161021300152x [12] Rosenmann, H.; Meiner, Z. Frontotemporal dementia: clinical features, genetics, pathogenesis and treatment.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Ther., 2014, 6(4), 46.http://dx.doi.org/ 10.1186/alzrt274 [14] Zweig, Y.R.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Ther., 2014, 6(2), 21.http://dx.doi.org/10.1186/alzrt251 [15] Zuidema, S.; Koopmans, R.; Verhey, F. Prevalence and predictors of neuropsychiatric symptoms in cognitively impaired nursing home patients.",OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Psychiatry Neurol., 2007, 20(1), 4 1-49.http://dx.doi.org/10.1177/0891988706292762 [16] Steinberg, M.; Shao, H.; Zandi, P.; Lyketsos, C.G.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Psych., 2008, 23(2), 170-177.http://dx.doi.org/10.1002/gps.1858 [17] Kales, H.C.; Chen P.; Blow, F.C.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Psychiatry, 2005, 13(6), 441-449.http://dx.doi.org/ 10.1097/00019442-200506000-00002 [18] Yaffe, K.; Fox, P.; Newcomer, R.; Sands, L.; Lindquist, K.; Dane, K.; Covinsky, K.E.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Assoc., 2002, 287(16), 2090-2097.http://dx.doi.org/10.1001/jama.",OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Med., 2003, 33(3), 257-271.http://dx.doi.org/10.2190/ABXK-FMWG-98YP-D1CU [20] Ostojic, D.; Vidovic, D.; Bacekovic, A.; Brecic, P.; Jukic, V. Prevalence of anxiety and depression in caregivers of Alzeheimer's dementia patients.",OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Int., 2014, 14 Suppl 2, 45-55.http://dx.doi.org/10.1111/ggi.12260 [22] Gendreau, J.",OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Soins Psychiatrie, 2014, (290), 26-30.http://dx.doi.org/10.1016/j.spsy.2013.10.006 [23] Barba, B.; Stump, M.; Fitzsimmons, S. The role of therapeutic use of self in the application of nonpharmacological interventions.",OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Nurs., 2014, 40(8), 9-12.http://dx.doi.org/10.3928/ 00989134-20140609-02 [24] Sink, K.M.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Assoc., 2005, 293(5), 596-608.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Nurs., 2014, 19(2), 72-77. http://dx.doi.org/10.12968/bjcn.2014.19.2.72 [27] Livingston, G.; Kelly, L.; Lewis-Holmes, E.; Baio, G.; Morris, S.; Patel, N.; Omar, R.Z.",OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Assess., 2014, 18(39), 1-226, v-vi.http://dx.doi.org/10.3310/hta18610 [28] Delphin-Combe, F.; Martin-Gaujard, G.; Roubaud, C.; Fortin, M.E.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Rev., 2002, (2): Cd002852.http://dx.doi.org/10.1002/14651858.cd002852 [30] Schneider, L.S.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Soc., 1990, 38(5), 553-563.http://dx.doi.org/10.1111/ j.1532-5415.1990.tb02407.x [31] Pollock, B.G.",OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Psychiat., 2002, 159(3), 460-465.http://dx.doi.org/10.1176/appi.ajp.159.3.460 [32] Stotsky, B. Multicenter study comparing thioridazine with diazepam and placebo in elderly, nonpsychotic patients with emotional and behavioral disorders.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Psychiatry, 2006, 14(3), 191-210.http://dx.doi.org/10.1097/01.JGP.0000200589.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Neurosci., 2006, 7(6), 492-500.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Psychiatry, 2015, 86(1), 101-109.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Psychiatry, 2006, 14(9), 767-776.http://dx.doi.org/10.1097/01.JGP.0000196628.12010.35 [38] Zhong, K.X.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Alzheimer Res., 2007, 4(1), 81-93.http://dx.doi.org/10.2174/156720507779939805 [39] De Deyn, P.P.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Pharmacother., 2013, 14(4), 459-474.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Psychiatry, 2001, 9(3), 283-288.http://dx.doi.org/ 10.1097/00019442-200108000-00013 [41] Madhusoodanan, S.; Shah, P.; Brenner, R.; Gupta, S. Pharmacological treatment of the psychosis of Alzheimer's disease: what is the best approach?",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"CNS Drugs, 2007, 21(2), 101-115.http://dx.doi.org/10.2165/00023210-200721020-00002 [42] De Deyn, P.; Jeste, D.V.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Psychopharm., 2005, 25(5), 463-467.http://dx.doi.org/10.1097/01.jcp.0000178415.22309.8f [43] Douglas, I.J.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"2007, 146(11), 775-786.http://dx.doi.org/10.7326/0003-4819-146-11-200706050-00006 [45] Kales, H.C.; Kim, H.M.; Zivin, K.; Valenstein, M.; Seyfried, L.S.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"J. Psychiatry, 2012, 169(1), 71-79.http://dx.doi.org/ 10.1176/appi.ajp.2011.11030347 [46] Bains, J.; Birks, J.; Dening, T. Antidepressants for treating depression in dementia.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Rev., 2002, (4): Cd003944.http://dx.doi.org/10.1002/14651858.cd003944 [47] Seitz, D.P.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"The Cochrane Library, 2011.http://dx.doi.org/10.1002/14651858.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Drug Aging, 2012, 29(10), 793-806.http://dx.doi.org/10.1007/s40266-012-0012-5 [49] Lyketsos, C.G.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Psychiat., 2003, 60(7), 737-746.http://dx.doi.org/10.1001/archpsyc.60.7.737 [50] Magai, C.; Kennedy, G.; Cohen, C.I.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Psychiatry, 2000, 8(1), 66-74.http://dx.doi.org/10.1097/00019442-200002000-00009 [51] Petracca, G.M.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Lancet, 2011, 378(9789), 403-411. http://dx.doi.org/10.1016/ S0140-6736(11)60830-1 [54] Bui, Q. Antidepressants for agitation and psychosis in patients with dementia.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Assoc., 2014, 311(7), 682-691.http://dx.doi.org/10.1001/ jama.2014.93 [56] Pollock, B.G.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Psychiatry, 2007, 15(11), 942-952.http://dx.doi.org/10.1097/ JGP.0b013e3180cc1ff5 [57] Cakir, S.; Kulaksizoglu, I.B.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Treat., 2008, 4(5), 963.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Other Demen., 2014.http://dx.doi.org/10.1177/1533317514524813 [59] Peisah, C.; Chan, D.K.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"J., 2011, 41(9), 651-657.http://dx.doi.org/10.1111/j.1445-5994.2011.02560.x [60] Porsteinsson, A.P.",OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Psychiatry, 2003, 11(4), 434-440.http://dx.doi.org/ 10.1097/00019442-200307000-00006 [62] Tariot, P.N.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Psychiatry, 2005, 13(11), 942-949.http://dx.doi.org/10.1176/appi.ajgp.13.11.942 [63] Lonergan, E.; Luxenberg, J. Valproate preparations for agitation in dementia.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Rev., 2009, (3): Cd003945.http://dx.doi.org/10.1002/14651858.cd003945.pub3 [64] Pinheiro, D. Anticonvulsant mood stabilizers in the treatment of behavioral and psychological symptoms of dementia (BPSD).",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"L'Encephale, 2008, 34(4), 409-415.http://dx.doi.org/10.1016/ j.encep.2007.10.006 [65] Sival, R.C.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Alzheimer Res., 2005, 2(5), 553-558.http://dx.doi.org/10.2174/156720505774932205 [67] Tariot, P.N.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Soc., 1994, 42(11), 1160-1166.http://dx.doi.",OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"2014, 12(6): 475-489.http://dx.doi.org/10.2174/ 1570159X13666141204220539 [69] Olin, J.T.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Psychiatry, 2001, 9(4), 400-405.http://dx.doi.org/10.1097/ 00019442-200111000-00008 [70] Trinh, N.H.; Hoblyn, J.; Mohanty, S.; Yaffe, K. Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Assoc., 2003, 289(2), 210-216.http://dx.doi.",OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Lancet, 2004, 363(9427), 2105-2115.http://dx.doi.org/10.1016/S0140-6736(04)16499-4 [73] Rolinski, M.; Fox, C.; Maidment, I.; McShane, R. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.",OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Rev., 2012, 3: Cd006504.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"PloS one, 2012, 7(5): e35185.http://dx.doi.org/10.1371/journal.pone.0035185 [75] McShane, R.; Areosa Sastre, A.; Minakaran, N. Memantine for dementia.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"http://dx.doi.org/10.1002/14651858.cd003154.pub5 [76] Chen XN, Meng QY, Bao AM, Swaab DF, Wang GH, Zhou JN.",OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Biol Psychiatry, 2009, 66(9), 832-839. http://dx.doi.org/10.1016/ j.biopsych.2009.05.031 [77] Hogan, D.B.",Non-OADS,/arxiv_data1/oa_pdf/90/ea/CN-14-307.PMC4876586.pdf
"Neurology, 1986, 36(4), 511-517. http://dx.doi.org/10.1212/WNL.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Neurol., 2001, 58(3), 512-515. http://dx.doi.org/10.1001/archneur.58.3.512	  [4] Gordon, P.H.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Neurology, 2006, 66(5), 647-653. http://dx.doi.org/10.1212/01.wnl.0000200962.94777.71	  [5] Rowland, L.P.; Shneider, N.A.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Med., 2001, 344(22), 1688-1700. http://dx.doi.org/10.1056/ NEJM200105313442207	  [6] Neymotin, A.; Petri, S.; Calingasan, N.Y.; Wille, E.; Schafer, P.; Stewart, C.; Hensley, K.; Beal, M.F.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Neurol., 2009, 220(1), 191-197. http://dx.doi.org/10.1016/j.expneurol.2009.08.028	  [7] Pandya, R.S.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Life Sci., 2013, 70(24), 4729-4745. http://dx.doi.org/10.1007/s00018-013-1415-0	  [8] Gordon, P.H.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Aging Dis., 2013, 4(5), 295-310. http://dx.doi.org/10.14336/ AD.2013.0400295	  [9] Rosen, D.R.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Nature, 1993, 364(6435), 362. http://dx.doi.org/10.1038/364362c0	  [10] Pratt, A.J.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Dis., 2012, 2012(2), 1-14. http://dx.doi.org/10.1038/364362c0	  [11] Boillee, S.; Yamanaka, K.; Lobsiger, C.S.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Science, 2006, 312(5778), 1389-1392. http://dx.doi.org/ 10.1126/science.1123511	  [12] Lacomblez, L.; Bensimon, G.; Leigh, P.N.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Lancet, 1996, 347(9013), 1425-1431. http://dx.doi.org/10.1016/S0140-6736(96)91680-3	  [13] Logroscino, G.; Traynor, B.J.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Psychiatry, 2008, 79(1), 6-11. http://dx.doi.org/10.1136/jnnp.2006.104828	  [14] Dunkel, P.; Chai, C.L.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Drugs, 2012, 21(9), 1267-1308. http://dx.doi.org/10.1517/13543784.2012.703178	  [15] Bensimon, G.; Lacomblez, L.; Meininger, V. A controlled  trial of riluzole in amyotrophic lateral sclerosis.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Med., 1994, 330(9), 585-591. http://dx.doi.org/ 10.1056/NEJM199403033300901	  [16] Deng, Y.; Xu, Z.; Xu, B.; Tian, Y.; Xin, X.; Deng, X.; Gao, J.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Brain Res., 2009, 1289, 106-117. http://dx.doi.org/10.1016/j.brainres.2009.07.012	  [17] Deflorio, C.; Onesti, E.; Lauro, C.; Tartaglia, G.; Giovannelli, A.; Limatola, C.; Inghilleri, M.; Grassi, F. Partial block by riluzole of muscle sodium channels in myotubes from amyotrophic lateral sclerosis patients.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Science, 1994, 264(5166), 1772-1775. http://dx.doi.org/10.1126/science.8209258	  [20] Gurney, M.E.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"http://dx.doi.org/10.1016/S0022-510X(97) 00247-5	  [21] Foust, K.D.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Mol Ther, 2013, 21(12), 2148-2159. http://dx.doi.org/10.1038/mt.2013.211	  [22] Thomsen, G.M.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Neurosci., 2014, 34(47), 15587-15600. http://dx.doi.org/ 10.1523/JNEUROSCI.2037-14.2014	  [23] Novoselov, S.S.; Mustill, W.J.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"http://dx.doi.org/10.1371/journal.pone.0073944	  [24] Rabinovich-Toidman, P.; Rabinovich-Nikitin, I.; Ezra, A.; Barbiro, B.; Fogel, H.; Slutsky, I.; Solomon, B. Mutant SOD1 Increases APP Expression and Phosphorylation in Cellular and Animal Models of ALS.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Lett., 2014, 24(6), 1532-1537. http://dx.doi.org/10.1016/j.bmcl.2014.01.078	  [26] McAllum, E.J.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Degener., 2013, 14(7-8), 586-590. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Dis., 2015, 81, 20-24. http://dx.doi.org/10.1016/j.nbd.2015.02.023	  [28] Miller, T.M.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Lancet Neurol., 2013, 12(5), 435-442. http://dx.doi.org/10.1016/S1474-4422(13)70061-9	  [29] Chen, T.; Benmohamed, R.; Kim, J.; Smith, K.; Amante, D.; Morimoto, R.I.; Kirsch, D.R.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Chem., 2012, 55(1), 515-527. http://dx.doi.org/10.1021/jm2014277	  [30] Zhang, Y.; Zhao, K.T.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Exp Neurol, 2008, 213(2), 448-455. http://dx.doi.org/10.1016/j.expneurol.2008.07.017	  [32] Nagase, M.; Yamamoto, Y.; Miyazaki, Y.; Yoshino, H. Increased oxidative stress in patients with amyotrophic lateral sclerosis and the effect of edaravone administration.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Redox Rep., 2015. http://dx.doi.org/10.1179/1351000215Y.0000000026	  [33] Lange, D.J.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Degener., 2013, 14(3), 199-204. http://dx.doi.org/10.3109/17482968.2012.724074	  [34] Wright, P.D.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Lett., 2010, 482(3), 188-192. http://dx.doi.org/10.1016/j.neulet.2010.07.020	  [35] Limpert, A.S.; Mattmann, M.E.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Chem., 2013, 9, 717-732. http://dx.doi.org/10.3762/bjoc.9.82	  [36] Fornai, F.; Longone, P.; Cafaro, L.; Kastsiuchenka, O.; Ferrucci, M.; Manca, M.L.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Lancet Neurol, 2010, 9(5), 481-488. http://dx.doi.org/10.1016/S1474-4422(10) 70068-5	  [39] Wang, L.; Popko, B.; Tixier, E.; Roos, R.P.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Dis., 2014, 71, 317-324. http://dx.doi.org/10.1016/j.nbd.2014.08.010	  [40] Vieira, F.G.; Ping, Q.; Moreno, A.J.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"http://dx.doi.org/10.1371/ journal.pone.0135570	  [41] McDonnell, M.E.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Chem., 2012, 20(18), 5642-5648. http://dx.doi.org/10.1016/ j.bmc.2012.07.004	  [42] Grosskreutz, J.; Zoerner, A.; Schlesinger, F.; Krampfl, K.; Dengler, R.; Bufler, J.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Neurosci., 2003, 17(6), 1173-1178. http://dx.doi.org/10.1046/j.1460-9568.2003.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Amyotroph Lateral Scler, 2011, 12(5), 340-344. http://dx.doi.org/ 10.3109/17482968.2011.584627	  [44] Pascuzzi, R.M.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Amyotroph Lateral Scler., 2010, 11(3), 266-271. http://dx.doi.org/ 10.3109/17482960903307805	  [45] Rothstein, J.D.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Nature, 2005, 433(7021), 73-77. http://dx.doi.org/10.1038/nature03180	  [46] Zhao, Y.; Cudkowicz, M.E.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Pharmacol., 2014, 54(10), 1180-1187. http://dx.doi.org/10.1002/ jcph.317	  [47] Gerber, Y.N.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Front Cell Neurosci, 2013, 7, 280. http://dx.doi.org/10.3389/fncel.2013.00280	  [48] Leng, Y.; Chuang, D.M.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Neurosci., 2006, 26(28), 7502-7512. http://dx.doi.org/10.1523/ JNEUROSCI.0096-06.2006	  [49] Ragancokova, D.; Song, Y.; Nau, H.; Dengler, R.; Krampfl, K.; Petri, S. Modulation of synaptic transmission and analysis of neuroprotective effects of valproic Acid and derivates in rat embryonic motoneurons.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Cell Mol Neurobiol, 2010, 30(6), 891-900. http://dx.doi.org/10.1007/s10571-010-9518-8	  [50] Lv, L.; Han, X.; Sun, Y .",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Neurol., 2012, 233(2), 783-790. http://dx.doi.org/ 10.1016/j.expneurol.2011.11.042	  [51] Feng, H.L.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Neuroscience, 2008, 155(3), 567-572. http://dx.doi.org/10.1016/j.neuroscience.2008.06.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Sci., 2014, 340(1-2), 103-108. http://dx.doi.org/10.1016/j.jns.2014.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Res., 2006, 83(7), 1179-1189. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Ther., 2012, 18(7), 547-557. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"http://dx.doi.org/10.1371/ journal.pone.0030243	  [56] Karam, C.; Barrett, M.J.; Imperato, T.; MacGowan, D.J.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Neurosci., 2013, 20(11), 1550-1553. http://dx.doi.org/10.1016/j.jocn.2013.01.011	  [57] Pattee, G.L.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Other Motor Neuron Disord., 2003, 4(2), 90-95. http://dx.doi.org/10.1080/ 14660820310012736	  [58] Liu, J.; Lillo, C.; Jonsson, P.A.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Neuron, 2004, 43(1), 5-17. http://dx.doi.org/10.1016/j.neuron.2004.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"http://dx.doi.org/10.1371/journal.pone.0103438	  [60] Carri, M.T.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"FEBS Lett., 1997, 414(2), 365-368. http://dx.doi.org/10.1016/S0014-5793(97)01051-X	  [61] Martin, L.J.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"IDrugs, 2010, 13(8), 568-580. http://dx.doi.org/10.1124/jpet.107.123000	  [62] Bordet, T.; Buisson, B.; Michaud, M.; Drouot, C.; Galea, P.; Delaage, P.; Akentieva, N.P.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Ther., 2007, 322(2), 709-720. http://dx.doi.org/ 10.1124/jpet.107.123000	  [63] Sunyach, C.; Michaud, M.; Arnoux, T.; Bernard-Marissal, N.; Aebischer, J.; Latyszenok, V.; Gouarne, C.; Raoul, C.; Pruss, R.M.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Neuropharmacology, 2012, 62(7), 2346-2352. http://dx.doi.org/10.1016/j.neuropharm.2012.02.013	  [64] Lenglet, T.; Lacomblez, L.; Abitbol, J.L.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Neurol., 2014, 21(3), 529-536. http://dx.doi.org/10.1111/ene.12344	  [65] Martin, L.J.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Cell Neurosci., 2014, 8, 433. http://dx.doi.org/10.3389/fncel.2014.00433",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Autophagy, 2014, 10(4), 588-602. http://dx.doi.org/10.4161/auto.27710	  [67] Katsumata, R.; Ishigaki, S.; Katsuno, M.; Kawai, K.; Sone, J.; Huang, Z.; Adachi, H.; Tanaka, F.; Urano, F.; Sobue, G. c-Abl inhibition delays motor neuron degeneration in the G93A mouse, an animal model of amyotrophic lateral sclerosis.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Lett., 2007, 416(3), 257-260. http://dx.doi.org/10.1016/j.neulet.2007.02.002	  [70] Grunfeld, J.F.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Neurol., 2007, 204(1), 260-263. http://dx.doi.org/10.1016/j.expneurol.2006.11.002	  [71] Kim, H.Y.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Neurol., 2014, 10(4), 342-347. http://dx.doi.org/10.3988/jcn.2014.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Psychiatry, 2015, 86(8), 879-886. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Chem., 2011, 18(36), 5655-5665. http://dx.doi.org/10.2174/ 092986711798347289	  [74] Iwasaki, Y.; Ikeda, K.; Shiojima, T.; Tagaya, N.; Kobayashi, T.; Kinoshita, M. Bromocriptine prevents neuron damage following inhibition of superoxide dismutase in cultured ventral spinal cord neurons.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Neurol., 2011, 232(1), 41-52. http://dx.doi.org/10.1016/j.expneurol.2011.08.001	  [76] Yacila, G.; Sari, Y.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Chem., 2014, 21(31), 3583-3593. http://dx.doi.org/10.2174/0929867321666140 601162710	  [77] Zhang, Y.; Li, H.; Yang, C.; Fan, D.F.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Res., 2015. http://dx.doi.org/10.1007/s11064-015-1750-7	  [78] Mancuso, R.; del Valle, J.; Modol, L.; Martinez, A.; Granado-Serrano, A.B.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"http://dx.doi.org/10.1371/journal.pone.0087728	  [81] Rodrigues, M.C.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Stroke Res., 2012, 3(3), 331-340. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Nat Biotechnol., 2011, 29(9), 824-828. http://dx.doi.org/10.1038/nbt.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"J. Neuroimmune Pharmacol., 2009, 4(4), 389-398. http://dx.doi.org/10.1007/s11481-009-9171-5	  [84] Chiu, I.M.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Dis., 2015, 80, 93-103. http://dx.doi.org/10.1016/j.nbd.2015.05.002	  [86] Noh, M.Y.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Lett., 2014, 574, 53-58. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"http://dx.doi.org/10.1212/NXI.0000000000000100 	  [88] Stommel, E.W.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Lateral Scler., 2009, 10(5-6), 393-404. http://dx.doi.org/10.3109/ 17482960802709416	  [89] Kiaei, M.; Petri, S.; Kipiani, K.; Gardian, G.; Choi, D.K.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Neurosci., 2006, 26(9), 2467-2473. http://dx.doi.org/10.1523/ JNEUROSCI.5253-05.2006	  [90] Hu, J.H.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Neurochem., 2003, 85(2), 432-442. http://dx.doi.org/10.1046/j.1471-4159.2003.01670.x	  [91] Koh, S.H.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Neurol., 2007, 205(2), 336-346. http://dx.doi.org/ 10.1016/j.expneurol.2007.03.004	  [92] Ahn, S.W.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Sci., 2014, 340(1-2), 112-116. http://dx.doi.org/10.1016/j.jns.2014.03.008	  [93] Lee, S.H.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Neurobiol., 2014, 23(1), 86-92. http://dx.doi.org/ 10.5607/en.2014.23.1.86	  [94] Evans, M.C.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Commun., 2014, 2, 66. http://dx.doi.org/10.1186/2051-5960-2-66	  [95] Tada, S.; Okuno, T.; Hitoshi, Y.; Yasui, T.; Honorat, J.A.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Neuroinflam., 2014, 11, 179. http://dx.doi.org/ 10.1186/s12974-014-0179-2",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Med., 2011, 208(12), 2429-2447. http://dx.doi.org/10.1084/ jem.20111313	  [97] Patel, P.; Julien, J.P.; Kriz, J. Early-stage treatment with Withaferin A reduces levels of misfolded superoxide dismutase 1 and extends lifespan in a mouse model of amyotrophic lateral sclerosis.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Neuro- therapeutics, 2015, 12(1), 217-233. http://dx.doi.org/10.1007/ s13311-014-0311-0	  [98] Wang, L.J.",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Apoptosis, 2002, 7(4), 329-334. http://dx.doi.org/10.1023/A:1016123413038	  [100] Battaglia, G.; Riozzi, B.; Bucci, D.; Di Menna, L.; M o l i n a r o ,  G .",Non-OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Dis., 2015, 74, 126-136. http://dx.doi.org/10.1016/j.nbd.2014.11.012	  [101] Korkmaz, O.T.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Lett., 2014, 566, 286-291. http://dx.doi.org/10.1016/j.neulet.2014.02.058	  [102] Tanaka, H.; Shimazawa, M.; Kimura, M.; Takata, M.; Tsuruma, K.; Yamada, M.; Takahashi, H.; Hozumi, I.; Niwa, J.; Iguchi, Y.; Nikawa, T.; Sobue, G.; Inuzuka, T.; Hara, H. The potential  of GPNMB as novel neuroprotective factor in amyotrophic  lateral sclerosis.",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Rep., 2012, 2, 573. http://dx.doi.org/10.1038/ srep00573	  [103] Nagahara, Y.; Shimazawa, M.; Tanaka, H .",OADS,/arxiv_data1/oa_pdf/54/53/CN-14-314.PMC4876587.pdf
"Scand ., 1996 , 94(6), 421 -422.http://dx.doi.org/10.1111/j.",OADS,/arxiv_data1/oa_pdf/2f/d3/CN-14-322.PMC4876588.pdf
"Gut, 2007 , 56(1), 115-120.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/2f/d3/CN-14-322.PMC4876588.pdf
"Lancet , 2007 , 369, 397 -408.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/2f/d3/CN-14-322.PMC4876588.pdf
"Med., 2005 ,  98(1), 557-563. http://dx.doi.org/10.1093/qjmed/hci095   [9] Zhai, Y.F.",OADS,/arxiv_data1/oa_pdf/2f/d3/CN-14-322.PMC4876588.pdf
"Lancet , 1982 , 319(8273) ,  643-647.http://dx.doi.org/10.1016/S0140 -6736(82)92201 -2  [11] Brewer , G.J.",Non-OADS,/arxiv_data1/oa_pdf/2f/d3/CN-14-322.PMC4876588.pdf
"Neurol ., 1987 , 44(5), 490-492.  http://dx.doi.org/10.1001/archneur.1987.00520170020016   [12] Brewer , G.J.",Non-OADS,/arxiv_data1/oa_pdf/2f/d3/CN-14-322.PMC4876588.pdf
"Neurol ., 2006 , 63(4), 521-527.http://dx.doi.org/10.1001/archneur.",Non-OADS,/arxiv_data1/oa_pdf/2f/d3/CN-14-322.PMC4876588.pdf
"Lancet  Neurol ., 2015 , 14(1), 103- 113.http://dx.doi.org/10.10 16/S1474 -4422(14)70190 -5  [14] Wang, X.P.",Non-OADS,/arxiv_data1/oa_pdf/2f/d3/CN-14-322.PMC4876588.pdf
"Medicine , 2007 , 86(2), 112-121.http://dx.doi.org/10.1097/MD.",Non-OADS,/arxiv_data1/oa_pdf/2f/d3/CN-14-322.PMC4876588.pdf
"Brain  Dev., 2006 , 28(3),  141-146.http://dx.doi.org/10.1016/j.braindev.2005.08.008   [17] Brewer , G.J.",OADS,/arxiv_data1/oa_pdf/2f/d3/CN-14-322.PMC4876588.pdf
"Med., 2005 , 145(3), 139-143.http://dx.doi.org/10.1016/   j.lab.2005.01.007   [20] Sinha , S.; Taly, A.B.",OADS,/arxiv_data1/oa_pdf/2f/d3/CN-14-322.PMC4876588.pdf
"Sci., 2008 , 264(1-2), 129- 132.http://dx.doi.org/10.1016/j.jns.2007.08.006   [21] Medici , V.; Sturniolo , G.C.",OADS,/arxiv_data1/oa_pdf/2f/d3/CN-14-322.PMC4876588.pdf
"CNS Drugs , 2005 ,  19, 185-192. http://dx.doi.org/10.2165/00023210 -200519030 -00001   [24] Brewer , G.J.",Non-OADS,/arxiv_data1/oa_pdf/2f/d3/CN-14-322.PMC4876588.pdf
"Sci., 2005 ,  228(2), 121-123.http://dx.doi.org/10.1016/j.jns.2004.10.017   [27] Nagasaka , H.; Inoue , I.; Inui, A.; Komatsu, H.;  Sogo, T.;   Murayama, K.;  Murakami, T.;  Yorifuji, T.;  Asayama, K.;   Katayama, S.;  Uemoto, S.;  Kobayashi, K.;  Takayanagi, M.;  Fujisawa, T.;  Tsukahara, H. Relationship  between  oxidative  stress   and antioxidant  systems  in the liver of patients  with Wilson   disease : hepatic  manifestation  in Wilson  disease  as a consequence   of augmented  oxidati ve stress.",OADS,/arxiv_data1/oa_pdf/2f/d3/CN-14-322.PMC4876588.pdf
"Res., 2006 , 60(4), 472- 477.http://dx.doi.org/10.1203/01.pdr.0000238341.12229.d3   [28] Brewer, G.J.",Non-OADS,/arxiv_data1/oa_pdf/2f/d3/CN-14-322.PMC4876588.pdf
"Neur opsychopharmac ., 2008 , 3(1), 153 -165.  http://dx.doi.org/10.1017/CBO9780511666971.",Non-OADS,/arxiv_data1/oa_pdf/2f/d3/CN-14-322.PMC4876588.pdf
"Lancet , 2007 , 369(9559), 397 -408.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/2f/d3/CN-14-322.PMC4876588.pdf
"Med .,  2013 , 19(3), 233 -240. http://dx.doi.org/10.1007/s11655 -012-1089 -8  [32] Weiss, K.H.",Non-OADS,/arxiv_data1/oa_pdf/2f/d3/CN-14-322.PMC4876588.pdf
",  2003 , 96, 566 -567.http://dx.doi.org/10.1093/qjmed/hcg093   [35] Xiao, J.J.; Yin, M.; Wang, Z.J.",Non-OADS,/arxiv_data1/oa_pdf/2f/d3/CN-14-322.PMC4876588.pdf
"Neuropharmacol ., 2014 , 12(4), 324 -433.  http://dx.doi.org/10.2174/1570159X12666140903094700       Received: May 15, 2015  Revised: July 16, 2015  Accepted: October 09, 2015",Non-OADS,/arxiv_data1/oa_pdf/2f/d3/CN-14-322.PMC4876588.pdf
"JAMA, 1995, 273, 1274-1278. http://dx.doi.org/10.1001/jama.1995.03520400044042 [2] Ward, A.; Tardiff, S.; Dye, C.; Arrighi, H. M. Rate of conversion from prodromal Alzheimer’s disease to Alzheimer’s dementia: a systematic review of the literature.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Extra, 2013, 3, 320-332.http://dx.doi.org/10.1159/000354370 [3] Aarsland, D.; Bronnick, K.; Williams-Gray, C.; Weintraub, D.; Marder, K.; Kulisevsky, J.; Burn, D.; Barone, P.; Pagonabarraga, J.; Allcock, L.; Santangelo, G.; Foltynie, T.; Janvin, C.; Larsen, J.P.; Barker, R.A.; Emre, M. M i l d  c o g n i t i v e  i m p a i r m e n t  i n  Parkinson disease: a multicenter pooled analysis.",OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Neurology, 2010, 75, 1062-1069.http://dx.doi.org/10.1212/WNL.0b013e3181f39d0e [4] Hely, M.A.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Disord., 2008, 23, 837-844.http://dx.doi.org/10.1002/mds.21956 [5] Corbett, A.; Smith, J.; Creese, B.; Ballard, C. Treatment of behavioral and psychological symptoms of Alzheimer’s disease.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Options Neurol., 2012, 14, 113-125.http://dx.doi.org/ 10.1007/s11940-012-0166-9 [6] Payne, J.L.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"1998, 10, 440-447.http://dx.doi.org/10.1176/jnp.10.4.440 [7] Hart, D. J.; Craig, D.; Compton, S. A.; Critchlow, S.; Kerrigan, B.M.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Psychiatry, 2003, 18, 1037-1042.http://dx.doi.org/10.1002/gps.1013 [8] Chaudhuri, K.; Healy, D.G.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Lancet Neurol., 2006, 5, 235-245.http://dx.doi.org/10.1016/S1474-4422(06)70373-8 [9] Aarsland, D.; Brønnick, K.; Ehrt, U.; De Deyn, P.P.",OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Psychiatry, 2007, 78, 36-42.http://dx.doi.org/10.1136/jnnp.2005.083113 [10] Llanque, S.; Savage, L.; Rosenburg, N.; Caserta, M. Concept Analysis: Alzheimer’s Caregiver Stress.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Nurs Forum., 2014, Advance online publication http://doi.org/10.1111/nuf.12090 [11] Colucci, L.; Bosco, M.; Fasanaro, A.M.; Gaeta, G.L.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Neurology, 2002, 59, 1708-1713.http://dx.doi.org/ 10.1212/01.WNL.0000036610.36834.E0 [13] Vossius, C.; Larsen, J. P.; Janvin, C.; Aarsland, D. The economic impact of cognitive impairment in Parkinson’s disease.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Disord., 2011, 26, 1541-1544.http://dx.doi.org/10.1002/mds.23661 [14] Mega, M.S.",OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Neuropsychopharmacol., 2000, 3, S3-S12.http://dx.doi.org/10.1017/S1461145700001942 [15] Halliday, G.M.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Disord., 2014, 29, 634-650.http://dx.doi.org/10.1002/mds.25857 [16] Emre, M.; Cummings, J.L.",OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Neurol., 2003, 60, 1745-1748.http://dx.doi.org/10.1001/archneur.60.12.1745 [18] Perry, E.K.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Disord., 1993, 7, 69-79.http://dx.doi.org/10.1097/00002093-199307020-00002 [19] Bohnen, N.I.",OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Neurol., 2006, 253, 242-247.http://dx.doi.org/10.1007/s00415-005-0971-0 [20] Maidment, I.; Fox, C.; Boustani, M. Cholinesterase inhibitors for Parkinson’s disease dementia.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Cochrane Libr., 2006.http://dx.doi.",OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Ther., 2011, 17, 428-441.http://dx.doi.org/10.1111/j.1755-5949.2010.00166.x [22] Shinotoh, H.; Namba, H.; Fukushi, K.; Nagatsuka, S.I.",OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Neurol., 2000, 48, 194-200.http://dx.doi.org/10.1002/ 1531-8249(200008)48:2%3C194::AID-ANA9%3E3.0.CO;2-X [23] Feldman, H.; Gauthier, S.; Hecker, J.; Vellas, B.; Subbiah, P.; Whalen, E.; others.",OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Neurology, 2001, 57, 613-620.http://dx.doi.org/10.1212/WNL.57.4.613 [24] Birks, J. Cholinesterase inhibitors for Alzheimer’s disease (Review).",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Res., 2013, 36, 375-399. http://dx.doi.org/10.1007/s12272-013-0036-3 [27] Feldman, H.H.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Psychiatry, 2007, 78, 1056-1063.http://dx.doi.org/10.1136/jnnp.2006.099424 [28] Burns, A.; Rossor, M.; Hecker, J.; Gauthier, S.; Petit, H.; Möller, H.J.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Disord., 1999, 10, 237-244.http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Neurology, 2007, 69, 459-469.http://dx.doi.org/10.1212/ 01.wnl.0000266627.96040.5a [31] Doody, R.S.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Neurol., 2001, 58, 427-433.http://dx.doi.org/10.1001/archneur.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Neuropsychopharmacol., 2000, 10, 368.http://dx.doi.org/10.1016/S0924-977X(00)80492-7",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Cochrane Libr., 2006.http://dx.doi.org/ 10.1002/14651858.cd001747.pub3 [34] Russ, T.C.",OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Cochrane Libr., 2012.http://dx.doi.org/ 10.1002/14651858.cd009132.pub2 [35] Cooper, J.A.",OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Brain, 1992, 115, 1701-1725.http://dx.doi.org/10.1093/brain/115.6.1701 [36] Bédard, M.A.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Brain Cogn., 1999, 40, 289-313.http://dx.doi.org/ 10.1006/brcg.1999.1083 [37] Birks, J.; Grimley Evans, J.; Iakovidou, V.; Tsolaki, M. Rivastigmine for Alzheimer’s disease.",OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Drugs, 2011, 71, 1209-1231.http://dx.doi.org/10.2165/11206380-000000000-00000 [40] Winblad, B.; Grossberg, G.; Frölich, L.; Farlow, M.; Zechner, S.; Nagel, J.; Lane, R. IDEAL A 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Neurology, 2007, 69, S14-S22.http://dx.doi.org/10.1212/01.wnl.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
2003.http://dx.doi.org/10.1002/14651858.,Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Cochrane Libr., 2006.http://dx.doi.org/10.1002/14651858.",OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Med., 2012, 366, 893-903.http://dx.doi.org/10.1056/NEJMoa1106668 [44] Farlow, M.R.",OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Ther., 2010, 32, 1234-1251.http://dx.doi.org/10.1016/ j.clinthera.2010.06.019 [45] Bullock, R.; Touchon, J.; Bergman, H.; Gambina, G.; He, Y.; Rapatz, G.; Nagel, J.; Lane, R. Rivastigmine and Donepezil treatment in moderate to moderately-severe Alzheimer’s disease over a 2-year period.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"O p i n ., 2005, 21, 1317-1327.http://dx.doi.org/10.1185/030079905X56565 [46] Wilkinson, D.G.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Ther., 1995, 68, 113-128. http://dx.doi.org/ 10.1016/0163-7258(95)02002-0 [48] Farlow, M.R.",OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Disord., 2007, 25, 408-422.http://dx.doi.",OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Neurology, 2001, 56, 1154-1166.http://dx.doi.org/10.1212/WNL.56.9.1154 [50] Jones, R. W.; Soininen, H.; Hager, K.; Aarsland, D.; Passmore, P.; Murthy, A.; Zhang, R.; Bahra, R. A multinational, randomised, 12-week study comparing the effects of Donepezil and Galantamine in patients with mild to moderate Alzheimer’s disease.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Psychiatry 2004, 19, 58-67.http://dx.doi.org/10.1002/gps.1038 [51] Wilcock, G.; Howe, I.; Coles, H.; Lilienfeld, S.; Truyen, L.; Zhu, Y.; Bullock, R.; Kershaw, P.A long-term comparison of Galantamine and Donepezil in the treatment of Alzheimer’s disease.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Drugs Aging, 2003, 20, 777-789.http://dx.doi.org/10.2165/ 00002512-200320100-00006 [52] Rolinski, M .",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Cochrane Libr., 2012.http://dx.doi.org/10.1002/14651858.cd006504.",OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Neuropharmacol., 2005, 28, 176-178.http://dx.doi.org/10.1097/01.wnf.0000172498.24770.54 [57] Grace, J.; Amick, M.M.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Psychiatry, 2009, 80, 18-23.http://dx.doi.org/10.1136/jnnp.2008.144048 [58] Aarsland, D.; Laake, K.; Larsen, J.P.; Janvin, C. Donepezil for cognitive impairment in Parkinson’s disease: a randomised controlled study.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Psychiatry, 2002, 72, 708-712.http://dx.doi.org/10.1136/jnnp.72.6.708 [59] Mamikonyan, E.; Xie, S.X.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Disord., 2015, 30, 9 1 2-918.http://dx.doi.org/10.1002/mds.26236 [60] Emre, M.; Aarsland, D.; Albanese, A.; Byrne, E.J.",OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Other Demen., 2011, 26,443-449.http://dx.doi.org/10.1177/1533317511424892 [62] Poewe, W.; Wolters, E.; Emre, M.; Onofrj, M.; Hsu, C.; Tekin, S.; Lane, R. Long-term benefits of Rivastigmine in dementia associated with Parkinson’s disease: an active treatment extension study.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Disord., 2006, 21, 456-461.http://dx.doi.org/10.1002/ mds.20700 [63] Oertel, W.; Poewe, W.; Wolters, E.; De Deyn, P.P.",OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"2008, 31, 79-94.http://dx.doi.org/ 10.2165/00002018-200831010-00007 [64] Emre, M.; Poewe, W.; De Deyn, P.P.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Neuropharmacol., 2014, 37, 9-16.http://dx.doi.org/10.1097/ wnf.0000000000000010 [65] Seppi, K.; Weintraub, D.; Coelho, M.; Perez-Lloret, S.; Fox, S. H.; Katzenschlager, R.; Hametner, E.M.; Poewe, W.; Rascol, O.; Goetz, C.G.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Disord., 2011, 26, S42-S80.http://dx.doi.org/10.1002/mds.23884 [66] Dubois, B.; Tolosa, E.; Katzenschlager, R.; Emre, M.; Lees, A.J.",OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Disord., 2012, 27, 1230-1238.http://dx.doi.org/10.1002/mds.25098 [67] Litvinenko, I.V.",OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Physiol., 2008, 38, 937-945.http://dx.doi.org/ 10.1007/s11055-008-9077-3 [68] Aarsland, D.; Hutchinson, M.; Larsen, J. P. Cognitive, psychiatric and motor response to Galantamine in Parkinson’s disease with dementia.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Psychiatry 2003, 18, S23-S32.http://dx.doi.org/10.1002/gps.938 [70] Danysz, W.; Parsons, C.G.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Res., 2000, 2, 85-97. http://dx.doi.org/10.1007/BF03033787 [71] Leroi, I.; Overshott, R.; Byrne, E.J.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"2009, 24, 1217-1221. http://dx.doi.org/10.1002/mds.22495 [72] Emre, M.; Ford, P.J.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Disord., 2014, 29, 663-672.http://dx.doi.org/ 10.1002/mds.25870 [73] Areosa, S. A.; Sherriff, F.; McShane, R. Memantine for dementia.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
2005.http://dx.doi.org/10.1002/14651858.cd003154.,Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Psychiatry, 2008, 69, 341-348.http://dx.doi.org/10.4088/JCP.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"2012, 9, 746-758.http://dx.doi.org/10.2174/156720512801322564 [77] McShane, R.; Areosa Sastre, A.; Minakaran, N. Memantine for dementia.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Cochrane Libr., 2006.http://dx.doi.org/10.1002/ 14651858.cd003154.pub5 [78] Aarsland, D.; Ballard, C.; Walker, Z.; Bostrom, F.; Alves, G.; Kossakowski, K.; Leroi, I.; Pozo-Rodriguez, F.; Minthon, L.; Londos, E. Memantine in patients with Parkinson’s disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.",OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Lancet Neurol., 2009, 8, 613-618.http://dx.doi.org/10.1016/S1474-4422(09)70146-2 [79] Emre, M.; Tsolaki, M.; Bonuccelli, U.; Destée, A.; Tolosa, E.; Kutzelnigg, A.; Ceballos-Baumann, A.; Zdravkovic, S.; Bladström, A.; Jones, R. M e m a n t i n e  f o r  p a t i e n t s  w i t h  P a r k i n s o n ’ s  d i s e a s e  dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Lancet Neurol., 2010, 9, 969-977.http://dx.doi.org/10.1016/S1474-4422(10)70194-0 [80] Hindle, J.V.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Rehabil., 2004, 14, 385-401.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Aging Neurosci., 2014, 6, 43.http://dx.doi.org/10.3389/fnagi.2014.00043 [83] Stern, Y.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Soc., 2002, 8, 448-460.http://dx.doi.org/10.1017/S1355617702813248 [84] Mowszowski, L.; Batchelor, J.; Naismith, S.L.",OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Psychogeriatr., 2010, 22, 537-548.http://dx.doi.org/10.1017/S1041610209991748 [85] Huntley, J.D.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Rev., 2013, 6.http://dx.doi.org/10.1002/14651858.cd003260.pub2 [87] McLellan, D. L. Functional recovery and the principles of disability medicine.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Cochrane Libr., 2012.http://dx.doi.org/10.1002/ 14651858.cd005562.pub2 [89] Reijnders, J.; van Heugten, C.; van Boxtel, M. Cognitive interventions in healthy older adults and people with mild cognitive impairment: a systematic review.",OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Rev., 2013, 12, 263-275.http://dx.doi.org/10.1016/j.arr.2012.07.003 [90] París, A.P.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Brain Res., 2012, 1452, 151-164.http://dx.doi.org/10.1016/j.brainres.",OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Sci., 2014, 35, 1173-1180.http://dx.doi.org/10.1007/s10072-014-1666-z [93] Angelucci, F.; Peppe, A.; Carlesimo, G. A.; Serafini, F.; Zabberoni, S.; Barban, F.; Shofany, J.; Caltagirone, C.; Costa, A.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Neurosci., 2015, 9.http://dx.doi.org/10.3389/fnhum.2015.00130 [94] Naismith, S.L.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Disord., 2013, 28, 1097-1103.http://dx.doi.org/10.1002/mds.25457 [95] Milman, U.; Atias, H.; Weiss, A.; Mirelman, A.; Hausdorff, J.M.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Lancet Neurol., 2011, 10, 415-423. http://dx.doi.org/10.1016/ S1474-4422(11)70073-4 [121] Hanagasi, H. A.; Gurvit, H.; Unsalan, P.; Horozoglu, H.; Tuncer, N.; Feyzioglu, A.; Gunal, D. I.; Yener, G. G.; Cakmur, R.; Sahin, H. A.; Emre, M. The effects of Rasagiline on cognitive deficits in Parkinson’s disease patients without dementia: a randomized, double-blind, placebo-controlled, multicenter Study.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Disord., 2011, 26, 1851-1858.http://dx.doi.org/10.1002/mds.23738 [122] Steinberg, M.; Shao, H.; Zandi, P.; Lyketsos, C. G.; Welsh-Bohmer, K.A.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Psychiatry, 2008, 23, 170-177.http://dx.doi.org/10.1002/gps.1858 [123] Schneider, L.S.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Psychiatry, 2006, 14, 191-210.http://dx.doi.org/10.1097/01.JGP.0000200589.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Drug Saf., 2011, 10, 35-43.http://dx.doi.org/10.1517/14740338.2010.506711 [125] Mintzer, J.E.",OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Psychiatry, 2007, 15, 918-931.http://dx.doi.org/10.1097/JGP.0b013e3181557b47 [126] Cummings, J.L.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Psychiatry, 2014, 86, 101-109.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Psychiatry, 2008, 23, 537-545.http://dx.doi.org/10.1002/gps.1949 [129] Gauthier, S.; Wirth, Y.; Möbius, H.J.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Psychiatry, 2005, 20, 459-464.http://dx.doi.org/10.1002/gps.1341 [130] Cohen-Mansfield, J.; Libin, A.; Marx, M.S.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"S c i ., 2007, 62, 908-916.http://dx.doi.org/10.1093/gerona/62.8.908 [131] Cohen-Mansfield, J.; Werner, P. Management of verbally disruptive behaviors in nursing home residents.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Sci., 1997, 52, M369-M377.http://dx.doi.org/ 10.1093/gerona/52A.6.M369",OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Neurosci., 2006, 7, 492-500.http://dx.doi.org/ 10.1038/nrn1926 [133] Goldman, J.G.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Options Neurol., 2014, 16, 1-18.http://dx.doi.org/10.1007/s11940-013-0281-2 [134] Aarsland, D.; Perry, R.; Larsen, J.P.; McKeith, I.G.",OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Psychiatry, 2005, 66, 633-637.http://dx.doi.org/10.4088/JCP.v66n0514 [135] Reading, P.J.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Disord., 2001, 16, 1171-1174.http://dx.doi.org/10.1002/mds.1204 [136] Burn, D.; Emre, M.; McKeith, I.; De Deyn, P.P.",OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Opin., 2002, 18, 258-264.http://dx.doi.org/10.1185/030079902125000813 [138] Ravina, B.; Putt, M.; Siderowf, A.; Farrar, J.T.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Psychiatry, 2005, 76, 934-939.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"The Lancet, 2014, 383, 533-540. http://dx.doi.org/ 10.1016/S0140-6736(13)62106-6 [140] Friedman, J.H.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Pharmacother., 2013, 14, 1969-1975.http://dx.doi.org/10.1517/14656566.2013.819345 [141] Ballanger, B.; Strafella, A.P.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Neurol., 2010, 67, 416-421.http://dx.doi.org/10.1001/archneurol.2010.35 [142] Creese, B.; Ballard, C.; Aarsland, D.; Londos, E.; Sharp, S.; Jones, E. Determining the association of the 5HTTLPR polymorphism with delusions and hallucinations in Lewy body dementias.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Psychiatry, 2014, 22, 580-586.http://dx.doi.org/10.1016/ j.jagp.2012.11.001 [143] Friedman, J.; Ravina, B.; Mills, R.; Williams, H.; Bahr, D.; Peters, P.; Tison, F.; Burn, D. A multi-center, placebo-controlled, double-blind trial to examine the safety and efficacy of Pimavanserin in the treatment of psychosis in Parkinson’s disease.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Sci., 2013, 333, e119-e120.http://dx.doi.org/10.1016/j.jns.2013.07.401 [145] Meltzer, H.Y.",OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Neuropsychopharmacology, 2009, 35, 881-892.http://dx.doi.org/ 10.1038/npp.2009.176 [146] Waldemar, G.; Gauthier, S.; Jones, R.; Wilkinson, D.; Cummings, J.; Lopez, O.; Zhang, R.; Xu, Y.; Sun, Y.; Knox, S.; Richardson, S.; Mackell, J.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Psychiatry, 2011, 26, 150-157.http://dx.doi.org/10.1002/gps.2507 [147] Teri, L.; Gibbons, L.E.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Jama, 2003, 290, 2015-2022.http://dx.doi.org/10.1001/jama.290.15.2015 [148] Rolland, Y.; Pillard, F.; Klapouszczak, A.; Reynish, E.; Thomas, D.; Andrieu, S.; Rivière, D.; Vellas, B.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Health, 2008, 12, 72-80.http://dx.doi.org/10.1080/13607860701529932 [150] Williams, C.L.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Other Demen., 2007, 22, 389-397.http://dx.doi.org/10.1177/ 1533317507305588 [151] Aarsland, D.; Larsen, J.P.; Lim, N.G.",OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Psychiatry, 1999, 67, 492-496.http://dx.doi.org/ 10.1136/jnnp.67.4.492 [152] Weintraub, D.; Morales, K.H.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"2005, 20, 1161-1169.http://dx.doi.org/10.1002/mds.20555 [153] Salami, O.; Lyketsos, C.; Rao, V. Treatment of sleep disturbance in Alzheimer’s dementia.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Psychiatry, 2011, 26, 771-782.http://dx.doi.org/10.1002/gps.2609 [154] Larsson, V.; Aarsland, D.; Ballard, C.; Minthon, L.; Londos, E. The effect of Memantine on sleep behaviour in dementia with Lewy bodies and Parkinson’s disease dementia.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Psychiatry, 2010, 25, 1030-1038.http://dx.doi.org/10.1002/gps.2506 [155] Trotti, L.M.",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Neurotherapeutics, 2014, 11, 68-77.http://dx.doi.org/10.1007/s13311-013-0236-z   Received: April 29, 2015 Revised: June 29, 2015 Accepted: July 08, 2015",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/CN-14-326.PMC4876589.pdf
"Lancet Neurol., 2013, 12(4), 346-356. http://dx.doi.org/10.1016/ S1474-4422(13)70025-5 [24] Verhagen M.L.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Lancet Neurol., 2014, 13(2), 141-149. http://dx.doi.org/10.1016/S1474-4422(13)70293-X [27] Nagy, H.; Takáts, A.; Tóth, A.; Bereczki, D.; Klivényi, P.; Dézsi, L.; Dibó, G.; Vécsei, L.; Kovács, N.; Aschermann, Z.; Komoly, S.; Varannai, L.; Z e m l é n y i, G.; V alikovics, A. E x p e r i e n c e  w i t h  levodopa/carbidopa intestinal gel in the treatment of advanced Parkinson's disease in Hungary.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Pharmacokinet., 2014, 39(4), 237-242. http://dx.doi.org/ 10.1007/s13318-013-0171-8 [30] Mancini, F.; Comi, C.; Oggioni, G.D.; Pacchetti, C.; Calandrella, D.; Coletti Moja, M.; Riboldazzi, G.; Tunesi, S.; Dal Fante, M.; Manfredi, L.; Lacerenza, M.; Cantello, R.; Antonini, A.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Disord., 2014, 20(1), 27-31. http://dx.doi.org/10.1016/j.parkreldis.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Neuro pharm acol., 2010, 33(2), 61-66. http://dx.doi.org/10.1097/WNF.0b013e3181 c5e60c [34] Pahwa, R.; Lyons, K.E.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Pharmacol., 2013, 53(5), 523-531. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"http://dx.doi.org/10.1002/jcph.514 [40] LeWitt, P.A.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Neuropharmacol., 2009, 32(4), 189-192. http://dx.doi.org/10.1097/ WNF.0b013e3181a27fae [42] Schrag, A. Entacapone in the Treatment of Parkinson’s Disease.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Lancet Neurol., 2005, 4, 366-370. http://dx.doi.org/10.1016/S1474-4422(05)70098-3 [43] Liashchenko, E.A.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"J., 2015, 23(1), 28-32. http://dx.doi.org/10.1016/j.jsps.2014.04.005 [45] Ferreira, J.J.; Rascol, O.; Poewe, W.; Sampaio, C.; Rocha, J.F.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Ther., 2010, 16(6), 337-347. http://dx.doi.org/ 10.1111/j.1755-5949.2010.00145.x [46] Ferreira, J.J.; Almeida, L.; Cunha, L.; Ticmeanu, M.; Rosa, M.M.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Neuro- pharmacol., 2008, 31(1), 2-18. http://dx.doi.org/10.1097/wnf.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"http://dx.doi.org/10.1111/ene.12666 [48] Bonifácio, M.J.; Torrão, L.; Loureiro, A.I.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Pharmacol., 2015, 172(7), 1739-1752. http://dx.doi.org/10.1111/bph.13020 [49] Tetrud, J.W.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Science, 1989, 245(4917), 519-22. http://dx.doi.org/10.1126/science.2502843 [50] Pålhagen, S.; Heinonen, E.; Hägglund, J .",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Neurology, 2006, 66(8), 1200-1206. http://dx.doi.org/10.1212/01.wnl.0000204007.46190.54 [51] Müller, T.; Hoffmann, J.A.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"J. Neural Transm., 2013, 120 ( 5 ) ,  7 6 1-765. http://dx.doi.org/10.1007/s00702-012-0927-3 [52] Deeks, E. D. Safinamide: First Global Approval.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Drugs., 2015, 75(6), 705-711. http://dx.doi.org/10.1007/s40265-015-0389-7 [53] Borgohain, R.; Szasz, J.; Stanzione, P.; Meshram, C.; Bhatt, M.H.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Disord., 2014, 29(2), 229-237. http://dx.doi.org/10.1002/mds.25751 [55] Mahmood, I.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Pharmacokinet., 1997, 33(2), 91-102. http://dx.doi.org/10.2165/00003088-199733020-00002 [56] Tábi, T.; Szökő, É.; Vécsei, L.; Magyar, K. The Pharmacokinetic Evaluation of Selegiline ODT for the Treatment of Parkinson’s Disease.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Toxicol., 2013, 9(5), 629-636. http://dx.doi.org/10.1517/17425255.2013.781152 [57] Lew, M.F.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Drug Deliv., 2014, 7544, 1-10. http://dx.doi.org/10.3109/10717544.2014.965801 [59] Müller, T. Pharmacokinetic/pharmacodynamic Evaluation of Rasagiline Mesylate for Parkinson’s Disease.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Toxicol., 2014, 10(10), 1423-1432. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Xenobiotica., 2013, 43(8), 705-710. http://dx.doi.org/10.3109/ 00498254.2012.758396 [61] Nandagopal, J.J.; DelBello, M.P.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Pharmacother., 2009, 10(10), 1665-1673. http://dx.doi.org/ 10.1517/14656560903048942 [62] Moore, T.J.; Glenmullen, J.; Mattison, D.R.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Med., 2014, 174(12), 1930. http://dx.doi.org/10.1001/ jamainternmed.2014.5262 [63] Nakaoka, S.; Ishizaki, T.; Urushihara, H.; Satoh, T.; Ikeda, S.; Morikawa, K.; Nakayama, T. Echocardiography for the Detection of Valvulopathy Associated with the Use of Ergot-Derived Dopamine Agonists in Patients with Parkinson’s Disease.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Med., 2011, 50(7), 687-694. http://dx.doi.org/10.2169/ internalmedicine.50.4344 [64] Zanettini, R.; Antonini, A.; Gatto, G.; Gentile, R.; Tesei, S.; Pezzoli, G. Regression of Cardiac Valvulopathy Related to Ergot-Derived Dopamine Agonists.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Ther., 2011, 29(6), 404-410. http://dx.doi.org/10.1111/j.1755-5922.2010.00169.x [65] Tintner, R.; Manian, P.; Gauthier, P.; Jankovic, J. Pleuropulmonary fibrosis after long-term treatment with the dopamine agonist pergolide for Parkinson Disease.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Arch Neurol., 2005, 62(8), 1290-5. http://dx.doi.org/10.1001/archneur.62.8.1290 [66] Zhou, C.Q.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Ther., 2014, 20(4), 368-376. http://dx.doi.org/10.1111/cns.12239",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Med., 2013, 52(3), 325-332. http://dx.doi.org/10.2169/internalmedicine.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Pharmacother., 2015, 16 ( 7 ) ,  9 6 1-970 http://dx.doi.org/10.1517/ 14656566.2015.1030336 [69] Elshoff, J.P.; Cawello, W.; Andreas, J.O.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Nihon Yakurigaku Zasshi., 2013, 141(1), 44-51. http://dx.doi.org/10.1254/fpj.141.44 [73] Trenkwalder, C.; Boesch, S.; Ceballos-Baumann, A.; Dressler, D.; Eggert, K.; Gasser, T.; Honig, H.; Müller, T.; Reichmann, H.; Sieb, J.P.; Storch, A.; Odin, P.; Poewe, W. Intermittierende Apomorphin-Injektionen Als Rescue-Therapie Beim Fortgeschrittenen M. Parkinson.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Nervenarzt., 2008, 79(4), 475-479. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
https://www.clinicaltrials.gov/ct2/show/NCT00955318 .,Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
https://www.clinicaltrials.gov/ct2/show/NCT00601523.,Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
